*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 1 3 # 1 A 29 ASP A 50 ASP.? 20.38 CL CL A 141 A 117 LYS A 47 LYS~? 18.08 C5 PG4 A 142 A 150 CYH A 117 CYH^? 10.83 CL CL A 141 coo 37.97 47.82 5.46 38.65 48.02 7.40 11.71 33.66 5.09 12.68 31.93 4.37 coo 41.02 51.33 13.36 40.18 47.06 9.99 4.15 29.38 6.95 0.12 26.77 10.99 coo 39.17 42.30 8.54 40.94 44.26 7.78 5.07 37.09 1.73 2.71 35.97 2.45 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 2 3 # 2 A 29 ASP A 50 ASP.? 20.38 CL CL A 141 A 117 LYS A 97 LYS.? 17.22 CL CL A 141 A 150 CYH A 117 CYH^? 10.83 CL CL A 141 coo 37.97 47.82 5.46 38.65 48.02 7.40 11.71 33.66 5.09 12.68 31.93 4.37 coo 41.02 51.33 13.36 40.18 47.06 9.99 12.14 41.01 8.19 12.52 43.66 3.40 coo 39.17 42.30 8.54 40.94 44.26 7.78 5.07 37.09 1.73 2.71 35.97 2.45 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 3 3 # 3 A 29 ASP B 50 ASP.? 10.53 C3 PG4 A 142 A 117 LYS B 47 LYS~? 12.98 C2 PG4 A 142 A 150 CYH B 117 CYH^? 10.38 CL CL B 141 coo 37.97 47.82 5.46 38.65 48.02 7.40 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 41.02 51.33 13.36 40.18 47.06 9.99 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 39.17 42.30 8.54 40.94 44.26 7.78 -29.38 36.33 11.07 -29.51 38.97 10.51 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 4 3 # 4 A 29 ASP C 50 ASP.? 22.48 O1 EDO C 140 A 117 LYS C 47 LYS~? 26.80 O1 EDO C 140 A 150 CYH C 117 CYH^? 14.56 O1 EDO C 140 coo 37.97 47.82 5.46 38.65 48.02 7.40 28.54 3.26 7.93 30.44 3.42 8.82 coo 41.02 51.33 13.36 40.18 47.06 9.99 28.25 11.83 5.90 28.26 16.33 1.39 coo 39.17 42.30 8.54 40.94 44.26 7.78 22.08 7.27 11.28 21.72 9.99 10.50 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 5 3 # 5 A 29 ASP C 50 ASP.? 22.48 O1 EDO C 140 A 117 LYS C 97 LYS.? 16.45 O1 EDO C 140 A 150 CYH C 117 CYH^? 14.56 O1 EDO C 140 coo 37.97 47.82 5.46 38.65 48.02 7.40 28.54 3.26 7.93 30.44 3.42 8.82 coo 41.02 51.33 13.36 40.18 47.06 9.99 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 39.17 42.30 8.54 40.94 44.26 7.78 22.08 7.27 11.28 21.72 9.99 10.50 3uao_o00 source 3UAO PUTATIVE ISOCHORISMATASE : 5 hits 3uao_o00 naa= 3 ULMN 4 13pk_c00 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 A 39 ARG A 111 ARG.? 7.83 OXT ACT A 139 A 219 LYS A 69 LYS~? 10.70 CH3 ACT A 140 A 376 GLY A 112 GLY^? 10.97 O ACT A 139 A 399 GLY A 64 GLY~? 8.05 O ACT A 140 coo -12.38 76.96 90.60 -12.31 75.41 87.97 -9.64 52.74 3.70 -9.14 55.70 2.93 coo -15.03 67.62 79.35 -16.01 71.68 83.38 -2.48 44.21 16.37 -5.74 47.67 20.09 coo -9.88 73.08 89.49 -9.40 72.65 89.00 -7.56 46.85 3.93 -6.95 47.44 3.87 coo -11.12 75.93 79.79 -10.82 76.54 80.30 -5.68 50.60 11.44 -5.90 50.48 12.19 ULMN 4 13pk_c00 3-PHOSPHOGLYCERATE KINASE user 2 4 # 2 A 39 ARG A 111 ARG.? 7.83 OXT ACT A 139 A 219 LYS A 93 LYS^? 11.69 O ACT A 139 A 376 GLY A 112 GLY^? 10.97 O ACT A 139 A 399 GLY A 64 GLY~? 8.05 O ACT A 140 coo -12.38 76.96 90.60 -12.31 75.41 87.97 -9.64 52.74 3.70 -9.14 55.70 2.93 coo -15.03 67.62 79.35 -16.01 71.68 83.38 3.67 49.37 7.73 5.94 48.81 2.98 coo -9.88 73.08 89.49 -9.40 72.65 89.00 -7.56 46.85 3.93 -6.95 47.44 3.87 coo -11.12 75.93 79.79 -10.82 76.54 80.30 -5.68 50.60 11.44 -5.90 50.48 12.19 13pk_c00 source 13pk 3-PHOSPHOGLYCERATE KINASE : 2 hits 13pk_c00 naa= 4 ULMN 4 1ddj_c07 PLASMINOGEN user 1 4 # 1 D 603 HIS A 110 HIS.? -3.69 OXT ACT A 139s D 646 ASP A 25 ASP.? 6.66 OXT ACT A 139 D 741 ALA A 27 ALA.? 10.44 O2 PG4 A 142 D 742 GLY A 112 GLY^? 10.97 O ACT A 139 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -11.26 44.90 0.82 -10.52 44.54 2.10 coo -29.22 39.61 36.72 -28.92 40.32 37.00 -7.56 46.85 3.93 -6.95 47.44 3.87 ULMN 4 1ddj_c07 PLASMINOGEN user 2 4 # 2 D 603 HIS B 110 HIS.? -3.67 O ACT B 139s D 646 ASP B 25 ASP.? 6.52 O ACT B 139 D 741 ALA B 27 ALA.? 10.43 O1 PG4 B 142 D 742 GLY B 112 GLY^? 10.91 OXT ACT B 139 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -46.84 38.28 15.22 -46.41 37.31 17.03 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -44.16 46.71 12.37 -43.44 46.31 11.09 coo -29.22 39.61 36.72 -28.92 40.32 37.00 -44.06 42.66 9.14 -44.28 41.84 9.20 ULMN 4 1ddj_c07 PLASMINOGEN user 3 4 # 3 D 603 HIS C 110 HIS.? 3.59 O ACT C 139s D 646 ASP C 25 ASP.? 6.36 O2 EDO C 140 D 741 ALA C 27 ALA.? 12.87 C1 EDO C 140 D 742 GLY C 112 GLY^? 11.00 OXT ACT C 139 coo -30.51 33.83 43.05 -30.50 33.12 45.03 4.54 8.83 15.35 4.90 7.96 17.23 coo -25.73 33.05 39.28 -27.50 34.05 39.88 4.46 12.53 17.74 4.84 11.35 19.48 coo -29.58 40.72 40.37 -30.29 39.69 41.25 7.09 17.23 12.10 7.71 16.76 10.77 coo -29.22 39.61 36.72 -28.92 40.32 37.00 7.28 13.06 9.10 7.06 12.23 9.16 1ddj_c07 source 1ddj PLASMINOGEN : 3 hits 1ddj_c07 naa= 4 ULMN 4 1ec9_c08 GLUCARATE DEHYDRATASE user 1 4 # 1 A 207 LYS A 93 LYS^? 11.69 O ACT A 139 A 313 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 339 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 373 GLU A 127 GLU^? 8.20 CL CL A 141 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 3.67 49.37 7.73 5.94 48.81 2.98 coo -13.77 -18.44 -12.02 -15.08 -19.60 -13.14 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -15.84 -18.80 -8.52 -17.83 -18.60 -9.07 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo -18.40 -37.63 -11.89 -18.73 -39.61 -11.35 2.90 34.77 -4.78 2.12 35.30 -6.66 ULMN 4 1ec9_c08 GLUCARATE DEHYDRATASE user 2 4 # 2 A 207 LYS B 93 LYS^? 4.13 CL CL B 141 A 313 ASP B 25 ASP.? 6.52 O ACT B 139 A 339 HIS B 110 HIS.? -3.67 O ACT B 139s A 373 GLU B 127 GLU^? 8.11 CL CL B 140 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -40.82 31.70 5.12 -39.31 29.65 9.95 coo -13.77 -18.44 -12.02 -15.08 -19.60 -13.14 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -15.84 -18.80 -8.52 -17.83 -18.60 -9.07 -46.84 38.28 15.22 -46.41 37.31 17.03 coo -18.40 -37.63 -11.89 -18.73 -39.61 -11.35 -28.31 39.11 17.60 -29.33 39.55 19.43 1ec9_c08 source 1ec9 GLUCARATE DEHYDRATASE : 2 hits 1ec9_c08 naa= 4 ULMN 4 1ec9_c09 GLUCARATE DEHYDRATASE user 1 4 # 1 B 207 LYS A 93 LYS^? 11.69 O ACT A 139 B 313 ASP A 25 ASP.? 6.66 OXT ACT A 139 B 339 HIS A 110 HIS.? -3.69 OXT ACT A 139s B 373 GLU A 127 GLU^? 8.20 CL CL A 141 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 3.67 49.37 7.73 5.94 48.81 2.98 coo -12.58 20.23 10.32 -13.80 21.58 11.35 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -14.24 20.83 6.67 -16.32 20.73 7.02 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo -14.73 39.78 9.65 -14.76 41.74 9.00 2.90 34.77 -4.78 2.12 35.30 -6.66 ULMN 4 1ec9_c09 GLUCARATE DEHYDRATASE user 2 4 # 2 B 207 LYS B 93 LYS^? 4.13 CL CL B 141 B 313 ASP B 25 ASP.? 6.52 O ACT B 139 B 339 HIS B 110 HIS.? -3.67 O ACT B 139s B 373 GLU B 127 GLU^? 8.11 CL CL B 140 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -40.82 31.70 5.12 -39.31 29.65 9.95 coo -12.58 20.23 10.32 -13.80 21.58 11.35 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -14.24 20.83 6.67 -16.32 20.73 7.02 -46.84 38.28 15.22 -46.41 37.31 17.03 coo -14.73 39.78 9.65 -14.76 41.74 9.00 -28.31 39.11 17.60 -29.33 39.55 19.43 1ec9_c09 source 1ec9 GLUCARATE DEHYDRATASE : 2 hits 1ec9_c09 naa= 4 ULMN 4 1ec9_c10 GLUCARATE DEHYDRATASE user 1 4 # 1 C 207 LYS A 93 LYS^? 11.69 O ACT A 139 C 313 ASP A 25 ASP.? 6.66 OXT ACT A 139 C 339 HIS A 110 HIS.? -3.69 OXT ACT A 139s C 373 GLU A 127 GLU^? 8.20 CL CL A 141 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 3.67 49.37 7.73 5.94 48.81 2.98 coo 14.38 -3.57 -21.43 15.64 -4.13 -22.99 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 16.32 -0.08 -20.39 18.30 -0.81 -20.35 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 19.17 4.23 -38.89 19.57 5.42 -40.57 2.90 34.77 -4.78 2.12 35.30 -6.66 ULMN 4 1ec9_c10 GLUCARATE DEHYDRATASE user 2 4 # 2 C 207 LYS B 93 LYS^? 4.13 CL CL B 141 C 313 ASP B 25 ASP.? 6.52 O ACT B 139 C 339 HIS B 110 HIS.? -3.67 O ACT B 139s C 373 GLU B 127 GLU^? 8.11 CL CL B 140 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -40.82 31.70 5.12 -39.31 29.65 9.95 coo 14.38 -3.57 -21.43 15.64 -4.13 -22.99 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 16.32 -0.08 -20.39 18.30 -0.81 -20.35 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 19.17 4.23 -38.89 19.57 5.42 -40.57 -28.31 39.11 17.60 -29.33 39.55 19.43 1ec9_c10 source 1ec9 GLUCARATE DEHYDRATASE : 2 hits 1ec9_c10 naa= 4 ULMN 4 1ec9_c11 GLUCARATE DEHYDRATASE user 1 4 # 1 D 207 LYS A 93 LYS^? 11.69 O ACT A 139 D 313 ASP A 25 ASP.? 6.66 OXT ACT A 139 D 339 HIS A 110 HIS.? -3.69 OXT ACT A 139s D 373 GLU A 127 GLU^? 8.20 CL CL A 141 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 3.67 49.37 7.73 5.94 48.81 2.98 coo 12.06 1.87 22.99 13.29 2.38 24.60 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 13.74 -1.84 22.10 15.79 -1.45 22.35 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 13.94 -5.98 40.88 13.74 -7.36 42.48 2.90 34.77 -4.78 2.12 35.30 -6.66 ULMN 4 1ec9_c11 GLUCARATE DEHYDRATASE user 2 4 # 2 D 207 LYS B 93 LYS^? 4.13 CL CL B 141 D 313 ASP B 25 ASP.? 6.52 O ACT B 139 D 339 HIS B 110 HIS.? -3.67 O ACT B 139s D 373 GLU B 127 GLU^? 8.11 CL CL B 140 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -40.82 31.70 5.12 -39.31 29.65 9.95 coo 12.06 1.87 22.99 13.29 2.38 24.60 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 13.74 -1.84 22.10 15.79 -1.45 22.35 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 13.94 -5.98 40.88 13.74 -7.36 42.48 -28.31 39.11 17.60 -29.33 39.55 19.43 1ec9_c11 source 1ec9 GLUCARATE DEHYDRATASE : 2 hits 1ec9_c11 naa= 4 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 4 # 1 A 481 GLU A 36 GLU~? 11.76 C4 PG4 A 142 A 485 LYS A 35 LYS~? 11.98 C3 PG4 A 142 A 488 GLU A 34 GLU~? 3.97 C2 PG4 A 142 A 603 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo -7.79 3.39 10.29 -9.01 4.74 9.32 -12.87 29.42 9.52 -11.52 29.66 11.15 coo -9.44 10.08 8.58 -11.94 6.98 8.10 -13.45 35.10 6.93 -14.45 39.53 11.08 coo -13.30 11.40 4.76 -13.95 9.40 5.16 -17.39 34.05 2.60 -18.36 35.64 1.56 coo -21.26 6.97 3.81 -20.43 4.23 9.21 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 4 # 2 A 481 GLU A 36 GLU~? 11.76 C4 PG4 A 142 A 485 LYS A 35 LYS~? 11.98 C3 PG4 A 142 A 488 GLU A 34 GLU~? 3.97 C2 PG4 A 142 A 603 LYS B 47 LYS~? 12.98 C2 PG4 A 142 coo -7.79 3.39 10.29 -9.01 4.74 9.32 -12.87 29.42 9.52 -11.52 29.66 11.15 coo -9.44 10.08 8.58 -11.94 6.98 8.10 -13.45 35.10 6.93 -14.45 39.53 11.08 coo -13.30 11.40 4.76 -13.95 9.40 5.16 -17.39 34.05 2.60 -18.36 35.64 1.56 coo -21.26 6.97 3.81 -20.43 4.23 9.21 -23.16 41.10 5.81 -22.85 46.07 1.96 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 4 # 3 A 481 GLU C 36 GLU~? -27.32 O1 EDO C 140s A 485 LYS C 35 LYS~? 18.91 O1 EDO C 141 A 488 GLU C 34 GLU~? 23.36 C1 EDO C 140 A 603 LYS A 47 LYS~? 18.08 C5 PG4 A 142 coo -7.79 3.39 10.29 -9.01 4.74 9.32 19.61 26.41 3.01 20.17 25.01 1.52 coo -9.44 10.08 8.58 -11.94 6.98 8.10 14.41 24.06 5.83 10.24 22.70 1.76 coo -13.30 11.40 4.76 -13.95 9.40 5.16 13.37 28.10 10.00 11.57 28.19 11.09 coo -21.26 6.97 3.81 -20.43 4.23 9.21 4.15 29.38 6.95 0.12 26.77 10.99 1jxa_c01 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 3 hits 1jxa_c01 naa= 4 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 4 # 1 481 GLU A 36 GLU~? 11.76 C4 PG4 A 142 485 LYS A 35 LYS~? 11.98 C3 PG4 A 142 488 GLU A 34 GLU~? 3.97 C2 PG4 A 142 603 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo 24.49 18.95 6.71 25.16 18.17 4.85 -12.87 29.42 9.52 -11.52 29.66 11.15 coo 21.77 13.74 4.55 26.03 15.07 4.05 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 22.93 13.34 0.22 24.67 14.21 1.12 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 31.74 12.46 -4.74 33.15 13.34 0.17 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 4 # 2 481 GLU B 36 GLU~? 11.82 C2 PG4 B 142 485 LYS B 35 LYS~? 12.61 C1 PG4 B 142 488 GLU B 34 GLU~? -4.36 C1 PG4 B 142s 603 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo 24.49 18.95 6.71 25.16 18.17 4.85 -31.60 55.95 3.54 -31.25 54.50 1.99 coo 21.77 13.74 4.55 26.03 15.07 4.05 -36.80 53.61 6.27 -41.39 52.63 2.26 coo 22.93 13.34 0.22 24.67 14.21 1.12 -37.87 57.41 10.67 -39.60 57.08 11.90 coo 31.74 12.46 -4.74 33.15 13.34 0.17 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 4 # 3 481 GLU C 36 GLU~? -27.32 O1 EDO C 140s 485 LYS C 35 LYS~? 18.91 O1 EDO C 141 488 GLU C 34 GLU~? 23.36 C1 EDO C 140 603 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo 24.49 18.95 6.71 25.16 18.17 4.85 19.61 26.41 3.01 20.17 25.01 1.52 coo 21.77 13.74 4.55 26.03 15.07 4.05 14.41 24.06 5.83 10.24 22.70 1.76 coo 22.93 13.34 0.22 24.67 14.21 1.12 13.37 28.10 10.00 11.57 28.19 11.09 coo 31.74 12.46 -4.74 33.15 13.34 0.17 15.48 20.46 18.00 15.72 26.44 16.52 1moq_c00 source 1moq GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 3 hits 1moq_c00 naa= 4 ULMN 4 1nbf_c00 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 1 4 # 1 A 218 ASN A 22 ASN.? 4.68 CL CL A 141 A 223 CYH A 23 CYH.? -5.05 CL CL A 141s A 464 HIS A 131 HIS^? 7.42 CL CL A 141 A 481 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 25.81 2.94 67.34 27.44 4.08 66.63 -5.54 39.12 -7.49 -3.92 39.63 -8.80 coo 23.87 7.02 63.74 25.15 9.47 64.38 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 24.42 11.42 68.19 23.64 9.50 68.50 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 18.97 8.24 70.69 20.97 8.96 70.68 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 4 1nbf_c00 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 2 4 # 2 A 218 ASN B 22 ASN.? 4.58 CL CL B 140 A 223 CYH B 23 CYH.? -4.94 CL CL B 140s A 464 HIS B 131 HIS^? 7.27 CL CL B 140 A 481 ASP B 25 ASP.? 6.52 O ACT B 139 coo 25.81 2.94 67.34 27.44 4.08 66.63 -36.08 44.16 20.41 -35.99 42.40 21.63 coo 23.87 7.02 63.74 25.15 9.47 64.38 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 24.42 11.42 68.19 23.64 9.50 68.50 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 18.97 8.24 70.69 20.97 8.96 70.68 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 4 1nbf_c00 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 3 4 # 3 A 218 ASN C 22 ASN.? 10.99 C1 EDO C 140 A 223 CYH C 23 CYH.? 8.42 C1 EDO C 140 A 464 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 481 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 25.81 2.94 67.34 27.44 4.08 66.63 15.07 15.33 20.31 15.13 13.86 21.83 coo 23.87 7.02 63.74 25.15 9.47 64.38 10.88 13.11 20.21 12.25 12.11 22.32 coo 24.42 11.42 68.19 23.64 9.50 68.50 8.46 11.73 13.23 7.93 9.80 13.86 coo 18.97 8.24 70.69 20.97 8.96 70.68 4.46 12.53 17.74 4.84 11.35 19.48 1nbf_c00 source 1nbf UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7 : 3 hits 1nbf_c00 naa= 4 ULMN 4 1nbf_c01 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 1 4 # 1 B 218 ASN A 22 ASN.? 4.68 CL CL A 141 B 223 CYH A 23 CYH.? -5.05 CL CL A 141s B 464 HIS A 131 HIS^? 7.42 CL CL A 141 B 481 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 15.07 11.28 -3.14 16.79 10.08 -2.73 -5.54 39.12 -7.49 -3.92 39.63 -8.80 coo 14.12 7.28 0.90 15.26 4.87 -0.05 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 13.33 2.93 -3.44 12.42 4.82 -3.59 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 7.26 6.09 -3.99 9.13 5.40 -4.65 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 4 1nbf_c01 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 2 4 # 2 B 218 ASN B 22 ASN.? 4.58 CL CL B 140 B 223 CYH B 23 CYH.? -4.94 CL CL B 140s B 464 HIS B 131 HIS^? 7.27 CL CL B 140 B 481 ASP B 25 ASP.? 6.52 O ACT B 139 coo 15.07 11.28 -3.14 16.79 10.08 -2.73 -36.08 44.16 20.41 -35.99 42.40 21.63 coo 14.12 7.28 0.90 15.26 4.87 -0.05 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 13.33 2.93 -3.44 12.42 4.82 -3.59 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 7.26 6.09 -3.99 9.13 5.40 -4.65 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 4 1nbf_c01 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 3 4 # 3 B 218 ASN C 22 ASN.? 10.99 C1 EDO C 140 B 223 CYH C 23 CYH.? 8.42 C1 EDO C 140 B 464 HIS C 131 HIS^? 6.39 C1 EDO C 140 B 481 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 15.07 11.28 -3.14 16.79 10.08 -2.73 15.07 15.33 20.31 15.13 13.86 21.83 coo 14.12 7.28 0.90 15.26 4.87 -0.05 10.88 13.11 20.21 12.25 12.11 22.32 coo 13.33 2.93 -3.44 12.42 4.82 -3.59 8.46 11.73 13.23 7.93 9.80 13.86 coo 7.26 6.09 -3.99 9.13 5.40 -4.65 4.46 12.53 17.74 4.84 11.35 19.48 1nbf_c01 source 1nbf UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7 : 3 hits 1nbf_c01 naa= 4 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 1 4 # 1 A 8 LYS A 20 LYS~? -2.81 O1 PG4 A 142s A 11 GLY A 130 GLY^? -4.84 CL CL A 141s A 45 GLY A 112 GLY^? 10.97 O ACT A 139 A 217 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 23.95 20.41 42.64 25.99 15.22 44.13 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 21.78 10.35 42.81 21.85 10.58 42.04 -4.89 41.74 -0.85 -4.61 41.77 -1.61 coo 27.49 8.11 39.28 26.75 8.17 38.90 -7.56 46.85 3.93 -6.95 47.44 3.87 coo 29.45 15.15 50.79 25.80 14.13 47.92 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 2 4 # 2 A 8 LYS A 69 LYS~? 10.70 CH3 ACT A 140 A 11 GLY A 64 GLY~? 8.05 O ACT A 140 A 45 GLY A 112 GLY^? 10.97 O ACT A 139 A 217 LYS A 93 LYS^? 11.69 O ACT A 139 coo 23.95 20.41 42.64 25.99 15.22 44.13 -2.48 44.21 16.37 -5.74 47.67 20.09 coo 21.78 10.35 42.81 21.85 10.58 42.04 -5.68 50.60 11.44 -5.90 50.48 12.19 coo 27.49 8.11 39.28 26.75 8.17 38.90 -7.56 46.85 3.93 -6.95 47.44 3.87 coo 29.45 15.15 50.79 25.80 14.13 47.92 3.67 49.37 7.73 5.94 48.81 2.98 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 3 4 # 3 A 8 LYS B 20 LYS~? -2.98 O4 PG4 B 142s A 11 GLY B 130 GLY^? -4.77 CL CL B 140s A 45 GLY B 112 GLY^? 10.91 OXT ACT B 139 A 217 LYS B 35 LYS~? 12.61 C1 PG4 B 142 coo 23.95 20.41 42.64 25.99 15.22 44.13 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 21.78 10.35 42.81 21.85 10.58 42.04 -38.21 42.69 13.79 -38.12 42.42 14.57 coo 27.49 8.11 39.28 26.75 8.17 38.90 -44.06 42.66 9.14 -44.28 41.84 9.20 coo 29.45 15.15 50.79 25.80 14.13 47.92 -36.80 53.61 6.27 -41.39 52.63 2.26 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 4 4 # 4 A 8 LYS C 20 LYS~? 21.67 C1 EDO C 140 A 11 GLY C 130 GLY^? 9.35 O1 EDO C 140 A 45 GLY C 112 GLY^? 11.00 OXT ACT C 139 A 217 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 23.95 20.41 42.64 25.99 15.22 44.13 15.48 20.46 18.00 15.72 26.44 16.52 coo 21.78 10.35 42.81 21.85 10.58 42.04 13.00 13.33 13.76 13.12 13.19 14.54 coo 27.49 8.11 39.28 26.75 8.17 38.90 7.28 13.06 9.10 7.06 12.23 9.16 coo 29.45 15.15 50.79 25.80 14.13 47.92 14.41 24.06 5.83 10.24 22.70 1.76 1oh9_c00 source 1oh9 ACETYLGLUTAMATE KINASE : 4 hits 1oh9_c00 naa= 4 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 151 VAL A 138 VAL.? 15.98 O ACT A 140 A 194 GLY B 123 GLY.? 16.67 C3 PG4 A 142 A 417 ILE C 92 ILE^? 11.49 O1 EDO C 141 A 457 ALA C 61 ALA~? -3.72 C1 EDO C 141s coo 60.43 93.31 8.03 62.16 94.30 8.93 -11.48 40.35 14.60 -11.70 42.52 14.97 coo 59.34 89.99 13.88 59.24 89.18 13.73 -18.03 36.67 16.32 -18.74 36.23 16.11 coo 39.61 128.90 22.54 40.04 128.24 23.80 7.57 4.59 3.17 7.42 4.98 1.78 coo 43.27 124.32 20.47 43.79 125.29 21.53 0.87 7.13 -0.12 0.41 6.02 -0.92 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 151 VAL A 138 VAL.? 15.98 O ACT A 140 A 194 GLY B 123 GLY.? 16.67 C3 PG4 A 142 A 417 ILE C 92 ILE^? 11.49 O1 EDO C 141 A 457 ALA C 67 ALA~? 12.01 O1 EDO C 141 coo 60.43 93.31 8.03 62.16 94.30 8.93 -11.48 40.35 14.60 -11.70 42.52 14.97 coo 59.34 89.99 13.88 59.24 89.18 13.73 -18.03 36.67 16.32 -18.74 36.23 16.11 coo 39.61 128.90 22.54 40.04 128.24 23.80 7.57 4.59 3.17 7.42 4.98 1.78 coo 43.27 124.32 20.47 43.79 125.29 21.53 9.23 12.17 0.82 8.63 11.92 2.24 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 151 VAL B 113 VAL^? 8.58 CL CL B 141 A 194 GLY B 55 GLY^? 4.13 CL CL B 141 A 417 ILE A 92 ILE^? 11.37 O ACT A 140 A 457 ALA A 61 ALA~? -3.67 C ACT A 140s coo 60.43 93.31 8.03 62.16 94.30 8.93 -40.84 40.81 8.64 -39.97 40.93 6.62 coo 59.34 89.99 13.88 59.24 89.18 13.73 -40.59 35.18 8.37 -40.32 35.97 8.08 coo 39.61 128.90 22.54 40.04 128.24 23.80 -0.18 50.78 9.82 -0.69 50.57 11.08 coo 43.27 124.32 20.47 43.79 125.29 21.53 -5.79 55.28 13.25 -5.05 56.25 14.14 1pix_c00 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 3 hits 1pix_c00 naa= 4 ULMN 4 1qtn_c00 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 1 4 # 1 A 258 ARG C 111 ARG.? 7.98 O ACT C 139 A 317 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 318 GLY C 130 GLY^? 9.35 O1 EDO C 140 A 360 CYH C 23 CYH.? 8.42 C1 EDO C 140 coo -8.98 40.59 45.04 -10.51 39.37 47.39 1.09 11.93 9.22 -1.20 10.06 10.11 coo -8.43 39.80 36.26 -8.18 39.59 38.31 8.46 11.73 13.23 7.93 9.80 13.86 coo -11.14 38.10 31.61 -11.46 38.10 32.37 13.00 13.33 13.76 13.12 13.19 14.54 coo -11.95 34.09 34.07 -11.89 34.73 36.80 10.88 13.11 20.21 12.25 12.11 22.32 1qtn_c00 source 1qtn ACETYL-ILE-GLU-THR-ASP-ALDEHYDE : 1 hits 1qtn_c00 naa= 4 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 77 TYR.? 19.05 CL CL A 141 B 190 LYS A 97 LYS.? 17.22 CL CL A 141 B 222 ASP A 50 ASP.? 20.38 CL CL A 141 coo 7.17 16.59 41.26 8.01 19.20 40.73 5.38 39.08 12.89 6.76 38.23 10.57 coo 13.38 20.00 35.06 11.43 22.49 39.53 12.14 41.01 8.19 12.52 43.66 3.40 coo 9.76 26.58 38.10 11.63 25.78 38.76 11.71 33.66 5.09 12.68 31.93 4.37 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 140 TYR C 77 TYR.? 19.70 O1 EDO C 140 B 190 LYS C 97 LYS.? 16.45 O1 EDO C 140 B 222 ASP C 50 ASP.? 22.48 O1 EDO C 140 coo 7.17 16.59 41.26 8.01 19.20 40.73 20.38 5.85 0.13 21.94 5.21 2.42 coo 13.38 20.00 35.06 11.43 22.49 39.53 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 9.76 26.58 38.10 11.63 25.78 38.76 28.54 3.26 7.93 30.44 3.42 8.82 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 2 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 97 LYS.? 17.22 CL CL A 141 A 222 ASP A 50 ASP.? 20.38 CL CL A 141 B 140 TYR A 77 TYR.? 19.05 CL CL A 141 coo -4.61 20.12 30.34 -2.74 22.65 25.95 12.14 41.01 8.19 12.52 43.66 3.40 coo -1.04 26.60 27.37 -2.94 25.93 26.69 11.71 33.66 5.09 12.68 31.93 4.37 coo 1.51 16.60 24.17 0.82 19.23 24.79 5.38 39.08 12.89 6.76 38.23 10.57 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 190 LYS C 97 LYS.? 16.45 O1 EDO C 140 A 222 ASP C 50 ASP.? 22.48 O1 EDO C 140 B 140 TYR C 77 TYR.? 19.70 O1 EDO C 140 coo -4.61 20.12 30.34 -2.74 22.65 25.95 22.33 -0.96 4.86 22.00 -3.43 10.72 coo -1.04 26.60 27.37 -2.94 25.93 26.69 28.54 3.26 7.93 30.44 3.42 8.82 coo 1.51 16.60 24.17 0.82 19.23 24.79 20.38 5.85 0.13 21.94 5.21 2.42 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 2 hits 1a05_c01 naa= 3 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 102 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 193 GLY A 55 GLY^? 10.36 O ACT A 139 coo 25.57 41.22 61.68 24.18 39.98 62.50 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 22.33 45.48 59.73 23.35 43.67 60.06 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 22.57 32.23 64.13 21.98 32.82 64.22 0.71 47.46 4.43 0.16 46.85 4.76 ULMN 3 1a0j_c12 TRYPSIN user 2 3 # 2 A 57 HIS A 131 HIS^? 7.42 CL CL A 141 A 102 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 193 GLY A 55 GLY^? 10.36 O ACT A 139 coo 25.57 41.22 61.68 24.18 39.98 62.50 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 22.33 45.48 59.73 23.35 43.67 60.06 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 22.57 32.23 64.13 21.98 32.82 64.22 0.71 47.46 4.43 0.16 46.85 4.76 ULMN 3 1a0j_c12 TRYPSIN user 3 3 # 3 A 57 HIS B 110 HIS.? -3.67 O ACT B 139s A 102 ASP B 25 ASP.? 6.52 O ACT B 139 A 193 GLY B 55 GLY^? 4.13 CL CL B 141 coo 25.57 41.22 61.68 24.18 39.98 62.50 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 22.33 45.48 59.73 23.35 43.67 60.06 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 22.57 32.23 64.13 21.98 32.82 64.22 -40.59 35.18 8.37 -40.32 35.97 8.08 ULMN 3 1a0j_c12 TRYPSIN user 4 3 # 4 A 57 HIS B 131 HIS^? 7.27 CL CL B 140 A 102 ASP B 25 ASP.? 6.52 O ACT B 139 A 193 GLY B 55 GLY^? 4.13 CL CL B 141 coo 25.57 41.22 61.68 24.18 39.98 62.50 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 22.33 45.48 59.73 23.35 43.67 60.06 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 22.57 32.23 64.13 21.98 32.82 64.22 -40.59 35.18 8.37 -40.32 35.97 8.08 ULMN 3 1a0j_c12 TRYPSIN user 5 3 # 5 A 57 HIS C 110 HIS.? 3.59 O ACT C 139s A 102 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 193 GLY C 55 GLY^? 8.81 O1 EDO C 140 coo 25.57 41.22 61.68 24.18 39.98 62.50 4.54 8.83 15.35 4.90 7.96 17.23 coo 22.33 45.48 59.73 23.35 43.67 60.06 4.46 12.53 17.74 4.84 11.35 19.48 coo 22.57 32.23 64.13 21.98 32.82 64.22 10.94 5.65 8.59 11.17 6.44 8.27 ULMN 3 1a0j_c12 TRYPSIN user 6 3 # 6 A 57 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 102 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 193 GLY C 55 GLY^? 8.81 O1 EDO C 140 coo 25.57 41.22 61.68 24.18 39.98 62.50 8.46 11.73 13.23 7.93 9.80 13.86 coo 22.33 45.48 59.73 23.35 43.67 60.06 4.46 12.53 17.74 4.84 11.35 19.48 coo 22.57 32.23 64.13 21.98 32.82 64.22 10.94 5.65 8.59 11.17 6.44 8.27 1a0j_c12 source 1a0j TRYPSIN : 6 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS A 110 HIS.? -3.69 OXT ACT A 139s B 102 ASP A 25 ASP.? 6.66 OXT ACT A 139 B 193 GLY A 55 GLY^? 10.36 O ACT A 139 coo 44.08 45.58 52.81 45.86 46.55 52.85 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 43.04 44.75 47.18 43.31 45.51 49.13 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 50.46 51.91 56.90 50.65 51.62 56.14 0.71 47.46 4.43 0.16 46.85 4.76 ULMN 3 1a0j_c13 TRYPSIN user 2 3 # 2 B 57 HIS A 131 HIS^? 7.42 CL CL A 141 B 102 ASP A 25 ASP.? 6.66 OXT ACT A 139 B 193 GLY A 55 GLY^? 10.36 O ACT A 139 coo 44.08 45.58 52.81 45.86 46.55 52.85 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 43.04 44.75 47.18 43.31 45.51 49.13 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 50.46 51.91 56.90 50.65 51.62 56.14 0.71 47.46 4.43 0.16 46.85 4.76 ULMN 3 1a0j_c13 TRYPSIN user 3 3 # 3 B 57 HIS B 110 HIS.? -3.67 O ACT B 139s B 102 ASP B 25 ASP.? 6.52 O ACT B 139 B 193 GLY B 55 GLY^? 4.13 CL CL B 141 coo 44.08 45.58 52.81 45.86 46.55 52.85 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 43.04 44.75 47.18 43.31 45.51 49.13 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 50.46 51.91 56.90 50.65 51.62 56.14 -40.59 35.18 8.37 -40.32 35.97 8.08 ULMN 3 1a0j_c13 TRYPSIN user 4 3 # 4 B 57 HIS B 131 HIS^? 7.27 CL CL B 140 B 102 ASP B 25 ASP.? 6.52 O ACT B 139 B 193 GLY B 55 GLY^? 4.13 CL CL B 141 coo 44.08 45.58 52.81 45.86 46.55 52.85 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 43.04 44.75 47.18 43.31 45.51 49.13 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 50.46 51.91 56.90 50.65 51.62 56.14 -40.59 35.18 8.37 -40.32 35.97 8.08 ULMN 3 1a0j_c13 TRYPSIN user 5 3 # 5 B 57 HIS C 110 HIS.? 3.59 O ACT C 139s B 102 ASP C 25 ASP.? 6.36 O2 EDO C 140 B 193 GLY C 55 GLY^? 8.81 O1 EDO C 140 coo 44.08 45.58 52.81 45.86 46.55 52.85 4.54 8.83 15.35 4.90 7.96 17.23 coo 43.04 44.75 47.18 43.31 45.51 49.13 4.46 12.53 17.74 4.84 11.35 19.48 coo 50.46 51.91 56.90 50.65 51.62 56.14 10.94 5.65 8.59 11.17 6.44 8.27 ULMN 3 1a0j_c13 TRYPSIN user 6 3 # 6 B 57 HIS C 131 HIS^? 6.39 C1 EDO C 140 B 102 ASP C 25 ASP.? 6.36 O2 EDO C 140 B 193 GLY C 55 GLY^? 8.81 O1 EDO C 140 coo 44.08 45.58 52.81 45.86 46.55 52.85 8.46 11.73 13.23 7.93 9.80 13.86 coo 43.04 44.75 47.18 43.31 45.51 49.13 4.46 12.53 17.74 4.84 11.35 19.48 coo 50.46 51.91 56.90 50.65 51.62 56.14 10.94 5.65 8.59 11.17 6.44 8.27 1a0j_c13 source 1a0j TRYPSIN : 6 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS A 110 HIS.? -3.69 OXT ACT A 139s C 102 ASP A 25 ASP.? 6.66 OXT ACT A 139 C 193 GLY A 55 GLY^? 10.36 O ACT A 139 coo 34.37 41.18 73.21 34.04 43.09 73.87 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 34.89 38.34 78.12 35.11 39.59 76.42 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 35.43 51.03 72.12 35.20 50.72 72.87 0.71 47.46 4.43 0.16 46.85 4.76 ULMN 3 1a0j_c14 TRYPSIN user 2 3 # 2 C 57 HIS A 131 HIS^? 7.42 CL CL A 141 C 102 ASP A 25 ASP.? 6.66 OXT ACT A 139 C 193 GLY A 55 GLY^? 10.36 O ACT A 139 coo 34.37 41.18 73.21 34.04 43.09 73.87 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 34.89 38.34 78.12 35.11 39.59 76.42 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 35.43 51.03 72.12 35.20 50.72 72.87 0.71 47.46 4.43 0.16 46.85 4.76 ULMN 3 1a0j_c14 TRYPSIN user 3 3 # 3 C 57 HIS B 110 HIS.? -3.67 O ACT B 139s C 102 ASP B 25 ASP.? 6.52 O ACT B 139 C 193 GLY B 55 GLY^? 4.13 CL CL B 141 coo 34.37 41.18 73.21 34.04 43.09 73.87 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 34.89 38.34 78.12 35.11 39.59 76.42 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 35.43 51.03 72.12 35.20 50.72 72.87 -40.59 35.18 8.37 -40.32 35.97 8.08 ULMN 3 1a0j_c14 TRYPSIN user 4 3 # 4 C 57 HIS B 131 HIS^? 7.27 CL CL B 140 C 102 ASP B 25 ASP.? 6.52 O ACT B 139 C 193 GLY B 55 GLY^? 4.13 CL CL B 141 coo 34.37 41.18 73.21 34.04 43.09 73.87 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 34.89 38.34 78.12 35.11 39.59 76.42 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 35.43 51.03 72.12 35.20 50.72 72.87 -40.59 35.18 8.37 -40.32 35.97 8.08 ULMN 3 1a0j_c14 TRYPSIN user 5 3 # 5 C 57 HIS C 110 HIS.? 3.59 O ACT C 139s C 102 ASP C 25 ASP.? 6.36 O2 EDO C 140 C 193 GLY C 55 GLY^? 8.81 O1 EDO C 140 coo 34.37 41.18 73.21 34.04 43.09 73.87 4.54 8.83 15.35 4.90 7.96 17.23 coo 34.89 38.34 78.12 35.11 39.59 76.42 4.46 12.53 17.74 4.84 11.35 19.48 coo 35.43 51.03 72.12 35.20 50.72 72.87 10.94 5.65 8.59 11.17 6.44 8.27 ULMN 3 1a0j_c14 TRYPSIN user 6 3 # 6 C 57 HIS C 131 HIS^? 6.39 C1 EDO C 140 C 102 ASP C 25 ASP.? 6.36 O2 EDO C 140 C 193 GLY C 55 GLY^? 8.81 O1 EDO C 140 coo 34.37 41.18 73.21 34.04 43.09 73.87 8.46 11.73 13.23 7.93 9.80 13.86 coo 34.89 38.34 78.12 35.11 39.59 76.42 4.46 12.53 17.74 4.84 11.35 19.48 coo 35.43 51.03 72.12 35.20 50.72 72.87 10.94 5.65 8.59 11.17 6.44 8.27 1a0j_c14 source 1a0j TRYPSIN : 6 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS A 110 HIS.? -3.69 OXT ACT A 139s D 102 ASP A 25 ASP.? 6.66 OXT ACT A 139 D 193 GLY A 55 GLY^? 10.36 O ACT A 139 coo 8.19 15.01 95.72 7.78 16.53 97.01 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 13.53 16.28 93.98 11.45 16.21 94.40 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 1.80 21.25 100.04 2.61 21.42 100.18 0.71 47.46 4.43 0.16 46.85 4.76 ULMN 3 1a0j_c15 TRYPSIN user 2 3 # 2 D 57 HIS A 131 HIS^? 7.42 CL CL A 141 D 102 ASP A 25 ASP.? 6.66 OXT ACT A 139 D 193 GLY A 55 GLY^? 10.36 O ACT A 139 coo 8.19 15.01 95.72 7.78 16.53 97.01 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 13.53 16.28 93.98 11.45 16.21 94.40 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 1.80 21.25 100.04 2.61 21.42 100.18 0.71 47.46 4.43 0.16 46.85 4.76 ULMN 3 1a0j_c15 TRYPSIN user 3 3 # 3 D 57 HIS B 110 HIS.? -3.67 O ACT B 139s D 102 ASP B 25 ASP.? 6.52 O ACT B 139 D 193 GLY B 55 GLY^? 4.13 CL CL B 141 coo 8.19 15.01 95.72 7.78 16.53 97.01 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 13.53 16.28 93.98 11.45 16.21 94.40 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 1.80 21.25 100.04 2.61 21.42 100.18 -40.59 35.18 8.37 -40.32 35.97 8.08 ULMN 3 1a0j_c15 TRYPSIN user 4 3 # 4 D 57 HIS B 131 HIS^? 7.27 CL CL B 140 D 102 ASP B 25 ASP.? 6.52 O ACT B 139 D 193 GLY B 55 GLY^? 4.13 CL CL B 141 coo 8.19 15.01 95.72 7.78 16.53 97.01 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 13.53 16.28 93.98 11.45 16.21 94.40 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 1.80 21.25 100.04 2.61 21.42 100.18 -40.59 35.18 8.37 -40.32 35.97 8.08 ULMN 3 1a0j_c15 TRYPSIN user 5 3 # 5 D 57 HIS C 110 HIS.? 3.59 O ACT C 139s D 102 ASP C 25 ASP.? 6.36 O2 EDO C 140 D 193 GLY C 55 GLY^? 8.81 O1 EDO C 140 coo 8.19 15.01 95.72 7.78 16.53 97.01 4.54 8.83 15.35 4.90 7.96 17.23 coo 13.53 16.28 93.98 11.45 16.21 94.40 4.46 12.53 17.74 4.84 11.35 19.48 coo 1.80 21.25 100.04 2.61 21.42 100.18 10.94 5.65 8.59 11.17 6.44 8.27 ULMN 3 1a0j_c15 TRYPSIN user 6 3 # 6 D 57 HIS C 131 HIS^? 6.39 C1 EDO C 140 D 102 ASP C 25 ASP.? 6.36 O2 EDO C 140 D 193 GLY C 55 GLY^? 8.81 O1 EDO C 140 coo 8.19 15.01 95.72 7.78 16.53 97.01 8.46 11.73 13.23 7.93 9.80 13.86 coo 13.53 16.28 93.98 11.45 16.21 94.40 4.46 12.53 17.74 4.84 11.35 19.48 coo 1.80 21.25 100.04 2.61 21.42 100.18 10.94 5.65 8.59 11.17 6.44 8.27 1a0j_c15 source 1a0j TRYPSIN : 6 hits 1a0j_c15 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 111 ARG.? 7.83 OXT ACT A 139 265 HIS A 131 HIS^? 7.42 CL CL A 141 274 TYR A 102 TYR^? -13.60 O ACT A 139s coo -15.18 55.46 8.55 -14.82 52.98 10.38 -9.64 52.74 3.70 -9.14 55.70 2.93 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 0.94 52.26 9.16 1.95 54.78 9.91 6.40 53.61 9.02 6.49 53.06 6.26 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG B 111 ARG.? 7.92 O ACT B 139 265 HIS B 131 HIS^? 7.27 CL CL B 140 274 TYR B 102 TYR^? 9.93 CL CL B 141 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -50.20 41.64 9.27 -52.60 39.78 9.98 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 0.94 52.26 9.16 1.95 54.78 9.91 -43.22 27.21 3.69 -42.78 27.37 6.43 ULMN 3 1a41_c01 TOPOISOMERASE I user 3 3 # 3 223 ARG C 111 ARG.? 7.98 O ACT C 139 265 HIS C 131 HIS^? 6.39 C1 EDO C 140 274 TYR C 102 TYR^? -13.61 OXT ACT C 139s coo -15.18 55.46 8.55 -14.82 52.98 10.38 1.09 11.93 9.22 -1.20 10.06 10.11 coo -14.48 45.59 11.18 -14.02 47.49 10.42 8.46 11.73 13.23 7.93 9.80 13.86 coo 0.94 52.26 9.16 1.95 54.78 9.91 8.48 -2.42 4.05 9.05 -2.18 6.78 1a41_c01 source 1a41 TOPOISOMERASE I : 3 hits 1a41_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 127 GLU^? 8.20 CL CL A 141 A 60 ASP A 50 ASP.? 20.38 CL CL A 141 A 175 TYR A 129 TYR^? 7.28 CL CL A 141 coo 46.10 28.27 19.27 45.48 26.99 20.84 2.90 34.77 -4.78 2.12 35.30 -6.66 coo 56.42 28.06 12.93 55.01 27.92 14.50 11.71 33.66 5.09 12.68 31.93 4.37 coo 45.02 22.04 15.38 46.16 24.00 13.76 -1.60 36.85 -1.08 -0.19 34.61 -1.92 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU B 127 GLU^? 8.11 CL CL B 140 A 60 ASP B 50 ASP.? 10.53 C3 PG4 A 142 A 175 TYR B 129 TYR^? 7.32 CL CL B 140 coo 46.10 28.27 19.27 45.48 26.99 20.84 -28.31 39.11 17.60 -29.33 39.55 19.43 coo 56.42 28.06 12.93 55.01 27.92 14.50 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 45.02 22.04 15.38 46.16 24.00 13.76 -32.31 42.16 13.95 -29.70 41.99 14.85 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 2 hits 1a50_c03 naa= 3 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR A 77 TYR.? 19.05 CL CL A 141 C 125 HIS A 73 HIS~? 21.61 O ACT A 140 C 156 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 5.38 39.08 12.89 6.76 38.23 10.57 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -2.08 37.56 18.58 -2.41 35.99 19.94 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -2.48 44.21 16.37 -5.74 47.67 20.09 1a79_c02 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_c02 naa= 3 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 1 3 # 1 16 ALA A 27 ALA.? 10.44 O2 PG4 A 142 19 HIS A 110 HIS.? -3.69 OXT ACT A 139s 22 HIS A 131 HIS^? 7.42 CL CL A 141 coo 53.27 36.51 45.29 51.98 36.45 44.47 -11.26 44.90 0.82 -10.52 44.54 2.10 coo 46.88 33.59 48.26 46.24 34.32 46.40 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 48.05 31.12 44.60 48.20 33.05 43.77 -5.82 46.49 -0.22 -4.38 47.88 -0.81 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 2 3 # 2 16 ALA A 27 ALA.? 10.44 O2 PG4 A 142 19 HIS A 131 HIS^? 7.42 CL CL A 141 22 HIS A 110 HIS.? -3.69 OXT ACT A 139s coo 53.27 36.51 45.29 51.98 36.45 44.47 -11.26 44.90 0.82 -10.52 44.54 2.10 coo 46.88 33.59 48.26 46.24 34.32 46.40 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 48.05 31.12 44.60 48.20 33.05 43.77 -5.26 51.32 -2.26 -4.16 51.41 -4.05 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 3 3 # 3 16 ALA B 27 ALA.? 10.43 O1 PG4 B 142 19 HIS B 110 HIS.? -3.67 O ACT B 139s 22 HIS B 131 HIS^? 7.27 CL CL B 140 coo 53.27 36.51 45.29 51.98 36.45 44.47 -44.16 46.71 12.37 -43.44 46.31 11.09 coo 46.88 33.59 48.26 46.24 34.32 46.40 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 48.05 31.12 44.60 48.20 33.05 43.77 -42.92 41.25 13.23 -43.42 39.34 13.91 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 4 3 # 4 16 ALA B 27 ALA.? 10.43 O1 PG4 B 142 19 HIS B 131 HIS^? 7.27 CL CL B 140 22 HIS B 110 HIS.? -3.67 O ACT B 139s coo 53.27 36.51 45.29 51.98 36.45 44.47 -44.16 46.71 12.37 -43.44 46.31 11.09 coo 46.88 33.59 48.26 46.24 34.32 46.40 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 48.05 31.12 44.60 48.20 33.05 43.77 -46.84 38.28 15.22 -46.41 37.31 17.03 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 5 3 # 5 16 ALA C 27 ALA.? 12.87 C1 EDO C 140 19 HIS C 110 HIS.? 3.59 O ACT C 139s 22 HIS C 131 HIS^? 6.39 C1 EDO C 140 coo 53.27 36.51 45.29 51.98 36.45 44.47 7.09 17.23 12.10 7.71 16.76 10.77 coo 46.88 33.59 48.26 46.24 34.32 46.40 4.54 8.83 15.35 4.90 7.96 17.23 coo 48.05 31.12 44.60 48.20 33.05 43.77 8.46 11.73 13.23 7.93 9.80 13.86 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 6 3 # 6 16 ALA C 27 ALA.? 12.87 C1 EDO C 140 19 HIS C 131 HIS^? 6.39 C1 EDO C 140 22 HIS C 110 HIS.? 3.59 O ACT C 139s coo 53.27 36.51 45.29 51.98 36.45 44.47 7.09 17.23 12.10 7.71 16.76 10.77 coo 46.88 33.59 48.26 46.24 34.32 46.40 8.46 11.73 13.23 7.93 9.80 13.86 coo 48.05 31.12 44.60 48.20 33.05 43.77 4.54 8.83 15.35 4.90 7.96 17.23 1a8h_c02 source 1a8h METHIONYL-TRNA SYNTHETASE : 6 hits 1a8h_c02 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 13 ASP~? 8.68 O4 PG4 A 142 187 GLU A 36 GLU~? 11.76 C4 PG4 A 142 229 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -12.87 29.42 9.52 -11.52 29.66 11.15 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP B 13 ASP~? 8.48 C4 PG4 B 142 187 GLU B 36 GLU~? 11.82 C2 PG4 B 142 229 LYS B 35 LYS~? 12.61 C1 PG4 B 142 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -24.74 52.92 14.33 -24.14 54.73 15.30 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -31.60 55.95 3.54 -31.25 54.50 1.99 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -36.80 53.61 6.27 -41.39 52.63 2.26 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP C 13 ASP~? 27.02 O1 EDO C 140 187 GLU C 36 GLU~? -27.32 O1 EDO C 140s 229 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo -52.57 56.60 47.75 -51.52 54.87 46.95 26.45 23.84 13.97 27.74 25.29 14.77 coo -45.08 48.37 46.81 -46.53 49.74 45.96 19.61 26.41 3.01 20.17 25.01 1.52 coo -47.40 44.36 48.48 -50.80 49.18 46.20 14.41 24.06 5.83 10.24 22.70 1.76 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 3 hits 1ald_c00 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 59 ASP.? 10.45 O ACT A 140 214 ASP A 50 ASP.? 20.38 CL CL A 141 289 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo -0.62 65.95 29.97 0.31 67.47 31.05 -11.63 55.20 7.79 -12.68 54.74 6.05 coo 26.86 59.76 46.36 25.42 58.23 45.92 11.71 33.66 5.09 12.68 31.93 4.37 coo 9.42 68.07 30.27 7.35 68.27 30.10 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 62 ASP~? -3.38 O ACT A 140s 214 ASP A 50 ASP.? 20.38 CL CL A 141 289 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo -0.62 65.95 29.97 0.31 67.47 31.05 -9.14 53.57 16.41 -8.61 54.95 17.94 coo 26.86 59.76 46.36 25.42 58.23 45.92 11.71 33.66 5.09 12.68 31.93 4.37 coo 9.42 68.07 30.27 7.35 68.27 30.10 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP B 59 ASP.? 11.98 O ACT B 139 214 ASP B 50 ASP.? 10.53 C3 PG4 A 142 289 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo -0.62 65.95 29.97 0.31 67.47 31.05 -53.34 42.20 5.44 -53.68 42.89 7.35 coo 26.86 59.76 46.36 25.42 58.23 45.92 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 9.42 68.07 30.27 7.35 68.27 30.10 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP C 59 ASP.? 10.26 O1 EDO C 141 214 ASP C 50 ASP.? 22.48 O1 EDO C 140 289 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo -0.62 65.95 29.97 0.31 67.47 31.05 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 26.86 59.76 46.36 25.42 58.23 45.92 28.54 3.26 7.93 30.44 3.42 8.82 coo 9.42 68.07 30.27 7.35 68.27 30.10 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP C 62 ASP~? -3.30 O1 EDO C 141s 214 ASP C 50 ASP.? 22.48 O1 EDO C 140 289 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo -0.62 65.95 29.97 0.31 67.47 31.05 0.59 10.79 -3.25 -0.22 9.73 -4.86 coo 26.86 59.76 46.36 25.42 58.23 45.92 28.54 3.26 7.93 30.44 3.42 8.82 coo 9.42 68.07 30.27 7.35 68.27 30.10 7.61 19.22 2.17 7.62 20.80 3.62 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 5 hits 1amy_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 59 ASP.? 10.45 O ACT A 140 204 GLU A 63 GLU~? 7.87 O ACT A 140 289 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo -0.62 65.95 29.97 0.31 67.47 31.05 -11.63 55.20 7.79 -12.68 54.74 6.05 coo 4.34 62.44 32.05 4.22 64.48 32.53 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 9.42 68.07 30.27 7.35 68.27 30.10 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 62 ASP~? -3.38 O ACT A 140s 204 GLU A 63 GLU~? 7.87 O ACT A 140 289 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo -0.62 65.95 29.97 0.31 67.47 31.05 -9.14 53.57 16.41 -8.61 54.95 17.94 coo 4.34 62.44 32.05 4.22 64.48 32.53 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 9.42 68.07 30.27 7.35 68.27 30.10 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP B 59 ASP.? 11.98 O ACT B 139 204 GLU B 63 GLU~? 16.01 OXT ACT B 139 289 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo -0.62 65.95 29.97 0.31 67.47 31.05 -53.34 42.20 5.44 -53.68 42.89 7.35 coo 4.34 62.44 32.05 4.22 64.48 32.53 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 9.42 68.07 30.27 7.35 68.27 30.10 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP C 59 ASP.? 10.26 O1 EDO C 141 204 GLU C 63 GLU~? 7.77 O1 EDO C 141 289 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo -0.62 65.95 29.97 0.31 67.47 31.05 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 4.34 62.44 32.05 4.22 64.48 32.53 1.11 13.80 1.11 0.04 14.34 2.91 coo 9.42 68.07 30.27 7.35 68.27 30.10 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP C 62 ASP~? -3.30 O1 EDO C 141s 204 GLU C 63 GLU~? 7.77 O1 EDO C 141 289 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo -0.62 65.95 29.97 0.31 67.47 31.05 0.59 10.79 -3.25 -0.22 9.73 -4.86 coo 4.34 62.44 32.05 4.22 64.48 32.53 1.11 13.80 1.11 0.04 14.34 2.91 coo 9.42 68.07 30.27 7.35 68.27 30.10 7.61 19.22 2.17 7.62 20.80 3.62 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 5 hits 1amy_c05 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 116 SER^? 8.34 CL CL A 141 A 292 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 322 HIS A 110 HIS.? -3.69 OXT ACT A 139s coo 36.34 32.23 39.60 36.43 34.62 39.93 3.70 40.55 1.12 4.15 42.69 0.09 coo 19.73 19.18 41.39 21.50 18.65 40.34 7.61 19.22 2.17 7.62 20.80 3.62 coo 41.69 45.14 46.60 41.78 47.19 46.18 -5.26 51.32 -2.26 -4.16 51.41 -4.05 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER B 116 SER^? 5.57 CL CL B 141 A 292 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 322 HIS B 110 HIS.? -3.67 O ACT B 139s coo 36.34 32.23 39.60 36.43 34.62 39.93 -33.11 35.74 11.62 -32.82 33.53 12.54 coo 19.73 19.18 41.39 21.50 18.65 40.34 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 41.69 45.14 46.60 41.78 47.19 46.18 -46.84 38.28 15.22 -46.41 37.31 17.03 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 2 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 116 SER^? 8.34 CL CL A 141 B 292 ASP C 135 ASP.? 16.41 O1 EDO C 141 B 322 HIS A 110 HIS.? -3.69 OXT ACT A 139s coo 35.42 71.28 22.94 36.24 69.06 22.37 3.70 40.55 1.12 4.15 42.69 0.09 coo 24.74 78.07 5.59 24.32 79.03 7.46 7.61 19.22 2.17 7.62 20.80 3.62 coo 48.81 64.16 26.34 49.30 62.16 26.73 -5.26 51.32 -2.26 -4.16 51.41 -4.05 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER B 116 SER^? 5.57 CL CL B 141 B 292 ASP A 135 ASP.? 12.08 C3 PG4 A 142 B 322 HIS B 110 HIS.? -3.67 O ACT B 139s coo 35.42 71.28 22.94 36.24 69.06 22.37 -33.11 35.74 11.62 -32.82 33.53 12.54 coo 24.74 78.07 5.59 24.32 79.03 7.46 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 48.81 64.16 26.34 49.30 62.16 26.73 -46.84 38.28 15.22 -46.41 37.31 17.03 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 2 hits 1aql_c03 naa= 3 ULMN 3 1b02_c02 THYMIDYLATE SYNTHASE user 1 3 # 1 A 71 GLU A 127 GLU^? 8.20 CL CL A 141 A 161 CYH A 23 CYH.? -5.05 CL CL A 141s A 192 ASN A 19 ASN~? 8.40 CL CL A 141 coo 1.71 48.67 0.56 0.18 47.85 1.75 2.90 34.77 -4.78 2.12 35.30 -6.66 coo -2.78 50.68 10.78 -4.68 50.49 8.71 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo -0.10 43.44 8.03 -1.33 45.05 7.36 -5.47 34.18 -6.27 -3.38 33.66 -6.11 ULMN 3 1b02_c02 THYMIDYLATE SYNTHASE user 2 3 # 2 A 71 GLU B 127 GLU^? 8.11 CL CL B 140 A 161 CYH B 23 CYH.? -4.94 CL CL B 140s A 192 ASN B 19 ASN~? 8.46 CL CL B 140 coo 1.71 48.67 0.56 0.18 47.85 1.75 -28.31 39.11 17.60 -29.33 39.55 19.43 coo -2.78 50.68 10.78 -4.68 50.49 8.71 -40.38 42.16 20.28 -39.12 40.88 22.30 coo -0.10 43.44 8.03 -1.33 45.05 7.36 -31.83 46.76 19.25 -30.45 45.13 19.08 1b02_c02 source 1b02 THYMIDYLATE SYNTHASE : 2 hits 1b02_c02 naa= 3 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 A 60 GLU A 34 GLU~? 3.97 C2 PG4 A 142 A 148 CYH B 117 CYH^? 10.38 CL CL B 141 A 179 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo 20.47 15.77 27.32 19.04 14.27 26.94 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 21.87 3.71 21.27 20.32 3.55 23.64 -29.38 36.33 11.07 -29.51 38.97 10.51 coo 17.09 11.24 20.19 17.85 10.05 21.76 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 A 60 GLU C 34 GLU~? 23.36 C1 EDO C 140 A 148 CYH A 117 CYH^? 10.83 CL CL A 141 A 179 ASP A 50 ASP.? 20.38 CL CL A 141 coo 20.47 15.77 27.32 19.04 14.27 26.94 13.37 28.10 10.00 11.57 28.19 11.09 coo 21.87 3.71 21.27 20.32 3.55 23.64 5.07 37.09 1.73 2.71 35.97 2.45 coo 17.09 11.24 20.19 17.85 10.05 21.76 11.71 33.66 5.09 12.68 31.93 4.37 1b5d_c04 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 2 hits 1b5d_c04 naa= 3 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 B 60 GLU A 34 GLU~? 3.97 C2 PG4 A 142 B 148 CYH B 117 CYH^? 10.38 CL CL B 141 B 179 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 30.30 0.93 3.58 31.01 1.18 0.88 -29.38 36.33 11.07 -29.51 38.97 10.51 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 B 60 GLU C 34 GLU~? 23.36 C1 EDO C 140 B 148 CYH A 117 CYH^? 10.83 CL CL A 141 B 179 ASP A 50 ASP.? 20.38 CL CL A 141 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 13.37 28.10 10.00 11.57 28.19 11.09 coo 30.30 0.93 3.58 31.01 1.18 0.88 5.07 37.09 1.73 2.71 35.97 2.45 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 11.71 33.66 5.09 12.68 31.93 4.37 1b5d_c05 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 2 hits 1b5d_c05 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 39 ARG~? 11.53 C4 PG4 A 142 A 141 THR A 70 THR~? 15.01 O ACT A 140 A 235 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo 6.21 93.81 36.58 4.58 96.33 37.17 -9.34 34.41 10.95 -12.33 34.37 11.59 coo 6.80 92.87 28.33 4.91 92.74 27.40 -4.79 41.37 15.30 -6.78 42.17 15.13 coo 12.98 90.36 47.57 11.26 89.62 46.62 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG C 39 ARG~? 23.08 O1 EDO C 141 A 141 THR C 70 THR~? 14.81 O1 EDO C 141 A 235 ASP A 50 ASP.? 20.38 CL CL A 141 coo 6.21 93.81 36.58 4.58 96.33 37.17 17.00 20.76 1.74 15.55 23.42 1.18 coo 6.80 92.87 28.33 4.91 92.74 27.40 13.33 13.35 -2.33 11.58 14.62 -2.10 coo 12.98 90.36 47.57 11.26 89.62 46.62 11.71 33.66 5.09 12.68 31.93 4.37 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 39 ARG~? 11.53 C4 PG4 A 142 D 141 THR A 70 THR~? 15.01 O ACT A 140 D 235 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -9.34 34.41 10.95 -12.33 34.37 11.59 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -4.79 41.37 15.30 -6.78 42.17 15.13 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG C 39 ARG~? 23.08 O1 EDO C 141 D 141 THR C 70 THR~? 14.81 O1 EDO C 141 D 235 ASP A 50 ASP.? 20.38 CL CL A 141 coo -8.33 92.80 100.06 -7.71 95.33 98.44 17.00 20.76 1.74 15.55 23.42 1.18 coo -9.24 93.49 108.77 -7.37 94.21 109.61 13.33 13.35 -2.33 11.58 14.62 -2.10 coo -14.64 87.74 89.51 -12.89 87.43 90.65 11.71 33.66 5.09 12.68 31.93 4.37 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 39 ARG~? 11.53 C4 PG4 A 142 C 141 THR A 70 THR~? 15.01 O ACT A 140 C 235 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -9.34 34.41 10.95 -12.33 34.37 11.59 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -4.79 41.37 15.30 -6.78 42.17 15.13 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG C 39 ARG~? 23.08 O1 EDO C 141 C 141 THR C 70 THR~? 14.81 O1 EDO C 141 C 235 ASP A 50 ASP.? 20.38 CL CL A 141 coo -5.79 67.26 36.83 -4.57 64.58 37.74 17.00 20.76 1.74 15.55 23.42 1.18 coo -6.81 68.31 28.28 -4.82 68.47 27.57 13.33 13.35 -2.33 11.58 14.62 -2.10 coo -13.01 70.96 47.58 -11.44 71.65 46.34 11.71 33.66 5.09 12.68 31.93 4.37 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 39 ARG~? 11.53 C4 PG4 A 142 B 141 THR A 70 THR~? 15.01 O ACT A 140 B 235 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo 8.13 67.41 100.27 7.18 68.35 97.45 -9.34 34.41 10.95 -12.33 34.37 11.59 coo 8.28 67.78 108.81 6.22 67.65 109.43 -4.79 41.37 15.30 -6.78 42.17 15.13 coo 14.55 73.52 89.47 12.81 73.95 90.56 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG C 39 ARG~? 23.08 O1 EDO C 141 B 141 THR C 70 THR~? 14.81 O1 EDO C 141 B 235 ASP A 50 ASP.? 20.38 CL CL A 141 coo 8.13 67.41 100.27 7.18 68.35 97.45 17.00 20.76 1.74 15.55 23.42 1.18 coo 8.28 67.78 108.81 6.22 67.65 109.43 13.33 13.35 -2.33 11.58 14.62 -2.10 coo 14.55 73.52 89.47 12.81 73.95 90.56 11.71 33.66 5.09 12.68 31.93 4.37 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_c03 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 25 ASP.? 6.66 OXT ACT A 139 16 HIS A 131 HIS^? 7.42 CL CL A 141 67 GLY A 96 GLY.? 18.28 CL CL A 141 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 8.58 41.34 9.59 9.11 41.71 9.12 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP B 25 ASP.? 6.52 O ACT B 139 16 HIS B 131 HIS^? 7.27 CL CL B 140 67 GLY B 96 GLY.? 10.89 CL CL B 141 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -31.38 31.41 3.04 -31.45 30.75 3.48 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP C 25 ASP.? 6.36 O2 EDO C 140 16 HIS C 131 HIS^? 6.39 C1 EDO C 140 67 GLY C 96 GLY.? 17.66 O1 EDO C 140 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 4.46 12.53 17.74 4.84 11.35 19.48 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 8.46 11.73 13.23 7.93 9.80 13.86 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 20.22 1.91 3.52 20.16 1.24 3.96 1be1_c02 source 1be1 GLUTAMATE MUTASE : 3 hits 1be1_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP B 59 ASP.? 11.98 O ACT B 139 435 GLU B 63 GLU~? 16.01 OXT ACT B 139 510 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo 88.62 69.90 41.16 89.05 70.67 43.04 -53.34 42.20 5.44 -53.68 42.89 7.35 coo 89.52 76.11 40.17 89.01 75.16 41.97 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 84.89 77.60 46.67 85.63 75.79 46.03 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1bf2_c00 ISOAMYLASE user 2 3 # 2 375 ASP C 59 ASP.? 10.26 O1 EDO C 141 435 GLU C 63 GLU~? 7.77 O1 EDO C 141 510 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 88.62 69.90 41.16 89.05 70.67 43.04 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 89.52 76.11 40.17 89.01 75.16 41.97 1.11 13.80 1.11 0.04 14.34 2.91 coo 84.89 77.60 46.67 85.63 75.79 46.03 7.61 19.22 2.17 7.62 20.80 3.62 1bf2_c00 source 1bf2 ISOAMYLASE : 2 hits 1bf2_c00 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 34 GLU~? 3.97 C2 PG4 A 142 A 503 TYR B 121 TYR.? 12.07 O3 PG4 A 142 A 537 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 24.06 146.21 11.09 22.89 146.18 9.36 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 15.91 140.69 8.32 15.71 143.39 9.13 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 16.65 144.44 13.24 18.34 145.22 12.33 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU C 34 GLU~? 23.36 C1 EDO C 140 A 503 TYR A 121 TYR.? -24.35 CL CL A 141s A 537 GLU C 36 GLU~? -27.32 O1 EDO C 140s coo 24.06 146.21 11.09 22.89 146.18 9.36 13.37 28.10 10.00 11.57 28.19 11.09 coo 15.91 140.69 8.32 15.71 143.39 9.13 16.31 29.26 0.34 18.85 29.40 1.41 coo 16.65 144.44 13.24 18.34 145.22 12.33 19.61 26.41 3.01 20.17 25.01 1.52 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 2 hits 1bgl_c08 naa= 3 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 1 3 # 1 A 53 SER A 33 SER~? 7.85 O3 PG4 A 142 A 54 PRO A 32 PRO~? 10.43 C3 PG4 A 142 A 96 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -17.39 31.64 7.36 -18.99 31.05 5.73 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -20.21 35.69 10.01 -18.57 35.31 8.56 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 2 3 # 2 A 53 SER B 49 SER.? 12.95 CL CL B 141 A 54 PRO A 32 PRO~? 10.43 C3 PG4 A 142 A 96 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -23.84 36.86 9.13 -26.20 37.40 8.61 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -20.21 35.69 10.01 -18.57 35.31 8.56 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 3 3 # 3 A 53 SER B 119 SER.? 14.69 C3 PG4 A 142 A 54 PRO A 32 PRO~? 10.43 C3 PG4 A 142 A 96 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -23.53 32.55 11.61 -23.32 34.95 11.84 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -20.21 35.69 10.01 -18.57 35.31 8.56 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -23.12 32.36 7.43 -21.08 32.27 8.01 1boo_c00 source 1boo N-4 CYTOSINE-SPECIFIC METHYLTRANSFERASE PVU II: 3 hits 1boo_c00 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 55 GLY^? 10.36 O ACT A 139 48 HIS A 110 HIS.? -3.69 OXT ACT A 139s 99 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 12.38 5.55 24.25 13.27 5.59 24.39 0.71 47.46 4.43 0.16 46.85 4.76 coo 18.80 12.68 24.53 17.69 13.54 26.08 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 17.07 18.51 26.62 16.67 17.07 28.09 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 2 3 # 2 30 GLY A 55 GLY^? 10.36 O ACT A 139 48 HIS A 131 HIS^? 7.42 CL CL A 141 99 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 12.38 5.55 24.25 13.27 5.59 24.39 0.71 47.46 4.43 0.16 46.85 4.76 coo 18.80 12.68 24.53 17.69 13.54 26.08 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 17.07 18.51 26.62 16.67 17.07 28.09 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 3 3 # 3 30 GLY B 55 GLY^? 4.13 CL CL B 141 48 HIS B 110 HIS.? -3.67 O ACT B 139s 99 ASP B 25 ASP.? 6.52 O ACT B 139 coo 12.38 5.55 24.25 13.27 5.59 24.39 -40.59 35.18 8.37 -40.32 35.97 8.08 coo 18.80 12.68 24.53 17.69 13.54 26.08 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 17.07 18.51 26.62 16.67 17.07 28.09 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 4 3 # 4 30 GLY B 55 GLY^? 4.13 CL CL B 141 48 HIS B 131 HIS^? 7.27 CL CL B 140 99 ASP B 25 ASP.? 6.52 O ACT B 139 coo 12.38 5.55 24.25 13.27 5.59 24.39 -40.59 35.18 8.37 -40.32 35.97 8.08 coo 18.80 12.68 24.53 17.69 13.54 26.08 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 17.07 18.51 26.62 16.67 17.07 28.09 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 5 3 # 5 30 GLY C 55 GLY^? 8.81 O1 EDO C 140 48 HIS C 110 HIS.? 3.59 O ACT C 139s 99 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 12.38 5.55 24.25 13.27 5.59 24.39 10.94 5.65 8.59 11.17 6.44 8.27 coo 18.80 12.68 24.53 17.69 13.54 26.08 4.54 8.83 15.35 4.90 7.96 17.23 coo 17.07 18.51 26.62 16.67 17.07 28.09 4.46 12.53 17.74 4.84 11.35 19.48 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 6 3 # 6 30 GLY C 55 GLY^? 8.81 O1 EDO C 140 48 HIS C 131 HIS^? 6.39 C1 EDO C 140 99 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 12.38 5.55 24.25 13.27 5.59 24.39 10.94 5.65 8.59 11.17 6.44 8.27 coo 18.80 12.68 24.53 17.69 13.54 26.08 8.46 11.73 13.23 7.93 9.80 13.86 coo 17.07 18.51 26.62 16.67 17.07 28.09 4.46 12.53 17.74 4.84 11.35 19.48 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 6 hits 1bp2_c00 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 21 PHE.? 5.40 O2 PG4 A 142 A 205 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 236 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 4.14 2.10 36.34 6.69 3.08 36.92 -8.98 38.97 -1.25 -10.83 37.74 0.41 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE B 21 PHE.? 5.26 O1 PG4 B 142 A 205 ASP B 135 ASP.? 12.47 O1 PG4 B 142 A 236 LYS B 31 LYS~? 7.73 C1 PG4 B 142 coo 4.14 2.10 36.34 6.69 3.08 36.92 -37.81 47.58 14.44 -37.79 49.81 12.79 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -41.17 57.91 7.48 -40.76 60.95 12.06 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE C 21 PHE.? 15.03 C1 EDO C 140 A 205 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 236 LYS C 31 LYS~? 22.12 CL CL A 141 coo 4.14 2.10 36.34 6.69 3.08 36.92 13.33 18.43 14.15 13.28 20.66 12.46 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 7.61 19.22 2.17 7.62 20.80 3.62 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 9.92 28.31 6.82 8.29 31.11 11.06 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 3 hits 1bs0_c01 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 59 ASP.? 10.45 O ACT A 140 A 354 GLU A 63 GLU~? 7.87 O ACT A 140 A 421 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo 31.05 49.37 64.51 31.97 51.11 63.85 -11.63 55.20 7.79 -12.68 54.74 6.05 coo 29.07 50.42 58.36 29.02 52.18 59.49 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 30.82 59.76 58.47 31.12 59.02 60.40 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP A 62 ASP~? -3.38 O ACT A 140s A 354 GLU A 63 GLU~? 7.87 O ACT A 140 A 421 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo 31.05 49.37 64.51 31.97 51.11 63.85 -9.14 53.57 16.41 -8.61 54.95 17.94 coo 29.07 50.42 58.36 29.02 52.18 59.49 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 30.82 59.76 58.47 31.12 59.02 60.40 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP B 59 ASP.? 11.98 O ACT B 139 A 354 GLU B 63 GLU~? 16.01 OXT ACT B 139 A 421 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo 31.05 49.37 64.51 31.97 51.11 63.85 -53.34 42.20 5.44 -53.68 42.89 7.35 coo 29.07 50.42 58.36 29.02 52.18 59.49 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 30.82 59.76 58.47 31.12 59.02 60.40 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 4 3 # 4 A 325 ASP B 62 ASP~? 20.96 OXT ACT B 139 A 354 GLU B 63 GLU~? 16.01 OXT ACT B 139 A 421 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo 31.05 49.37 64.51 31.97 51.11 63.85 -50.88 40.70 -3.44 -51.62 39.45 -5.01 coo 29.07 50.42 58.36 29.02 52.18 59.49 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 30.82 59.76 58.47 31.12 59.02 60.40 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 5 3 # 5 A 325 ASP C 59 ASP.? 10.26 O1 EDO C 141 A 354 GLU C 63 GLU~? 7.77 O1 EDO C 141 A 421 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 31.05 49.37 64.51 31.97 51.11 63.85 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 29.07 50.42 58.36 29.02 52.18 59.49 1.11 13.80 1.11 0.04 14.34 2.91 coo 30.82 59.76 58.47 31.12 59.02 60.40 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 6 3 # 6 A 325 ASP C 62 ASP~? -3.30 O1 EDO C 141s A 354 GLU C 63 GLU~? 7.77 O1 EDO C 141 A 421 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 31.05 49.37 64.51 31.97 51.11 63.85 0.59 10.79 -3.25 -0.22 9.73 -4.86 coo 29.07 50.42 58.36 29.02 52.18 59.49 1.11 13.80 1.11 0.04 14.34 2.91 coo 30.82 59.76 58.47 31.12 59.02 60.40 7.61 19.22 2.17 7.62 20.80 3.62 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 6 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 59 ASP.? 10.45 O ACT A 140 B 354 GLU A 63 GLU~? 7.87 O ACT A 140 B 421 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo 25.90 8.19 53.87 25.36 6.97 52.29 -11.63 55.20 7.79 -12.68 54.74 6.05 coo 27.87 10.66 47.95 27.82 8.60 48.27 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 26.02 1.87 43.38 25.90 1.97 45.49 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP A 62 ASP~? -3.38 O ACT A 140s B 354 GLU A 63 GLU~? 7.87 O ACT A 140 B 421 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo 25.90 8.19 53.87 25.36 6.97 52.29 -9.14 53.57 16.41 -8.61 54.95 17.94 coo 27.87 10.66 47.95 27.82 8.60 48.27 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 26.02 1.87 43.38 25.90 1.97 45.49 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP B 59 ASP.? 11.98 O ACT B 139 B 354 GLU B 63 GLU~? 16.01 OXT ACT B 139 B 421 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo 25.90 8.19 53.87 25.36 6.97 52.29 -53.34 42.20 5.44 -53.68 42.89 7.35 coo 27.87 10.66 47.95 27.82 8.60 48.27 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 26.02 1.87 43.38 25.90 1.97 45.49 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP B 62 ASP~? 20.96 OXT ACT B 139 B 354 GLU B 63 GLU~? 16.01 OXT ACT B 139 B 421 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo 25.90 8.19 53.87 25.36 6.97 52.29 -50.88 40.70 -3.44 -51.62 39.45 -5.01 coo 27.87 10.66 47.95 27.82 8.60 48.27 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 26.02 1.87 43.38 25.90 1.97 45.49 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 5 3 # 5 B 325 ASP C 59 ASP.? 10.26 O1 EDO C 141 B 354 GLU C 63 GLU~? 7.77 O1 EDO C 141 B 421 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 25.90 8.19 53.87 25.36 6.97 52.29 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 27.87 10.66 47.95 27.82 8.60 48.27 1.11 13.80 1.11 0.04 14.34 2.91 coo 26.02 1.87 43.38 25.90 1.97 45.49 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 6 3 # 6 B 325 ASP C 62 ASP~? -3.30 O1 EDO C 141s B 354 GLU C 63 GLU~? 7.77 O1 EDO C 141 B 421 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 25.90 8.19 53.87 25.36 6.97 52.29 0.59 10.79 -3.25 -0.22 9.73 -4.86 coo 27.87 10.66 47.95 27.82 8.60 48.27 1.11 13.80 1.11 0.04 14.34 2.91 coo 26.02 1.87 43.38 25.90 1.97 45.49 7.61 19.22 2.17 7.62 20.80 3.62 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 6 hits 1bvz_c09 naa= 3 ULMN 3 1bwd_c02 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 1 3 # 1 A 179 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 227 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 332 CYH A 57 CYH^? 5.51 O ACT A 139 coo 123.98 30.59 1.90 124.68 28.67 1.28 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 119.16 28.51 2.63 120.67 28.31 1.13 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 114.70 31.13 -3.42 115.96 29.28 -1.69 -4.80 51.41 4.83 -3.45 51.64 2.37 ULMN 3 1bwd_c02 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 2 3 # 2 A 179 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 227 HIS A 131 HIS^? 7.42 CL CL A 141 A 332 CYH A 57 CYH^? 5.51 O ACT A 139 coo 123.98 30.59 1.90 124.68 28.67 1.28 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 119.16 28.51 2.63 120.67 28.31 1.13 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 114.70 31.13 -3.42 115.96 29.28 -1.69 -4.80 51.41 4.83 -3.45 51.64 2.37 ULMN 3 1bwd_c02 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 3 3 # 3 A 179 ASP B 25 ASP.? 6.52 O ACT B 139 A 227 HIS B 110 HIS.? -3.67 O ACT B 139s A 332 CYH B 57 CYH^? 5.44 OXT ACT B 139 coo 123.98 30.59 1.90 124.68 28.67 1.28 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 119.16 28.51 2.63 120.67 28.31 1.13 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 114.70 31.13 -3.42 115.96 29.28 -1.69 -46.68 38.10 8.15 -46.29 36.73 10.60 ULMN 3 1bwd_c02 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 4 3 # 4 A 179 ASP B 25 ASP.? 6.52 O ACT B 139 A 227 HIS B 131 HIS^? 7.27 CL CL B 140 A 332 CYH B 57 CYH^? 5.44 OXT ACT B 139 coo 123.98 30.59 1.90 124.68 28.67 1.28 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 119.16 28.51 2.63 120.67 28.31 1.13 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 114.70 31.13 -3.42 115.96 29.28 -1.69 -46.68 38.10 8.15 -46.29 36.73 10.60 ULMN 3 1bwd_c02 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 5 3 # 5 A 179 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 227 HIS C 110 HIS.? 3.59 O ACT C 139s A 332 CYH C 57 CYH^? 5.55 OXT ACT C 139 coo 123.98 30.59 1.90 124.68 28.67 1.28 4.46 12.53 17.74 4.84 11.35 19.48 coo 119.16 28.51 2.63 120.67 28.31 1.13 4.54 8.83 15.35 4.90 7.96 17.23 coo 114.70 31.13 -3.42 115.96 29.28 -1.69 4.72 8.42 8.22 5.18 7.19 10.69 ULMN 3 1bwd_c02 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 6 3 # 6 A 179 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 227 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 332 CYH C 57 CYH^? 5.55 OXT ACT C 139 coo 123.98 30.59 1.90 124.68 28.67 1.28 4.46 12.53 17.74 4.84 11.35 19.48 coo 119.16 28.51 2.63 120.67 28.31 1.13 8.46 11.73 13.23 7.93 9.80 13.86 coo 114.70 31.13 -3.42 115.96 29.28 -1.69 4.72 8.42 8.22 5.18 7.19 10.69 1bwd_c02 source 1bwd INOSAMINE-PHOSPHATE AMIDINOTRANSFERASE : 6 hits 1bwd_c02 naa= 3 ULMN 3 1bwd_c03 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 1 3 # 1 B 179 ASP A 25 ASP.? 6.66 OXT ACT A 139 B 227 HIS A 110 HIS.? -3.69 OXT ACT A 139s B 332 CYH A 57 CYH^? 5.51 O ACT A 139 coo 94.18 76.57 24.23 93.74 77.97 22.66 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 89.34 74.44 23.40 90.11 76.41 23.55 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 85.03 76.39 29.77 85.85 76.14 27.06 -4.80 51.41 4.83 -3.45 51.64 2.37 ULMN 3 1bwd_c03 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 2 3 # 2 B 179 ASP A 25 ASP.? 6.66 OXT ACT A 139 B 227 HIS A 131 HIS^? 7.42 CL CL A 141 B 332 CYH A 57 CYH^? 5.51 O ACT A 139 coo 94.18 76.57 24.23 93.74 77.97 22.66 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 89.34 74.44 23.40 90.11 76.41 23.55 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 85.03 76.39 29.77 85.85 76.14 27.06 -4.80 51.41 4.83 -3.45 51.64 2.37 ULMN 3 1bwd_c03 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 3 3 # 3 B 179 ASP B 25 ASP.? 6.52 O ACT B 139 B 227 HIS B 110 HIS.? -3.67 O ACT B 139s B 332 CYH B 57 CYH^? 5.44 OXT ACT B 139 coo 94.18 76.57 24.23 93.74 77.97 22.66 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 89.34 74.44 23.40 90.11 76.41 23.55 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 85.03 76.39 29.77 85.85 76.14 27.06 -46.68 38.10 8.15 -46.29 36.73 10.60 ULMN 3 1bwd_c03 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 4 3 # 4 B 179 ASP B 25 ASP.? 6.52 O ACT B 139 B 227 HIS B 131 HIS^? 7.27 CL CL B 140 B 332 CYH B 57 CYH^? 5.44 OXT ACT B 139 coo 94.18 76.57 24.23 93.74 77.97 22.66 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 89.34 74.44 23.40 90.11 76.41 23.55 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 85.03 76.39 29.77 85.85 76.14 27.06 -46.68 38.10 8.15 -46.29 36.73 10.60 ULMN 3 1bwd_c03 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 5 3 # 5 B 179 ASP C 25 ASP.? 6.36 O2 EDO C 140 B 227 HIS C 110 HIS.? 3.59 O ACT C 139s B 332 CYH C 57 CYH^? 5.55 OXT ACT C 139 coo 94.18 76.57 24.23 93.74 77.97 22.66 4.46 12.53 17.74 4.84 11.35 19.48 coo 89.34 74.44 23.40 90.11 76.41 23.55 4.54 8.83 15.35 4.90 7.96 17.23 coo 85.03 76.39 29.77 85.85 76.14 27.06 4.72 8.42 8.22 5.18 7.19 10.69 ULMN 3 1bwd_c03 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 6 3 # 6 B 179 ASP C 25 ASP.? 6.36 O2 EDO C 140 B 227 HIS C 131 HIS^? 6.39 C1 EDO C 140 B 332 CYH C 57 CYH^? 5.55 OXT ACT C 139 coo 94.18 76.57 24.23 93.74 77.97 22.66 4.46 12.53 17.74 4.84 11.35 19.48 coo 89.34 74.44 23.40 90.11 76.41 23.55 8.46 11.73 13.23 7.93 9.80 13.86 coo 85.03 76.39 29.77 85.85 76.14 27.06 4.72 8.42 8.22 5.18 7.19 10.69 1bwd_c03 source 1bwd INOSAMINE-PHOSPHATE AMIDINOTRANSFERASE : 6 hits 1bwd_c03 naa= 3 ULMN 3 1bzc_c00 PROTEIN-TYROSINE-PHOSPHATASE user 1 3 # 1 A 181 ASP A 59 ASP.? 10.45 O ACT A 140 A 215 CYH A 57 CYH^? 5.51 O ACT A 139 A 221 ARG A 111 ARG.? 7.83 OXT ACT A 139 coo -20.67 62.35 15.68 -20.16 63.09 17.59 -11.63 55.20 7.79 -12.68 54.74 6.05 coo -17.06 60.65 8.77 -19.43 59.04 8.89 -4.80 51.41 4.83 -3.45 51.64 2.37 coo -21.54 63.29 10.68 -19.32 62.77 12.69 -9.64 52.74 3.70 -9.14 55.70 2.93 ULMN 3 1bzc_c00 PROTEIN-TYROSINE-PHOSPHATASE user 2 3 # 2 A 181 ASP B 59 ASP.? 11.98 O ACT B 139 A 215 CYH B 57 CYH^? 5.44 OXT ACT B 139 A 221 ARG B 111 ARG.? 7.92 O ACT B 139 coo -20.67 62.35 15.68 -20.16 63.09 17.59 -53.34 42.20 5.44 -53.68 42.89 7.35 coo -17.06 60.65 8.77 -19.43 59.04 8.89 -46.68 38.10 8.15 -46.29 36.73 10.60 coo -21.54 63.29 10.68 -19.32 62.77 12.69 -50.20 41.64 9.27 -52.60 39.78 9.98 ULMN 3 1bzc_c00 PROTEIN-TYROSINE-PHOSPHATASE user 3 3 # 3 A 181 ASP C 59 ASP.? 10.26 O1 EDO C 141 A 215 CYH C 57 CYH^? 5.55 OXT ACT C 139 A 221 ARG C 111 ARG.? 7.98 O ACT C 139 coo -20.67 62.35 15.68 -20.16 63.09 17.59 -1.96 12.33 5.23 -2.08 13.48 6.95 coo -17.06 60.65 8.77 -19.43 59.04 8.89 4.72 8.42 8.22 5.18 7.19 10.69 coo -21.54 63.29 10.68 -19.32 62.77 12.69 1.09 11.93 9.22 -1.20 10.06 10.11 1bzc_c00 source 1bzc PROTEIN-TYROSINE-PHOSPHATASE : 3 hits 1bzc_c00 naa= 3 ULMN 3 1c82_c01 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 408 TYR A 106 TYR.? -4.43 O ACT A 139s A 462 ARG A 111 ARG.? 7.83 OXT ACT A 139 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -3.42 56.19 3.13 -4.04 54.71 0.79 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 -9.64 52.74 3.70 -9.14 55.70 2.93 ULMN 3 1c82_c01 HYALURONATE LYASE user 2 3 # 2 A 399 HIS B 110 HIS.? -3.67 O ACT B 139s A 408 TYR B 106 TYR.? -4.35 OXT ACT B 139s A 462 ARG B 111 ARG.? 7.92 O ACT B 139 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -50.21 34.52 9.84 -49.25 35.77 12.19 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 -50.20 41.64 9.27 -52.60 39.78 9.98 ULMN 3 1c82_c01 HYALURONATE LYASE user 3 3 # 3 A 399 HIS C 110 HIS.? 3.59 O ACT C 139s A 408 TYR C 106 TYR.? -4.43 OXT ACT C 139s A 462 ARG C 111 ARG.? 7.98 O ACT C 139 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 4.54 8.83 15.35 4.90 7.96 17.23 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 1.32 4.77 9.99 2.33 6.07 12.30 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 1.09 11.93 9.22 -1.20 10.06 10.11 1c82_c01 source 1c82 HYALURONATE LYASE : 3 hits 1c82_c01 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 16 HIS A 131 HIS^? 7.42 CL CL A 141 A 67 GLY A 108 GLY.? -3.28 OXT ACT A 139s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -4.76 57.33 -1.04 -5.23 57.51 -0.39 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 2 3 # 2 A 14 ASP B 25 ASP.? 6.52 O ACT B 139 A 16 HIS B 110 HIS.? -3.67 O ACT B 139s A 67 GLY B 130 GLY^? -4.77 CL CL B 140s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -38.21 42.69 13.79 -38.12 42.42 14.57 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 3 3 # 3 A 14 ASP B 25 ASP.? 6.52 O ACT B 139 A 16 HIS B 131 HIS^? 7.27 CL CL B 140 A 67 GLY B 108 GLY.? -3.23 O ACT B 139s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -51.79 35.03 13.96 -52.23 35.35 13.34 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 4 3 # 4 A 14 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 16 HIS C 110 HIS.? 3.59 O ACT C 139s A 67 GLY C 130 GLY^? 9.35 O1 EDO C 140 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 4.46 12.53 17.74 4.84 11.35 19.48 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 4.54 8.83 15.35 4.90 7.96 17.23 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 13.00 13.33 13.76 13.12 13.19 14.54 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 5 3 # 5 A 14 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 16 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 67 GLY C 108 GLY.? -3.29 O ACT C 139s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 4.46 12.53 17.74 4.84 11.35 19.48 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 8.46 11.73 13.23 7.93 9.80 13.86 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -0.26 5.40 14.09 -0.70 5.70 13.45 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 5 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP A 25 ASP.? 6.66 OXT ACT A 139 C 16 HIS A 110 HIS.? -3.69 OXT ACT A 139s C 67 GLY A 130 GLY^? -4.84 CL CL A 141s coo 10.04 44.27 88.44 9.47 42.32 89.03 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 6.38 39.80 88.71 6.88 38.89 86.87 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 17.63 42.50 89.25 18.11 42.29 88.64 -4.89 41.74 -0.85 -4.61 41.77 -1.61 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 2 3 # 2 C 14 ASP A 25 ASP.? 6.66 OXT ACT A 139 C 16 HIS A 131 HIS^? 7.42 CL CL A 141 C 67 GLY A 108 GLY.? -3.28 OXT ACT A 139s coo 10.04 44.27 88.44 9.47 42.32 89.03 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 6.38 39.80 88.71 6.88 38.89 86.87 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 17.63 42.50 89.25 18.11 42.29 88.64 -4.76 57.33 -1.04 -5.23 57.51 -0.39 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 3 3 # 3 C 14 ASP B 25 ASP.? 6.52 O ACT B 139 C 16 HIS B 110 HIS.? -3.67 O ACT B 139s C 67 GLY B 130 GLY^? -4.77 CL CL B 140s coo 10.04 44.27 88.44 9.47 42.32 89.03 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 6.38 39.80 88.71 6.88 38.89 86.87 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 17.63 42.50 89.25 18.11 42.29 88.64 -38.21 42.69 13.79 -38.12 42.42 14.57 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 4 3 # 4 C 14 ASP B 25 ASP.? 6.52 O ACT B 139 C 16 HIS B 131 HIS^? 7.27 CL CL B 140 C 67 GLY B 108 GLY.? -3.23 O ACT B 139s coo 10.04 44.27 88.44 9.47 42.32 89.03 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 6.38 39.80 88.71 6.88 38.89 86.87 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 17.63 42.50 89.25 18.11 42.29 88.64 -51.79 35.03 13.96 -52.23 35.35 13.34 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 5 3 # 5 C 14 ASP C 25 ASP.? 6.36 O2 EDO C 140 C 16 HIS C 110 HIS.? 3.59 O ACT C 139s C 67 GLY C 130 GLY^? 9.35 O1 EDO C 140 coo 10.04 44.27 88.44 9.47 42.32 89.03 4.46 12.53 17.74 4.84 11.35 19.48 coo 6.38 39.80 88.71 6.88 38.89 86.87 4.54 8.83 15.35 4.90 7.96 17.23 coo 17.63 42.50 89.25 18.11 42.29 88.64 13.00 13.33 13.76 13.12 13.19 14.54 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 6 3 # 6 C 14 ASP C 25 ASP.? 6.36 O2 EDO C 140 C 16 HIS C 131 HIS^? 6.39 C1 EDO C 140 C 67 GLY C 108 GLY.? -3.29 O ACT C 139s coo 10.04 44.27 88.44 9.47 42.32 89.03 4.46 12.53 17.74 4.84 11.35 19.48 coo 6.38 39.80 88.71 6.88 38.89 86.87 8.46 11.73 13.23 7.93 9.80 13.86 coo 17.63 42.50 89.25 18.11 42.29 88.64 -0.26 5.40 14.09 -0.70 5.70 13.45 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 6 hits 1cb7_c07 naa= 3 ULMN 3 1cb8_c01 CHONDROITINASE AC user 1 3 # 1 A 225 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 234 TYR A 106 TYR.? -4.43 O ACT A 139s A 288 ARG A 111 ARG.? 7.83 OXT ACT A 139 coo 27.04 28.61 41.75 26.86 28.65 43.84 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 21.80 30.48 43.67 23.70 29.06 45.12 -3.42 56.19 3.13 -4.04 54.71 0.79 coo 24.79 22.62 45.60 24.87 25.42 46.81 -9.64 52.74 3.70 -9.14 55.70 2.93 ULMN 3 1cb8_c01 CHONDROITINASE AC user 2 3 # 2 A 225 HIS B 110 HIS.? -3.67 O ACT B 139s A 234 TYR B 106 TYR.? -4.35 OXT ACT B 139s A 288 ARG B 111 ARG.? 7.92 O ACT B 139 coo 27.04 28.61 41.75 26.86 28.65 43.84 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 21.80 30.48 43.67 23.70 29.06 45.12 -50.21 34.52 9.84 -49.25 35.77 12.19 coo 24.79 22.62 45.60 24.87 25.42 46.81 -50.20 41.64 9.27 -52.60 39.78 9.98 ULMN 3 1cb8_c01 CHONDROITINASE AC user 3 3 # 3 A 225 HIS C 110 HIS.? 3.59 O ACT C 139s A 234 TYR C 106 TYR.? -4.43 OXT ACT C 139s A 288 ARG C 111 ARG.? 7.98 O ACT C 139 coo 27.04 28.61 41.75 26.86 28.65 43.84 4.54 8.83 15.35 4.90 7.96 17.23 coo 21.80 30.48 43.67 23.70 29.06 45.12 1.32 4.77 9.99 2.33 6.07 12.30 coo 24.79 22.62 45.60 24.87 25.42 46.81 1.09 11.93 9.22 -1.20 10.06 10.11 1cb8_c01 source 1cb8 CHONDROITINASE AC : 3 hits 1cb8_c01 naa= 3 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 59 ASP.? 10.45 O ACT A 140 257 GLU A 63 GLU~? 7.87 O ACT A 140 328 ASP A 62 ASP~? -3.38 O ACT A 140s coo 45.62 80.42 43.69 45.65 82.01 45.07 -11.63 55.20 7.79 -12.68 54.74 6.05 coo 48.97 85.16 40.39 47.18 86.25 40.47 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 45.39 90.72 40.63 45.07 89.14 41.90 -9.14 53.57 16.41 -8.61 54.95 17.94 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 62 ASP~? -3.38 O ACT A 140s 257 GLU A 63 GLU~? 7.87 O ACT A 140 328 ASP A 59 ASP.? 10.45 O ACT A 140 coo 45.62 80.42 43.69 45.65 82.01 45.07 -9.14 53.57 16.41 -8.61 54.95 17.94 coo 48.97 85.16 40.39 47.18 86.25 40.47 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 45.39 90.72 40.63 45.07 89.14 41.90 -11.63 55.20 7.79 -12.68 54.74 6.05 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 135 ASP.? 12.08 C3 PG4 A 142 257 GLU A 63 GLU~? 7.87 O ACT A 140 328 ASP A 59 ASP.? 10.45 O ACT A 140 coo 45.62 80.42 43.69 45.65 82.01 45.07 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 48.97 85.16 40.39 47.18 86.25 40.47 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 45.39 90.72 40.63 45.07 89.14 41.90 -11.63 55.20 7.79 -12.68 54.74 6.05 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP A 135 ASP.? 12.08 C3 PG4 A 142 257 GLU A 63 GLU~? 7.87 O ACT A 140 328 ASP A 62 ASP~? -3.38 O ACT A 140s coo 45.62 80.42 43.69 45.65 82.01 45.07 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 48.97 85.16 40.39 47.18 86.25 40.47 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 45.39 90.72 40.63 45.07 89.14 41.90 -9.14 53.57 16.41 -8.61 54.95 17.94 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP B 59 ASP.? 11.98 O ACT B 139 257 GLU B 63 GLU~? 16.01 OXT ACT B 139 328 ASP B 62 ASP~? 20.96 OXT ACT B 139 coo 45.62 80.42 43.69 45.65 82.01 45.07 -53.34 42.20 5.44 -53.68 42.89 7.35 coo 48.97 85.16 40.39 47.18 86.25 40.47 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 45.39 90.72 40.63 45.07 89.14 41.90 -50.88 40.70 -3.44 -51.62 39.45 -5.01 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP B 59 ASP.? 11.98 O ACT B 139 257 GLU B 63 GLU~? 16.01 OXT ACT B 139 328 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo 45.62 80.42 43.69 45.65 82.01 45.07 -53.34 42.20 5.44 -53.68 42.89 7.35 coo 48.97 85.16 40.39 47.18 86.25 40.47 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 45.39 90.72 40.63 45.07 89.14 41.90 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP B 62 ASP~? 20.96 OXT ACT B 139 257 GLU B 63 GLU~? 16.01 OXT ACT B 139 328 ASP B 59 ASP.? 11.98 O ACT B 139 coo 45.62 80.42 43.69 45.65 82.01 45.07 -50.88 40.70 -3.44 -51.62 39.45 -5.01 coo 48.97 85.16 40.39 47.18 86.25 40.47 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 45.39 90.72 40.63 45.07 89.14 41.90 -53.34 42.20 5.44 -53.68 42.89 7.35 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP B 62 ASP~? 20.96 OXT ACT B 139 257 GLU B 63 GLU~? 16.01 OXT ACT B 139 328 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo 45.62 80.42 43.69 45.65 82.01 45.07 -50.88 40.70 -3.44 -51.62 39.45 -5.01 coo 48.97 85.16 40.39 47.18 86.25 40.47 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 45.39 90.72 40.63 45.07 89.14 41.90 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 9 3 # 9 229 ASP B 135 ASP.? 12.47 O1 PG4 B 142 257 GLU B 63 GLU~? 16.01 OXT ACT B 139 328 ASP B 59 ASP.? 11.98 O ACT B 139 coo 45.62 80.42 43.69 45.65 82.01 45.07 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 48.97 85.16 40.39 47.18 86.25 40.47 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 45.39 90.72 40.63 45.07 89.14 41.90 -53.34 42.20 5.44 -53.68 42.89 7.35 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 10 3 # 10 229 ASP B 135 ASP.? 12.47 O1 PG4 B 142 257 GLU B 63 GLU~? 16.01 OXT ACT B 139 328 ASP B 62 ASP~? 20.96 OXT ACT B 139 coo 45.62 80.42 43.69 45.65 82.01 45.07 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 48.97 85.16 40.39 47.18 86.25 40.47 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 45.39 90.72 40.63 45.07 89.14 41.90 -50.88 40.70 -3.44 -51.62 39.45 -5.01 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 11 3 # 11 229 ASP C 59 ASP.? 10.26 O1 EDO C 141 257 GLU C 63 GLU~? 7.77 O1 EDO C 141 328 ASP C 62 ASP~? -3.30 O1 EDO C 141s coo 45.62 80.42 43.69 45.65 82.01 45.07 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 48.97 85.16 40.39 47.18 86.25 40.47 1.11 13.80 1.11 0.04 14.34 2.91 coo 45.39 90.72 40.63 45.07 89.14 41.90 0.59 10.79 -3.25 -0.22 9.73 -4.86 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 12 3 # 12 229 ASP C 59 ASP.? 10.26 O1 EDO C 141 257 GLU C 63 GLU~? 7.77 O1 EDO C 141 328 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 45.62 80.42 43.69 45.65 82.01 45.07 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 48.97 85.16 40.39 47.18 86.25 40.47 1.11 13.80 1.11 0.04 14.34 2.91 coo 45.39 90.72 40.63 45.07 89.14 41.90 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 13 3 # 13 229 ASP C 62 ASP~? -3.30 O1 EDO C 141s 257 GLU C 63 GLU~? 7.77 O1 EDO C 141 328 ASP C 59 ASP.? 10.26 O1 EDO C 141 coo 45.62 80.42 43.69 45.65 82.01 45.07 0.59 10.79 -3.25 -0.22 9.73 -4.86 coo 48.97 85.16 40.39 47.18 86.25 40.47 1.11 13.80 1.11 0.04 14.34 2.91 coo 45.39 90.72 40.63 45.07 89.14 41.90 -1.96 12.33 5.23 -2.08 13.48 6.95 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 14 3 # 14 229 ASP C 62 ASP~? -3.30 O1 EDO C 141s 257 GLU C 63 GLU~? 7.77 O1 EDO C 141 328 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 45.62 80.42 43.69 45.65 82.01 45.07 0.59 10.79 -3.25 -0.22 9.73 -4.86 coo 48.97 85.16 40.39 47.18 86.25 40.47 1.11 13.80 1.11 0.04 14.34 2.91 coo 45.39 90.72 40.63 45.07 89.14 41.90 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 15 3 # 15 229 ASP C 135 ASP.? 16.41 O1 EDO C 141 257 GLU C 63 GLU~? 7.77 O1 EDO C 141 328 ASP C 59 ASP.? 10.26 O1 EDO C 141 coo 45.62 80.42 43.69 45.65 82.01 45.07 7.61 19.22 2.17 7.62 20.80 3.62 coo 48.97 85.16 40.39 47.18 86.25 40.47 1.11 13.80 1.11 0.04 14.34 2.91 coo 45.39 90.72 40.63 45.07 89.14 41.90 -1.96 12.33 5.23 -2.08 13.48 6.95 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 16 3 # 16 229 ASP C 135 ASP.? 16.41 O1 EDO C 141 257 GLU C 63 GLU~? 7.77 O1 EDO C 141 328 ASP C 62 ASP~? -3.30 O1 EDO C 141s coo 45.62 80.42 43.69 45.65 82.01 45.07 7.61 19.22 2.17 7.62 20.80 3.62 coo 48.97 85.16 40.39 47.18 86.25 40.47 1.11 13.80 1.11 0.04 14.34 2.91 coo 45.39 90.72 40.63 45.07 89.14 41.90 0.59 10.79 -3.25 -0.22 9.73 -4.86 1cdg_c04 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 16 hits 1cdg_c04 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 88 GLY.? 6.36 OXT ACT A 140 A 228 SER A 105 SER^? -10.47 OXT ACT A 140s A 549 ASP A 104 ASP^? 12.12 O ACT A 139 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -7.82 61.10 9.16 -7.39 60.58 9.65 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -1.08 59.98 7.21 -2.28 61.98 6.72 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 2.26 57.49 7.12 4.30 57.24 7.17 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 123 GLY.? 19.54 CL CL A 141 A 228 SER A 119 SER.? 16.13 CL CL A 141 A 549 ASP A 50 ASP.? 20.38 CL CL A 141 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 10.21 27.06 -3.71 10.24 27.88 -3.50 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 11.23 33.92 0.93 9.27 32.55 0.99 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 11.71 33.66 5.09 12.68 31.93 4.37 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY B 88 GLY.? 14.05 OXT ACT B 139 A 228 SER B 105 SER^? -11.53 OXT ACT B 139s A 549 ASP B 104 ASP^? 11.90 OXT ACT B 139 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -56.66 36.05 3.82 -56.03 35.91 3.31 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -52.43 30.61 5.66 -54.69 30.59 6.35 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -48.63 28.94 5.87 -47.34 27.30 5.89 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY B 123 GLY.? 16.67 C3 PG4 A 142 A 228 SER B 119 SER.? 14.69 C3 PG4 A 142 A 549 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -18.03 36.67 16.32 -18.74 36.23 16.11 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -23.53 32.55 11.61 -23.32 34.95 11.84 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 A 198 GLY C 88 GLY.? -5.77 O2 EDO C 141s A 228 SER C 105 SER^? -10.66 O2 EDO C 141s A 549 ASP C 104 ASP^? 12.14 OXT ACT C 139 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -5.16 6.02 3.89 -4.51 5.85 3.40 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -0.84 0.76 5.94 -3.19 0.66 6.57 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 3.02 -0.89 6.06 4.36 -2.50 5.95 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 A 198 GLY C 123 GLY.? 23.83 O1 EDO C 140 A 228 SER C 119 SER.? 19.22 O1 EDO C 140 A 549 ASP C 50 ASP.? 22.48 O1 EDO C 140 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 33.40 7.92 16.67 32.70 7.46 16.47 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 27.99 3.53 12.09 28.26 5.94 12.28 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 28.54 3.26 7.93 30.44 3.42 8.82 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 6 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY B 123 GLY.? 16.67 C3 PG4 A 142 B1228 SER B 119 SER.? 14.69 C3 PG4 A 142 B1549 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo 126.34 72.75 125.66 125.95 73.27 126.11 -18.03 36.67 16.32 -18.74 36.23 16.11 coo 131.65 74.68 129.41 130.31 72.73 128.82 -23.53 32.55 11.61 -23.32 34.95 11.84 coo 134.72 69.43 130.42 133.03 70.65 130.08 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY C 123 GLY.? 23.83 O1 EDO C 140 B1228 SER C 119 SER.? 19.22 O1 EDO C 140 B1549 ASP C 50 ASP.? 22.48 O1 EDO C 140 coo 126.34 72.75 125.66 125.95 73.27 126.11 33.40 7.92 16.67 32.70 7.46 16.47 coo 131.65 74.68 129.41 130.31 72.73 128.82 27.99 3.53 12.09 28.26 5.94 12.28 coo 134.72 69.43 130.42 133.03 70.65 130.08 28.54 3.26 7.93 30.44 3.42 8.82 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 2 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 36 GLU~? 11.76 C4 PG4 A 142 A 89 GLU B 122 GLU.? 20.16 C3 PG4 A 142 A 120 SER B 119 SER.? 14.69 C3 PG4 A 142 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -12.87 29.42 9.52 -11.52 29.66 11.15 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -18.00 33.10 19.61 -16.43 34.38 20.27 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU B 122 GLU.? 20.16 C3 PG4 A 142 A 89 GLU B 127 GLU^? 8.11 CL CL B 140 A 120 SER B 119 SER.? 14.69 C3 PG4 A 142 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -18.00 33.10 19.61 -16.43 34.38 20.27 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -28.31 39.11 17.60 -29.33 39.55 19.43 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU B 127 GLU^? 8.11 CL CL B 140 A 89 GLU B 122 GLU.? 20.16 C3 PG4 A 142 A 120 SER B 119 SER.? 14.69 C3 PG4 A 142 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -28.31 39.11 17.60 -29.33 39.55 19.43 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -18.00 33.10 19.61 -16.43 34.38 20.27 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -23.53 32.55 11.61 -23.32 34.95 11.84 1cns_c00 source 1cns CHITINASE : 3 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 36 GLU~? 11.76 C4 PG4 A 142 B 89 GLU B 122 GLU.? 20.16 C3 PG4 A 142 B 120 SER B 119 SER.? 14.69 C3 PG4 A 142 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -12.87 29.42 9.52 -11.52 29.66 11.15 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -18.00 33.10 19.61 -16.43 34.38 20.27 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU B 122 GLU.? 20.16 C3 PG4 A 142 B 89 GLU B 127 GLU^? 8.11 CL CL B 140 B 120 SER B 49 SER.? 12.95 CL CL B 141 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -18.00 33.10 19.61 -16.43 34.38 20.27 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -28.31 39.11 17.60 -29.33 39.55 19.43 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -23.84 36.86 9.13 -26.20 37.40 8.61 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU B 122 GLU.? 20.16 C3 PG4 A 142 B 89 GLU B 127 GLU^? 8.11 CL CL B 140 B 120 SER B 119 SER.? 14.69 C3 PG4 A 142 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -18.00 33.10 19.61 -16.43 34.38 20.27 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -28.31 39.11 17.60 -29.33 39.55 19.43 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU B 127 GLU^? 8.11 CL CL B 140 B 89 GLU B 122 GLU.? 20.16 C3 PG4 A 142 B 120 SER B 119 SER.? 14.69 C3 PG4 A 142 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -28.31 39.11 17.60 -29.33 39.55 19.43 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -18.00 33.10 19.61 -16.43 34.38 20.27 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -23.53 32.55 11.61 -23.32 34.95 11.84 1cns_c01 source 1cns CHITINASE : 4 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 121 TYR.? -24.35 CL CL A 141s A 173 ASP A 50 ASP.? 20.38 CL CL A 141 C 48 ARG C 39 ARG~? 23.08 O1 EDO C 141 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 16.31 29.26 0.34 18.85 29.40 1.41 coo 24.35 4.55 25.11 25.94 3.23 25.53 11.71 33.66 5.09 12.68 31.93 4.37 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 17.00 20.76 1.74 15.55 23.42 1.18 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR B 121 TYR.? 12.07 O3 PG4 A 142 A 173 ASP B 50 ASP.? 10.53 C3 PG4 A 142 C 48 ARG A 39 ARG~? 11.53 C4 PG4 A 142 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 24.35 4.55 25.11 25.94 3.23 25.53 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -9.34 34.41 10.95 -12.33 34.37 11.59 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 39 ARG~? 11.53 C4 PG4 A 142 C 101 TYR B 121 TYR.? 12.07 O3 PG4 A 142 C 173 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo 32.27 5.62 48.15 31.93 6.48 51.06 -9.34 34.41 10.95 -12.33 34.37 11.59 coo 29.64 3.64 57.39 31.22 5.14 55.65 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG C 39 ARG~? 23.08 O1 EDO C 141 C 101 TYR A 121 TYR.? -24.35 CL CL A 141s C 173 ASP A 50 ASP.? 20.38 CL CL A 141 coo 32.27 5.62 48.15 31.93 6.48 51.06 17.00 20.76 1.74 15.55 23.42 1.18 coo 29.64 3.64 57.39 31.22 5.14 55.65 16.31 29.26 0.34 18.85 29.40 1.41 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 11.71 33.66 5.09 12.68 31.93 4.37 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 39 ARG~? 11.53 C4 PG4 A 142 D 101 TYR B 121 TYR.? 12.07 O3 PG4 A 142 D 173 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo 69.08 8.58 32.60 69.70 10.81 30.58 -9.34 34.41 10.95 -12.33 34.37 11.59 coo 71.77 11.86 24.26 70.23 12.22 26.56 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 71.60 6.14 19.25 70.26 6.87 20.69 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG C 39 ARG~? 23.08 O1 EDO C 141 D 101 TYR A 121 TYR.? -24.35 CL CL A 141s D 173 ASP A 50 ASP.? 20.38 CL CL A 141 coo 69.08 8.58 32.60 69.70 10.81 30.58 17.00 20.76 1.74 15.55 23.42 1.18 coo 71.77 11.86 24.26 70.23 12.22 26.56 16.31 29.26 0.34 18.85 29.40 1.41 coo 71.60 6.14 19.25 70.26 6.87 20.69 11.71 33.66 5.09 12.68 31.93 4.37 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 121 TYR.? -24.35 CL CL A 141s B 173 ASP A 50 ASP.? 20.38 CL CL A 141 D 48 ARG C 39 ARG~? 23.08 O1 EDO C 141 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 16.31 29.26 0.34 18.85 29.40 1.41 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 11.71 33.66 5.09 12.68 31.93 4.37 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 17.00 20.76 1.74 15.55 23.42 1.18 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR B 121 TYR.? 12.07 O3 PG4 A 142 B 173 ASP B 50 ASP.? 10.53 C3 PG4 A 142 D 48 ARG A 39 ARG~? 11.53 C4 PG4 A 142 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -9.34 34.41 10.95 -12.33 34.37 11.59 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c03 naa= 3 ULMN 3 1d5r_c00 PHOSPHOINOSITIDE PHOSPHOTASE PTEN user 1 3 # 1 A 92 ASP A 59 ASP.? 10.45 O ACT A 140 A 124 CYH A 57 CYH^? 5.51 O ACT A 139 A 130 ARG A 111 ARG.? 7.83 OXT ACT A 139 coo 38.50 84.15 22.11 36.72 85.12 21.46 -11.63 55.20 7.79 -12.68 54.74 6.05 coo 39.50 92.46 25.29 36.94 91.57 26.24 -4.80 51.41 4.83 -3.45 51.64 2.37 coo 39.28 86.97 26.61 39.95 87.60 23.68 -9.64 52.74 3.70 -9.14 55.70 2.93 ULMN 3 1d5r_c00 PHOSPHOINOSITIDE PHOSPHOTASE PTEN user 2 3 # 2 A 92 ASP B 59 ASP.? 11.98 O ACT B 139 A 124 CYH B 57 CYH^? 5.44 OXT ACT B 139 A 130 ARG B 111 ARG.? 7.92 O ACT B 139 coo 38.50 84.15 22.11 36.72 85.12 21.46 -53.34 42.20 5.44 -53.68 42.89 7.35 coo 39.50 92.46 25.29 36.94 91.57 26.24 -46.68 38.10 8.15 -46.29 36.73 10.60 coo 39.28 86.97 26.61 39.95 87.60 23.68 -50.20 41.64 9.27 -52.60 39.78 9.98 ULMN 3 1d5r_c00 PHOSPHOINOSITIDE PHOSPHOTASE PTEN user 3 3 # 3 A 92 ASP C 59 ASP.? 10.26 O1 EDO C 141 A 124 CYH C 57 CYH^? 5.55 OXT ACT C 139 A 130 ARG C 111 ARG.? 7.98 O ACT C 139 coo 38.50 84.15 22.11 36.72 85.12 21.46 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 39.50 92.46 25.29 36.94 91.57 26.24 4.72 8.42 8.22 5.18 7.19 10.69 coo 39.28 86.97 26.61 39.95 87.60 23.68 1.09 11.93 9.22 -1.20 10.06 10.11 1d5r_c00 source 1d5r PHOSPHOINOSITIDE PHOSPHOTASE PTEN : 3 hits 1d5r_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 56 ILE A 56 ILE^? 12.41 O ACT A 139 A 82 TYR A 71 TYR~? 13.98 CL CL A 141 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -2.60 48.39 7.69 -2.93 47.67 8.89 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -3.80 41.21 9.78 -5.71 41.25 7.73 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP B 59 ASP.? 11.98 O ACT B 139 A 56 ILE B 56 ILE^? 9.21 CL CL B 141 A 82 TYR B 91 TYR^? 6.76 CL CL B 141 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -53.34 42.20 5.44 -53.68 42.89 7.35 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -43.03 37.62 5.28 -42.60 38.32 4.11 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -45.69 32.60 8.25 -43.08 32.05 9.08 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP B 59 ASP.? 11.98 O ACT B 139 A 56 ILE B 92 ILE^? 10.67 CL CL B 141 A 82 TYR B 91 TYR^? 6.76 CL CL B 141 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -53.34 42.20 5.44 -53.68 42.89 7.35 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -43.94 34.38 3.02 -44.11 34.85 1.75 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -45.69 32.60 8.25 -43.08 32.05 9.08 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP B 135 ASP.? 12.47 O1 PG4 B 142 A 56 ILE B 56 ILE^? 9.21 CL CL B 141 A 82 TYR B 71 TYR~? 11.95 CL CL B 141 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -43.03 37.62 5.28 -42.60 38.32 4.11 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -37.36 42.24 3.20 -38.26 43.87 5.26 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 5 3 # 5 A 37 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 56 ILE C 56 ILE^? 12.37 OXT ACT C 139 A 82 TYR C 71 TYR~? 15.80 O1 EDO C 140 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 7.61 19.22 2.17 7.62 20.80 3.62 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 8.47 7.86 5.41 8.82 8.51 4.13 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 13.97 12.69 3.28 12.99 14.27 5.33 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 5 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 135 ASP.? 12.08 C3 PG4 A 142 B 56 ILE A 56 ILE^? 12.41 O ACT A 139 B 82 TYR A 71 TYR~? 13.98 CL CL A 141 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -2.60 48.39 7.69 -2.93 47.67 8.89 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -3.80 41.21 9.78 -5.71 41.25 7.73 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP B 135 ASP.? 12.47 O1 PG4 B 142 B 56 ILE B 56 ILE^? 9.21 CL CL B 141 B 82 TYR B 71 TYR~? 11.95 CL CL B 141 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -43.03 37.62 5.28 -42.60 38.32 4.11 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -37.36 42.24 3.20 -38.26 43.87 5.26 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP C 135 ASP.? 16.41 O1 EDO C 141 B 56 ILE C 56 ILE^? 12.37 OXT ACT C 139 B 82 TYR C 71 TYR~? 15.80 O1 EDO C 140 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 7.61 19.22 2.17 7.62 20.80 3.62 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 8.47 7.86 5.41 8.82 8.51 4.13 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 13.97 12.69 3.28 12.99 14.27 5.33 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 3 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 102 TYR^? -13.60 O ACT A 139s A 243 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 272 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 2.03 68.31 21.46 0.66 68.36 23.90 6.40 53.61 9.02 6.49 53.06 6.26 coo 16.93 55.67 9.65 17.16 54.23 11.19 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 14.13 45.79 13.40 14.25 49.41 18.30 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 121 TYR.? -24.35 CL CL A 141s A 243 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 272 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo 2.03 68.31 21.46 0.66 68.36 23.90 16.31 29.26 0.34 18.85 29.40 1.41 coo 16.93 55.67 9.65 17.16 54.23 11.19 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 14.13 45.79 13.40 14.25 49.41 18.30 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR B 102 TYR^? 9.93 CL CL B 141 A 243 ASP B 135 ASP.? 12.47 O1 PG4 B 142 A 272 LYS B 35 LYS~? 12.61 C1 PG4 B 142 coo 2.03 68.31 21.46 0.66 68.36 23.90 -43.22 27.21 3.69 -42.78 27.37 6.43 coo 16.93 55.67 9.65 17.16 54.23 11.19 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 14.13 45.79 13.40 14.25 49.41 18.30 -36.80 53.61 6.27 -41.39 52.63 2.26 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR B 121 TYR.? 12.07 O3 PG4 A 142 A 243 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 272 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo 2.03 68.31 21.46 0.66 68.36 23.90 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 16.93 55.67 9.65 17.16 54.23 11.19 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 14.13 45.79 13.40 14.25 49.41 18.30 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR C 102 TYR^? -13.61 OXT ACT C 139s A 243 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 272 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 2.03 68.31 21.46 0.66 68.36 23.90 8.48 -2.42 4.05 9.05 -2.18 6.78 coo 16.93 55.67 9.65 17.16 54.23 11.19 7.61 19.22 2.17 7.62 20.80 3.62 coo 14.13 45.79 13.40 14.25 49.41 18.30 14.41 24.06 5.83 10.24 22.70 1.76 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR C 121 TYR.? -26.53 O1 EDO C 140s A 243 ASP C 13 ASP~? 27.02 O1 EDO C 140 A 272 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo 2.03 68.31 21.46 0.66 68.36 23.90 34.69 1.42 12.98 35.97 -0.87 12.11 coo 16.93 55.67 9.65 17.16 54.23 11.19 26.45 23.84 13.97 27.74 25.29 14.77 coo 14.13 45.79 13.40 14.25 49.41 18.30 15.48 20.46 18.00 15.72 26.44 16.52 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 6 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 69 LYS~? 10.70 CH3 ACT A 140 A 177 GLU A 63 GLU~? 7.87 O ACT A 140 A 201 LEU A 66 LEU~? 10.51 O ACT A 140 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -2.48 44.21 16.37 -5.74 47.67 20.09 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -8.21 47.33 15.56 -9.57 45.91 16.65 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 1 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 69 LYS~? 10.70 CH3 ACT A 140 B 177 GLU A 63 GLU~? 7.87 O ACT A 140 B 201 LEU A 66 LEU~? 10.51 O ACT A 140 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -2.48 44.21 16.37 -5.74 47.67 20.09 coo 27.00 6.35 51.01 26.30 4.53 50.18 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -8.21 47.33 15.56 -9.57 45.91 16.65 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 1 hits 1daa_c01 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 131 HIS^? 7.42 CL CL A 141 B 646 ASP A 25 ASP.? 6.66 OXT ACT A 139 B 739 GLY A 64 GLY~? 8.05 O ACT A 140 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -5.68 50.60 11.44 -5.90 50.48 12.19 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS B 131 HIS^? 7.27 CL CL B 140 B 646 ASP B 25 ASP.? 6.52 O ACT B 139 B 739 GLY B 64 GLY~? 14.04 CL CL B 141 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -42.92 41.25 13.23 -43.42 39.34 13.91 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -46.53 39.33 1.61 -46.53 39.59 0.85 ULMN 3 1ddj_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS C 131 HIS^? 6.39 C1 EDO C 140 B 646 ASP C 25 ASP.? 6.36 O2 EDO C 140 B 739 GLY C 64 GLY~? 8.12 O1 EDO C 141 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 8.46 11.73 13.23 7.93 9.80 13.86 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 4.46 12.53 17.74 4.84 11.35 19.48 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 4.96 9.44 1.72 4.95 9.71 0.95 1ddj_c13 source 1ddj PLASMINOGEN : 3 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 110 HIS.? -3.69 OXT ACT A 139s D 646 ASP A 25 ASP.? 6.66 OXT ACT A 139 D 739 GLY A 64 GLY~? 8.05 O ACT A 140 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -5.68 50.60 11.44 -5.90 50.48 12.19 ULMN 3 1ddj_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 131 HIS^? 7.42 CL CL A 141 D 646 ASP A 25 ASP.? 6.66 OXT ACT A 139 D 739 GLY A 64 GLY~? 8.05 O ACT A 140 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -5.68 50.60 11.44 -5.90 50.48 12.19 ULMN 3 1ddj_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS B 110 HIS.? -3.67 O ACT B 139s D 646 ASP B 25 ASP.? 6.52 O ACT B 139 D 739 GLY B 64 GLY~? 14.04 CL CL B 141 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -46.84 38.28 15.22 -46.41 37.31 17.03 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -46.53 39.33 1.61 -46.53 39.59 0.85 ULMN 3 1ddj_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS B 131 HIS^? 7.27 CL CL B 140 D 646 ASP B 25 ASP.? 6.52 O ACT B 139 D 739 GLY B 64 GLY~? 14.04 CL CL B 141 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -42.92 41.25 13.23 -43.42 39.34 13.91 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -46.53 39.33 1.61 -46.53 39.59 0.85 ULMN 3 1ddj_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS C 110 HIS.? 3.59 O ACT C 139s D 646 ASP C 25 ASP.? 6.36 O2 EDO C 140 D 739 GLY C 64 GLY~? 8.12 O1 EDO C 141 coo -30.51 33.83 43.05 -30.50 33.12 45.03 4.54 8.83 15.35 4.90 7.96 17.23 coo -25.73 33.05 39.28 -27.50 34.05 39.88 4.46 12.53 17.74 4.84 11.35 19.48 coo -27.66 47.32 40.66 -27.81 47.01 41.41 4.96 9.44 1.72 4.95 9.71 0.95 ULMN 3 1ddj_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS C 131 HIS^? 6.39 C1 EDO C 140 D 646 ASP C 25 ASP.? 6.36 O2 EDO C 140 D 739 GLY C 64 GLY~? 8.12 O1 EDO C 141 coo -30.51 33.83 43.05 -30.50 33.12 45.03 8.46 11.73 13.23 7.93 9.80 13.86 coo -25.73 33.05 39.28 -27.50 34.05 39.88 4.46 12.53 17.74 4.84 11.35 19.48 coo -27.66 47.32 40.66 -27.81 47.01 41.41 4.96 9.44 1.72 4.95 9.71 0.95 1ddj_c15 source 1ddj PLASMINOGEN : 6 hits 1ddj_c15 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 34 GLU~? 3.97 C2 PG4 A 142 A 226 THR A 46 THR~? 14.87 CL CL A 141 A 229 LYS C 31 LYS~? 22.12 CL CL A 141 coo 9.66 102.78 70.07 9.79 101.18 71.42 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 7.24 97.46 49.60 8.11 95.69 48.80 2.59 32.57 5.50 1.31 33.68 6.79 coo 10.53 97.56 43.71 9.33 93.71 47.17 9.92 28.31 6.82 8.29 31.11 11.06 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU A 36 GLU~? 11.76 C4 PG4 A 142 A 226 THR B 11 THR~? 14.82 C3 PG4 B 142 A 229 LYS B 16 LYS~? 5.16 C5 PG4 B 142 coo 9.66 102.78 70.07 9.79 101.18 71.42 -12.87 29.42 9.52 -11.52 29.66 11.15 coo 7.24 97.46 49.60 8.11 95.69 48.80 -22.01 47.86 13.55 -21.15 45.90 13.39 coo 10.53 97.56 43.71 9.33 93.71 47.17 -29.09 50.01 17.90 -28.96 54.88 21.75 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU A 87 GLU.? -6.93 OXT ACT A 140s A 226 THR B 11 THR~? 14.82 C3 PG4 B 142 A 229 LYS B 15 LYS~? 14.97 CL CL B 140 coo 9.66 102.78 70.07 9.79 101.18 71.42 -6.70 64.26 13.84 -7.80 66.10 14.16 coo 7.24 97.46 49.60 8.11 95.69 48.80 -22.01 47.86 13.55 -21.15 45.90 13.39 coo 10.53 97.56 43.71 9.33 93.71 47.17 -27.71 47.06 15.95 -22.68 43.71 17.22 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU A 87 GLU.? -6.93 OXT ACT A 140s A 226 THR B 11 THR~? 14.82 C3 PG4 B 142 A 229 LYS B 16 LYS~? 5.16 C5 PG4 B 142 coo 9.66 102.78 70.07 9.79 101.18 71.42 -6.70 64.26 13.84 -7.80 66.10 14.16 coo 7.24 97.46 49.60 8.11 95.69 48.80 -22.01 47.86 13.55 -21.15 45.90 13.39 coo 10.53 97.56 43.71 9.33 93.71 47.17 -29.09 50.01 17.90 -28.96 54.88 21.75 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU B 34 GLU~? -4.36 C1 PG4 B 142s A 226 THR B 46 THR~? 13.77 CL CL B 141 A 229 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 9.66 102.78 70.07 9.79 101.18 71.42 -37.87 57.41 10.67 -39.60 57.08 11.90 coo 7.24 97.46 49.60 8.11 95.69 48.80 -26.72 40.90 7.30 -28.39 41.56 6.14 coo 10.53 97.56 43.71 9.33 93.71 47.17 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 57 GLU C 36 GLU~? -27.32 O1 EDO C 140s A 226 THR A 11 THR~? 14.98 O4 PG4 A 142 A 229 LYS A 16 LYS~? 4.07 C8 PG4 A 142 coo 9.66 102.78 70.07 9.79 101.18 71.42 19.61 26.41 3.01 20.17 25.01 1.52 coo 7.24 97.46 49.60 8.11 95.69 48.80 -1.34 25.09 -0.69 0.81 25.31 -0.69 coo 10.53 97.56 43.71 9.33 93.71 47.17 -6.79 30.20 -4.87 -11.32 27.78 -7.03 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 57 GLU C 87 GLU.? 6.56 O2 EDO C 141s A 226 THR A 10 THR~? 12.25 O4 PG4 A 142 A 229 LYS A 15 LYS~? 13.64 CL CL A 141 coo 9.66 102.78 70.07 9.79 101.18 71.42 -7.39 3.44 -0.70 -9.50 3.44 -0.94 coo 7.24 97.46 49.60 8.11 95.69 48.80 -3.81 22.42 0.42 -4.77 21.36 -1.16 coo 10.53 97.56 43.71 9.33 93.71 47.17 -3.53 30.44 -3.03 2.12 29.06 -5.24 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 57 GLU C 87 GLU.? 6.56 O2 EDO C 141s A 226 THR A 11 THR~? 14.98 O4 PG4 A 142 A 229 LYS A 15 LYS~? 13.64 CL CL A 141 coo 9.66 102.78 70.07 9.79 101.18 71.42 -7.39 3.44 -0.70 -9.50 3.44 -0.94 coo 7.24 97.46 49.60 8.11 95.69 48.80 -1.34 25.09 -0.69 0.81 25.31 -0.69 coo 10.53 97.56 43.71 9.33 93.71 47.17 -3.53 30.44 -3.03 2.12 29.06 -5.24 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 A 57 GLU C 87 GLU.? 6.56 O2 EDO C 141s A 226 THR A 11 THR~? 14.98 O4 PG4 A 142 A 229 LYS A 16 LYS~? 4.07 C8 PG4 A 142 coo 9.66 102.78 70.07 9.79 101.18 71.42 -7.39 3.44 -0.70 -9.50 3.44 -0.94 coo 7.24 97.46 49.60 8.11 95.69 48.80 -1.34 25.09 -0.69 0.81 25.31 -0.69 coo 10.53 97.56 43.71 9.33 93.71 47.17 -6.79 30.20 -4.87 -11.32 27.78 -7.03 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 9 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 34 GLU~? 3.97 C2 PG4 A 142 B 226 THR A 46 THR~? 14.87 CL CL A 141 B 229 LYS C 31 LYS~? 22.12 CL CL A 141 coo 15.90 87.61 49.61 13.92 86.96 49.36 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 20.74 95.78 68.68 19.29 96.84 69.83 2.59 32.57 5.50 1.31 33.68 6.79 coo 22.32 101.61 71.64 17.89 98.63 71.55 9.92 28.31 6.82 8.29 31.11 11.06 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU A 36 GLU~? 11.76 C4 PG4 A 142 B 226 THR B 11 THR~? 14.82 C3 PG4 B 142 B 229 LYS B 16 LYS~? 5.16 C5 PG4 B 142 coo 15.90 87.61 49.61 13.92 86.96 49.36 -12.87 29.42 9.52 -11.52 29.66 11.15 coo 20.74 95.78 68.68 19.29 96.84 69.83 -22.01 47.86 13.55 -21.15 45.90 13.39 coo 22.32 101.61 71.64 17.89 98.63 71.55 -29.09 50.01 17.90 -28.96 54.88 21.75 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU A 87 GLU.? -6.93 OXT ACT A 140s B 226 THR B 11 THR~? 14.82 C3 PG4 B 142 B 229 LYS B 15 LYS~? 14.97 CL CL B 140 coo 15.90 87.61 49.61 13.92 86.96 49.36 -6.70 64.26 13.84 -7.80 66.10 14.16 coo 20.74 95.78 68.68 19.29 96.84 69.83 -22.01 47.86 13.55 -21.15 45.90 13.39 coo 22.32 101.61 71.64 17.89 98.63 71.55 -27.71 47.06 15.95 -22.68 43.71 17.22 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 57 GLU A 87 GLU.? -6.93 OXT ACT A 140s B 226 THR B 11 THR~? 14.82 C3 PG4 B 142 B 229 LYS B 16 LYS~? 5.16 C5 PG4 B 142 coo 15.90 87.61 49.61 13.92 86.96 49.36 -6.70 64.26 13.84 -7.80 66.10 14.16 coo 20.74 95.78 68.68 19.29 96.84 69.83 -22.01 47.86 13.55 -21.15 45.90 13.39 coo 22.32 101.61 71.64 17.89 98.63 71.55 -29.09 50.01 17.90 -28.96 54.88 21.75 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 57 GLU B 34 GLU~? -4.36 C1 PG4 B 142s B 226 THR B 46 THR~? 13.77 CL CL B 141 B 229 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 15.90 87.61 49.61 13.92 86.96 49.36 -37.87 57.41 10.67 -39.60 57.08 11.90 coo 20.74 95.78 68.68 19.29 96.84 69.83 -26.72 40.90 7.30 -28.39 41.56 6.14 coo 22.32 101.61 71.64 17.89 98.63 71.55 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 57 GLU C 36 GLU~? -27.32 O1 EDO C 140s B 226 THR A 11 THR~? 14.98 O4 PG4 A 142 B 229 LYS A 16 LYS~? 4.07 C8 PG4 A 142 coo 15.90 87.61 49.61 13.92 86.96 49.36 19.61 26.41 3.01 20.17 25.01 1.52 coo 20.74 95.78 68.68 19.29 96.84 69.83 -1.34 25.09 -0.69 0.81 25.31 -0.69 coo 22.32 101.61 71.64 17.89 98.63 71.55 -6.79 30.20 -4.87 -11.32 27.78 -7.03 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 57 GLU C 87 GLU.? 6.56 O2 EDO C 141s B 226 THR A 11 THR~? 14.98 O4 PG4 A 142 B 229 LYS A 15 LYS~? 13.64 CL CL A 141 coo 15.90 87.61 49.61 13.92 86.96 49.36 -7.39 3.44 -0.70 -9.50 3.44 -0.94 coo 20.74 95.78 68.68 19.29 96.84 69.83 -1.34 25.09 -0.69 0.81 25.31 -0.69 coo 22.32 101.61 71.64 17.89 98.63 71.55 -3.53 30.44 -3.03 2.12 29.06 -5.24 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 57 GLU C 87 GLU.? 6.56 O2 EDO C 141s B 226 THR A 11 THR~? 14.98 O4 PG4 A 142 B 229 LYS A 16 LYS~? 4.07 C8 PG4 A 142 coo 15.90 87.61 49.61 13.92 86.96 49.36 -7.39 3.44 -0.70 -9.50 3.44 -0.94 coo 20.74 95.78 68.68 19.29 96.84 69.83 -1.34 25.09 -0.69 0.81 25.31 -0.69 coo 22.32 101.61 71.64 17.89 98.63 71.55 -6.79 30.20 -4.87 -11.32 27.78 -7.03 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 8 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 34 GLU~? 3.97 C2 PG4 A 142 C 226 THR A 46 THR~? 14.87 CL CL A 141 C 229 LYS C 31 LYS~? 22.12 CL CL A 141 coo 5.43 40.40 61.63 4.27 41.99 60.90 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 22.16 45.88 73.63 23.23 47.70 73.25 2.59 32.57 5.50 1.31 33.68 6.79 coo 28.90 45.91 73.55 25.22 49.72 72.97 9.92 28.31 6.82 8.29 31.11 11.06 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU A 36 GLU~? 11.76 C4 PG4 A 142 C 226 THR B 11 THR~? 14.82 C3 PG4 B 142 C 229 LYS B 16 LYS~? 5.16 C5 PG4 B 142 coo 5.43 40.40 61.63 4.27 41.99 60.90 -12.87 29.42 9.52 -11.52 29.66 11.15 coo 22.16 45.88 73.63 23.23 47.70 73.25 -22.01 47.86 13.55 -21.15 45.90 13.39 coo 28.90 45.91 73.55 25.22 49.72 72.97 -29.09 50.01 17.90 -28.96 54.88 21.75 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU A 87 GLU.? -6.93 OXT ACT A 140s C 226 THR B 11 THR~? 14.82 C3 PG4 B 142 C 229 LYS B 15 LYS~? 14.97 CL CL B 140 coo 5.43 40.40 61.63 4.27 41.99 60.90 -6.70 64.26 13.84 -7.80 66.10 14.16 coo 22.16 45.88 73.63 23.23 47.70 73.25 -22.01 47.86 13.55 -21.15 45.90 13.39 coo 28.90 45.91 73.55 25.22 49.72 72.97 -27.71 47.06 15.95 -22.68 43.71 17.22 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 57 GLU A 87 GLU.? -6.93 OXT ACT A 140s C 226 THR B 11 THR~? 14.82 C3 PG4 B 142 C 229 LYS B 16 LYS~? 5.16 C5 PG4 B 142 coo 5.43 40.40 61.63 4.27 41.99 60.90 -6.70 64.26 13.84 -7.80 66.10 14.16 coo 22.16 45.88 73.63 23.23 47.70 73.25 -22.01 47.86 13.55 -21.15 45.90 13.39 coo 28.90 45.91 73.55 25.22 49.72 72.97 -29.09 50.01 17.90 -28.96 54.88 21.75 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 57 GLU B 34 GLU~? -4.36 C1 PG4 B 142s C 226 THR B 46 THR~? 13.77 CL CL B 141 C 229 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 5.43 40.40 61.63 4.27 41.99 60.90 -37.87 57.41 10.67 -39.60 57.08 11.90 coo 22.16 45.88 73.63 23.23 47.70 73.25 -26.72 40.90 7.30 -28.39 41.56 6.14 coo 28.90 45.91 73.55 25.22 49.72 72.97 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 57 GLU C 36 GLU~? -27.32 O1 EDO C 140s C 226 THR A 11 THR~? 14.98 O4 PG4 A 142 C 229 LYS A 16 LYS~? 4.07 C8 PG4 A 142 coo 5.43 40.40 61.63 4.27 41.99 60.90 19.61 26.41 3.01 20.17 25.01 1.52 coo 22.16 45.88 73.63 23.23 47.70 73.25 -1.34 25.09 -0.69 0.81 25.31 -0.69 coo 28.90 45.91 73.55 25.22 49.72 72.97 -6.79 30.20 -4.87 -11.32 27.78 -7.03 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 57 GLU C 87 GLU.? 6.56 O2 EDO C 141s C 226 THR A 11 THR~? 14.98 O4 PG4 A 142 C 229 LYS A 15 LYS~? 13.64 CL CL A 141 coo 5.43 40.40 61.63 4.27 41.99 60.90 -7.39 3.44 -0.70 -9.50 3.44 -0.94 coo 22.16 45.88 73.63 23.23 47.70 73.25 -1.34 25.09 -0.69 0.81 25.31 -0.69 coo 28.90 45.91 73.55 25.22 49.72 72.97 -3.53 30.44 -3.03 2.12 29.06 -5.24 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 57 GLU C 87 GLU.? 6.56 O2 EDO C 141s C 226 THR A 11 THR~? 14.98 O4 PG4 A 142 C 229 LYS A 16 LYS~? 4.07 C8 PG4 A 142 coo 5.43 40.40 61.63 4.27 41.99 60.90 -7.39 3.44 -0.70 -9.50 3.44 -0.94 coo 22.16 45.88 73.63 23.23 47.70 73.25 -1.34 25.09 -0.69 0.81 25.31 -0.69 coo 28.90 45.91 73.55 25.22 49.72 72.97 -6.79 30.20 -4.87 -11.32 27.78 -7.03 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 8 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 34 GLU~? 3.97 C2 PG4 A 142 D 226 THR A 46 THR~? 14.87 CL CL A 141 D 229 LYS C 31 LYS~? 22.12 CL CL A 141 coo 26.07 55.89 66.14 25.33 56.50 68.01 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 11.79 47.62 52.67 10.10 46.51 53.39 2.59 32.57 5.50 1.31 33.68 6.79 coo 10.05 41.79 49.80 7.94 44.71 53.76 9.92 28.31 6.82 8.29 31.11 11.06 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU A 36 GLU~? 11.76 C4 PG4 A 142 D 226 THR B 11 THR~? 14.82 C3 PG4 B 142 D 229 LYS B 16 LYS~? 5.16 C5 PG4 B 142 coo 26.07 55.89 66.14 25.33 56.50 68.01 -12.87 29.42 9.52 -11.52 29.66 11.15 coo 11.79 47.62 52.67 10.10 46.51 53.39 -22.01 47.86 13.55 -21.15 45.90 13.39 coo 10.05 41.79 49.80 7.94 44.71 53.76 -29.09 50.01 17.90 -28.96 54.88 21.75 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU A 87 GLU.? -6.93 OXT ACT A 140s D 226 THR B 11 THR~? 14.82 C3 PG4 B 142 D 229 LYS B 15 LYS~? 14.97 CL CL B 140 coo 26.07 55.89 66.14 25.33 56.50 68.01 -6.70 64.26 13.84 -7.80 66.10 14.16 coo 11.79 47.62 52.67 10.10 46.51 53.39 -22.01 47.86 13.55 -21.15 45.90 13.39 coo 10.05 41.79 49.80 7.94 44.71 53.76 -27.71 47.06 15.95 -22.68 43.71 17.22 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 57 GLU A 87 GLU.? -6.93 OXT ACT A 140s D 226 THR B 11 THR~? 14.82 C3 PG4 B 142 D 229 LYS B 16 LYS~? 5.16 C5 PG4 B 142 coo 26.07 55.89 66.14 25.33 56.50 68.01 -6.70 64.26 13.84 -7.80 66.10 14.16 coo 11.79 47.62 52.67 10.10 46.51 53.39 -22.01 47.86 13.55 -21.15 45.90 13.39 coo 10.05 41.79 49.80 7.94 44.71 53.76 -29.09 50.01 17.90 -28.96 54.88 21.75 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 57 GLU B 34 GLU~? -4.36 C1 PG4 B 142s D 226 THR B 46 THR~? 13.77 CL CL B 141 D 229 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 26.07 55.89 66.14 25.33 56.50 68.01 -37.87 57.41 10.67 -39.60 57.08 11.90 coo 11.79 47.62 52.67 10.10 46.51 53.39 -26.72 40.90 7.30 -28.39 41.56 6.14 coo 10.05 41.79 49.80 7.94 44.71 53.76 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 57 GLU C 36 GLU~? -27.32 O1 EDO C 140s D 226 THR A 11 THR~? 14.98 O4 PG4 A 142 D 229 LYS A 16 LYS~? 4.07 C8 PG4 A 142 coo 26.07 55.89 66.14 25.33 56.50 68.01 19.61 26.41 3.01 20.17 25.01 1.52 coo 11.79 47.62 52.67 10.10 46.51 53.39 -1.34 25.09 -0.69 0.81 25.31 -0.69 coo 10.05 41.79 49.80 7.94 44.71 53.76 -6.79 30.20 -4.87 -11.32 27.78 -7.03 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 57 GLU C 87 GLU.? 6.56 O2 EDO C 141s D 226 THR A 11 THR~? 14.98 O4 PG4 A 142 D 229 LYS A 15 LYS~? 13.64 CL CL A 141 coo 26.07 55.89 66.14 25.33 56.50 68.01 -7.39 3.44 -0.70 -9.50 3.44 -0.94 coo 11.79 47.62 52.67 10.10 46.51 53.39 -1.34 25.09 -0.69 0.81 25.31 -0.69 coo 10.05 41.79 49.80 7.94 44.71 53.76 -3.53 30.44 -3.03 2.12 29.06 -5.24 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 57 GLU C 87 GLU.? 6.56 O2 EDO C 141s D 226 THR A 11 THR~? 14.98 O4 PG4 A 142 D 229 LYS A 16 LYS~? 4.07 C8 PG4 A 142 coo 26.07 55.89 66.14 25.33 56.50 68.01 -7.39 3.44 -0.70 -9.50 3.44 -0.94 coo 11.79 47.62 52.67 10.10 46.51 53.39 -1.34 25.09 -0.69 0.81 25.31 -0.69 coo 10.05 41.79 49.80 7.94 44.71 53.76 -6.79 30.20 -4.87 -11.32 27.78 -7.03 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 8 hits 1dfo_c07 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 200 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 229 LYS B 47 LYS~? 12.98 C2 PG4 A 142 coo 1.13 77.49 40.64 0.62 75.57 39.98 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 0.84 91.24 49.01 2.91 91.61 49.23 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 10.53 97.56 43.71 9.33 93.71 47.17 -23.16 41.10 5.81 -22.85 46.07 1.96 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS C 110 HIS.? 3.59 O ACT C 139s A 200 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 229 LYS A 47 LYS~? 18.08 C5 PG4 A 142 coo 1.13 77.49 40.64 0.62 75.57 39.98 4.54 8.83 15.35 4.90 7.96 17.23 coo 0.84 91.24 49.01 2.91 91.61 49.23 7.61 19.22 2.17 7.62 20.80 3.62 coo 10.53 97.56 43.71 9.33 93.71 47.17 4.15 29.38 6.95 0.12 26.77 10.99 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 110 HIS.? -3.69 OXT ACT A 139s B 200 ASP A 135 ASP.? 12.08 C3 PG4 A 142 B 229 LYS B 47 LYS~? 12.98 C2 PG4 A 142 coo 9.24 94.26 88.22 8.02 94.07 89.92 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 17.54 90.31 75.01 17.17 92.01 73.80 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 22.32 101.61 71.64 17.89 98.63 71.55 -23.16 41.10 5.81 -22.85 46.07 1.96 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS C 110 HIS.? 3.59 O ACT C 139s B 200 ASP C 135 ASP.? 16.41 O1 EDO C 141 B 229 LYS A 47 LYS~? 18.08 C5 PG4 A 142 coo 9.24 94.26 88.22 8.02 94.07 89.92 4.54 8.83 15.35 4.90 7.96 17.23 coo 17.54 90.31 75.01 17.17 92.01 73.80 7.61 19.22 2.17 7.62 20.80 3.62 coo 22.32 101.61 71.64 17.89 98.63 71.55 4.15 29.38 6.95 0.12 26.77 10.99 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 110 HIS.? -3.69 OXT ACT A 139s C 200 ASP A 135 ASP.? 12.08 C3 PG4 A 142 C 229 LYS B 47 LYS~? 12.98 C2 PG4 A 142 coo 26.77 65.84 83.49 27.06 67.76 84.27 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 19.52 52.01 79.59 20.28 51.65 77.65 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 28.90 45.91 73.55 25.22 49.72 72.97 -23.16 41.10 5.81 -22.85 46.07 1.96 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS C 110 HIS.? 3.59 O ACT C 139s C 200 ASP C 135 ASP.? 16.41 O1 EDO C 141 C 229 LYS A 47 LYS~? 18.08 C5 PG4 A 142 coo 26.77 65.84 83.49 27.06 67.76 84.27 4.54 8.83 15.35 4.90 7.96 17.23 coo 19.52 52.01 79.59 20.28 51.65 77.65 7.61 19.22 2.17 7.62 20.80 3.62 coo 28.90 45.91 73.55 25.22 49.72 72.97 4.15 29.38 6.95 0.12 26.77 10.99 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 110 HIS.? -3.69 OXT ACT A 139s D 200 ASP A 135 ASP.? 12.08 C3 PG4 A 142 D 229 LYS B 47 LYS~? 12.98 C2 PG4 A 142 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 4.60 52.95 52.50 5.57 51.29 53.40 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 10.05 41.79 49.80 7.94 44.71 53.76 -23.16 41.10 5.81 -22.85 46.07 1.96 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS C 110 HIS.? 3.59 O ACT C 139s D 200 ASP C 135 ASP.? 16.41 O1 EDO C 141 D 229 LYS A 47 LYS~? 18.08 C5 PG4 A 142 coo -10.90 48.74 53.41 -12.98 48.90 53.67 4.54 8.83 15.35 4.90 7.96 17.23 coo 4.60 52.95 52.50 5.57 51.29 53.40 7.61 19.22 2.17 7.62 20.80 3.62 coo 10.05 41.79 49.80 7.94 44.71 53.76 4.15 29.38 6.95 0.12 26.77 10.99 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 133 TYR A 71 TYR~? 13.98 CL CL A 141 A 138 ARG A 39 ARG~? 11.53 C4 PG4 A 142 A 161 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo 29.03 88.95 86.80 28.09 90.57 84.75 -3.80 41.21 9.78 -5.71 41.25 7.73 coo 23.31 93.18 82.88 23.00 93.71 79.86 -9.34 34.41 10.95 -12.33 34.37 11.59 coo 33.83 91.15 88.62 31.07 91.06 83.02 -2.48 44.21 16.37 -5.74 47.67 20.09 1dhp_c00 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 1 hits 1dhp_c00 naa= 3 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 133 TYR A 71 TYR~? 13.98 CL CL A 141 B 138 ARG A 39 ARG~? 11.53 C4 PG4 A 142 B 161 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo 4.62 122.69 99.88 5.46 122.82 97.24 -3.80 41.21 9.78 -5.71 41.25 7.73 coo 10.44 122.27 94.08 11.02 123.87 91.53 -9.34 34.41 10.95 -12.33 34.37 11.59 coo -0.17 119.75 99.65 2.51 123.83 95.70 -2.48 44.21 16.37 -5.74 47.67 20.09 1dhp_c01 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 1 hits 1dhp_c01 naa= 3 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 1 3 # 1 123 CYH A 57 CYH^? 5.51 O ACT A 139 171 ASP A 25 ASP.? 6.66 OXT ACT A 139 202 HIS A 110 HIS.? -3.69 OXT ACT A 139s coo 13.53 50.63 6.92 14.43 49.91 4.38 -4.80 51.41 4.83 -3.45 51.64 2.37 coo 11.86 58.52 0.90 11.25 56.63 1.71 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 12.37 53.26 1.34 11.86 52.62 3.19 -5.26 51.32 -2.26 -4.16 51.41 -4.05 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 2 3 # 2 123 CYH A 57 CYH^? 5.51 O ACT A 139 171 ASP A 25 ASP.? 6.66 OXT ACT A 139 202 HIS A 131 HIS^? 7.42 CL CL A 141 coo 13.53 50.63 6.92 14.43 49.91 4.38 -4.80 51.41 4.83 -3.45 51.64 2.37 coo 11.86 58.52 0.90 11.25 56.63 1.71 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 12.37 53.26 1.34 11.86 52.62 3.19 -5.82 46.49 -0.22 -4.38 47.88 -0.81 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 3 3 # 3 123 CYH B 57 CYH^? 5.44 OXT ACT B 139 171 ASP B 25 ASP.? 6.52 O ACT B 139 202 HIS B 110 HIS.? -3.67 O ACT B 139s coo 13.53 50.63 6.92 14.43 49.91 4.38 -46.68 38.10 8.15 -46.29 36.73 10.60 coo 11.86 58.52 0.90 11.25 56.63 1.71 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 12.37 53.26 1.34 11.86 52.62 3.19 -46.84 38.28 15.22 -46.41 37.31 17.03 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 4 3 # 4 123 CYH B 57 CYH^? 5.44 OXT ACT B 139 171 ASP B 25 ASP.? 6.52 O ACT B 139 202 HIS B 131 HIS^? 7.27 CL CL B 140 coo 13.53 50.63 6.92 14.43 49.91 4.38 -46.68 38.10 8.15 -46.29 36.73 10.60 coo 11.86 58.52 0.90 11.25 56.63 1.71 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 12.37 53.26 1.34 11.86 52.62 3.19 -42.92 41.25 13.23 -43.42 39.34 13.91 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 5 3 # 5 123 CYH C 57 CYH^? 5.55 OXT ACT C 139 171 ASP C 25 ASP.? 6.36 O2 EDO C 140 202 HIS C 110 HIS.? 3.59 O ACT C 139s coo 13.53 50.63 6.92 14.43 49.91 4.38 4.72 8.42 8.22 5.18 7.19 10.69 coo 11.86 58.52 0.90 11.25 56.63 1.71 4.46 12.53 17.74 4.84 11.35 19.48 coo 12.37 53.26 1.34 11.86 52.62 3.19 4.54 8.83 15.35 4.90 7.96 17.23 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 6 3 # 6 123 CYH C 57 CYH^? 5.55 OXT ACT C 139 171 ASP C 25 ASP.? 6.36 O2 EDO C 140 202 HIS C 131 HIS^? 6.39 C1 EDO C 140 coo 13.53 50.63 6.92 14.43 49.91 4.38 4.72 8.42 8.22 5.18 7.19 10.69 coo 11.86 58.52 0.90 11.25 56.63 1.71 4.46 12.53 17.74 4.84 11.35 19.48 coo 12.37 53.26 1.34 11.86 52.62 3.19 8.46 11.73 13.23 7.93 9.80 13.86 1din_c00 source 1din DIENELACTONE HYDROLASE : 6 hits 1din_c00 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 77 TYR.? 19.05 CL CL A 141 A 183 LYS A 97 LYS.? 17.22 CL CL A 141 A 278 ASP A 50 ASP.? 20.38 CL CL A 141 coo 19.43 18.53 42.32 17.66 18.80 40.15 5.38 39.08 12.89 6.76 38.23 10.57 coo 21.92 15.80 36.19 17.64 19.44 36.35 12.14 41.01 8.19 12.52 43.66 3.40 coo 15.46 19.03 31.40 15.01 18.25 33.31 11.71 33.66 5.09 12.68 31.93 4.37 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR A 121 TYR.? -24.35 CL CL A 141s A 183 LYS C 31 LYS~? 22.12 CL CL A 141 A 278 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 19.43 18.53 42.32 17.66 18.80 40.15 16.31 29.26 0.34 18.85 29.40 1.41 coo 21.92 15.80 36.19 17.64 19.44 36.35 9.92 28.31 6.82 8.29 31.11 11.06 coo 15.46 19.03 31.40 15.01 18.25 33.31 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1do8_c00 MALIC ENZYME user 3 3 # 3 A 112 TYR A 121 TYR.? -24.35 CL CL A 141s A 183 LYS C 35 LYS~? 18.91 O1 EDO C 141 A 278 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 19.43 18.53 42.32 17.66 18.80 40.15 16.31 29.26 0.34 18.85 29.40 1.41 coo 21.92 15.80 36.19 17.64 19.44 36.35 14.41 24.06 5.83 10.24 22.70 1.76 coo 15.46 19.03 31.40 15.01 18.25 33.31 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1do8_c00 MALIC ENZYME user 4 3 # 4 A 112 TYR A 129 TYR^? 7.28 CL CL A 141 A 183 LYS A 15 LYS~? 13.64 CL CL A 141 A 278 ASP A 13 ASP~? 8.68 O4 PG4 A 142 coo 19.43 18.53 42.32 17.66 18.80 40.15 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo 21.92 15.80 36.19 17.64 19.44 36.35 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 15.46 19.03 31.40 15.01 18.25 33.31 -7.05 24.91 -1.30 -7.93 23.21 -2.19 ULMN 3 1do8_c00 MALIC ENZYME user 5 3 # 5 A 112 TYR B 129 TYR^? 7.32 CL CL B 140 A 183 LYS B 15 LYS~? 14.97 CL CL B 140 A 278 ASP B 13 ASP~? 8.48 C4 PG4 B 142 coo 19.43 18.53 42.32 17.66 18.80 40.15 -32.31 42.16 13.95 -29.70 41.99 14.85 coo 21.92 15.80 36.19 17.64 19.44 36.35 -27.71 47.06 15.95 -22.68 43.71 17.22 coo 15.46 19.03 31.40 15.01 18.25 33.31 -24.74 52.92 14.33 -24.14 54.73 15.30 ULMN 3 1do8_c00 MALIC ENZYME user 6 3 # 6 A 112 TYR C 77 TYR.? 19.70 O1 EDO C 140 A 183 LYS C 97 LYS.? 16.45 O1 EDO C 140 A 278 ASP C 50 ASP.? 22.48 O1 EDO C 140 coo 19.43 18.53 42.32 17.66 18.80 40.15 20.38 5.85 0.13 21.94 5.21 2.42 coo 21.92 15.80 36.19 17.64 19.44 36.35 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 15.46 19.03 31.40 15.01 18.25 33.31 28.54 3.26 7.93 30.44 3.42 8.82 ULMN 3 1do8_c00 MALIC ENZYME user 7 3 # 7 A 112 TYR C 129 TYR^? 13.46 O1 EDO C 140 A 183 LYS C 15 LYS~? 19.87 O1 EDO C 140 A 278 ASP C 13 ASP~? 27.02 O1 EDO C 140 coo 19.43 18.53 42.32 17.66 18.80 40.15 18.89 13.20 13.92 21.55 13.21 14.74 coo 21.92 15.80 36.19 17.64 19.44 36.35 23.48 18.06 15.81 27.69 13.80 17.86 coo 15.46 19.03 31.40 15.01 18.25 33.31 26.45 23.84 13.97 27.74 25.29 14.77 1do8_c00 source 1do8 MALIC ENZYME : 7 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 77 TYR.? 19.05 CL CL A 141 B 183 LYS A 97 LYS.? 17.22 CL CL A 141 B 278 ASP A 50 ASP.? 20.38 CL CL A 141 coo 58.62 15.99 58.34 60.98 14.60 58.93 5.38 39.08 12.89 6.76 38.23 10.57 coo 60.11 10.60 53.63 62.59 10.74 58.67 12.14 41.01 8.19 12.52 43.66 3.40 coo 66.50 7.32 58.45 66.26 9.42 58.23 11.71 33.66 5.09 12.68 31.93 4.37 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR A 121 TYR.? -24.35 CL CL A 141s B 183 LYS C 31 LYS~? 22.12 CL CL A 141 B 278 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 58.62 15.99 58.34 60.98 14.60 58.93 16.31 29.26 0.34 18.85 29.40 1.41 coo 60.11 10.60 53.63 62.59 10.74 58.67 9.92 28.31 6.82 8.29 31.11 11.06 coo 66.50 7.32 58.45 66.26 9.42 58.23 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1do8_c01 MALIC ENZYME user 3 3 # 3 B 112 TYR A 121 TYR.? -24.35 CL CL A 141s B 183 LYS C 35 LYS~? 18.91 O1 EDO C 141 B 278 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 58.62 15.99 58.34 60.98 14.60 58.93 16.31 29.26 0.34 18.85 29.40 1.41 coo 60.11 10.60 53.63 62.59 10.74 58.67 14.41 24.06 5.83 10.24 22.70 1.76 coo 66.50 7.32 58.45 66.26 9.42 58.23 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1do8_c01 MALIC ENZYME user 4 3 # 4 B 112 TYR A 129 TYR^? 7.28 CL CL A 141 B 183 LYS A 15 LYS~? 13.64 CL CL A 141 B 278 ASP A 13 ASP~? 8.68 O4 PG4 A 142 coo 58.62 15.99 58.34 60.98 14.60 58.93 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo 60.11 10.60 53.63 62.59 10.74 58.67 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 66.50 7.32 58.45 66.26 9.42 58.23 -7.05 24.91 -1.30 -7.93 23.21 -2.19 ULMN 3 1do8_c01 MALIC ENZYME user 5 3 # 5 B 112 TYR B 129 TYR^? 7.32 CL CL B 140 B 183 LYS B 15 LYS~? 14.97 CL CL B 140 B 278 ASP B 13 ASP~? 8.48 C4 PG4 B 142 coo 58.62 15.99 58.34 60.98 14.60 58.93 -32.31 42.16 13.95 -29.70 41.99 14.85 coo 60.11 10.60 53.63 62.59 10.74 58.67 -27.71 47.06 15.95 -22.68 43.71 17.22 coo 66.50 7.32 58.45 66.26 9.42 58.23 -24.74 52.92 14.33 -24.14 54.73 15.30 ULMN 3 1do8_c01 MALIC ENZYME user 6 3 # 6 B 112 TYR C 77 TYR.? 19.70 O1 EDO C 140 B 183 LYS C 97 LYS.? 16.45 O1 EDO C 140 B 278 ASP C 50 ASP.? 22.48 O1 EDO C 140 coo 58.62 15.99 58.34 60.98 14.60 58.93 20.38 5.85 0.13 21.94 5.21 2.42 coo 60.11 10.60 53.63 62.59 10.74 58.67 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 66.50 7.32 58.45 66.26 9.42 58.23 28.54 3.26 7.93 30.44 3.42 8.82 ULMN 3 1do8_c01 MALIC ENZYME user 7 3 # 7 B 112 TYR C 129 TYR^? 13.46 O1 EDO C 140 B 183 LYS C 15 LYS~? 19.87 O1 EDO C 140 B 278 ASP C 13 ASP~? 27.02 O1 EDO C 140 coo 58.62 15.99 58.34 60.98 14.60 58.93 18.89 13.20 13.92 21.55 13.21 14.74 coo 60.11 10.60 53.63 62.59 10.74 58.67 23.48 18.06 15.81 27.69 13.80 17.86 coo 66.50 7.32 58.45 66.26 9.42 58.23 26.45 23.84 13.97 27.74 25.29 14.77 1do8_c01 source 1do8 MALIC ENZYME : 7 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 77 TYR.? 19.05 CL CL A 141 C 183 LYS A 97 LYS.? 17.22 CL CL A 141 C 278 ASP A 50 ASP.? 20.38 CL CL A 141 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 5.38 39.08 12.89 6.76 38.23 10.57 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 12.14 41.01 8.19 12.52 43.66 3.40 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 11.71 33.66 5.09 12.68 31.93 4.37 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR A 121 TYR.? -24.35 CL CL A 141s C 183 LYS C 31 LYS~? 22.12 CL CL A 141 C 278 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 16.31 29.26 0.34 18.85 29.40 1.41 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 9.92 28.31 6.82 8.29 31.11 11.06 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1do8_c02 MALIC ENZYME user 3 3 # 3 C 112 TYR A 121 TYR.? -24.35 CL CL A 141s C 183 LYS C 35 LYS~? 18.91 O1 EDO C 141 C 278 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 16.31 29.26 0.34 18.85 29.40 1.41 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 14.41 24.06 5.83 10.24 22.70 1.76 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1do8_c02 MALIC ENZYME user 4 3 # 4 C 112 TYR A 129 TYR^? 7.28 CL CL A 141 C 183 LYS A 15 LYS~? 13.64 CL CL A 141 C 278 ASP A 13 ASP~? 8.68 O4 PG4 A 142 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -7.05 24.91 -1.30 -7.93 23.21 -2.19 ULMN 3 1do8_c02 MALIC ENZYME user 5 3 # 5 C 112 TYR B 129 TYR^? 7.32 CL CL B 140 C 183 LYS B 15 LYS~? 14.97 CL CL B 140 C 278 ASP B 13 ASP~? 8.48 C4 PG4 B 142 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -32.31 42.16 13.95 -29.70 41.99 14.85 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -27.71 47.06 15.95 -22.68 43.71 17.22 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -24.74 52.92 14.33 -24.14 54.73 15.30 ULMN 3 1do8_c02 MALIC ENZYME user 6 3 # 6 C 112 TYR C 77 TYR.? 19.70 O1 EDO C 140 C 183 LYS C 97 LYS.? 16.45 O1 EDO C 140 C 278 ASP C 50 ASP.? 22.48 O1 EDO C 140 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 20.38 5.85 0.13 21.94 5.21 2.42 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 28.54 3.26 7.93 30.44 3.42 8.82 ULMN 3 1do8_c02 MALIC ENZYME user 7 3 # 7 C 112 TYR C 129 TYR^? 13.46 O1 EDO C 140 C 183 LYS C 15 LYS~? 19.87 O1 EDO C 140 C 278 ASP C 13 ASP~? 27.02 O1 EDO C 140 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 18.89 13.20 13.92 21.55 13.21 14.74 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 23.48 18.06 15.81 27.69 13.80 17.86 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 26.45 23.84 13.97 27.74 25.29 14.77 1do8_c02 source 1do8 MALIC ENZYME : 7 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 77 TYR.? 19.05 CL CL A 141 D 183 LYS A 97 LYS.? 17.22 CL CL A 141 D 278 ASP A 50 ASP.? 20.38 CL CL A 141 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 5.38 39.08 12.89 6.76 38.23 10.57 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 12.14 41.01 8.19 12.52 43.66 3.40 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 11.71 33.66 5.09 12.68 31.93 4.37 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR A 121 TYR.? -24.35 CL CL A 141s D 183 LYS C 31 LYS~? 22.12 CL CL A 141 D 278 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 16.31 29.26 0.34 18.85 29.40 1.41 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 9.92 28.31 6.82 8.29 31.11 11.06 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1do8_c03 MALIC ENZYME user 3 3 # 3 D 112 TYR A 121 TYR.? -24.35 CL CL A 141s D 183 LYS C 35 LYS~? 18.91 O1 EDO C 141 D 278 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 16.31 29.26 0.34 18.85 29.40 1.41 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 14.41 24.06 5.83 10.24 22.70 1.76 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1do8_c03 MALIC ENZYME user 4 3 # 4 D 112 TYR A 129 TYR^? 7.28 CL CL A 141 D 183 LYS A 15 LYS~? 13.64 CL CL A 141 D 278 ASP A 13 ASP~? 8.68 O4 PG4 A 142 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -7.05 24.91 -1.30 -7.93 23.21 -2.19 ULMN 3 1do8_c03 MALIC ENZYME user 5 3 # 5 D 112 TYR B 129 TYR^? 7.32 CL CL B 140 D 183 LYS B 15 LYS~? 14.97 CL CL B 140 D 278 ASP B 13 ASP~? 8.48 C4 PG4 B 142 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -32.31 42.16 13.95 -29.70 41.99 14.85 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -27.71 47.06 15.95 -22.68 43.71 17.22 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -24.74 52.92 14.33 -24.14 54.73 15.30 ULMN 3 1do8_c03 MALIC ENZYME user 6 3 # 6 D 112 TYR C 77 TYR.? 19.70 O1 EDO C 140 D 183 LYS C 97 LYS.? 16.45 O1 EDO C 140 D 278 ASP C 50 ASP.? 22.48 O1 EDO C 140 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 20.38 5.85 0.13 21.94 5.21 2.42 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 28.54 3.26 7.93 30.44 3.42 8.82 ULMN 3 1do8_c03 MALIC ENZYME user 7 3 # 7 D 112 TYR C 129 TYR^? 13.46 O1 EDO C 140 D 183 LYS C 15 LYS~? 19.87 O1 EDO C 140 D 278 ASP C 13 ASP~? 27.02 O1 EDO C 140 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 18.89 13.20 13.92 21.55 13.21 14.74 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 23.48 18.06 15.81 27.69 13.80 17.86 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 26.45 23.84 13.97 27.74 25.29 14.77 1do8_c03 source 1do8 MALIC ENZYME : 7 hits 1do8_c03 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS A 110 HIS.? -3.69 OXT ACT A 139s E 102 ASP A 25 ASP.? 6.66 OXT ACT A 139 E 193 GLY A 55 GLY^? 10.36 O ACT A 139 coo 11.39 26.86 25.95 9.85 26.64 27.36 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 10.90 32.83 25.96 10.83 30.68 25.98 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 4.57 20.60 30.29 4.74 21.36 30.66 0.71 47.46 4.43 0.16 46.85 4.76 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 2 3 # 2 E 57 HIS B 110 HIS.? -3.67 O ACT B 139s E 102 ASP B 25 ASP.? 6.52 O ACT B 139 E 193 GLY B 55 GLY^? 4.13 CL CL B 141 coo 11.39 26.86 25.95 9.85 26.64 27.36 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 10.90 32.83 25.96 10.83 30.68 25.98 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 4.57 20.60 30.29 4.74 21.36 30.66 -40.59 35.18 8.37 -40.32 35.97 8.08 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 3 3 # 3 E 57 HIS C 110 HIS.? 3.59 O ACT C 139s E 102 ASP C 25 ASP.? 6.36 O2 EDO C 140 E 193 GLY C 55 GLY^? 8.81 O1 EDO C 140 coo 11.39 26.86 25.95 9.85 26.64 27.36 4.54 8.83 15.35 4.90 7.96 17.23 coo 10.90 32.83 25.96 10.83 30.68 25.98 4.46 12.53 17.74 4.84 11.35 19.48 coo 4.57 20.60 30.29 4.74 21.36 30.66 10.94 5.65 8.59 11.17 6.44 8.27 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 3 hits 1ds2_c02 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 215 LYS A 20 LYS~? -2.81 O1 PG4 A 142s A 277 LYS A 15 LYS~? 13.64 CL CL A 141 coo 0.50 24.09 51.68 1.51 29.34 52.35 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 13.06 30.79 51.73 11.40 35.76 53.48 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 13.04 31.88 60.72 10.57 35.34 57.49 -3.53 30.44 -3.03 2.12 29.06 -5.24 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS B 31 LYS~? 7.73 C1 PG4 B 142 A 215 LYS B 20 LYS~? -2.98 O4 PG4 B 142s A 277 LYS B 15 LYS~? 14.97 CL CL B 140 coo 0.50 24.09 51.68 1.51 29.34 52.35 -41.17 57.91 7.48 -40.76 60.95 12.06 coo 13.06 30.79 51.73 11.40 35.76 53.48 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 13.04 31.88 60.72 10.57 35.34 57.49 -27.71 47.06 15.95 -22.68 43.71 17.22 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 A 131 LYS C 31 LYS~? 22.12 CL CL A 141 A 215 LYS C 20 LYS~? 21.67 C1 EDO C 140 A 277 LYS C 15 LYS~? 19.87 O1 EDO C 140 coo 0.50 24.09 51.68 1.51 29.34 52.35 9.92 28.31 6.82 8.29 31.11 11.06 coo 13.06 30.79 51.73 11.40 35.76 53.48 15.48 20.46 18.00 15.72 26.44 16.52 coo 13.04 31.88 60.72 10.57 35.34 57.49 23.48 18.06 15.81 27.69 13.80 17.86 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 3 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 35 LYS~? 11.98 C3 PG4 A 142 B 215 LYS A 20 LYS~? -2.81 O1 PG4 A 142s B 277 LYS A 15 LYS~? 13.64 CL CL A 141 coo 6.78 45.91 16.15 7.82 40.81 15.84 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 17.88 38.77 19.81 16.38 34.23 17.24 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 20.33 37.78 11.20 16.77 34.53 13.47 -3.53 30.44 -3.03 2.12 29.06 -5.24 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS B 35 LYS~? 12.61 C1 PG4 B 142 B 215 LYS B 20 LYS~? -2.98 O4 PG4 B 142s B 277 LYS B 15 LYS~? 14.97 CL CL B 140 coo 6.78 45.91 16.15 7.82 40.81 15.84 -36.80 53.61 6.27 -41.39 52.63 2.26 coo 17.88 38.77 19.81 16.38 34.23 17.24 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 20.33 37.78 11.20 16.77 34.53 13.47 -27.71 47.06 15.95 -22.68 43.71 17.22 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 B 131 LYS C 35 LYS~? 18.91 O1 EDO C 141 B 215 LYS C 20 LYS~? 21.67 C1 EDO C 140 B 277 LYS C 15 LYS~? 19.87 O1 EDO C 140 coo 6.78 45.91 16.15 7.82 40.81 15.84 14.41 24.06 5.83 10.24 22.70 1.76 coo 17.88 38.77 19.81 16.38 34.23 17.24 15.48 20.46 18.00 15.72 26.44 16.52 coo 20.33 37.78 11.20 16.77 34.53 13.47 23.48 18.06 15.81 27.69 13.80 17.86 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 3 hits 1e19_c01 naa= 3 ULMN 3 1e2t_c00 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 A 69 CYH A 23 CYH.? -5.05 CL CL A 141s A 107 HIS A 131 HIS^? 7.42 CL CL A 141 A 122 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 107.06 101.85 70.21 107.82 99.27 70.56 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 112.02 99.34 69.11 112.26 101.12 70.20 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 114.37 105.59 70.16 113.40 104.00 71.21 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1e2t_c00 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 A 69 CYH B 23 CYH.? -4.94 CL CL B 140s A 107 HIS B 131 HIS^? 7.27 CL CL B 140 A 122 ASP B 25 ASP.? 6.52 O ACT B 139 coo 107.06 101.85 70.21 107.82 99.27 70.56 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 112.02 99.34 69.11 112.26 101.12 70.20 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 114.37 105.59 70.16 113.40 104.00 71.21 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1e2t_c00 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 3 3 # 3 A 69 CYH C 23 CYH.? 8.42 C1 EDO C 140 A 107 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 122 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 107.06 101.85 70.21 107.82 99.27 70.56 10.88 13.11 20.21 12.25 12.11 22.32 coo 112.02 99.34 69.11 112.26 101.12 70.20 8.46 11.73 13.23 7.93 9.80 13.86 coo 114.37 105.59 70.16 113.40 104.00 71.21 4.46 12.53 17.74 4.84 11.35 19.48 1e2t_c00 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 3 hits 1e2t_c00 naa= 3 ULMN 3 1e2t_c01 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 B 69 CYH A 23 CYH.? -5.05 CL CL A 141s B 107 HIS A 131 HIS^? 7.42 CL CL A 141 B 122 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 71.18 90.15 69.62 72.19 87.91 68.26 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 68.66 85.12 69.19 67.36 86.67 68.68 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 63.06 88.82 69.94 64.68 88.56 68.63 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1e2t_c01 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 B 69 CYH B 23 CYH.? -4.94 CL CL B 140s B 107 HIS B 131 HIS^? 7.27 CL CL B 140 B 122 ASP B 25 ASP.? 6.52 O ACT B 139 coo 71.18 90.15 69.62 72.19 87.91 68.26 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 68.66 85.12 69.19 67.36 86.67 68.68 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 63.06 88.82 69.94 64.68 88.56 68.63 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1e2t_c01 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 3 3 # 3 B 69 CYH C 23 CYH.? 8.42 C1 EDO C 140 B 107 HIS C 131 HIS^? 6.39 C1 EDO C 140 B 122 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 71.18 90.15 69.62 72.19 87.91 68.26 10.88 13.11 20.21 12.25 12.11 22.32 coo 68.66 85.12 69.19 67.36 86.67 68.68 8.46 11.73 13.23 7.93 9.80 13.86 coo 63.06 88.82 69.94 64.68 88.56 68.63 4.46 12.53 17.74 4.84 11.35 19.48 1e2t_c01 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 3 hits 1e2t_c01 naa= 3 ULMN 3 1e2t_c02 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 C 69 CYH A 23 CYH.? -5.05 CL CL A 141s C 107 HIS A 131 HIS^? 7.42 CL CL A 141 C 122 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 87.22 70.88 82.51 87.10 73.53 83.33 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 83.94 73.51 86.28 84.82 71.77 87.03 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 83.85 67.31 89.02 85.24 68.84 88.61 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1e2t_c02 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 C 69 CYH B 23 CYH.? -4.94 CL CL B 140s C 107 HIS B 131 HIS^? 7.27 CL CL B 140 C 122 ASP B 25 ASP.? 6.52 O ACT B 139 coo 87.22 70.88 82.51 87.10 73.53 83.33 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 83.94 73.51 86.28 84.82 71.77 87.03 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 83.85 67.31 89.02 85.24 68.84 88.61 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1e2t_c02 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 3 3 # 3 C 69 CYH C 23 CYH.? 8.42 C1 EDO C 140 C 107 HIS C 131 HIS^? 6.39 C1 EDO C 140 C 122 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 87.22 70.88 82.51 87.10 73.53 83.33 10.88 13.11 20.21 12.25 12.11 22.32 coo 83.94 73.51 86.28 84.82 71.77 87.03 8.46 11.73 13.23 7.93 9.80 13.86 coo 83.85 67.31 89.02 85.24 68.84 88.61 4.46 12.53 17.74 4.84 11.35 19.48 1e2t_c02 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 3 hits 1e2t_c02 naa= 3 ULMN 3 1e2t_c03 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 D 69 CYH A 23 CYH.? -5.05 CL CL A 141s D 107 HIS A 131 HIS^? 7.42 CL CL A 141 D 122 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 103.83 82.01 50.25 102.30 84.27 50.28 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 104.67 87.04 47.86 104.93 85.42 46.57 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 108.03 83.30 43.35 106.06 83.62 44.11 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1e2t_c03 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 D 69 CYH B 23 CYH.? -4.94 CL CL B 140s D 107 HIS B 131 HIS^? 7.27 CL CL B 140 D 122 ASP B 25 ASP.? 6.52 O ACT B 139 coo 103.83 82.01 50.25 102.30 84.27 50.28 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 104.67 87.04 47.86 104.93 85.42 46.57 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 108.03 83.30 43.35 106.06 83.62 44.11 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1e2t_c03 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 3 3 # 3 D 69 CYH C 23 CYH.? 8.42 C1 EDO C 140 D 107 HIS C 131 HIS^? 6.39 C1 EDO C 140 D 122 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 103.83 82.01 50.25 102.30 84.27 50.28 10.88 13.11 20.21 12.25 12.11 22.32 coo 104.67 87.04 47.86 104.93 85.42 46.57 8.46 11.73 13.23 7.93 9.80 13.86 coo 108.03 83.30 43.35 106.06 83.62 44.11 4.46 12.53 17.74 4.84 11.35 19.48 1e2t_c03 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 3 hits 1e2t_c03 naa= 3 ULMN 3 1e2t_c04 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 E 69 CYH A 23 CYH.? -5.05 CL CL A 141s E 107 HIS A 131 HIS^? 7.42 CL CL A 141 E 122 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 26.92 104.93 15.26 26.00 102.32 15.14 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 21.83 102.75 16.48 21.72 104.53 15.38 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 19.90 109.15 15.39 20.77 107.51 14.36 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1e2t_c04 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 E 69 CYH B 23 CYH.? -4.94 CL CL B 140s E 107 HIS B 131 HIS^? 7.27 CL CL B 140 E 122 ASP B 25 ASP.? 6.52 O ACT B 139 coo 26.92 104.93 15.26 26.00 102.32 15.14 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 21.83 102.75 16.48 21.72 104.53 15.38 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 19.90 109.15 15.39 20.77 107.51 14.36 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1e2t_c04 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 3 3 # 3 E 69 CYH C 23 CYH.? 8.42 C1 EDO C 140 E 107 HIS C 131 HIS^? 6.39 C1 EDO C 140 E 122 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 26.92 104.93 15.26 26.00 102.32 15.14 10.88 13.11 20.21 12.25 12.11 22.32 coo 21.83 102.75 16.48 21.72 104.53 15.38 8.46 11.73 13.23 7.93 9.80 13.86 coo 19.90 109.15 15.39 20.77 107.51 14.36 4.46 12.53 17.74 4.84 11.35 19.48 1e2t_c04 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 3 hits 1e2t_c04 naa= 3 ULMN 3 1e2t_c05 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 F 69 CYH A 23 CYH.? -5.05 CL CL A 141s F 107 HIS A 131 HIS^? 7.42 CL CL A 141 F 122 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 61.95 90.52 15.40 60.72 88.41 16.77 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 64.03 85.31 15.74 65.44 86.77 16.21 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 69.94 88.54 14.99 68.36 88.38 16.36 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1e2t_c05 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 F 69 CYH B 23 CYH.? -4.94 CL CL B 140s F 107 HIS B 131 HIS^? 7.27 CL CL B 140 F 122 ASP B 25 ASP.? 6.52 O ACT B 139 coo 61.95 90.52 15.40 60.72 88.41 16.77 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 64.03 85.31 15.74 65.44 86.77 16.21 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 69.94 88.54 14.99 68.36 88.38 16.36 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1e2t_c05 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 3 3 # 3 F 69 CYH C 23 CYH.? 8.42 C1 EDO C 140 F 107 HIS C 131 HIS^? 6.39 C1 EDO C 140 F 122 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 61.95 90.52 15.40 60.72 88.41 16.77 10.88 13.11 20.21 12.25 12.11 22.32 coo 64.03 85.31 15.74 65.44 86.77 16.21 8.46 11.73 13.23 7.93 9.80 13.86 coo 69.94 88.54 14.99 68.36 88.38 16.36 4.46 12.53 17.74 4.84 11.35 19.48 1e2t_c05 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 3 hits 1e2t_c05 naa= 3 ULMN 3 1e2t_c06 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 G 69 CYH A 23 CYH.? -5.05 CL CL A 141s G 107 HIS A 131 HIS^? 7.42 CL CL A 141 G 122 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 29.36 85.15 35.54 31.07 87.28 35.30 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 28.98 90.29 37.87 28.74 88.77 39.28 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 25.53 86.86 42.58 27.46 86.99 41.71 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1e2t_c06 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 G 69 CYH B 23 CYH.? -4.94 CL CL B 140s G 107 HIS B 131 HIS^? 7.27 CL CL B 140 G 122 ASP B 25 ASP.? 6.52 O ACT B 139 coo 29.36 85.15 35.54 31.07 87.28 35.30 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 28.98 90.29 37.87 28.74 88.77 39.28 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 25.53 86.86 42.58 27.46 86.99 41.71 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1e2t_c06 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 3 3 # 3 G 69 CYH C 23 CYH.? 8.42 C1 EDO C 140 G 107 HIS C 131 HIS^? 6.39 C1 EDO C 140 G 122 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 29.36 85.15 35.54 31.07 87.28 35.30 10.88 13.11 20.21 12.25 12.11 22.32 coo 28.98 90.29 37.87 28.74 88.77 39.28 8.46 11.73 13.23 7.93 9.80 13.86 coo 25.53 86.86 42.58 27.46 86.99 41.71 4.46 12.53 17.74 4.84 11.35 19.48 1e2t_c06 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 3 hits 1e2t_c06 naa= 3 ULMN 3 1e2t_c07 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 H 69 CYH A 23 CYH.? -5.05 CL CL A 141s H 107 HIS A 131 HIS^? 7.42 CL CL A 141 H 122 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 44.08 72.69 2.52 44.26 75.30 1.64 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 47.49 75.16 -1.32 46.47 73.52 -2.11 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 47.09 69.01 -4.12 45.87 70.66 -3.64 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1e2t_c07 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 H 69 CYH B 23 CYH.? -4.94 CL CL B 140s H 107 HIS B 131 HIS^? 7.27 CL CL B 140 H 122 ASP B 25 ASP.? 6.52 O ACT B 139 coo 44.08 72.69 2.52 44.26 75.30 1.64 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 47.49 75.16 -1.32 46.47 73.52 -2.11 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 47.09 69.01 -4.12 45.87 70.66 -3.64 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1e2t_c07 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 3 3 # 3 H 69 CYH C 23 CYH.? 8.42 C1 EDO C 140 H 107 HIS C 131 HIS^? 6.39 C1 EDO C 140 H 122 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 44.08 72.69 2.52 44.26 75.30 1.64 10.88 13.11 20.21 12.25 12.11 22.32 coo 47.49 75.16 -1.32 46.47 73.52 -2.11 8.46 11.73 13.23 7.93 9.80 13.86 coo 47.09 69.01 -4.12 45.87 70.66 -3.64 4.46 12.53 17.74 4.84 11.35 19.48 1e2t_c07 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 3 hits 1e2t_c07 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 41 ALA~? 7.42 C5 PG4 A 142 A 136 TYR A 129 TYR^? 7.28 CL CL A 141 A 140 LYS A 15 LYS~? 13.64 CL CL A 141 coo 55.90 7.49 23.83 56.71 8.23 22.76 -5.52 30.29 3.75 -6.35 30.92 2.62 coo 59.38 10.02 17.51 59.95 9.89 20.21 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo 59.52 3.69 18.67 62.31 6.19 22.58 -3.53 30.44 -3.03 2.12 29.06 -5.24 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA A 74 ALA~? 16.60 C4 PG4 A 142 A 136 TYR A 71 TYR~? 13.98 CL CL A 141 A 140 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo 55.90 7.49 23.83 56.71 8.23 22.76 -2.32 35.67 14.22 -3.50 35.87 13.30 coo 59.38 10.02 17.51 59.95 9.89 20.21 -3.80 41.21 9.78 -5.71 41.25 7.73 coo 59.52 3.69 18.67 62.31 6.19 22.58 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 3 3 # 3 A 107 ALA B 41 ALA~? 7.74 C3 PG4 B 142 A 136 TYR B 129 TYR^? 7.32 CL CL B 140 A 140 LYS B 15 LYS~? 14.97 CL CL B 140 coo 55.90 7.49 23.83 56.71 8.23 22.76 -28.62 49.01 9.26 -29.46 49.43 10.44 coo 59.38 10.02 17.51 59.95 9.89 20.21 -32.31 42.16 13.95 -29.70 41.99 14.85 coo 59.52 3.69 18.67 62.31 6.19 22.58 -27.71 47.06 15.95 -22.68 43.71 17.22 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 4 3 # 4 A 107 ALA C 41 ALA~? 20.40 O1 EDO C 140 A 136 TYR C 129 TYR^? 13.46 O1 EDO C 140 A 140 LYS C 15 LYS~? 19.87 O1 EDO C 140 coo 55.90 7.49 23.83 56.71 8.23 22.76 22.65 19.75 9.03 21.76 20.17 10.16 coo 59.38 10.02 17.51 59.95 9.89 20.21 18.89 13.20 13.92 21.55 13.21 14.74 coo 59.52 3.69 18.67 62.31 6.19 22.58 23.48 18.06 15.81 27.69 13.80 17.86 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 4 hits 1e7q_c01 naa= 3 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 1 3 # 1 A 205 LYS A 16 LYS~? 4.07 C8 PG4 A 142 A 207 LYS A 20 LYS~? -2.81 O1 PG4 A 142s A 366 ASP A 13 ASP~? 8.68 O4 PG4 A 142 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -7.05 24.91 -1.30 -7.93 23.21 -2.19 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 2 3 # 2 A 205 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 207 LYS A 35 LYS~? 11.98 C3 PG4 A 142 A 366 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -19.32 36.76 5.88 -23.26 35.95 1.25 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -13.45 35.10 6.93 -14.45 39.53 11.08 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 3 3 # 3 A 205 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 207 LYS B 47 LYS~? 12.98 C2 PG4 A 142 A 366 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -19.32 36.76 5.88 -23.26 35.95 1.25 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -23.16 41.10 5.81 -22.85 46.07 1.96 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 4 3 # 4 A 205 LYS A 35 LYS~? 11.98 C3 PG4 A 142 A 207 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 366 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -13.45 35.10 6.93 -14.45 39.53 11.08 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -19.32 36.76 5.88 -23.26 35.95 1.25 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 5 3 # 5 A 205 LYS B 16 LYS~? 5.16 C5 PG4 B 142 A 207 LYS B 20 LYS~? -2.98 O4 PG4 B 142s A 366 ASP B 13 ASP~? 8.48 C4 PG4 B 142 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -29.09 50.01 17.90 -28.96 54.88 21.75 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -35.63 49.45 18.32 -35.72 55.05 16.66 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -24.74 52.92 14.33 -24.14 54.73 15.30 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 6 3 # 6 A 205 LYS B 35 LYS~? 12.61 C1 PG4 B 142 A 207 LYS B 31 LYS~? 7.73 C1 PG4 B 142 A 366 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -36.80 53.61 6.27 -41.39 52.63 2.26 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -41.17 57.91 7.48 -40.76 60.95 12.06 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 7 3 # 7 A 205 LYS C 35 LYS~? 18.91 O1 EDO C 141 A 207 LYS C 31 LYS~? 22.12 CL CL A 141 A 366 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 14.41 24.06 5.83 10.24 22.70 1.76 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 9.92 28.31 6.82 8.29 31.11 11.06 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 7.61 19.22 2.17 7.62 20.80 3.62 1ec9_c04 source 1ec9 GLUCARATE DEHYDRATASE : 7 hits 1ec9_c04 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS A 16 LYS~? 4.07 C8 PG4 A 142 B 207 LYS A 20 LYS~? -2.81 O1 PG4 A 142s B 366 ASP A 13 ASP~? 8.68 O4 PG4 A 142 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -7.05 24.91 -1.30 -7.93 23.21 -2.19 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 2 3 # 2 B 205 LYS A 35 LYS~? 11.98 C3 PG4 A 142 B 207 LYS A 31 LYS~? 8.03 C2 PG4 A 142 B 366 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -13.45 35.10 6.93 -14.45 39.53 11.08 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -19.32 36.76 5.88 -23.26 35.95 1.25 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 3 3 # 3 B 205 LYS B 16 LYS~? 5.16 C5 PG4 B 142 B 207 LYS B 20 LYS~? -2.98 O4 PG4 B 142s B 366 ASP B 13 ASP~? 8.48 C4 PG4 B 142 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -29.09 50.01 17.90 -28.96 54.88 21.75 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -35.63 49.45 18.32 -35.72 55.05 16.66 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -24.74 52.92 14.33 -24.14 54.73 15.30 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 4 3 # 4 B 205 LYS B 35 LYS~? 12.61 C1 PG4 B 142 B 207 LYS B 31 LYS~? 7.73 C1 PG4 B 142 B 366 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -36.80 53.61 6.27 -41.39 52.63 2.26 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -41.17 57.91 7.48 -40.76 60.95 12.06 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 5 3 # 5 B 205 LYS C 35 LYS~? 18.91 O1 EDO C 141 B 207 LYS C 31 LYS~? 22.12 CL CL A 141 B 366 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 14.41 24.06 5.83 10.24 22.70 1.76 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 9.92 28.31 6.82 8.29 31.11 11.06 coo -11.13 25.71 4.86 -10.82 24.43 3.24 7.61 19.22 2.17 7.62 20.80 3.62 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 5 hits 1ec9_c05 naa= 3 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 1 3 # 1 C 205 LYS A 16 LYS~? 4.07 C8 PG4 A 142 C 207 LYS A 20 LYS~? -2.81 O1 PG4 A 142s C 366 ASP A 13 ASP~? 8.68 O4 PG4 A 142 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -7.05 24.91 -1.30 -7.93 23.21 -2.19 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 2 3 # 2 C 205 LYS A 31 LYS~? 8.03 C2 PG4 A 142 C 207 LYS A 35 LYS~? 11.98 C3 PG4 A 142 C 366 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 3 3 # 3 C 205 LYS A 31 LYS~? 8.03 C2 PG4 A 142 C 207 LYS B 47 LYS~? 12.98 C2 PG4 A 142 C 366 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 4 3 # 4 C 205 LYS A 35 LYS~? 11.98 C3 PG4 A 142 C 207 LYS A 31 LYS~? 8.03 C2 PG4 A 142 C 366 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 5 3 # 5 C 205 LYS B 16 LYS~? 5.16 C5 PG4 B 142 C 207 LYS B 20 LYS~? -2.98 O4 PG4 B 142s C 366 ASP B 13 ASP~? 8.48 C4 PG4 B 142 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -24.74 52.92 14.33 -24.14 54.73 15.30 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 6 3 # 6 C 205 LYS B 35 LYS~? 12.61 C1 PG4 B 142 C 207 LYS B 31 LYS~? 7.73 C1 PG4 B 142 C 366 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -36.80 53.61 6.27 -41.39 52.63 2.26 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -41.17 57.91 7.48 -40.76 60.95 12.06 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 7 3 # 7 C 205 LYS C 31 LYS~? 22.12 CL CL A 141 C 207 LYS A 47 LYS~? 18.08 C5 PG4 A 142 C 366 ASP A 50 ASP.? 20.38 CL CL A 141 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 9.92 28.31 6.82 8.29 31.11 11.06 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 4.15 29.38 6.95 0.12 26.77 10.99 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 11.71 33.66 5.09 12.68 31.93 4.37 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 8 3 # 8 C 205 LYS C 31 LYS~? 22.12 CL CL A 141 C 207 LYS C 35 LYS~? 18.91 O1 EDO C 141 C 366 ASP A 50 ASP.? 20.38 CL CL A 141 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 9.92 28.31 6.82 8.29 31.11 11.06 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 14.41 24.06 5.83 10.24 22.70 1.76 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 11.71 33.66 5.09 12.68 31.93 4.37 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 9 3 # 9 C 205 LYS C 35 LYS~? 18.91 O1 EDO C 141 C 207 LYS C 31 LYS~? 22.12 CL CL A 141 C 366 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 14.41 24.06 5.83 10.24 22.70 1.76 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 9.92 28.31 6.82 8.29 31.11 11.06 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 7.61 19.22 2.17 7.62 20.80 3.62 1ec9_c06 source 1ec9 GLUCARATE DEHYDRATASE : 9 hits 1ec9_c06 naa= 3 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 1 3 # 1 D 205 LYS A 16 LYS~? 4.07 C8 PG4 A 142 D 207 LYS A 20 LYS~? -2.81 O1 PG4 A 142s D 366 ASP A 13 ASP~? 8.68 O4 PG4 A 142 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -7.05 24.91 -1.30 -7.93 23.21 -2.19 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 2 3 # 2 D 205 LYS A 35 LYS~? 11.98 C3 PG4 A 142 D 207 LYS A 31 LYS~? 8.03 C2 PG4 A 142 D 366 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 3 3 # 3 D 205 LYS B 16 LYS~? 5.16 C5 PG4 B 142 D 207 LYS B 20 LYS~? -2.98 O4 PG4 B 142s D 366 ASP B 13 ASP~? 8.48 C4 PG4 B 142 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -24.74 52.92 14.33 -24.14 54.73 15.30 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 4 3 # 4 D 205 LYS B 35 LYS~? 12.61 C1 PG4 B 142 D 207 LYS B 31 LYS~? 7.73 C1 PG4 B 142 D 366 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -36.80 53.61 6.27 -41.39 52.63 2.26 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -41.17 57.91 7.48 -40.76 60.95 12.06 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 5 3 # 5 D 205 LYS C 35 LYS~? 18.91 O1 EDO C 141 D 207 LYS C 31 LYS~? 22.12 CL CL A 141 D 366 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 14.41 24.06 5.83 10.24 22.70 1.76 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 9.92 28.31 6.82 8.29 31.11 11.06 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 7.61 19.22 2.17 7.62 20.80 3.62 1ec9_c07 source 1ec9 GLUCARATE DEHYDRATASE : 5 hits 1ec9_c07 naa= 3 ULMN 3 1ecf_c00 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 1 3 # 1 A 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 A 101 ASN A 95 ASN^? 17.50 CL CL A 141 A 102 GLY A 96 GLY.? 18.28 CL CL A 141 coo 71.16 56.96 42.22 68.62 58.09 42.46 6.93 49.75 11.94 4.86 49.15 13.48 coo 72.93 61.40 42.14 73.34 60.57 44.12 9.19 45.75 7.76 10.53 44.74 6.44 coo 70.24 64.11 45.02 69.59 63.75 44.65 8.58 41.34 9.59 9.11 41.71 9.12 ULMN 3 1ecf_c00 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 2 3 # 2 A 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 A 101 ASN A 95 ASN^? 17.50 CL CL A 141 A 102 GLY A 99 GLY.? 22.26 CL CL A 141 coo 71.16 56.96 42.22 68.62 58.09 42.46 6.93 49.75 11.94 4.86 49.15 13.48 coo 72.93 61.40 42.14 73.34 60.57 44.12 9.19 45.75 7.76 10.53 44.74 6.44 coo 70.24 64.11 45.02 69.59 63.75 44.65 11.11 45.17 12.38 11.21 45.57 11.70 ULMN 3 1ecf_c00 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 3 3 # 3 A 1 CYH A 117 CYH^? 10.83 CL CL A 141 A 101 ASN A 126 ASN.? 14.45 CL CL A 141 A 102 GLY A 124 GLY.? 17.44 CL CL A 141 coo 71.16 56.96 42.22 68.62 58.09 42.46 5.07 37.09 1.73 2.71 35.97 2.45 coo 72.93 61.40 42.14 73.34 60.57 44.12 8.44 35.40 -3.89 10.18 35.21 -2.70 coo 70.24 64.11 45.02 69.59 63.75 44.65 9.25 29.57 -1.03 9.14 29.65 -1.86 ULMN 3 1ecf_c00 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 4 3 # 4 A 1 CYH B 101 CYH^? 12.74 CL CL B 141 A 101 ASN B 95 ASN^? 8.94 CL CL B 141 A 102 GLY B 96 GLY.? 10.89 CL CL B 141 coo 71.16 56.96 42.22 68.62 58.09 42.46 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 72.93 61.40 42.14 73.34 60.57 44.12 -34.95 28.63 4.74 -33.53 27.80 6.13 coo 70.24 64.11 45.02 69.59 63.75 44.65 -31.38 31.41 3.04 -31.45 30.75 3.48 ULMN 3 1ecf_c00 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 5 3 # 5 A 1 CYH B 101 CYH^? 12.74 CL CL B 141 A 101 ASN B 95 ASN^? 8.94 CL CL B 141 A 102 GLY B 99 GLY.? 13.44 CL CL B 141 coo 71.16 56.96 42.22 68.62 58.09 42.46 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 72.93 61.40 42.14 73.34 60.57 44.12 -34.95 28.63 4.74 -33.53 27.80 6.13 coo 70.24 64.11 45.02 69.59 63.75 44.65 -33.56 27.44 0.16 -33.84 27.10 0.81 ULMN 3 1ecf_c00 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 6 3 # 6 A 1 CYH B 117 CYH^? 10.38 CL CL B 141 A 101 ASN B 126 ASN.? 13.70 CL CL B 141 A 102 GLY B 124 GLY.? 14.98 C3 PG4 A 142 coo 71.16 56.96 42.22 68.62 58.09 42.46 -29.38 36.33 11.07 -29.51 38.97 10.51 coo 72.93 61.40 42.14 73.34 60.57 44.12 -26.16 33.99 16.45 -25.15 32.54 15.21 coo 70.24 64.11 45.02 69.59 63.75 44.65 -20.73 36.34 13.64 -20.83 36.37 14.48 ULMN 3 1ecf_c00 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 7 3 # 7 A 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 A 101 ASN C 95 ASN^? 15.21 O1 EDO C 140 A 102 GLY C 96 GLY.? 17.66 O1 EDO C 140 coo 71.16 56.96 42.22 68.62 58.09 42.46 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 72.93 61.40 42.14 73.34 60.57 44.12 16.76 -0.79 5.39 18.34 -1.36 6.71 coo 70.24 64.11 45.02 69.59 63.75 44.65 20.22 1.91 3.52 20.16 1.24 3.96 ULMN 3 1ecf_c00 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 8 3 # 8 A 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 A 101 ASN C 95 ASN^? 15.21 O1 EDO C 140 A 102 GLY C 99 GLY.? 20.09 O1 EDO C 140 coo 71.16 56.96 42.22 68.62 58.09 42.46 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 72.93 61.40 42.14 73.34 60.57 44.12 16.76 -0.79 5.39 18.34 -1.36 6.71 coo 70.24 64.11 45.02 69.59 63.75 44.65 18.17 -2.27 0.74 17.88 -2.54 1.41 ULMN 3 1ecf_c00 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 9 3 # 9 A 1 CYH C 117 CYH^? 14.56 O1 EDO C 140 A 101 ASN C 126 ASN.? 16.94 O1 EDO C 140 A 102 GLY C 124 GLY.? 21.39 O1 EDO C 140 coo 71.16 56.96 42.22 68.62 58.09 42.46 22.08 7.27 11.28 21.72 9.99 10.50 coo 72.93 61.40 42.14 73.34 60.57 44.12 25.29 5.14 16.83 26.51 3.77 15.70 coo 70.24 64.11 45.02 69.59 63.75 44.65 30.75 7.42 13.97 30.63 7.48 14.80 1ecf_c00 source 1ecf GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRA: 9 hits 1ecf_c00 naa= 3 ULMN 3 1ecf_c01 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 1 3 # 1 B 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 B 101 ASN A 95 ASN^? 17.50 CL CL A 141 B 102 GLY A 96 GLY.? 18.28 CL CL A 141 coo 75.18 21.70 37.98 75.10 20.53 35.34 6.93 49.75 11.94 4.86 49.15 13.48 coo 75.17 17.26 39.63 77.17 18.02 39.88 9.19 45.75 7.76 10.53 44.74 6.44 coo 77.89 14.61 36.82 77.45 14.93 36.19 8.58 41.34 9.59 9.11 41.71 9.12 ULMN 3 1ecf_c01 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 2 3 # 2 B 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 B 101 ASN A 95 ASN^? 17.50 CL CL A 141 B 102 GLY A 99 GLY.? 22.26 CL CL A 141 coo 75.18 21.70 37.98 75.10 20.53 35.34 6.93 49.75 11.94 4.86 49.15 13.48 coo 75.17 17.26 39.63 77.17 18.02 39.88 9.19 45.75 7.76 10.53 44.74 6.44 coo 77.89 14.61 36.82 77.45 14.93 36.19 11.11 45.17 12.38 11.21 45.57 11.70 ULMN 3 1ecf_c01 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 3 3 # 3 B 1 CYH B 101 CYH^? 12.74 CL CL B 141 B 101 ASN B 95 ASN^? 8.94 CL CL B 141 B 102 GLY B 96 GLY.? 10.89 CL CL B 141 coo 75.18 21.70 37.98 75.10 20.53 35.34 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 75.17 17.26 39.63 77.17 18.02 39.88 -34.95 28.63 4.74 -33.53 27.80 6.13 coo 77.89 14.61 36.82 77.45 14.93 36.19 -31.38 31.41 3.04 -31.45 30.75 3.48 ULMN 3 1ecf_c01 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 4 3 # 4 B 1 CYH B 101 CYH^? 12.74 CL CL B 141 B 101 ASN B 95 ASN^? 8.94 CL CL B 141 B 102 GLY B 99 GLY.? 13.44 CL CL B 141 coo 75.18 21.70 37.98 75.10 20.53 35.34 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 75.17 17.26 39.63 77.17 18.02 39.88 -34.95 28.63 4.74 -33.53 27.80 6.13 coo 77.89 14.61 36.82 77.45 14.93 36.19 -33.56 27.44 0.16 -33.84 27.10 0.81 ULMN 3 1ecf_c01 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 5 3 # 5 B 1 CYH B 117 CYH^? 10.38 CL CL B 141 B 101 ASN B 126 ASN.? 13.70 CL CL B 141 B 102 GLY B 124 GLY.? 14.98 C3 PG4 A 142 coo 75.18 21.70 37.98 75.10 20.53 35.34 -29.38 36.33 11.07 -29.51 38.97 10.51 coo 75.17 17.26 39.63 77.17 18.02 39.88 -26.16 33.99 16.45 -25.15 32.54 15.21 coo 77.89 14.61 36.82 77.45 14.93 36.19 -20.73 36.34 13.64 -20.83 36.37 14.48 ULMN 3 1ecf_c01 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 6 3 # 6 B 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 B 101 ASN C 95 ASN^? 15.21 O1 EDO C 140 B 102 GLY C 96 GLY.? 17.66 O1 EDO C 140 coo 75.18 21.70 37.98 75.10 20.53 35.34 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 75.17 17.26 39.63 77.17 18.02 39.88 16.76 -0.79 5.39 18.34 -1.36 6.71 coo 77.89 14.61 36.82 77.45 14.93 36.19 20.22 1.91 3.52 20.16 1.24 3.96 ULMN 3 1ecf_c01 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 7 3 # 7 B 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 B 101 ASN C 95 ASN^? 15.21 O1 EDO C 140 B 102 GLY C 99 GLY.? 20.09 O1 EDO C 140 coo 75.18 21.70 37.98 75.10 20.53 35.34 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 75.17 17.26 39.63 77.17 18.02 39.88 16.76 -0.79 5.39 18.34 -1.36 6.71 coo 77.89 14.61 36.82 77.45 14.93 36.19 18.17 -2.27 0.74 17.88 -2.54 1.41 1ecf_c01 source 1ecf GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRA: 7 hits 1ecf_c01 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS A 131 HIS^? 7.42 CL CL A 141 A 177 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 203 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo 8.74 45.76 47.19 9.33 46.93 45.56 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 11.68 42.31 52.96 12.05 43.92 51.65 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 18.07 52.81 49.62 14.17 49.99 48.07 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS B 131 HIS^? 7.27 CL CL B 140 A 177 ASP B 25 ASP.? 6.52 O ACT B 139 A 203 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo 8.74 45.76 47.19 9.33 46.93 45.56 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 11.68 42.31 52.96 12.05 43.92 51.65 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 18.07 52.81 49.62 14.17 49.99 48.07 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 3 3 # 3 A 99 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 177 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 203 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo 8.74 45.76 47.19 9.33 46.93 45.56 8.46 11.73 13.23 7.93 9.80 13.86 coo 11.68 42.31 52.96 12.05 43.92 51.65 4.46 12.53 17.74 4.84 11.35 19.48 coo 18.07 52.81 49.62 14.17 49.99 48.07 15.48 20.46 18.00 15.72 26.44 16.52 1ecx_c02 source 1ecx AMINOTRANSFERASE : 3 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS A 131 HIS^? 7.42 CL CL A 141 B 177 ASP A 25 ASP.? 6.66 OXT ACT A 139 B 203 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo 14.87 88.04 21.51 13.64 87.90 19.81 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 15.87 92.46 27.37 14.46 91.76 25.94 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 3.60 91.42 23.52 8.20 89.55 22.63 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 2 3 # 2 B 99 HIS B 131 HIS^? 7.27 CL CL B 140 B 177 ASP B 25 ASP.? 6.52 O ACT B 139 B 203 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo 14.87 88.04 21.51 13.64 87.90 19.81 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 15.87 92.46 27.37 14.46 91.76 25.94 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 3.60 91.42 23.52 8.20 89.55 22.63 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 3 3 # 3 B 99 HIS C 131 HIS^? 6.39 C1 EDO C 140 B 177 ASP C 25 ASP.? 6.36 O2 EDO C 140 B 203 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo 14.87 88.04 21.51 13.64 87.90 19.81 8.46 11.73 13.23 7.93 9.80 13.86 coo 15.87 92.46 27.37 14.46 91.76 25.94 4.46 12.53 17.74 4.84 11.35 19.48 coo 3.60 91.42 23.52 8.20 89.55 22.63 15.48 20.46 18.00 15.72 26.44 16.52 1ecx_c03 source 1ecx AMINOTRANSFERASE : 3 hits 1ecx_c03 naa= 3 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 A 66 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 110 GLY A 108 GLY.? -3.28 OXT ACT A 139s A 140 TYR A 91 TYR^? -8.03 O ACT A 139s coo 24.53 0.12 1.91 23.47 1.90 2.27 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 22.96 1.26 5.85 23.32 1.32 6.60 -4.76 57.33 -1.04 -5.23 57.51 -0.39 coo 21.28 7.32 1.28 21.07 5.14 3.02 0.50 53.22 4.73 2.11 51.22 3.73 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 A 66 HIS B 110 HIS.? -3.67 O ACT B 139s A 110 GLY B 108 GLY.? -3.23 O ACT B 139s A 140 TYR B 91 TYR^? 6.76 CL CL B 141 coo 24.53 0.12 1.91 23.47 1.90 2.27 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 22.96 1.26 5.85 23.32 1.32 6.60 -51.79 35.03 13.96 -52.23 35.35 13.34 coo 21.28 7.32 1.28 21.07 5.14 3.02 -45.69 32.60 8.25 -43.08 32.05 9.08 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 A 66 HIS C 110 HIS.? 3.59 O ACT C 139s A 110 GLY C 108 GLY.? -3.29 O ACT C 139s A 140 TYR C 91 TYR^? -7.96 OXT ACT C 139s coo 24.53 0.12 1.91 23.47 1.90 2.27 4.54 8.83 15.35 4.90 7.96 17.23 coo 22.96 1.26 5.85 23.32 1.32 6.60 -0.26 5.40 14.09 -0.70 5.70 13.45 coo 21.28 7.32 1.28 21.07 5.14 3.02 5.87 2.89 8.45 8.51 2.56 9.46 1ef8_c00 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 3 hits 1ef8_c00 naa= 3 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 B 66 HIS A 110 HIS.? -3.69 OXT ACT A 139s B 110 GLY A 108 GLY.? -3.28 OXT ACT A 139s B 140 TYR A 91 TYR^? -8.03 O ACT A 139s coo 15.25 42.02 9.50 15.08 40.17 8.54 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 16.54 37.86 10.86 17.07 37.78 11.48 -4.76 57.33 -1.04 -5.23 57.51 -0.39 coo 8.70 35.97 10.91 11.44 36.02 10.35 0.50 53.22 4.73 2.11 51.22 3.73 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 B 66 HIS B 110 HIS.? -3.67 O ACT B 139s B 110 GLY B 108 GLY.? -3.23 O ACT B 139s B 140 TYR B 91 TYR^? 6.76 CL CL B 141 coo 15.25 42.02 9.50 15.08 40.17 8.54 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 16.54 37.86 10.86 17.07 37.78 11.48 -51.79 35.03 13.96 -52.23 35.35 13.34 coo 8.70 35.97 10.91 11.44 36.02 10.35 -45.69 32.60 8.25 -43.08 32.05 9.08 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 B 66 HIS C 110 HIS.? 3.59 O ACT C 139s B 110 GLY C 108 GLY.? -3.29 O ACT C 139s B 140 TYR C 91 TYR^? -7.96 OXT ACT C 139s coo 15.25 42.02 9.50 15.08 40.17 8.54 4.54 8.83 15.35 4.90 7.96 17.23 coo 16.54 37.86 10.86 17.07 37.78 11.48 -0.26 5.40 14.09 -0.70 5.70 13.45 coo 8.70 35.97 10.91 11.44 36.02 10.35 5.87 2.89 8.45 8.51 2.56 9.46 1ef8_c01 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 3 hits 1ef8_c01 naa= 3 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 C 66 HIS A 110 HIS.? -3.69 OXT ACT A 139s C 110 GLY A 108 GLY.? -3.28 OXT ACT A 139s C 140 TYR A 91 TYR^? -8.03 O ACT A 139s coo -9.82 10.01 28.41 -9.17 11.02 26.71 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -4.76 57.33 -1.04 -5.23 57.51 -0.39 coo -4.68 8.05 21.05 -4.91 10.19 22.84 0.50 53.22 4.73 2.11 51.22 3.73 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 C 66 HIS B 110 HIS.? -3.67 O ACT B 139s C 110 GLY B 108 GLY.? -3.23 O ACT B 139s C 140 TYR B 91 TYR^? 6.76 CL CL B 141 coo -9.82 10.01 28.41 -9.17 11.02 26.71 -46.84 38.28 15.22 -46.41 37.31 17.03 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -51.79 35.03 13.96 -52.23 35.35 13.34 coo -4.68 8.05 21.05 -4.91 10.19 22.84 -45.69 32.60 8.25 -43.08 32.05 9.08 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 C 66 HIS C 110 HIS.? 3.59 O ACT C 139s C 110 GLY C 108 GLY.? -3.29 O ACT C 139s C 140 TYR C 91 TYR^? -7.96 OXT ACT C 139s coo -9.82 10.01 28.41 -9.17 11.02 26.71 4.54 8.83 15.35 4.90 7.96 17.23 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -0.26 5.40 14.09 -0.70 5.70 13.45 coo -4.68 8.05 21.05 -4.91 10.19 22.84 5.87 2.89 8.45 8.51 2.56 9.46 1ef8_c02 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 3 hits 1ef8_c02 naa= 3 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 B 107 ASP A 25 ASP.? 6.66 OXT ACT A 139 B 246 ASP A 104 ASP^? 12.12 O ACT A 139 B 275 HIS A 110 HIS.? -3.69 OXT ACT A 139s coo 34.84 56.77 81.62 34.95 54.74 82.03 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 43.18 49.30 68.39 44.75 49.87 69.78 2.26 57.49 7.12 4.30 57.24 7.17 coo 38.73 55.10 77.62 36.80 55.01 78.46 -5.26 51.32 -2.26 -4.16 51.41 -4.05 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 B 107 ASP A 25 ASP.? 6.66 OXT ACT A 139 B 246 ASP A 135 ASP.? 12.08 C3 PG4 A 142 B 275 HIS A 131 HIS^? 7.42 CL CL A 141 coo 34.84 56.77 81.62 34.95 54.74 82.03 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 43.18 49.30 68.39 44.75 49.87 69.78 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 38.73 55.10 77.62 36.80 55.01 78.46 -5.82 46.49 -0.22 -4.38 47.88 -0.81 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 B 107 ASP B 25 ASP.? 6.52 O ACT B 139 B 246 ASP B 104 ASP^? 11.90 OXT ACT B 139 B 275 HIS B 110 HIS.? -3.67 O ACT B 139s coo 34.84 56.77 81.62 34.95 54.74 82.03 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 43.18 49.30 68.39 44.75 49.87 69.78 -48.63 28.94 5.87 -47.34 27.30 5.89 coo 38.73 55.10 77.62 36.80 55.01 78.46 -46.84 38.28 15.22 -46.41 37.31 17.03 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 B 107 ASP B 25 ASP.? 6.52 O ACT B 139 B 246 ASP B 135 ASP.? 12.47 O1 PG4 B 142 B 275 HIS B 131 HIS^? 7.27 CL CL B 140 coo 34.84 56.77 81.62 34.95 54.74 82.03 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 43.18 49.30 68.39 44.75 49.87 69.78 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 38.73 55.10 77.62 36.80 55.01 78.46 -42.92 41.25 13.23 -43.42 39.34 13.91 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 B 107 ASP C 25 ASP.? 6.36 O2 EDO C 140 B 246 ASP C 104 ASP^? 12.14 OXT ACT C 139 B 275 HIS C 110 HIS.? 3.59 O ACT C 139s coo 34.84 56.77 81.62 34.95 54.74 82.03 4.46 12.53 17.74 4.84 11.35 19.48 coo 43.18 49.30 68.39 44.75 49.87 69.78 3.02 -0.89 6.06 4.36 -2.50 5.95 coo 38.73 55.10 77.62 36.80 55.01 78.46 4.54 8.83 15.35 4.90 7.96 17.23 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 B 107 ASP C 25 ASP.? 6.36 O2 EDO C 140 B 246 ASP C 135 ASP.? 16.41 O1 EDO C 141 B 275 HIS C 131 HIS^? 6.39 C1 EDO C 140 coo 34.84 56.77 81.62 34.95 54.74 82.03 4.46 12.53 17.74 4.84 11.35 19.48 coo 43.18 49.30 68.39 44.75 49.87 69.78 7.61 19.22 2.17 7.62 20.80 3.62 coo 38.73 55.10 77.62 36.80 55.01 78.46 8.46 11.73 13.23 7.93 9.80 13.86 1ehy_c01 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 6 hits 1ehy_c01 naa= 3 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 C 107 ASP A 25 ASP.? 6.66 OXT ACT A 139 C 246 ASP A 104 ASP^? 12.12 O ACT A 139 C 275 HIS A 110 HIS.? -3.69 OXT ACT A 139s coo 1.90 35.26 72.76 3.20 35.74 71.18 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 12.03 20.33 71.56 10.48 19.25 70.56 2.26 57.49 7.12 4.30 57.24 7.17 coo 3.92 29.96 71.75 4.22 31.96 72.31 -5.26 51.32 -2.26 -4.16 51.41 -4.05 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 C 107 ASP A 25 ASP.? 6.66 OXT ACT A 139 C 246 ASP A 135 ASP.? 12.08 C3 PG4 A 142 C 275 HIS A 131 HIS^? 7.42 CL CL A 141 coo 1.90 35.26 72.76 3.20 35.74 71.18 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 12.03 20.33 71.56 10.48 19.25 70.56 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 3.92 29.96 71.75 4.22 31.96 72.31 -5.82 46.49 -0.22 -4.38 47.88 -0.81 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 C 107 ASP B 25 ASP.? 6.52 O ACT B 139 C 246 ASP B 104 ASP^? 11.90 OXT ACT B 139 C 275 HIS B 110 HIS.? -3.67 O ACT B 139s coo 1.90 35.26 72.76 3.20 35.74 71.18 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 12.03 20.33 71.56 10.48 19.25 70.56 -48.63 28.94 5.87 -47.34 27.30 5.89 coo 3.92 29.96 71.75 4.22 31.96 72.31 -46.84 38.28 15.22 -46.41 37.31 17.03 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 C 107 ASP B 25 ASP.? 6.52 O ACT B 139 C 246 ASP B 135 ASP.? 12.47 O1 PG4 B 142 C 275 HIS B 131 HIS^? 7.27 CL CL B 140 coo 1.90 35.26 72.76 3.20 35.74 71.18 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 12.03 20.33 71.56 10.48 19.25 70.56 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 3.92 29.96 71.75 4.22 31.96 72.31 -42.92 41.25 13.23 -43.42 39.34 13.91 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 C 107 ASP C 25 ASP.? 6.36 O2 EDO C 140 C 246 ASP C 104 ASP^? 12.14 OXT ACT C 139 C 275 HIS C 110 HIS.? 3.59 O ACT C 139s coo 1.90 35.26 72.76 3.20 35.74 71.18 4.46 12.53 17.74 4.84 11.35 19.48 coo 12.03 20.33 71.56 10.48 19.25 70.56 3.02 -0.89 6.06 4.36 -2.50 5.95 coo 3.92 29.96 71.75 4.22 31.96 72.31 4.54 8.83 15.35 4.90 7.96 17.23 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 C 107 ASP C 25 ASP.? 6.36 O2 EDO C 140 C 246 ASP C 135 ASP.? 16.41 O1 EDO C 141 C 275 HIS C 131 HIS^? 6.39 C1 EDO C 140 coo 1.90 35.26 72.76 3.20 35.74 71.18 4.46 12.53 17.74 4.84 11.35 19.48 coo 12.03 20.33 71.56 10.48 19.25 70.56 7.61 19.22 2.17 7.62 20.80 3.62 coo 3.92 29.96 71.75 4.22 31.96 72.31 8.46 11.73 13.23 7.93 9.80 13.86 1ehy_c02 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 6 hits 1ehy_c02 naa= 3 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 D 107 ASP B 25 ASP.? 6.52 O ACT B 139 D 246 ASP B 135 ASP.? 12.47 O1 PG4 B 142 D 275 HIS B 131 HIS^? 7.27 CL CL B 140 coo 37.41 19.89 81.58 37.64 21.98 81.53 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 23.50 26.43 88.52 24.76 26.47 90.29 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 33.16 21.44 85.29 34.07 21.53 83.40 -42.92 41.25 13.23 -43.42 39.34 13.91 1ehy_c03 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 1 hits 1ehy_c03 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 131 HIS^? 7.42 CL CL A 141 A 197 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 223 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS B 131 HIS^? 7.27 CL CL B 140 A 197 ASP B 25 ASP.? 6.52 O ACT B 139 A 223 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -42.92 41.25 13.23 -43.42 39.34 13.91 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 A 114 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 197 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 223 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 8.46 11.73 13.23 7.93 9.80 13.86 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 4.46 12.53 17.74 4.84 11.35 19.48 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 15.48 20.46 18.00 15.72 26.44 16.52 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 3 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS A 131 HIS^? 7.42 CL CL A 141 B 197 ASP A 25 ASP.? 6.66 OXT ACT A 139 B 223 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS B 131 HIS^? 7.27 CL CL B 140 B 197 ASP B 25 ASP.? 6.52 O ACT B 139 B 223 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -42.92 41.25 13.23 -43.42 39.34 13.91 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 B 114 HIS C 131 HIS^? 6.39 C1 EDO C 140 B 197 ASP C 25 ASP.? 6.36 O2 EDO C 140 B 223 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 8.46 11.73 13.23 7.93 9.80 13.86 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 4.46 12.53 17.74 4.84 11.35 19.48 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 15.48 20.46 18.00 15.72 26.44 16.52 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 3 hits 1elq_c03 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 58 ALA^? 8.62 O ACT A 140 A 257 ALA A 61 ALA~? -3.67 C ACT A 140s A 328 ASP A 104 ASP^? 12.12 O ACT A 139 coo 39.84 24.12 8.44 38.50 24.23 9.11 -7.65 52.47 7.15 -7.34 51.97 8.48 coo 43.22 26.73 5.37 41.81 27.09 5.79 -5.79 55.28 13.25 -5.05 56.25 14.14 coo 38.17 34.10 6.67 37.72 32.06 6.84 2.26 57.49 7.12 4.30 57.24 7.17 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA B 58 ALA^? 11.90 OXT ACT B 139 A 257 ALA B 61 ALA~? 16.48 OXT ACT B 139 A 328 ASP B 104 ASP^? 11.90 OXT ACT B 139 coo 39.84 24.12 8.44 38.50 24.23 9.11 -49.08 40.03 5.89 -48.46 40.08 4.54 coo 43.22 26.73 5.37 41.81 27.09 5.79 -50.66 37.12 -0.21 -51.15 35.97 -1.06 coo 38.17 34.10 6.67 37.72 32.06 6.84 -48.63 28.94 5.87 -47.34 27.30 5.89 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA C 58 ALA^? 8.51 O1 EDO C 141 A 257 ALA C 61 ALA~? -3.72 C1 EDO C 141s A 328 ASP C 104 ASP^? 12.14 OXT ACT C 139 coo 39.84 24.12 8.44 38.50 24.23 9.11 2.32 10.24 5.90 2.90 10.23 4.51 coo 43.22 26.73 5.37 41.81 27.09 5.79 0.87 7.13 -0.12 0.41 6.02 -0.92 coo 38.17 34.10 6.67 37.72 32.06 6.84 3.02 -0.89 6.06 4.36 -2.50 5.95 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 3 hits 1eo7_c00 naa= 3 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 A 116 SER A 37 SER~? 5.05 O3 PG4 A 142 A 140 TYR B 121 TYR.? 12.07 O3 PG4 A 142 A 144 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 34.67 35.79 48.83 33.57 37.88 49.47 -11.55 30.40 5.05 -13.38 29.33 4.03 coo 29.60 38.99 53.89 30.10 37.88 51.36 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 32.73 32.94 54.42 29.29 32.83 50.35 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 A 116 SER A 72 SER~? 17.31 O ACT A 140 A 140 TYR A 71 TYR~? 13.98 CL CL A 141 A 144 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo 34.67 35.79 48.83 33.57 37.88 49.47 0.42 40.55 13.73 0.47 42.26 15.43 coo 29.60 38.99 53.89 30.10 37.88 51.36 -3.80 41.21 9.78 -5.71 41.25 7.73 coo 32.73 32.94 54.42 29.29 32.83 50.35 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 A 116 SER C 37 SER~? 25.30 O1 EDO C 140 A 140 TYR A 121 TYR.? -24.35 CL CL A 141s A 144 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 34.67 35.79 48.83 33.57 37.88 49.47 19.44 24.86 7.68 19.21 27.10 8.59 coo 29.60 38.99 53.89 30.10 37.88 51.36 16.31 29.26 0.34 18.85 29.40 1.41 coo 32.73 32.94 54.42 29.29 32.83 50.35 14.41 24.06 5.83 10.24 22.70 1.76 1eq2_c00 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c00 naa= 3 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 B 116 SER A 37 SER~? 5.05 O3 PG4 A 142 B 140 TYR B 121 TYR.? 12.07 O3 PG4 A 142 B 144 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 30.90 35.65 89.60 29.85 37.72 88.83 -11.55 30.40 5.05 -13.38 29.33 4.03 coo 24.43 38.83 86.53 27.07 38.03 86.12 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 25.13 32.62 89.49 27.74 32.61 84.91 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 B 116 SER A 72 SER~? 17.31 O ACT A 140 B 140 TYR A 71 TYR~? 13.98 CL CL A 141 B 144 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo 30.90 35.65 89.60 29.85 37.72 88.83 0.42 40.55 13.73 0.47 42.26 15.43 coo 24.43 38.83 86.53 27.07 38.03 86.12 -3.80 41.21 9.78 -5.71 41.25 7.73 coo 25.13 32.62 89.49 27.74 32.61 84.91 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 B 116 SER C 37 SER~? 25.30 O1 EDO C 140 B 140 TYR A 121 TYR.? -24.35 CL CL A 141s B 144 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 30.90 35.65 89.60 29.85 37.72 88.83 19.44 24.86 7.68 19.21 27.10 8.59 coo 24.43 38.83 86.53 27.07 38.03 86.12 16.31 29.26 0.34 18.85 29.40 1.41 coo 25.13 32.62 89.49 27.74 32.61 84.91 14.41 24.06 5.83 10.24 22.70 1.76 1eq2_c01 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c01 naa= 3 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 C 116 SER A 37 SER~? 5.05 O3 PG4 A 142 C 140 TYR B 121 TYR.? 12.07 O3 PG4 A 142 C 144 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -11.55 30.40 5.05 -13.38 29.33 4.03 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -17.06 30.29 11.99 -16.35 28.08 10.43 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 C 116 SER A 72 SER~? 17.31 O ACT A 140 C 140 TYR A 71 TYR~? 13.98 CL CL A 141 C 144 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo -8.96 33.70 98.81 -8.96 35.77 97.56 0.42 40.55 13.73 0.47 42.26 15.43 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -3.80 41.21 9.78 -5.71 41.25 7.73 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 C 116 SER C 37 SER~? 25.30 O1 EDO C 140 C 140 TYR A 121 TYR.? -24.35 CL CL A 141s C 144 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo -8.96 33.70 98.81 -8.96 35.77 97.56 19.44 24.86 7.68 19.21 27.10 8.59 coo -8.28 37.01 91.79 -6.99 36.16 94.13 16.31 29.26 0.34 18.85 29.40 1.41 coo -10.48 30.66 93.19 -5.27 31.07 94.32 14.41 24.06 5.83 10.24 22.70 1.76 1eq2_c02 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c02 naa= 3 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 D 116 SER A 37 SER~? 5.05 O3 PG4 A 142 D 140 TYR B 121 TYR.? 12.07 O3 PG4 A 142 D 144 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -11.55 30.40 5.05 -13.38 29.33 4.03 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -17.06 30.29 11.99 -16.35 28.08 10.43 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 D 116 SER A 72 SER~? 17.31 O ACT A 140 D 140 TYR A 71 TYR~? 13.98 CL CL A 141 D 144 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo -29.80 31.30 63.54 -28.79 33.52 63.37 0.42 40.55 13.73 0.47 42.26 15.43 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -3.80 41.21 9.78 -5.71 41.25 7.73 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 D 116 SER C 37 SER~? 25.30 O1 EDO C 140 D 140 TYR A 121 TYR.? -24.35 CL CL A 141s D 144 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo -29.80 31.30 63.54 -28.79 33.52 63.37 19.44 24.86 7.68 19.21 27.10 8.59 coo -23.30 35.33 62.20 -25.10 34.24 64.06 16.31 29.26 0.34 18.85 29.40 1.41 coo -24.76 28.82 60.31 -24.27 29.01 65.58 14.41 24.06 5.83 10.24 22.70 1.76 1eq2_c03 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c03 naa= 3 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 E 116 SER A 37 SER~? 5.05 O3 PG4 A 142 E 140 TYR B 121 TYR.? 12.07 O3 PG4 A 142 E 144 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -11.55 30.40 5.05 -13.38 29.33 4.03 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 E 116 SER A 72 SER~? 17.31 O ACT A 140 E 140 TYR A 71 TYR~? 13.98 CL CL A 141 E 144 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo -3.01 32.72 32.71 -2.80 34.91 33.79 0.42 40.55 13.73 0.47 42.26 15.43 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -3.80 41.21 9.78 -5.71 41.25 7.73 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 E 116 SER C 37 SER~? 25.30 O1 EDO C 140 E 140 TYR A 121 TYR.? -24.35 CL CL A 141s E 144 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo -3.01 32.72 32.71 -2.80 34.91 33.79 19.44 24.86 7.68 19.21 27.10 8.59 coo 0.04 36.70 38.68 -2.21 35.46 37.50 16.31 29.26 0.34 18.85 29.40 1.41 coo 1.93 30.52 36.31 -2.84 30.18 38.54 14.41 24.06 5.83 10.24 22.70 1.76 1eq2_c04 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c04 naa= 3 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 F 116 SER A 37 SER~? 5.05 O3 PG4 A 142 F 140 TYR B 121 TYR.? 12.07 O3 PG4 A 142 F 144 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 55.30 92.46 56.72 55.15 90.39 55.38 -11.55 30.40 5.05 -13.38 29.33 4.03 coo 54.49 89.31 49.65 53.35 90.16 52.06 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 56.78 95.62 51.15 51.59 95.31 52.37 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 F 116 SER A 72 SER~? 17.31 O ACT A 140 F 140 TYR A 71 TYR~? 13.98 CL CL A 141 F 144 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo 55.30 92.46 56.72 55.15 90.39 55.38 0.42 40.55 13.73 0.47 42.26 15.43 coo 54.49 89.31 49.65 53.35 90.16 52.06 -3.80 41.21 9.78 -5.71 41.25 7.73 coo 56.78 95.62 51.15 51.59 95.31 52.37 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 F 116 SER C 37 SER~? 25.30 O1 EDO C 140 F 140 TYR A 121 TYR.? -24.35 CL CL A 141s F 144 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 55.30 92.46 56.72 55.15 90.39 55.38 19.44 24.86 7.68 19.21 27.10 8.59 coo 54.49 89.31 49.65 53.35 90.16 52.06 16.31 29.26 0.34 18.85 29.40 1.41 coo 56.78 95.62 51.15 51.59 95.31 52.37 14.41 24.06 5.83 10.24 22.70 1.76 1eq2_c05 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c05 naa= 3 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 G 116 SER A 37 SER~? 5.05 O3 PG4 A 142 G 140 TYR B 121 TYR.? 12.07 O3 PG4 A 142 G 144 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 76.25 95.63 21.56 75.29 93.40 21.36 -11.55 30.40 5.05 -13.38 29.33 4.03 coo 69.78 91.62 20.06 71.51 92.68 22.02 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 71.19 98.21 18.32 70.69 97.75 23.67 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 G 116 SER A 72 SER~? 17.31 O ACT A 140 G 140 TYR A 71 TYR~? 13.98 CL CL A 141 G 144 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo 76.25 95.63 21.56 75.29 93.40 21.36 0.42 40.55 13.73 0.47 42.26 15.43 coo 69.78 91.62 20.06 71.51 92.68 22.02 -3.80 41.21 9.78 -5.71 41.25 7.73 coo 71.19 98.21 18.32 70.69 97.75 23.67 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 G 116 SER C 37 SER~? 25.30 O1 EDO C 140 G 140 TYR A 121 TYR.? -24.35 CL CL A 141s G 144 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 76.25 95.63 21.56 75.29 93.40 21.36 19.44 24.86 7.68 19.21 27.10 8.59 coo 69.78 91.62 20.06 71.51 92.68 22.02 16.31 29.26 0.34 18.85 29.40 1.41 coo 71.19 98.21 18.32 70.69 97.75 23.67 14.41 24.06 5.83 10.24 22.70 1.76 1eq2_c06 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c06 naa= 3 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 H 116 SER A 37 SER~? 5.05 O3 PG4 A 142 H 140 TYR B 121 TYR.? 12.07 O3 PG4 A 142 H 144 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 15.45 90.62 47.70 16.55 88.57 46.97 -11.55 30.40 5.05 -13.38 29.33 4.03 coo 21.92 87.58 44.67 19.30 88.41 44.23 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 21.26 93.70 47.67 18.47 93.68 43.08 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 H 116 SER A 72 SER~? 17.31 O ACT A 140 H 140 TYR A 71 TYR~? 13.98 CL CL A 141 H 144 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo 15.45 90.62 47.70 16.55 88.57 46.97 0.42 40.55 13.73 0.47 42.26 15.43 coo 21.92 87.58 44.67 19.30 88.41 44.23 -3.80 41.21 9.78 -5.71 41.25 7.73 coo 21.26 93.70 47.67 18.47 93.68 43.08 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 H 116 SER C 37 SER~? 25.30 O1 EDO C 140 H 140 TYR A 121 TYR.? -24.35 CL CL A 141s H 144 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 15.45 90.62 47.70 16.55 88.57 46.97 19.44 24.86 7.68 19.21 27.10 8.59 coo 21.92 87.58 44.67 19.30 88.41 44.23 16.31 29.26 0.34 18.85 29.40 1.41 coo 21.26 93.70 47.67 18.47 93.68 43.08 14.41 24.06 5.83 10.24 22.70 1.76 1eq2_c07 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c07 naa= 3 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 I 116 SER A 37 SER~? 5.05 O3 PG4 A 142 I 140 TYR B 121 TYR.? 12.07 O3 PG4 A 142 I 144 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 11.78 90.82 7.18 12.84 88.72 7.93 -11.55 30.40 5.05 -13.38 29.33 4.03 coo 16.78 87.76 12.19 16.39 88.69 9.59 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 13.67 93.83 12.65 17.08 93.94 8.58 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 I 116 SER A 72 SER~? 17.31 O ACT A 140 I 140 TYR A 71 TYR~? 13.98 CL CL A 141 I 144 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo 11.78 90.82 7.18 12.84 88.72 7.93 0.42 40.55 13.73 0.47 42.26 15.43 coo 16.78 87.76 12.19 16.39 88.69 9.59 -3.80 41.21 9.78 -5.71 41.25 7.73 coo 13.67 93.83 12.65 17.08 93.94 8.58 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 I 116 SER C 37 SER~? 25.30 O1 EDO C 140 I 140 TYR A 121 TYR.? -24.35 CL CL A 141s I 144 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 11.78 90.82 7.18 12.84 88.72 7.93 19.44 24.86 7.68 19.21 27.10 8.59 coo 16.78 87.76 12.19 16.39 88.69 9.59 16.31 29.26 0.34 18.85 29.40 1.41 coo 13.67 93.83 12.65 17.08 93.94 8.58 14.41 24.06 5.83 10.24 22.70 1.76 1eq2_c08 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c08 naa= 3 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 J 116 SER A 37 SER~? 5.05 O3 PG4 A 142 J 140 TYR B 121 TYR.? 12.07 O3 PG4 A 142 J 144 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -11.55 30.40 5.05 -13.38 29.33 4.03 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 J 116 SER A 72 SER~? 17.31 O ACT A 140 J 140 TYR A 71 TYR~? 13.98 CL CL A 141 J 144 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 0.42 40.55 13.73 0.47 42.26 15.43 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -3.80 41.21 9.78 -5.71 41.25 7.73 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 J 116 SER C 37 SER~? 25.30 O1 EDO C 140 J 140 TYR A 121 TYR.? -24.35 CL CL A 141s J 144 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 19.44 24.86 7.68 19.21 27.10 8.59 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 16.31 29.26 0.34 18.85 29.40 1.41 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 14.41 24.06 5.83 10.24 22.70 1.76 1eq2_c09 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c09 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 10 THR~? 12.25 O4 PG4 A 142 A 159 LYS A 16 LYS~? 4.07 C8 PG4 A 142 A 193 GLU A 127 GLU^? 8.20 CL CL A 141 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -3.81 22.42 0.42 -4.77 21.36 -1.16 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo -5.33 11.71 69.72 -4.62 11.92 67.73 2.90 34.77 -4.78 2.12 35.30 -6.66 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR B 10 THR~? 12.38 C3 PG4 B 142 A 159 LYS B 16 LYS~? 5.16 C5 PG4 B 142 A 193 GLU B 127 GLU^? 8.11 CL CL B 140 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -20.91 51.38 12.52 -20.63 52.82 14.06 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -29.09 50.01 17.90 -28.96 54.88 21.75 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -28.31 39.11 17.60 -29.33 39.55 19.43 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 2 hits 1et0_c02 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 131 HIS^? 7.42 CL CL A 141 C 62 LYS A 20 LYS~? -2.81 O1 PG4 A 142s F 35 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 15.40 22.79 16.66 13.93 24.10 15.98 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 19.95 18.98 4.81 18.82 20.94 10.49 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 16.32 15.30 17.19 17.71 14.73 18.69 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS B 131 HIS^? 7.27 CL CL B 140 C 62 LYS B 20 LYS~? -2.98 O4 PG4 B 142s F 35 ASP B 25 ASP.? 6.52 O ACT B 139 coo 15.40 22.79 16.66 13.93 24.10 15.98 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 19.95 18.98 4.81 18.82 20.94 10.49 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 16.32 15.30 17.19 17.71 14.73 18.69 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 3 3 # 3 A 105 HIS C 131 HIS^? 6.39 C1 EDO C 140 C 62 LYS C 20 LYS~? 21.67 C1 EDO C 140 F 35 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 15.40 22.79 16.66 13.93 24.10 15.98 8.46 11.73 13.23 7.93 9.80 13.86 coo 19.95 18.98 4.81 18.82 20.94 10.49 15.48 20.46 18.00 15.72 26.44 16.52 coo 16.32 15.30 17.19 17.71 14.73 18.69 4.46 12.53 17.74 4.84 11.35 19.48 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 3 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 20 LYS~? -2.81 O1 PG4 A 142s C 105 HIS A 131 HIS^? 7.42 CL CL A 141 D 35 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 38.76 28.25 7.87 36.33 26.41 13.58 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 34.93 19.72 17.37 34.72 18.17 15.98 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 41.01 23.02 20.83 40.65 24.26 22.55 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS B 20 LYS~? -2.98 O4 PG4 B 142s C 105 HIS B 131 HIS^? 7.27 CL CL B 140 D 35 ASP B 25 ASP.? 6.52 O ACT B 139 coo 38.76 28.25 7.87 36.33 26.41 13.58 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 34.93 19.72 17.37 34.72 18.17 15.98 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 41.01 23.02 20.83 40.65 24.26 22.55 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 3 3 # 3 B 62 LYS C 20 LYS~? 21.67 C1 EDO C 140 C 105 HIS C 131 HIS^? 6.39 C1 EDO C 140 D 35 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 38.76 28.25 7.87 36.33 26.41 13.58 15.48 20.46 18.00 15.72 26.44 16.52 coo 34.93 19.72 17.37 34.72 18.17 15.98 8.46 11.73 13.23 7.93 9.80 13.86 coo 41.01 23.02 20.83 40.65 24.26 22.55 4.46 12.53 17.74 4.84 11.35 19.48 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 3 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 20 LYS~? -2.81 O1 PG4 A 142s B 105 HIS A 131 HIS^? 7.42 CL CL A 141 E 35 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 20.51 39.76 8.83 21.23 37.38 14.18 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 27.18 37.56 20.68 29.07 38.28 20.13 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 19.97 40.39 22.03 18.53 39.30 23.18 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS B 20 LYS~? -2.98 O4 PG4 B 142s B 105 HIS B 131 HIS^? 7.27 CL CL B 140 E 35 ASP B 25 ASP.? 6.52 O ACT B 139 coo 20.51 39.76 8.83 21.23 37.38 14.18 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 27.18 37.56 20.68 29.07 38.28 20.13 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 19.97 40.39 22.03 18.53 39.30 23.18 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 3 3 # 3 A 62 LYS C 20 LYS~? 21.67 C1 EDO C 140 B 105 HIS C 131 HIS^? 6.39 C1 EDO C 140 E 35 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 20.51 39.76 8.83 21.23 37.38 14.18 15.48 20.46 18.00 15.72 26.44 16.52 coo 27.18 37.56 20.68 29.07 38.28 20.13 8.46 11.73 13.23 7.93 9.80 13.86 coo 19.97 40.39 22.03 18.53 39.30 23.18 4.46 12.53 17.74 4.84 11.35 19.48 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 3 hits 1f80_c05 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 131 HIS^? 7.42 CL CL A 141 A 210 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 244 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo 11.28 44.53 18.60 9.91 46.00 19.20 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 10.51 37.86 19.71 9.07 39.38 20.04 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -1.20 42.34 17.67 3.19 45.13 19.06 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS B 131 HIS^? 7.27 CL CL B 140 A 210 ASP B 25 ASP.? 6.52 O ACT B 139 A 244 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo 11.28 44.53 18.60 9.91 46.00 19.20 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 10.51 37.86 19.71 9.07 39.38 20.04 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -1.20 42.34 17.67 3.19 45.13 19.06 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 136 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 210 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 244 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo 11.28 44.53 18.60 9.91 46.00 19.20 8.46 11.73 13.23 7.93 9.80 13.86 coo 10.51 37.86 19.71 9.07 39.38 20.04 4.46 12.53 17.74 4.84 11.35 19.48 coo -1.20 42.34 17.67 3.19 45.13 19.06 15.48 20.46 18.00 15.72 26.44 16.52 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 3 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 131 HIS^? 7.42 CL CL A 141 B 210 ASP A 25 ASP.? 6.66 OXT ACT A 139 B 244 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo 10.08 50.18 41.78 8.91 48.61 41.04 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 9.06 56.85 40.30 7.71 55.27 39.90 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -2.38 51.82 41.62 2.07 49.19 40.42 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS B 131 HIS^? 7.27 CL CL B 140 B 210 ASP B 25 ASP.? 6.52 O ACT B 139 B 244 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo 10.08 50.18 41.78 8.91 48.61 41.04 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 9.06 56.85 40.30 7.71 55.27 39.90 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -2.38 51.82 41.62 2.07 49.19 40.42 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 136 HIS C 131 HIS^? 6.39 C1 EDO C 140 B 210 ASP C 25 ASP.? 6.36 O2 EDO C 140 B 244 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo 10.08 50.18 41.78 8.91 48.61 41.04 8.46 11.73 13.23 7.93 9.80 13.86 coo 9.06 56.85 40.30 7.71 55.27 39.90 4.46 12.53 17.74 4.84 11.35 19.48 coo -2.38 51.82 41.62 2.07 49.19 40.42 15.48 20.46 18.00 15.72 26.44 16.52 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 3 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 51 TYR^? 16.77 CL CL A 141 A 142 LEU A 54 LEU^? 13.39 CL CL A 141 A 165 LYS A 97 LYS.? 17.22 CL CL A 141 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 10.36 38.26 5.81 11.48 39.56 3.61 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 1.39 44.20 7.42 0.67 42.39 8.32 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 12.14 41.01 8.19 12.52 43.66 3.40 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR A 51 TYR^? 16.77 CL CL A 141 A 142 LEU A 75 LEU~? 16.49 CL CL A 141 A 165 LYS A 97 LYS.? 17.22 CL CL A 141 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 10.36 38.26 5.81 11.48 39.56 3.61 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 1.36 36.77 11.23 -0.02 37.22 9.63 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 12.14 41.01 8.19 12.52 43.66 3.40 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR A 71 TYR~? 13.98 CL CL A 141 A 142 LEU A 42 LEU~? 11.43 C4 PG4 A 142 A 165 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -3.80 41.21 9.78 -5.71 41.25 7.73 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -3.93 34.56 5.49 -2.88 36.46 5.38 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR A 71 TYR~? 13.98 CL CL A 141 A 142 LEU A 132 LEU^? 9.00 CL CL A 141 A 165 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -3.80 41.21 9.78 -5.71 41.25 7.73 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -6.85 40.71 3.28 -5.83 39.05 2.38 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 137 TYR A 71 TYR~? 13.98 CL CL A 141 A 142 LEU A 134 LEU.? 12.12 O ACT A 140 A 165 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -3.80 41.21 9.78 -5.71 41.25 7.73 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -9.54 46.58 8.31 -8.62 48.40 7.58 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 137 TYR A 129 TYR^? 7.28 CL CL A 141 A 142 LEU A 132 LEU^? 9.00 CL CL A 141 A 165 LYS A 15 LYS~? 13.64 CL CL A 141 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -6.85 40.71 3.28 -5.83 39.05 2.38 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -3.53 30.44 -3.03 2.12 29.06 -5.24 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 A 137 TYR B 129 TYR^? 7.32 CL CL B 140 A 142 LEU B 132 LEU^? 8.96 CL CL B 140 A 165 LYS B 15 LYS~? 14.97 CL CL B 140 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -32.31 42.16 13.95 -29.70 41.99 14.85 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -38.39 45.08 9.70 -36.46 44.99 10.68 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -27.71 47.06 15.95 -22.68 43.71 17.22 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 A 137 TYR C 51 TYR^? 16.95 O1 EDO C 140 A 142 LEU C 54 LEU^? 13.23 O1 EDO C 140 A 165 LYS C 97 LYS.? 16.45 O1 EDO C 140 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 23.83 1.97 7.35 23.34 0.41 9.61 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 14.21 6.77 5.72 15.50 8.29 4.92 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 22.33 -0.96 4.86 22.00 -3.43 10.72 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 A 137 TYR C 51 TYR^? 16.95 O1 EDO C 140 A 142 LEU C 75 LEU~? 18.85 O1 EDO C 140 A 165 LYS C 97 LYS.? 16.45 O1 EDO C 140 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 23.83 1.97 7.35 23.34 0.41 9.61 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 20.44 10.54 1.79 19.46 11.72 3.37 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 22.33 -0.96 4.86 22.00 -3.43 10.72 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 A 137 TYR C 129 TYR^? 13.46 O1 EDO C 140 A 142 LEU C 132 LEU^? 13.22 O1 EDO C 140 A 165 LYS C 15 LYS~? 19.87 O1 EDO C 140 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 18.89 13.20 13.92 21.55 13.21 14.74 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 12.86 15.51 9.60 14.79 15.72 10.59 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 23.48 18.06 15.81 27.69 13.80 17.86 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 10 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 51 TYR^? 16.77 CL CL A 141 B 142 LEU A 54 LEU^? 13.39 CL CL A 141 B 165 LYS A 97 LYS.? 17.22 CL CL A 141 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 10.36 38.26 5.81 11.48 39.56 3.61 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 1.39 44.20 7.42 0.67 42.39 8.32 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 12.14 41.01 8.19 12.52 43.66 3.40 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR A 51 TYR^? 16.77 CL CL A 141 B 142 LEU A 75 LEU~? 16.49 CL CL A 141 B 165 LYS A 97 LYS.? 17.22 CL CL A 141 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 10.36 38.26 5.81 11.48 39.56 3.61 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 1.36 36.77 11.23 -0.02 37.22 9.63 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 12.14 41.01 8.19 12.52 43.66 3.40 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR A 71 TYR~? 13.98 CL CL A 141 B 142 LEU A 42 LEU~? 11.43 C4 PG4 A 142 B 165 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -3.80 41.21 9.78 -5.71 41.25 7.73 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -3.93 34.56 5.49 -2.88 36.46 5.38 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR A 71 TYR~? 13.98 CL CL A 141 B 142 LEU A 132 LEU^? 9.00 CL CL A 141 B 165 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -3.80 41.21 9.78 -5.71 41.25 7.73 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -6.85 40.71 3.28 -5.83 39.05 2.38 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 137 TYR A 129 TYR^? 7.28 CL CL A 141 B 142 LEU A 132 LEU^? 9.00 CL CL A 141 B 165 LYS A 15 LYS~? 13.64 CL CL A 141 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -6.85 40.71 3.28 -5.83 39.05 2.38 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -3.53 30.44 -3.03 2.12 29.06 -5.24 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 137 TYR B 129 TYR^? 7.32 CL CL B 140 B 142 LEU B 132 LEU^? 8.96 CL CL B 140 B 165 LYS B 15 LYS~? 14.97 CL CL B 140 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -32.31 42.16 13.95 -29.70 41.99 14.85 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -38.39 45.08 9.70 -36.46 44.99 10.68 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -27.71 47.06 15.95 -22.68 43.71 17.22 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 B 137 TYR C 51 TYR^? 16.95 O1 EDO C 140 B 142 LEU C 54 LEU^? 13.23 O1 EDO C 140 B 165 LYS C 97 LYS.? 16.45 O1 EDO C 140 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 23.83 1.97 7.35 23.34 0.41 9.61 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 14.21 6.77 5.72 15.50 8.29 4.92 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 22.33 -0.96 4.86 22.00 -3.43 10.72 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 B 137 TYR C 51 TYR^? 16.95 O1 EDO C 140 B 142 LEU C 75 LEU~? 18.85 O1 EDO C 140 B 165 LYS C 97 LYS.? 16.45 O1 EDO C 140 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 23.83 1.97 7.35 23.34 0.41 9.61 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 20.44 10.54 1.79 19.46 11.72 3.37 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 22.33 -0.96 4.86 22.00 -3.43 10.72 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 B 137 TYR C 129 TYR^? 13.46 O1 EDO C 140 B 142 LEU C 132 LEU^? 13.22 O1 EDO C 140 B 165 LYS C 15 LYS~? 19.87 O1 EDO C 140 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 18.89 13.20 13.92 21.55 13.21 14.74 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 12.86 15.51 9.60 14.79 15.72 10.59 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 23.48 18.06 15.81 27.69 13.80 17.86 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 9 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 51 TYR^? 16.77 CL CL A 141 C 142 LEU A 75 LEU~? 16.49 CL CL A 141 C 165 LYS A 97 LYS.? 17.22 CL CL A 141 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 10.36 38.26 5.81 11.48 39.56 3.61 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 1.36 36.77 11.23 -0.02 37.22 9.63 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 12.14 41.01 8.19 12.52 43.66 3.40 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR A 71 TYR~? 13.98 CL CL A 141 C 142 LEU A 42 LEU~? 11.43 C4 PG4 A 142 C 165 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -3.80 41.21 9.78 -5.71 41.25 7.73 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -3.93 34.56 5.49 -2.88 36.46 5.38 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR A 71 TYR~? 13.98 CL CL A 141 C 142 LEU A 132 LEU^? 9.00 CL CL A 141 C 165 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -3.80 41.21 9.78 -5.71 41.25 7.73 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -6.85 40.71 3.28 -5.83 39.05 2.38 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR A 129 TYR^? 7.28 CL CL A 141 C 142 LEU A 114 LEU^? 5.93 CL CL A 141 C 165 LYS A 15 LYS~? 13.64 CL CL A 141 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -0.96 44.81 0.79 -1.59 45.51 -1.13 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -3.53 30.44 -3.03 2.12 29.06 -5.24 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 137 TYR A 129 TYR^? 7.28 CL CL A 141 C 142 LEU A 132 LEU^? 9.00 CL CL A 141 C 165 LYS A 15 LYS~? 13.64 CL CL A 141 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -6.85 40.71 3.28 -5.83 39.05 2.38 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -3.53 30.44 -3.03 2.12 29.06 -5.24 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 C 137 TYR B 129 TYR^? 7.32 CL CL B 140 C 142 LEU B 132 LEU^? 8.96 CL CL B 140 C 165 LYS B 15 LYS~? 14.97 CL CL B 140 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -32.31 42.16 13.95 -29.70 41.99 14.85 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -38.39 45.08 9.70 -36.46 44.99 10.68 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -27.71 47.06 15.95 -22.68 43.71 17.22 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 C 137 TYR C 51 TYR^? 16.95 O1 EDO C 140 C 142 LEU C 75 LEU~? 18.85 O1 EDO C 140 C 165 LYS C 97 LYS.? 16.45 O1 EDO C 140 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 23.83 1.97 7.35 23.34 0.41 9.61 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 20.44 10.54 1.79 19.46 11.72 3.37 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 22.33 -0.96 4.86 22.00 -3.43 10.72 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 C 137 TYR C 129 TYR^? 13.46 O1 EDO C 140 C 142 LEU C 132 LEU^? 13.22 O1 EDO C 140 C 165 LYS C 15 LYS~? 19.87 O1 EDO C 140 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 18.89 13.20 13.92 21.55 13.21 14.74 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 12.86 15.51 9.60 14.79 15.72 10.59 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 23.48 18.06 15.81 27.69 13.80 17.86 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 8 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 51 TYR^? 16.77 CL CL A 141 D 142 LEU A 54 LEU^? 13.39 CL CL A 141 D 165 LYS A 97 LYS.? 17.22 CL CL A 141 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 10.36 38.26 5.81 11.48 39.56 3.61 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 1.39 44.20 7.42 0.67 42.39 8.32 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 12.14 41.01 8.19 12.52 43.66 3.40 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR A 51 TYR^? 16.77 CL CL A 141 D 142 LEU A 75 LEU~? 16.49 CL CL A 141 D 165 LYS A 97 LYS.? 17.22 CL CL A 141 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 10.36 38.26 5.81 11.48 39.56 3.61 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 1.36 36.77 11.23 -0.02 37.22 9.63 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 12.14 41.01 8.19 12.52 43.66 3.40 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR A 71 TYR~? 13.98 CL CL A 141 D 142 LEU A 42 LEU~? 11.43 C4 PG4 A 142 D 165 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -3.80 41.21 9.78 -5.71 41.25 7.73 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -3.93 34.56 5.49 -2.88 36.46 5.38 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR A 71 TYR~? 13.98 CL CL A 141 D 142 LEU A 132 LEU^? 9.00 CL CL A 141 D 165 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -3.80 41.21 9.78 -5.71 41.25 7.73 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -6.85 40.71 3.28 -5.83 39.05 2.38 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 137 TYR A 129 TYR^? 7.28 CL CL A 141 D 142 LEU A 132 LEU^? 9.00 CL CL A 141 D 165 LYS A 15 LYS~? 13.64 CL CL A 141 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -6.85 40.71 3.28 -5.83 39.05 2.38 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -3.53 30.44 -3.03 2.12 29.06 -5.24 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 137 TYR B 129 TYR^? 7.32 CL CL B 140 D 142 LEU B 132 LEU^? 8.96 CL CL B 140 D 165 LYS B 15 LYS~? 14.97 CL CL B 140 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -32.31 42.16 13.95 -29.70 41.99 14.85 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -38.39 45.08 9.70 -36.46 44.99 10.68 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -27.71 47.06 15.95 -22.68 43.71 17.22 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 D 137 TYR C 51 TYR^? 16.95 O1 EDO C 140 D 142 LEU C 54 LEU^? 13.23 O1 EDO C 140 D 165 LYS C 97 LYS.? 16.45 O1 EDO C 140 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 23.83 1.97 7.35 23.34 0.41 9.61 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 14.21 6.77 5.72 15.50 8.29 4.92 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 22.33 -0.96 4.86 22.00 -3.43 10.72 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 D 137 TYR C 51 TYR^? 16.95 O1 EDO C 140 D 142 LEU C 75 LEU~? 18.85 O1 EDO C 140 D 165 LYS C 97 LYS.? 16.45 O1 EDO C 140 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 23.83 1.97 7.35 23.34 0.41 9.61 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 20.44 10.54 1.79 19.46 11.72 3.37 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 22.33 -0.96 4.86 22.00 -3.43 10.72 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 D 137 TYR C 129 TYR^? 13.46 O1 EDO C 140 D 142 LEU C 132 LEU^? 13.22 O1 EDO C 140 D 165 LYS C 15 LYS~? 19.87 O1 EDO C 140 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 18.89 13.20 13.92 21.55 13.21 14.74 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 12.86 15.51 9.60 14.79 15.72 10.59 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 23.48 18.06 15.81 27.69 13.80 17.86 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 9 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 49 SER.? 14.71 CL CL A 141 A 48 THR A 46 THR~? 14.87 CL CL A 141 A 165 LYS A 97 LYS.? 17.22 CL CL A 141 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 7.42 32.00 3.53 5.70 33.62 4.04 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 2.59 32.57 5.50 1.31 33.68 6.79 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 12.14 41.01 8.19 12.52 43.66 3.40 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER A 49 SER.? 14.71 CL CL A 141 A 48 THR A 46 THR~? 14.87 CL CL A 141 A 165 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 7.42 32.00 3.53 5.70 33.62 4.04 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 2.59 32.57 5.50 1.31 33.68 6.79 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 14.41 24.06 5.83 10.24 22.70 1.76 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 47 SER A 72 SER~? 17.31 O ACT A 140 A 48 THR A 70 THR~? 15.01 O ACT A 140 A 165 LYS A 93 LYS^? 11.69 O ACT A 139 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 0.42 40.55 13.73 0.47 42.26 15.43 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -4.79 41.37 15.30 -6.78 42.17 15.13 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 3.67 49.37 7.73 5.94 48.81 2.98 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 47 SER B 49 SER.? 12.95 CL CL B 141 A 48 THR B 46 THR~? 13.77 CL CL B 141 A 165 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -23.84 36.86 9.13 -26.20 37.40 8.61 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -26.72 40.90 7.30 -28.39 41.56 6.14 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 47 SER B 72 SER~? 14.74 CL CL B 141 A 48 THR B 70 THR~? 17.42 CL CL B 141 A 165 LYS B 93 LYS^? 4.13 CL CL B 141 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -34.82 39.01 -0.84 -36.29 38.18 -2.55 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -38.15 43.23 -2.29 -39.92 44.50 -2.06 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -40.82 31.70 5.12 -39.31 29.65 9.95 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 47 SER C 49 SER.? 18.04 O1 EDO C 140 A 48 THR C 46 THR~? 18.81 O1 EDO C 140 A 165 LYS C 97 LYS.? 16.45 O1 EDO C 140 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 27.68 7.76 9.43 25.38 8.17 8.83 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 24.68 11.60 7.33 23.08 12.18 5.97 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 22.33 -0.96 4.86 22.00 -3.43 10.72 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 A 47 SER C 72 SER~? 17.51 O1 EDO C 141 A 48 THR C 70 THR~? 14.81 O1 EDO C 141 A 165 LYS C 93 LYS^? 9.06 O1 EDO C 140 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 16.69 9.29 -0.73 15.39 8.20 -2.46 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 13.33 13.35 -2.33 11.58 14.62 -2.10 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 10.75 2.06 5.39 12.48 0.59 10.09 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 7 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 49 SER.? 14.71 CL CL A 141 B 48 THR A 46 THR~? 14.87 CL CL A 141 B 165 LYS A 97 LYS.? 17.22 CL CL A 141 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 7.42 32.00 3.53 5.70 33.62 4.04 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 2.59 32.57 5.50 1.31 33.68 6.79 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 12.14 41.01 8.19 12.52 43.66 3.40 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER A 49 SER.? 14.71 CL CL A 141 B 48 THR A 46 THR~? 14.87 CL CL A 141 B 165 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 7.42 32.00 3.53 5.70 33.62 4.04 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 2.59 32.57 5.50 1.31 33.68 6.79 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 14.41 24.06 5.83 10.24 22.70 1.76 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 47 SER A 72 SER~? 17.31 O ACT A 140 B 48 THR A 70 THR~? 15.01 O ACT A 140 B 165 LYS A 93 LYS^? 11.69 O ACT A 139 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 0.42 40.55 13.73 0.47 42.26 15.43 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -4.79 41.37 15.30 -6.78 42.17 15.13 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 3.67 49.37 7.73 5.94 48.81 2.98 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 47 SER B 49 SER.? 12.95 CL CL B 141 B 48 THR B 46 THR~? 13.77 CL CL B 141 B 165 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -23.84 36.86 9.13 -26.20 37.40 8.61 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -26.72 40.90 7.30 -28.39 41.56 6.14 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 47 SER B 72 SER~? 14.74 CL CL B 141 B 48 THR B 70 THR~? 17.42 CL CL B 141 B 165 LYS B 93 LYS^? 4.13 CL CL B 141 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -34.82 39.01 -0.84 -36.29 38.18 -2.55 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -38.15 43.23 -2.29 -39.92 44.50 -2.06 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -40.82 31.70 5.12 -39.31 29.65 9.95 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 47 SER C 49 SER.? 18.04 O1 EDO C 140 B 48 THR C 46 THR~? 18.81 O1 EDO C 140 B 165 LYS C 97 LYS.? 16.45 O1 EDO C 140 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 27.68 7.76 9.43 25.38 8.17 8.83 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 24.68 11.60 7.33 23.08 12.18 5.97 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 22.33 -0.96 4.86 22.00 -3.43 10.72 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 B 47 SER C 72 SER~? 17.51 O1 EDO C 141 B 48 THR C 70 THR~? 14.81 O1 EDO C 141 B 165 LYS C 93 LYS^? 9.06 O1 EDO C 140 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 16.69 9.29 -0.73 15.39 8.20 -2.46 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 13.33 13.35 -2.33 11.58 14.62 -2.10 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 10.75 2.06 5.39 12.48 0.59 10.09 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 7 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 49 SER.? 14.71 CL CL A 141 C 48 THR A 46 THR~? 14.87 CL CL A 141 C 165 LYS A 97 LYS.? 17.22 CL CL A 141 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 7.42 32.00 3.53 5.70 33.62 4.04 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 2.59 32.57 5.50 1.31 33.68 6.79 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 12.14 41.01 8.19 12.52 43.66 3.40 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER A 49 SER.? 14.71 CL CL A 141 C 48 THR A 46 THR~? 14.87 CL CL A 141 C 165 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 7.42 32.00 3.53 5.70 33.62 4.04 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 2.59 32.57 5.50 1.31 33.68 6.79 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 14.41 24.06 5.83 10.24 22.70 1.76 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 47 SER A 72 SER~? 17.31 O ACT A 140 C 48 THR A 70 THR~? 15.01 O ACT A 140 C 165 LYS A 93 LYS^? 11.69 O ACT A 139 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 0.42 40.55 13.73 0.47 42.26 15.43 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -4.79 41.37 15.30 -6.78 42.17 15.13 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 3.67 49.37 7.73 5.94 48.81 2.98 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 47 SER B 49 SER.? 12.95 CL CL B 141 C 48 THR B 46 THR~? 13.77 CL CL B 141 C 165 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -23.84 36.86 9.13 -26.20 37.40 8.61 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -26.72 40.90 7.30 -28.39 41.56 6.14 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 47 SER B 72 SER~? 14.74 CL CL B 141 C 48 THR B 70 THR~? 17.42 CL CL B 141 C 165 LYS B 93 LYS^? 4.13 CL CL B 141 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -34.82 39.01 -0.84 -36.29 38.18 -2.55 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -38.15 43.23 -2.29 -39.92 44.50 -2.06 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -40.82 31.70 5.12 -39.31 29.65 9.95 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 C 47 SER C 49 SER.? 18.04 O1 EDO C 140 C 48 THR C 46 THR~? 18.81 O1 EDO C 140 C 165 LYS C 97 LYS.? 16.45 O1 EDO C 140 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 27.68 7.76 9.43 25.38 8.17 8.83 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 24.68 11.60 7.33 23.08 12.18 5.97 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 22.33 -0.96 4.86 22.00 -3.43 10.72 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 C 47 SER C 72 SER~? 17.51 O1 EDO C 141 C 48 THR C 70 THR~? 14.81 O1 EDO C 141 C 165 LYS C 93 LYS^? 9.06 O1 EDO C 140 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 16.69 9.29 -0.73 15.39 8.20 -2.46 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 13.33 13.35 -2.33 11.58 14.62 -2.10 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 10.75 2.06 5.39 12.48 0.59 10.09 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 7 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 49 SER.? 14.71 CL CL A 141 D 48 THR A 46 THR~? 14.87 CL CL A 141 D 165 LYS A 97 LYS.? 17.22 CL CL A 141 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 7.42 32.00 3.53 5.70 33.62 4.04 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 2.59 32.57 5.50 1.31 33.68 6.79 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 12.14 41.01 8.19 12.52 43.66 3.40 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER A 49 SER.? 14.71 CL CL A 141 D 48 THR A 46 THR~? 14.87 CL CL A 141 D 165 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 7.42 32.00 3.53 5.70 33.62 4.04 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 2.59 32.57 5.50 1.31 33.68 6.79 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 14.41 24.06 5.83 10.24 22.70 1.76 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 47 SER A 72 SER~? 17.31 O ACT A 140 D 48 THR A 70 THR~? 15.01 O ACT A 140 D 165 LYS A 93 LYS^? 11.69 O ACT A 139 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 0.42 40.55 13.73 0.47 42.26 15.43 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -4.79 41.37 15.30 -6.78 42.17 15.13 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 3.67 49.37 7.73 5.94 48.81 2.98 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 47 SER B 49 SER.? 12.95 CL CL B 141 D 48 THR B 46 THR~? 13.77 CL CL B 141 D 165 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -23.84 36.86 9.13 -26.20 37.40 8.61 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -26.72 40.90 7.30 -28.39 41.56 6.14 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 47 SER B 72 SER~? 14.74 CL CL B 141 D 48 THR B 70 THR~? 17.42 CL CL B 141 D 165 LYS B 93 LYS^? 4.13 CL CL B 141 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -34.82 39.01 -0.84 -36.29 38.18 -2.55 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -38.15 43.23 -2.29 -39.92 44.50 -2.06 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -40.82 31.70 5.12 -39.31 29.65 9.95 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 47 SER C 49 SER.? 18.04 O1 EDO C 140 D 48 THR C 46 THR~? 18.81 O1 EDO C 140 D 165 LYS C 97 LYS.? 16.45 O1 EDO C 140 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 27.68 7.76 9.43 25.38 8.17 8.83 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 24.68 11.60 7.33 23.08 12.18 5.97 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 22.33 -0.96 4.86 22.00 -3.43 10.72 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 D 47 SER C 72 SER~? 17.51 O1 EDO C 141 D 48 THR C 70 THR~? 14.81 O1 EDO C 141 D 165 LYS C 93 LYS^? 9.06 O1 EDO C 140 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 16.69 9.29 -0.73 15.39 8.20 -2.46 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 13.33 13.35 -2.33 11.58 14.62 -2.10 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 10.75 2.06 5.39 12.48 0.59 10.09 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 7 hits 1fdy_c07 naa= 3 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 B 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 B 98 ASN A 95 ASN^? 17.50 CL CL A 141 B 99 GLY A 96 GLY.? 18.28 CL CL A 141 coo 60.40 53.51 86.58 58.33 55.30 85.83 6.93 49.75 11.94 4.86 49.15 13.48 coo 61.33 49.28 88.22 61.64 50.04 86.28 9.19 45.75 7.76 10.53 44.74 6.44 coo 60.75 49.64 92.68 61.49 50.04 92.62 8.58 41.34 9.59 9.11 41.71 9.12 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 B 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 B 98 ASN A 95 ASN^? 17.50 CL CL A 141 B 99 GLY A 99 GLY.? 22.26 CL CL A 141 coo 60.40 53.51 86.58 58.33 55.30 85.83 6.93 49.75 11.94 4.86 49.15 13.48 coo 61.33 49.28 88.22 61.64 50.04 86.28 9.19 45.75 7.76 10.53 44.74 6.44 coo 60.75 49.64 92.68 61.49 50.04 92.62 11.11 45.17 12.38 11.21 45.57 11.70 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 3 # 3 B 1 CYH B 101 CYH^? 12.74 CL CL B 141 B 98 ASN B 95 ASN^? 8.94 CL CL B 141 B 99 GLY B 96 GLY.? 10.89 CL CL B 141 coo 60.40 53.51 86.58 58.33 55.30 85.83 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 61.33 49.28 88.22 61.64 50.04 86.28 -34.95 28.63 4.74 -33.53 27.80 6.13 coo 60.75 49.64 92.68 61.49 50.04 92.62 -31.38 31.41 3.04 -31.45 30.75 3.48 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 3 # 4 B 1 CYH B 101 CYH^? 12.74 CL CL B 141 B 98 ASN B 95 ASN^? 8.94 CL CL B 141 B 99 GLY B 99 GLY.? 13.44 CL CL B 141 coo 60.40 53.51 86.58 58.33 55.30 85.83 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 61.33 49.28 88.22 61.64 50.04 86.28 -34.95 28.63 4.74 -33.53 27.80 6.13 coo 60.75 49.64 92.68 61.49 50.04 92.62 -33.56 27.44 0.16 -33.84 27.10 0.81 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 5 3 # 5 B 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 B 98 ASN C 95 ASN^? 15.21 O1 EDO C 140 B 99 GLY C 96 GLY.? 17.66 O1 EDO C 140 coo 60.40 53.51 86.58 58.33 55.30 85.83 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 61.33 49.28 88.22 61.64 50.04 86.28 16.76 -0.79 5.39 18.34 -1.36 6.71 coo 60.75 49.64 92.68 61.49 50.04 92.62 20.22 1.91 3.52 20.16 1.24 3.96 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 6 3 # 6 B 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 B 98 ASN C 95 ASN^? 15.21 O1 EDO C 140 B 99 GLY C 99 GLY.? 20.09 O1 EDO C 140 coo 60.40 53.51 86.58 58.33 55.30 85.83 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 61.33 49.28 88.22 61.64 50.04 86.28 16.76 -0.79 5.39 18.34 -1.36 6.71 coo 60.75 49.64 92.68 61.49 50.04 92.62 18.17 -2.27 0.74 17.88 -2.54 1.41 1gdo_c00 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 6 hits 1gdo_c00 naa= 3 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 D 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 D 98 ASN A 95 ASN^? 17.50 CL CL A 141 D 99 GLY A 96 GLY.? 18.28 CL CL A 141 coo 45.17 35.76 43.57 47.17 33.90 42.78 6.93 49.75 11.94 4.86 49.15 13.48 coo 44.24 40.01 45.19 43.94 39.25 43.24 9.19 45.75 7.76 10.53 44.74 6.44 coo 44.81 39.60 49.65 44.07 39.23 49.57 8.58 41.34 9.59 9.11 41.71 9.12 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 D 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 D 98 ASN A 95 ASN^? 17.50 CL CL A 141 D 99 GLY A 99 GLY.? 22.26 CL CL A 141 coo 45.17 35.76 43.57 47.17 33.90 42.78 6.93 49.75 11.94 4.86 49.15 13.48 coo 44.24 40.01 45.19 43.94 39.25 43.24 9.19 45.75 7.76 10.53 44.74 6.44 coo 44.81 39.60 49.65 44.07 39.23 49.57 11.11 45.17 12.38 11.21 45.57 11.70 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 3 # 3 D 1 CYH B 101 CYH^? 12.74 CL CL B 141 D 98 ASN B 95 ASN^? 8.94 CL CL B 141 D 99 GLY B 96 GLY.? 10.89 CL CL B 141 coo 45.17 35.76 43.57 47.17 33.90 42.78 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 44.24 40.01 45.19 43.94 39.25 43.24 -34.95 28.63 4.74 -33.53 27.80 6.13 coo 44.81 39.60 49.65 44.07 39.23 49.57 -31.38 31.41 3.04 -31.45 30.75 3.48 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 3 # 4 D 1 CYH B 101 CYH^? 12.74 CL CL B 141 D 98 ASN B 95 ASN^? 8.94 CL CL B 141 D 99 GLY B 99 GLY.? 13.44 CL CL B 141 coo 45.17 35.76 43.57 47.17 33.90 42.78 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 44.24 40.01 45.19 43.94 39.25 43.24 -34.95 28.63 4.74 -33.53 27.80 6.13 coo 44.81 39.60 49.65 44.07 39.23 49.57 -33.56 27.44 0.16 -33.84 27.10 0.81 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 5 3 # 5 D 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 D 98 ASN C 95 ASN^? 15.21 O1 EDO C 140 D 99 GLY C 96 GLY.? 17.66 O1 EDO C 140 coo 45.17 35.76 43.57 47.17 33.90 42.78 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 44.24 40.01 45.19 43.94 39.25 43.24 16.76 -0.79 5.39 18.34 -1.36 6.71 coo 44.81 39.60 49.65 44.07 39.23 49.57 20.22 1.91 3.52 20.16 1.24 3.96 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 6 3 # 6 D 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 D 98 ASN C 95 ASN^? 15.21 O1 EDO C 140 D 99 GLY C 99 GLY.? 20.09 O1 EDO C 140 coo 45.17 35.76 43.57 47.17 33.90 42.78 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 44.24 40.01 45.19 43.94 39.25 43.24 16.76 -0.79 5.39 18.34 -1.36 6.71 coo 44.81 39.60 49.65 44.07 39.23 49.57 18.17 -2.27 0.74 17.88 -2.54 1.41 1gdo_c01 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 6 hits 1gdo_c01 naa= 3 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 A 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 A 98 ASN A 95 ASN^? 17.50 CL CL A 141 A 99 GLY A 96 GLY.? 18.28 CL CL A 141 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 6.93 49.75 11.94 4.86 49.15 13.48 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 9.19 45.75 7.76 10.53 44.74 6.44 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 8.58 41.34 9.59 9.11 41.71 9.12 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 A 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 A 98 ASN A 95 ASN^? 17.50 CL CL A 141 A 99 GLY A 99 GLY.? 22.26 CL CL A 141 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 6.93 49.75 11.94 4.86 49.15 13.48 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 9.19 45.75 7.76 10.53 44.74 6.44 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 11.11 45.17 12.38 11.21 45.57 11.70 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 3 # 3 A 1 CYH B 101 CYH^? 12.74 CL CL B 141 A 98 ASN B 95 ASN^? 8.94 CL CL B 141 A 99 GLY B 96 GLY.? 10.89 CL CL B 141 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 -34.95 28.63 4.74 -33.53 27.80 6.13 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 -31.38 31.41 3.04 -31.45 30.75 3.48 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 3 # 4 A 1 CYH B 101 CYH^? 12.74 CL CL B 141 A 98 ASN B 95 ASN^? 8.94 CL CL B 141 A 99 GLY B 99 GLY.? 13.44 CL CL B 141 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 -34.95 28.63 4.74 -33.53 27.80 6.13 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 -33.56 27.44 0.16 -33.84 27.10 0.81 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 5 3 # 5 A 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 A 98 ASN C 95 ASN^? 15.21 O1 EDO C 140 A 99 GLY C 96 GLY.? 17.66 O1 EDO C 140 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 16.76 -0.79 5.39 18.34 -1.36 6.71 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 20.22 1.91 3.52 20.16 1.24 3.96 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 6 3 # 6 A 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 A 98 ASN C 95 ASN^? 15.21 O1 EDO C 140 A 99 GLY C 99 GLY.? 20.09 O1 EDO C 140 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 16.76 -0.79 5.39 18.34 -1.36 6.71 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 18.17 -2.27 0.74 17.88 -2.54 1.41 1gdo_c02 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 6 hits 1gdo_c02 naa= 3 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 C 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 C 98 ASN A 95 ASN^? 17.50 CL CL A 141 C 99 GLY A 96 GLY.? 18.28 CL CL A 141 coo 25.27 14.39 86.45 23.28 16.25 85.80 6.93 49.75 11.94 4.86 49.15 13.48 coo 25.97 10.04 88.17 26.35 10.81 86.26 9.19 45.75 7.76 10.53 44.74 6.44 coo 25.32 10.47 92.61 26.06 10.86 92.54 8.58 41.34 9.59 9.11 41.71 9.12 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 C 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 C 98 ASN A 95 ASN^? 17.50 CL CL A 141 C 99 GLY A 99 GLY.? 22.26 CL CL A 141 coo 25.27 14.39 86.45 23.28 16.25 85.80 6.93 49.75 11.94 4.86 49.15 13.48 coo 25.97 10.04 88.17 26.35 10.81 86.26 9.19 45.75 7.76 10.53 44.74 6.44 coo 25.32 10.47 92.61 26.06 10.86 92.54 11.11 45.17 12.38 11.21 45.57 11.70 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 3 # 3 C 1 CYH B 101 CYH^? 12.74 CL CL B 141 C 98 ASN B 95 ASN^? 8.94 CL CL B 141 C 99 GLY B 96 GLY.? 10.89 CL CL B 141 coo 25.27 14.39 86.45 23.28 16.25 85.80 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 25.97 10.04 88.17 26.35 10.81 86.26 -34.95 28.63 4.74 -33.53 27.80 6.13 coo 25.32 10.47 92.61 26.06 10.86 92.54 -31.38 31.41 3.04 -31.45 30.75 3.48 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 3 # 4 C 1 CYH B 101 CYH^? 12.74 CL CL B 141 C 98 ASN B 95 ASN^? 8.94 CL CL B 141 C 99 GLY B 99 GLY.? 13.44 CL CL B 141 coo 25.27 14.39 86.45 23.28 16.25 85.80 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 25.97 10.04 88.17 26.35 10.81 86.26 -34.95 28.63 4.74 -33.53 27.80 6.13 coo 25.32 10.47 92.61 26.06 10.86 92.54 -33.56 27.44 0.16 -33.84 27.10 0.81 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 5 3 # 5 C 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 C 98 ASN C 95 ASN^? 15.21 O1 EDO C 140 C 99 GLY C 96 GLY.? 17.66 O1 EDO C 140 coo 25.27 14.39 86.45 23.28 16.25 85.80 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 25.97 10.04 88.17 26.35 10.81 86.26 16.76 -0.79 5.39 18.34 -1.36 6.71 coo 25.32 10.47 92.61 26.06 10.86 92.54 20.22 1.91 3.52 20.16 1.24 3.96 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 6 3 # 6 C 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 C 98 ASN C 95 ASN^? 15.21 O1 EDO C 140 C 99 GLY C 99 GLY.? 20.09 O1 EDO C 140 coo 25.27 14.39 86.45 23.28 16.25 85.80 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 25.97 10.04 88.17 26.35 10.81 86.26 16.76 -0.79 5.39 18.34 -1.36 6.71 coo 25.32 10.47 92.61 26.06 10.86 92.54 18.17 -2.27 0.74 17.88 -2.54 1.41 1gdo_c03 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 6 hits 1gdo_c03 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 127 GLU^? 8.20 CL CL A 141 A 47 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 161 TYR A 129 TYR^? 7.28 CL CL A 141 coo 37.12 18.35 73.76 37.09 16.69 72.44 2.90 34.77 -4.78 2.12 35.30 -6.66 coo 29.81 8.06 73.13 30.21 10.11 72.95 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 37.29 15.56 67.90 37.37 13.79 70.08 -1.60 36.85 -1.08 -0.19 34.61 -1.92 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU C 36 GLU~? -27.32 O1 EDO C 140s A 47 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 161 TYR A 121 TYR.? -24.35 CL CL A 141s coo 37.12 18.35 73.76 37.09 16.69 72.44 19.61 26.41 3.01 20.17 25.01 1.52 coo 29.81 8.06 73.13 30.21 10.11 72.95 7.61 19.22 2.17 7.62 20.80 3.62 coo 37.29 15.56 67.90 37.37 13.79 70.08 16.31 29.26 0.34 18.85 29.40 1.41 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 2 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 127 GLU^? 8.20 CL CL A 141 B 47 ASP A 13 ASP~? 8.68 O4 PG4 A 142 B 161 TYR A 129 TYR^? 7.28 CL CL A 141 coo 53.87 35.49 53.22 55.44 35.72 54.61 2.90 34.77 -4.78 2.12 35.30 -6.66 coo 63.47 43.65 53.95 61.45 43.07 54.06 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 56.38 35.81 59.19 58.25 35.77 57.10 -1.60 36.85 -1.08 -0.19 34.61 -1.92 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU C 36 GLU~? -27.32 O1 EDO C 140s B 47 ASP C 135 ASP.? 16.41 O1 EDO C 141 B 161 TYR A 121 TYR.? -24.35 CL CL A 141s coo 53.87 35.49 53.22 55.44 35.72 54.61 19.61 26.41 3.01 20.17 25.01 1.52 coo 63.47 43.65 53.95 61.45 43.07 54.06 7.61 19.22 2.17 7.62 20.80 3.62 coo 56.38 35.81 59.19 58.25 35.77 57.10 16.31 29.26 0.34 18.85 29.40 1.41 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 2 hits 1geq_c03 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 137 PHE.? 13.51 C4 PG4 A 142 A 298 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 329 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -6.61 37.64 11.75 -5.17 36.03 10.04 coo 2.59 0.29 25.55 4.65 0.18 25.07 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 12.42 6.10 23.27 9.95 1.57 20.16 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE B 137 PHE.? 13.84 C2 PG4 B 142 A 298 ASP B 135 ASP.? 12.47 O1 PG4 B 142 A 329 LYS B 31 LYS~? 7.73 C1 PG4 B 142 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -35.71 46.57 1.24 -33.59 46.16 2.95 coo 2.59 0.29 25.55 4.65 0.18 25.07 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 12.42 6.10 23.27 9.95 1.57 20.16 -41.17 57.91 7.48 -40.76 60.95 12.06 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE C 137 PHE.? 20.25 O1 EDO C 140 A 298 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 329 LYS C 31 LYS~? 22.12 CL CL A 141 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 15.58 16.76 1.11 17.72 16.39 2.83 coo 2.59 0.29 25.55 4.65 0.18 25.07 7.61 19.22 2.17 7.62 20.80 3.62 coo 12.42 6.10 23.27 9.95 1.57 20.16 9.92 28.31 6.82 8.29 31.11 11.06 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 3 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 137 PHE.? 13.51 C4 PG4 A 142 B 298 ASP A 135 ASP.? 12.08 C3 PG4 A 142 B 329 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -6.61 37.64 11.75 -5.17 36.03 10.04 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE B 137 PHE.? 13.84 C2 PG4 B 142 B 298 ASP B 135 ASP.? 12.47 O1 PG4 B 142 B 329 LYS B 31 LYS~? 7.73 C1 PG4 B 142 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -35.71 46.57 1.24 -33.59 46.16 2.95 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -41.17 57.91 7.48 -40.76 60.95 12.06 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE C 137 PHE.? 20.25 O1 EDO C 140 B 298 ASP C 135 ASP.? 16.41 O1 EDO C 141 B 329 LYS C 31 LYS~? 22.12 CL CL A 141 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 15.58 16.76 1.11 17.72 16.39 2.83 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 7.61 19.22 2.17 7.62 20.80 3.62 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 9.92 28.31 6.82 8.29 31.11 11.06 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 3 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 137 PHE.? 13.51 C4 PG4 A 142 C 298 ASP A 135 ASP.? 12.08 C3 PG4 A 142 C 329 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 17.41 60.57 64.39 18.40 58.12 65.34 -6.61 37.64 11.75 -5.17 36.03 10.04 coo 24.10 66.43 63.33 24.18 64.30 63.40 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 27.64 56.61 58.17 22.18 57.92 60.36 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE B 137 PHE.? 13.84 C2 PG4 B 142 C 298 ASP B 135 ASP.? 12.47 O1 PG4 B 142 C 329 LYS B 31 LYS~? 7.73 C1 PG4 B 142 coo 17.41 60.57 64.39 18.40 58.12 65.34 -35.71 46.57 1.24 -33.59 46.16 2.95 coo 24.10 66.43 63.33 24.18 64.30 63.40 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 27.64 56.61 58.17 22.18 57.92 60.36 -41.17 57.91 7.48 -40.76 60.95 12.06 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE C 137 PHE.? 20.25 O1 EDO C 140 C 298 ASP C 135 ASP.? 16.41 O1 EDO C 141 C 329 LYS C 31 LYS~? 22.12 CL CL A 141 coo 17.41 60.57 64.39 18.40 58.12 65.34 15.58 16.76 1.11 17.72 16.39 2.83 coo 24.10 66.43 63.33 24.18 64.30 63.40 7.61 19.22 2.17 7.62 20.80 3.62 coo 27.64 56.61 58.17 22.18 57.92 60.36 9.92 28.31 6.82 8.29 31.11 11.06 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 3 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 137 PHE.? 13.51 C4 PG4 A 142 D 298 ASP A 135 ASP.? 12.08 C3 PG4 A 142 D 329 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 35.44 53.35 83.81 35.65 54.53 81.28 -6.61 37.64 11.75 -5.17 36.03 10.04 coo 29.72 46.46 83.60 30.79 47.36 81.99 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 36.89 44.91 74.55 37.33 48.94 79.01 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE B 137 PHE.? 13.84 C2 PG4 B 142 D 298 ASP B 135 ASP.? 12.47 O1 PG4 B 142 D 329 LYS B 31 LYS~? 7.73 C1 PG4 B 142 coo 35.44 53.35 83.81 35.65 54.53 81.28 -35.71 46.57 1.24 -33.59 46.16 2.95 coo 29.72 46.46 83.60 30.79 47.36 81.99 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 36.89 44.91 74.55 37.33 48.94 79.01 -41.17 57.91 7.48 -40.76 60.95 12.06 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE C 137 PHE.? 20.25 O1 EDO C 140 D 298 ASP C 135 ASP.? 16.41 O1 EDO C 141 D 329 LYS C 31 LYS~? 22.12 CL CL A 141 coo 35.44 53.35 83.81 35.65 54.53 81.28 15.58 16.76 1.11 17.72 16.39 2.83 coo 29.72 46.46 83.60 30.79 47.36 81.99 7.61 19.22 2.17 7.62 20.80 3.62 coo 36.89 44.91 74.55 37.33 48.94 79.01 9.92 28.31 6.82 8.29 31.11 11.06 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 3 hits 1gtx_c03 naa= 3 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 A 151 SER A 37 SER~? 5.05 O3 PG4 A 142 A 164 TYR B 121 TYR.? 12.07 O3 PG4 A 142 A 168 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 32.37 52.40 49.35 31.32 53.88 47.74 -11.55 30.40 5.05 -13.38 29.33 4.03 coo 29.69 55.04 42.83 31.98 53.56 43.49 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 26.96 50.99 47.03 31.03 48.83 44.33 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 A 151 SER A 72 SER~? 17.31 O ACT A 140 A 164 TYR A 71 TYR~? 13.98 CL CL A 141 A 168 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo 32.37 52.40 49.35 31.32 53.88 47.74 0.42 40.55 13.73 0.47 42.26 15.43 coo 29.69 55.04 42.83 31.98 53.56 43.49 -3.80 41.21 9.78 -5.71 41.25 7.73 coo 26.96 50.99 47.03 31.03 48.83 44.33 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 A 151 SER C 37 SER~? 25.30 O1 EDO C 140 A 164 TYR A 121 TYR.? -24.35 CL CL A 141s A 168 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 32.37 52.40 49.35 31.32 53.88 47.74 19.44 24.86 7.68 19.21 27.10 8.59 coo 29.69 55.04 42.83 31.98 53.56 43.49 16.31 29.26 0.34 18.85 29.40 1.41 coo 26.96 50.99 47.03 31.03 48.83 44.33 14.41 24.06 5.83 10.24 22.70 1.76 1gz6_c00 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 3 hits 1gz6_c00 naa= 3 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 B 151 SER A 37 SER~? 5.05 O3 PG4 A 142 B 164 TYR B 121 TYR.? 12.07 O3 PG4 A 142 B 168 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 13.08 50.93 56.67 13.12 48.99 55.27 -11.55 30.40 5.05 -13.38 29.33 4.03 coo 11.52 46.03 51.32 10.06 47.90 52.76 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 15.72 50.86 51.22 10.77 52.35 51.39 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 B 151 SER A 72 SER~? 17.31 O ACT A 140 B 164 TYR A 71 TYR~? 13.98 CL CL A 141 B 168 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo 13.08 50.93 56.67 13.12 48.99 55.27 0.42 40.55 13.73 0.47 42.26 15.43 coo 11.52 46.03 51.32 10.06 47.90 52.76 -3.80 41.21 9.78 -5.71 41.25 7.73 coo 15.72 50.86 51.22 10.77 52.35 51.39 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 B 151 SER C 37 SER~? 25.30 O1 EDO C 140 B 164 TYR A 121 TYR.? -24.35 CL CL A 141s B 168 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 13.08 50.93 56.67 13.12 48.99 55.27 19.44 24.86 7.68 19.21 27.10 8.59 coo 11.52 46.03 51.32 10.06 47.90 52.76 16.31 29.26 0.34 18.85 29.40 1.41 coo 15.72 50.86 51.22 10.77 52.35 51.39 14.41 24.06 5.83 10.24 22.70 1.76 1gz6_c01 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 3 hits 1gz6_c01 naa= 3 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 C 151 SER A 37 SER~? 5.05 O3 PG4 A 142 C 164 TYR B 121 TYR.? 12.07 O3 PG4 A 142 C 168 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 11.22 34.38 82.32 11.07 36.29 83.78 -11.55 30.40 5.05 -13.38 29.33 4.03 coo 8.83 39.27 87.38 7.60 37.43 85.69 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 12.98 34.46 88.14 8.11 32.96 87.14 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 C 151 SER A 72 SER~? 17.31 O ACT A 140 C 164 TYR A 71 TYR~? 13.98 CL CL A 141 C 168 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo 11.22 34.38 82.32 11.07 36.29 83.78 0.42 40.55 13.73 0.47 42.26 15.43 coo 8.83 39.27 87.38 7.60 37.43 85.69 -3.80 41.21 9.78 -5.71 41.25 7.73 coo 12.98 34.46 88.14 8.11 32.96 87.14 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 C 151 SER C 37 SER~? 25.30 O1 EDO C 140 C 164 TYR A 121 TYR.? -24.35 CL CL A 141s C 168 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 11.22 34.38 82.32 11.07 36.29 83.78 19.44 24.86 7.68 19.21 27.10 8.59 coo 8.83 39.27 87.38 7.60 37.43 85.69 16.31 29.26 0.34 18.85 29.40 1.41 coo 12.98 34.46 88.14 8.11 32.96 87.14 14.41 24.06 5.83 10.24 22.70 1.76 1gz6_c02 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 3 hits 1gz6_c02 naa= 3 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 D 151 SER A 37 SER~? 5.05 O3 PG4 A 142 D 164 TYR B 121 TYR.? 12.07 O3 PG4 A 142 D 168 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 29.15 32.90 92.57 27.86 31.44 94.02 -11.55 30.40 5.05 -13.38 29.33 4.03 coo 25.49 30.28 98.59 27.88 31.73 98.26 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 23.46 34.31 94.02 27.08 36.46 97.29 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 D 151 SER A 72 SER~? 17.31 O ACT A 140 D 164 TYR A 71 TYR~? 13.98 CL CL A 141 D 168 LYS A 69 LYS~? 10.70 CH3 ACT A 140 coo 29.15 32.90 92.57 27.86 31.44 94.02 0.42 40.55 13.73 0.47 42.26 15.43 coo 25.49 30.28 98.59 27.88 31.73 98.26 -3.80 41.21 9.78 -5.71 41.25 7.73 coo 23.46 34.31 94.02 27.08 36.46 97.29 -2.48 44.21 16.37 -5.74 47.67 20.09 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 D 151 SER C 37 SER~? 25.30 O1 EDO C 140 D 164 TYR A 121 TYR.? -24.35 CL CL A 141s D 168 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 29.15 32.90 92.57 27.86 31.44 94.02 19.44 24.86 7.68 19.21 27.10 8.59 coo 25.49 30.28 98.59 27.88 31.73 98.26 16.31 29.26 0.34 18.85 29.40 1.41 coo 23.46 34.31 94.02 27.08 36.46 97.29 14.41 24.06 5.83 10.24 22.70 1.76 1gz6_c03 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 3 hits 1gz6_c03 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 327 GLU B 63 GLU~? 16.01 OXT ACT B 139 A 339 ARG B 111 ARG.? 7.92 O ACT B 139 coo 85.81 57.99 116.01 86.03 55.86 115.89 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 75.11 41.01 160.30 76.65 40.06 161.41 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 82.23 40.35 159.87 85.09 40.67 161.01 -50.20 41.64 9.27 -52.60 39.78 9.98 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 50 ASP.? 20.38 CL CL A 141 A 327 GLU B 36 GLU~? 11.82 C2 PG4 B 142 A 339 ARG B 39 ARG~? 11.86 C2 PG4 B 142 coo 85.81 57.99 116.01 86.03 55.86 115.89 11.71 33.66 5.09 12.68 31.93 4.37 coo 75.11 41.01 160.30 76.65 40.06 161.41 -31.60 55.95 3.54 -31.25 54.50 1.99 coo 82.23 40.35 159.87 85.09 40.67 161.01 -34.24 50.49 2.21 -35.83 53.07 1.56 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 327 GLU C 63 GLU~? 7.77 O1 EDO C 141 A 339 ARG C 111 ARG.? 7.98 O ACT C 139 coo 85.81 57.99 116.01 86.03 55.86 115.89 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 75.11 41.01 160.30 76.65 40.06 161.41 1.11 13.80 1.11 0.04 14.34 2.91 coo 82.23 40.35 159.87 85.09 40.67 161.01 1.09 11.93 9.22 -1.20 10.06 10.11 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP C 13 ASP~? 27.02 O1 EDO C 140 A 327 GLU A 63 GLU~? 7.87 O ACT A 140 A 339 ARG A 111 ARG.? 7.83 OXT ACT A 139 coo 85.81 57.99 116.01 86.03 55.86 115.89 26.45 23.84 13.97 27.74 25.29 14.77 coo 75.11 41.01 160.30 76.65 40.06 161.41 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 82.23 40.35 159.87 85.09 40.67 161.01 -9.64 52.74 3.70 -9.14 55.70 2.93 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP C 50 ASP.? 22.48 O1 EDO C 140 A 327 GLU A 36 GLU~? 11.76 C4 PG4 A 142 A 339 ARG A 39 ARG~? 11.53 C4 PG4 A 142 coo 85.81 57.99 116.01 86.03 55.86 115.89 28.54 3.26 7.93 30.44 3.42 8.82 coo 75.11 41.01 160.30 76.65 40.06 161.41 -12.87 29.42 9.52 -11.52 29.66 11.15 coo 82.23 40.35 159.87 85.09 40.67 161.01 -9.34 34.41 10.95 -12.33 34.37 11.59 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 5 hits 1hto_c00 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS A 131 HIS^? 7.42 CL CL A 141 A 200 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 226 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo 23.24 46.58 4.39 24.43 46.59 2.66 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 24.51 43.28 11.18 25.17 44.50 9.58 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 34.47 51.09 7.19 28.58 51.18 7.53 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS B 131 HIS^? 7.27 CL CL B 140 A 200 ASP B 25 ASP.? 6.52 O ACT B 139 A 226 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo 23.24 46.58 4.39 24.43 46.59 2.66 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 24.51 43.28 11.18 25.17 44.50 9.58 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 34.47 51.09 7.19 28.58 51.18 7.53 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1i29_c01 CSDB user 3 3 # 3 A 123 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 200 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 226 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo 23.24 46.58 4.39 24.43 46.59 2.66 8.46 11.73 13.23 7.93 9.80 13.86 coo 24.51 43.28 11.18 25.17 44.50 9.58 4.46 12.53 17.74 4.84 11.35 19.48 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.48 20.46 18.00 15.72 26.44 16.52 1i29_c01 source 1i29 CSDB : 3 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 113 VAL^? 10.83 CL CL A 141 A 200 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 226 LYS B 47 LYS~? 12.98 C2 PG4 A 142 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -4.32 44.96 4.32 -4.01 44.19 6.37 coo 24.51 43.28 11.18 25.17 44.50 9.58 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 34.47 51.09 7.19 28.58 51.18 7.53 -23.16 41.10 5.81 -22.85 46.07 1.96 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL C 113 VAL^? 11.48 O1 EDO C 140 A 200 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 226 LYS A 47 LYS~? 18.08 C5 PG4 A 142 coo 19.13 38.05 1.41 19.72 38.80 -0.53 10.57 11.31 8.67 11.34 11.45 6.59 coo 24.51 43.28 11.18 25.17 44.50 9.58 7.61 19.22 2.17 7.62 20.80 3.62 coo 34.47 51.09 7.19 28.58 51.18 7.53 4.15 29.38 6.95 0.12 26.77 10.99 1i29_c03 source 1i29 CSDB : 2 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 15 LYS~? 13.64 CL CL A 141 A 74 LYS A 20 LYS~? -2.81 O1 PG4 A 142s A 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS A 16 LYS~? 4.07 C8 PG4 A 142 A 74 LYS A 20 LYS~? -2.81 O1 PG4 A 142s A 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS A 20 LYS~? -2.81 O1 PG4 A 142s A 74 LYS A 15 LYS~? 13.64 CL CL A 141 A 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS A 20 LYS~? -2.81 O1 PG4 A 142s A 74 LYS A 16 LYS~? 4.07 C8 PG4 A 142 A 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 A 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 74 LYS A 35 LYS~? 11.98 C3 PG4 A 142 A 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 A 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 74 LYS B 47 LYS~? 12.98 C2 PG4 A 142 A 165 GLU B 127 GLU^? 8.11 CL CL B 140 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -28.31 39.11 17.60 -29.33 39.55 19.43 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 A 14 LYS A 35 LYS~? 11.98 C3 PG4 A 142 A 74 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 A 14 LYS B 20 LYS~? -2.98 O4 PG4 B 142s A 74 LYS B 15 LYS~? 14.97 CL CL B 140 A 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -27.71 47.06 15.95 -22.68 43.71 17.22 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 A 14 LYS B 20 LYS~? -2.98 O4 PG4 B 142s A 74 LYS B 16 LYS~? 5.16 C5 PG4 B 142 A 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 A 14 LYS B 47 LYS~? 12.98 C2 PG4 A 142 A 74 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 A 14 LYS C 20 LYS~? 21.67 C1 EDO C 140 A 74 LYS C 15 LYS~? 19.87 O1 EDO C 140 A 165 GLU C 36 GLU~? -27.32 O1 EDO C 140s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 15.48 20.46 18.00 15.72 26.44 16.52 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 23.48 18.06 15.81 27.69 13.80 17.86 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 19.61 26.41 3.01 20.17 25.01 1.52 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 A 14 LYS C 31 LYS~? 22.12 CL CL A 141 A 74 LYS A 47 LYS~? 18.08 C5 PG4 A 142 A 165 GLU A 127 GLU^? 8.20 CL CL A 141 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 9.92 28.31 6.82 8.29 31.11 11.06 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 4.15 29.38 6.95 0.12 26.77 10.99 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 2.90 34.77 -4.78 2.12 35.30 -6.66 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 12 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 15 LYS~? 13.64 CL CL A 141 B 74 LYS A 20 LYS~? -2.81 O1 PG4 A 142s B 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS A 16 LYS~? 4.07 C8 PG4 A 142 B 74 LYS A 20 LYS~? -2.81 O1 PG4 A 142s B 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS A 20 LYS~? -2.81 O1 PG4 A 142s B 74 LYS A 15 LYS~? 13.64 CL CL A 141 B 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS A 20 LYS~? -2.81 O1 PG4 A 142s B 74 LYS A 16 LYS~? 4.07 C8 PG4 A 142 B 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 B 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 B 74 LYS A 35 LYS~? 11.98 C3 PG4 A 142 B 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -19.32 36.76 5.88 -23.26 35.95 1.25 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -13.45 35.10 6.93 -14.45 39.53 11.08 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 B 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 B 74 LYS B 47 LYS~? 12.98 C2 PG4 A 142 B 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -19.32 36.76 5.88 -23.26 35.95 1.25 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -23.16 41.10 5.81 -22.85 46.07 1.96 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 B 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 B 74 LYS B 47 LYS~? 12.98 C2 PG4 A 142 B 165 GLU B 127 GLU^? 8.11 CL CL B 140 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -19.32 36.76 5.88 -23.26 35.95 1.25 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -23.16 41.10 5.81 -22.85 46.07 1.96 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -28.31 39.11 17.60 -29.33 39.55 19.43 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 B 14 LYS A 35 LYS~? 11.98 C3 PG4 A 142 B 74 LYS A 31 LYS~? 8.03 C2 PG4 A 142 B 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -13.45 35.10 6.93 -14.45 39.53 11.08 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -19.32 36.76 5.88 -23.26 35.95 1.25 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 B 14 LYS B 15 LYS~? 14.97 CL CL B 140 B 74 LYS B 20 LYS~? -2.98 O4 PG4 B 142s B 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -27.71 47.06 15.95 -22.68 43.71 17.22 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -35.63 49.45 18.32 -35.72 55.05 16.66 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 B 14 LYS B 16 LYS~? 5.16 C5 PG4 B 142 B 74 LYS B 20 LYS~? -2.98 O4 PG4 B 142s B 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -29.09 50.01 17.90 -28.96 54.88 21.75 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -35.63 49.45 18.32 -35.72 55.05 16.66 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 B 14 LYS B 20 LYS~? -2.98 O4 PG4 B 142s B 74 LYS B 15 LYS~? 14.97 CL CL B 140 B 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -35.63 49.45 18.32 -35.72 55.05 16.66 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -27.71 47.06 15.95 -22.68 43.71 17.22 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 B 14 LYS B 20 LYS~? -2.98 O4 PG4 B 142s B 74 LYS B 16 LYS~? 5.16 C5 PG4 B 142 B 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -35.63 49.45 18.32 -35.72 55.05 16.66 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -29.09 50.01 17.90 -28.96 54.88 21.75 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 13 3 # 13 B 14 LYS B 47 LYS~? 12.98 C2 PG4 A 142 B 74 LYS A 31 LYS~? 8.03 C2 PG4 A 142 B 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -23.16 41.10 5.81 -22.85 46.07 1.96 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -19.32 36.76 5.88 -23.26 35.95 1.25 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 14 3 # 14 B 14 LYS C 15 LYS~? 19.87 O1 EDO C 140 B 74 LYS C 20 LYS~? 21.67 C1 EDO C 140 B 165 GLU C 36 GLU~? -27.32 O1 EDO C 140s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 23.48 18.06 15.81 27.69 13.80 17.86 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 15.48 20.46 18.00 15.72 26.44 16.52 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 19.61 26.41 3.01 20.17 25.01 1.52 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 15 3 # 15 B 14 LYS C 20 LYS~? 21.67 C1 EDO C 140 B 74 LYS C 15 LYS~? 19.87 O1 EDO C 140 B 165 GLU C 36 GLU~? -27.32 O1 EDO C 140s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 15.48 20.46 18.00 15.72 26.44 16.52 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 23.48 18.06 15.81 27.69 13.80 17.86 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 19.61 26.41 3.01 20.17 25.01 1.52 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 15 hits 1idt_c01 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 135 ASP.? 12.08 C3 PG4 A 142 158 THR A 70 THR~? 15.01 O ACT A 140 317 ASP A 62 ASP~? -3.38 O ACT A 140s coo -2.63 8.40 35.07 -3.66 9.81 36.17 -12.78 43.39 10.70 -14.12 42.52 9.22 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -4.79 41.37 15.30 -6.78 42.17 15.13 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -9.14 53.57 16.41 -8.61 54.95 17.94 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP B 135 ASP.? 12.47 O1 PG4 B 142 158 THR B 70 THR~? 17.42 CL CL B 141 317 ASP B 62 ASP~? 20.96 OXT ACT B 139 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -43.74 49.08 2.60 -43.70 50.44 4.24 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -38.15 43.23 -2.29 -39.92 44.50 -2.06 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -50.88 40.70 -3.44 -51.62 39.45 -5.01 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 3 # 3 54 ASP C 135 ASP.? 16.41 O1 EDO C 141 158 THR C 70 THR~? 14.81 O1 EDO C 141 317 ASP C 62 ASP~? -3.30 O1 EDO C 141s coo -2.63 8.40 35.07 -3.66 9.81 36.17 7.61 19.22 2.17 7.62 20.80 3.62 coo -5.30 12.75 41.86 -4.34 13.05 39.99 13.33 13.35 -2.33 11.58 14.62 -2.10 coo -12.63 17.64 33.66 -10.65 17.90 34.40 0.59 10.79 -3.25 -0.22 9.73 -4.86 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 3 hits 1inp_c02 naa= 3 ULMN 3 1jdw_c01 L-ARGININE-GLYCINE AMIDINOTRANSFERASuser 1 3 # 1 254 ASP A 25 ASP.? 6.66 OXT ACT A 139 303 HIS A 110 HIS.? -3.69 OXT ACT A 139s 407 CYH A 57 CYH^? 5.51 O ACT A 139 coo 49.08 66.55 9.14 50.71 67.89 8.88 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 47.11 68.57 13.19 49.07 68.74 12.45 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 49.32 64.84 19.61 47.95 67.13 18.88 -4.80 51.41 4.83 -3.45 51.64 2.37 ULMN 3 1jdw_c01 L-ARGININE-GLYCINE AMIDINOTRANSFERASuser 2 3 # 2 254 ASP A 25 ASP.? 6.66 OXT ACT A 139 303 HIS A 131 HIS^? 7.42 CL CL A 141 407 CYH A 57 CYH^? 5.51 O ACT A 139 coo 49.08 66.55 9.14 50.71 67.89 8.88 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 47.11 68.57 13.19 49.07 68.74 12.45 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 49.32 64.84 19.61 47.95 67.13 18.88 -4.80 51.41 4.83 -3.45 51.64 2.37 ULMN 3 1jdw_c01 L-ARGININE-GLYCINE AMIDINOTRANSFERASuser 3 3 # 3 254 ASP B 25 ASP.? 6.52 O ACT B 139 303 HIS B 110 HIS.? -3.67 O ACT B 139s 407 CYH B 57 CYH^? 5.44 OXT ACT B 139 coo 49.08 66.55 9.14 50.71 67.89 8.88 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 47.11 68.57 13.19 49.07 68.74 12.45 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 49.32 64.84 19.61 47.95 67.13 18.88 -46.68 38.10 8.15 -46.29 36.73 10.60 ULMN 3 1jdw_c01 L-ARGININE-GLYCINE AMIDINOTRANSFERASuser 4 3 # 4 254 ASP B 25 ASP.? 6.52 O ACT B 139 303 HIS B 131 HIS^? 7.27 CL CL B 140 407 CYH B 57 CYH^? 5.44 OXT ACT B 139 coo 49.08 66.55 9.14 50.71 67.89 8.88 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 47.11 68.57 13.19 49.07 68.74 12.45 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 49.32 64.84 19.61 47.95 67.13 18.88 -46.68 38.10 8.15 -46.29 36.73 10.60 ULMN 3 1jdw_c01 L-ARGININE-GLYCINE AMIDINOTRANSFERASuser 5 3 # 5 254 ASP C 25 ASP.? 6.36 O2 EDO C 140 303 HIS C 110 HIS.? 3.59 O ACT C 139s 407 CYH C 57 CYH^? 5.55 OXT ACT C 139 coo 49.08 66.55 9.14 50.71 67.89 8.88 4.46 12.53 17.74 4.84 11.35 19.48 coo 47.11 68.57 13.19 49.07 68.74 12.45 4.54 8.83 15.35 4.90 7.96 17.23 coo 49.32 64.84 19.61 47.95 67.13 18.88 4.72 8.42 8.22 5.18 7.19 10.69 ULMN 3 1jdw_c01 L-ARGININE-GLYCINE AMIDINOTRANSFERASuser 6 3 # 6 254 ASP C 25 ASP.? 6.36 O2 EDO C 140 303 HIS C 131 HIS^? 6.39 C1 EDO C 140 407 CYH C 57 CYH^? 5.55 OXT ACT C 139 coo 49.08 66.55 9.14 50.71 67.89 8.88 4.46 12.53 17.74 4.84 11.35 19.48 coo 47.11 68.57 13.19 49.07 68.74 12.45 8.46 11.73 13.23 7.93 9.80 13.86 coo 49.32 64.84 19.61 47.95 67.13 18.88 4.72 8.42 8.22 5.18 7.19 10.69 1jdw_c01 source 1jdw L-ARGININE-GLYCINE AMIDINOTRANSFERASE : 6 hits 1jdw_c01 naa= 3 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 A 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 A 98 ASN A 95 ASN^? 17.50 CL CL A 141 A 99 GLY A 96 GLY.? 18.28 CL CL A 141 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 6.93 49.75 11.94 4.86 49.15 13.48 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 9.19 45.75 7.76 10.53 44.74 6.44 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 8.58 41.34 9.59 9.11 41.71 9.12 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 A 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 A 98 ASN A 95 ASN^? 17.50 CL CL A 141 A 99 GLY A 99 GLY.? 22.26 CL CL A 141 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 6.93 49.75 11.94 4.86 49.15 13.48 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 9.19 45.75 7.76 10.53 44.74 6.44 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 11.11 45.17 12.38 11.21 45.57 11.70 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 3 # 3 A 1 CYH B 101 CYH^? 12.74 CL CL B 141 A 98 ASN B 95 ASN^? 8.94 CL CL B 141 A 99 GLY B 96 GLY.? 10.89 CL CL B 141 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 -34.95 28.63 4.74 -33.53 27.80 6.13 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 -31.38 31.41 3.04 -31.45 30.75 3.48 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 3 # 4 A 1 CYH B 101 CYH^? 12.74 CL CL B 141 A 98 ASN B 95 ASN^? 8.94 CL CL B 141 A 99 GLY B 99 GLY.? 13.44 CL CL B 141 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 -34.95 28.63 4.74 -33.53 27.80 6.13 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 -33.56 27.44 0.16 -33.84 27.10 0.81 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 5 3 # 5 A 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 A 98 ASN C 95 ASN^? 15.21 O1 EDO C 140 A 99 GLY C 96 GLY.? 17.66 O1 EDO C 140 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 12.11 -0.99 1.20 11.66 1.09 -0.44 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 16.76 -0.79 5.39 18.34 -1.36 6.71 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 20.22 1.91 3.52 20.16 1.24 3.96 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 6 3 # 6 A 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 A 98 ASN C 95 ASN^? 15.21 O1 EDO C 140 A 99 GLY C 99 GLY.? 20.09 O1 EDO C 140 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 12.11 -0.99 1.20 11.66 1.09 -0.44 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 16.76 -0.79 5.39 18.34 -1.36 6.71 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 18.17 -2.27 0.74 17.88 -2.54 1.41 1jxa_c02 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 6 hits 1jxa_c02 naa= 3 ULMN 3 1jxa_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 B 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 B 98 ASN A 95 ASN^? 17.50 CL CL A 141 B 99 GLY A 96 GLY.? 18.28 CL CL A 141 coo 5.70 59.29 33.36 6.39 60.24 35.89 6.93 49.75 11.94 4.86 49.15 13.48 coo 7.58 64.91 33.71 8.60 63.38 34.75 9.19 45.75 7.76 10.53 44.74 6.44 coo 6.08 65.78 38.20 5.37 65.61 37.90 8.58 41.34 9.59 9.11 41.71 9.12 ULMN 3 1jxa_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 B 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 B 98 ASN A 95 ASN^? 17.50 CL CL A 141 B 99 GLY A 99 GLY.? 22.26 CL CL A 141 coo 5.70 59.29 33.36 6.39 60.24 35.89 6.93 49.75 11.94 4.86 49.15 13.48 coo 7.58 64.91 33.71 8.60 63.38 34.75 9.19 45.75 7.76 10.53 44.74 6.44 coo 6.08 65.78 38.20 5.37 65.61 37.90 11.11 45.17 12.38 11.21 45.57 11.70 ULMN 3 1jxa_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 3 # 3 B 1 CYH A 117 CYH^? 10.83 CL CL A 141 B 98 ASN A 126 ASN.? 14.45 CL CL A 141 B 99 GLY A 124 GLY.? 17.44 CL CL A 141 coo 5.70 59.29 33.36 6.39 60.24 35.89 5.07 37.09 1.73 2.71 35.97 2.45 coo 7.58 64.91 33.71 8.60 63.38 34.75 8.44 35.40 -3.89 10.18 35.21 -2.70 coo 6.08 65.78 38.20 5.37 65.61 37.90 9.25 29.57 -1.03 9.14 29.65 -1.86 ULMN 3 1jxa_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 3 # 4 B 1 CYH B 101 CYH^? 12.74 CL CL B 141 B 98 ASN B 95 ASN^? 8.94 CL CL B 141 B 99 GLY B 96 GLY.? 10.89 CL CL B 141 coo 5.70 59.29 33.36 6.39 60.24 35.89 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 7.58 64.91 33.71 8.60 63.38 34.75 -34.95 28.63 4.74 -33.53 27.80 6.13 coo 6.08 65.78 38.20 5.37 65.61 37.90 -31.38 31.41 3.04 -31.45 30.75 3.48 ULMN 3 1jxa_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 5 3 # 5 B 1 CYH B 101 CYH^? 12.74 CL CL B 141 B 98 ASN B 95 ASN^? 8.94 CL CL B 141 B 99 GLY B 99 GLY.? 13.44 CL CL B 141 coo 5.70 59.29 33.36 6.39 60.24 35.89 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 7.58 64.91 33.71 8.60 63.38 34.75 -34.95 28.63 4.74 -33.53 27.80 6.13 coo 6.08 65.78 38.20 5.37 65.61 37.90 -33.56 27.44 0.16 -33.84 27.10 0.81 ULMN 3 1jxa_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 6 3 # 6 B 1 CYH B 117 CYH^? 10.38 CL CL B 141 B 98 ASN B 126 ASN.? 13.70 CL CL B 141 B 99 GLY B 124 GLY.? 14.98 C3 PG4 A 142 coo 5.70 59.29 33.36 6.39 60.24 35.89 -29.38 36.33 11.07 -29.51 38.97 10.51 coo 7.58 64.91 33.71 8.60 63.38 34.75 -26.16 33.99 16.45 -25.15 32.54 15.21 coo 6.08 65.78 38.20 5.37 65.61 37.90 -20.73 36.34 13.64 -20.83 36.37 14.48 ULMN 3 1jxa_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 7 3 # 7 B 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 B 98 ASN C 95 ASN^? 15.21 O1 EDO C 140 B 99 GLY C 96 GLY.? 17.66 O1 EDO C 140 coo 5.70 59.29 33.36 6.39 60.24 35.89 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 7.58 64.91 33.71 8.60 63.38 34.75 16.76 -0.79 5.39 18.34 -1.36 6.71 coo 6.08 65.78 38.20 5.37 65.61 37.90 20.22 1.91 3.52 20.16 1.24 3.96 ULMN 3 1jxa_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 8 3 # 8 B 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 B 98 ASN C 95 ASN^? 15.21 O1 EDO C 140 B 99 GLY C 99 GLY.? 20.09 O1 EDO C 140 coo 5.70 59.29 33.36 6.39 60.24 35.89 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 7.58 64.91 33.71 8.60 63.38 34.75 16.76 -0.79 5.39 18.34 -1.36 6.71 coo 6.08 65.78 38.20 5.37 65.61 37.90 18.17 -2.27 0.74 17.88 -2.54 1.41 ULMN 3 1jxa_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 9 3 # 9 B 1 CYH C 117 CYH^? 14.56 O1 EDO C 140 B 98 ASN C 126 ASN.? 16.94 O1 EDO C 140 B 99 GLY C 124 GLY.? 21.39 O1 EDO C 140 coo 5.70 59.29 33.36 6.39 60.24 35.89 22.08 7.27 11.28 21.72 9.99 10.50 coo 7.58 64.91 33.71 8.60 63.38 34.75 25.29 5.14 16.83 26.51 3.77 15.70 coo 6.08 65.78 38.20 5.37 65.61 37.90 30.75 7.42 13.97 30.63 7.48 14.80 1jxa_c03 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 9 hits 1jxa_c03 naa= 3 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 C 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 C 98 ASN A 95 ASN^? 17.50 CL CL A 141 C 99 GLY A 99 GLY.? 22.26 CL CL A 141 coo 4.88 17.74 73.58 7.14 19.23 72.93 6.93 49.75 11.94 4.86 49.15 13.48 coo 8.21 16.91 78.64 7.09 18.75 78.67 9.19 45.75 7.76 10.53 44.74 6.44 coo 11.04 18.39 74.90 10.95 17.56 74.65 11.11 45.17 12.38 11.21 45.57 11.70 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 C 1 CYH B 101 CYH^? 12.74 CL CL B 141 C 98 ASN B 95 ASN^? 8.94 CL CL B 141 C 99 GLY B 99 GLY.? 13.44 CL CL B 141 coo 4.88 17.74 73.58 7.14 19.23 72.93 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 8.21 16.91 78.64 7.09 18.75 78.67 -34.95 28.63 4.74 -33.53 27.80 6.13 coo 11.04 18.39 74.90 10.95 17.56 74.65 -33.56 27.44 0.16 -33.84 27.10 0.81 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 3 # 3 C 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 C 98 ASN C 95 ASN^? 15.21 O1 EDO C 140 C 99 GLY C 99 GLY.? 20.09 O1 EDO C 140 coo 4.88 17.74 73.58 7.14 19.23 72.93 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 8.21 16.91 78.64 7.09 18.75 78.67 16.76 -0.79 5.39 18.34 -1.36 6.71 coo 11.04 18.39 74.90 10.95 17.56 74.65 18.17 -2.27 0.74 17.88 -2.54 1.41 1jxa_c04 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 3 hits 1jxa_c04 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 34 GLU~? 3.97 C2 PG4 A 142 A 56 LYS B 47 LYS~? 12.98 C2 PG4 A 142 A 258 ARG A 39 ARG~? 11.53 C4 PG4 A 142 coo 42.33 1.56 26.99 42.38 2.91 28.66 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -9.34 34.41 10.95 -12.33 34.37 11.59 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU C 34 GLU~? 23.36 C1 EDO C 140 A 56 LYS A 47 LYS~? 18.08 C5 PG4 A 142 A 258 ARG C 39 ARG~? 23.08 O1 EDO C 141 coo 42.33 1.56 26.99 42.38 2.91 28.66 13.37 28.10 10.00 11.57 28.19 11.09 coo 38.45 -0.44 19.89 37.36 0.90 25.90 4.15 29.38 6.95 0.12 26.77 10.99 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 17.00 20.76 1.74 15.55 23.42 1.18 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 34 GLU~? 3.97 C2 PG4 A 142 B 56 LYS B 47 LYS~? 12.98 C2 PG4 A 142 B 258 ARG A 39 ARG~? 11.53 C4 PG4 A 142 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 2.64 1.83 34.81 1.56 1.13 32.02 -9.34 34.41 10.95 -12.33 34.37 11.59 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU C 34 GLU~? 23.36 C1 EDO C 140 B 56 LYS A 47 LYS~? 18.08 C5 PG4 A 142 B 258 ARG C 39 ARG~? 23.08 O1 EDO C 141 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 13.37 28.10 10.00 11.57 28.19 11.09 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 4.15 29.38 6.95 0.12 26.77 10.99 coo 2.64 1.83 34.81 1.56 1.13 32.02 17.00 20.76 1.74 15.55 23.42 1.18 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 34 GLU~? 3.97 C2 PG4 A 142 C 56 LYS B 47 LYS~? 12.98 C2 PG4 A 142 C 258 ARG A 39 ARG~? 11.53 C4 PG4 A 142 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -9.34 34.41 10.95 -12.33 34.37 11.59 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU C 34 GLU~? 23.36 C1 EDO C 140 C 56 LYS A 47 LYS~? 18.08 C5 PG4 A 142 C 258 ARG C 39 ARG~? 23.08 O1 EDO C 141 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 13.37 28.10 10.00 11.57 28.19 11.09 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 4.15 29.38 6.95 0.12 26.77 10.99 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 17.00 20.76 1.74 15.55 23.42 1.18 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 34 GLU~? 3.97 C2 PG4 A 142 D 56 LYS B 47 LYS~? 12.98 C2 PG4 A 142 D 258 ARG A 39 ARG~? 11.53 C4 PG4 A 142 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -9.34 34.41 10.95 -12.33 34.37 11.59 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU C 34 GLU~? 23.36 C1 EDO C 140 D 56 LYS A 47 LYS~? 18.08 C5 PG4 A 142 D 258 ARG C 39 ARG~? 23.08 O1 EDO C 141 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 13.37 28.10 10.00 11.57 28.19 11.09 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 4.15 29.38 6.95 0.12 26.77 10.99 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 17.00 20.76 1.74 15.55 23.42 1.18 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU B 36 GLU~? 11.82 C2 PG4 B 142 A 163 ARG B 40 ARG~? 9.95 C3 PG4 B 142 A 222 ARG B 39 ARG~? 11.86 C2 PG4 B 142 coo 51.27 81.34 48.31 51.67 80.79 50.28 -31.60 55.95 3.54 -31.25 54.50 1.99 coo 48.06 78.22 50.94 48.51 78.27 53.98 -28.07 54.35 5.16 -26.37 56.02 7.18 coo 54.85 84.16 52.60 54.26 81.23 53.34 -34.24 50.49 2.21 -35.83 53.07 1.56 1kim_c00 source 1kim THYMIDINE KINASE : 1 hits 1kim_c00 naa= 3 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 1 3 # 1 A 290 ARG A 111 ARG.? 7.83 OXT ACT A 139 A 351 HIS A 131 HIS^? 7.42 CL CL A 141 A 386 LEU A 134 LEU.? 12.12 O ACT A 140 coo 57.36 53.34 128.83 58.45 50.56 128.34 -9.64 52.74 3.70 -9.14 55.70 2.93 coo 60.60 50.64 133.59 60.63 48.82 132.56 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 63.28 54.23 126.45 63.53 52.07 126.70 -9.54 46.58 8.31 -8.62 48.40 7.58 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 2 3 # 2 A 290 ARG B 111 ARG.? 7.92 O ACT B 139 A 351 HIS B 131 HIS^? 7.27 CL CL B 140 A 386 LEU B 134 LEU.? 13.82 OXT ACT B 139 coo 57.36 53.34 128.83 58.45 50.56 128.34 -50.20 41.64 9.27 -52.60 39.78 9.98 coo 60.60 50.64 133.59 60.63 48.82 132.56 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 63.28 54.23 126.45 63.53 52.07 126.70 -44.97 44.65 4.78 -46.05 42.93 5.57 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 3 3 # 3 A 290 ARG C 111 ARG.? 7.98 O ACT C 139 A 351 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 386 LEU C 134 LEU.? 12.00 O1 EDO C 141 coo 57.36 53.34 128.83 58.45 50.56 128.34 1.09 11.93 9.22 -1.20 10.06 10.11 coo 60.60 50.64 133.59 60.63 48.82 132.56 8.46 11.73 13.23 7.93 9.80 13.86 coo 63.28 54.23 126.45 63.53 52.07 126.70 6.41 14.95 4.68 5.41 13.16 5.46 1knp_c00 source 1knp L-ASPARTATE OXIDASE : 3 hits 1knp_c00 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 15 LYS~? 13.64 CL CL A 141 A 74 LYS A 20 LYS~? -2.81 O1 PG4 A 142s A 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 24.97 5.82 58.78 26.79 1.97 55.46 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 19.46 3.44 61.93 23.95 1.12 60.13 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 16 LYS~? 4.07 C8 PG4 A 142 A 74 LYS A 20 LYS~? -2.81 O1 PG4 A 142s A 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 24.97 5.82 58.78 26.79 1.97 55.46 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 19.46 3.44 61.93 23.95 1.12 60.13 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 20 LYS~? -2.81 O1 PG4 A 142s A 74 LYS A 15 LYS~? 13.64 CL CL A 141 A 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 24.97 5.82 58.78 26.79 1.97 55.46 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 19.46 3.44 61.93 23.95 1.12 60.13 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS A 20 LYS~? -2.81 O1 PG4 A 142s A 74 LYS A 16 LYS~? 4.07 C8 PG4 A 142 A 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 24.97 5.82 58.78 26.79 1.97 55.46 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 19.46 3.44 61.93 23.95 1.12 60.13 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 74 LYS A 35 LYS~? 11.98 C3 PG4 A 142 A 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 24.97 5.82 58.78 26.79 1.97 55.46 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 19.46 3.44 61.93 23.95 1.12 60.13 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 74 LYS B 47 LYS~? 12.98 C2 PG4 A 142 A 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 24.97 5.82 58.78 26.79 1.97 55.46 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 19.46 3.44 61.93 23.95 1.12 60.13 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 74 LYS B 47 LYS~? 12.98 C2 PG4 A 142 A 165 GLU B 127 GLU^? 8.11 CL CL B 140 coo 24.97 5.82 58.78 26.79 1.97 55.46 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 19.46 3.44 61.93 23.95 1.12 60.13 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -28.31 39.11 17.60 -29.33 39.55 19.43 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS A 35 LYS~? 11.98 C3 PG4 A 142 A 74 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 24.97 5.82 58.78 26.79 1.97 55.46 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 19.46 3.44 61.93 23.95 1.12 60.13 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS B 15 LYS~? 14.97 CL CL B 140 A 74 LYS B 20 LYS~? -2.98 O4 PG4 B 142s A 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo 24.97 5.82 58.78 26.79 1.97 55.46 -27.71 47.06 15.95 -22.68 43.71 17.22 coo 19.46 3.44 61.93 23.95 1.12 60.13 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS B 16 LYS~? 5.16 C5 PG4 B 142 A 74 LYS B 20 LYS~? -2.98 O4 PG4 B 142s A 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo 24.97 5.82 58.78 26.79 1.97 55.46 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 19.46 3.44 61.93 23.95 1.12 60.13 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS B 20 LYS~? -2.98 O4 PG4 B 142s A 74 LYS B 15 LYS~? 14.97 CL CL B 140 A 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo 24.97 5.82 58.78 26.79 1.97 55.46 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 19.46 3.44 61.93 23.95 1.12 60.13 -27.71 47.06 15.95 -22.68 43.71 17.22 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS B 20 LYS~? -2.98 O4 PG4 B 142s A 74 LYS B 16 LYS~? 5.16 C5 PG4 B 142 A 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo 24.97 5.82 58.78 26.79 1.97 55.46 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 19.46 3.44 61.93 23.95 1.12 60.13 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 A 14 LYS B 47 LYS~? 12.98 C2 PG4 A 142 A 74 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 24.97 5.82 58.78 26.79 1.97 55.46 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 19.46 3.44 61.93 23.95 1.12 60.13 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 A 14 LYS C 15 LYS~? 19.87 O1 EDO C 140 A 74 LYS C 20 LYS~? 21.67 C1 EDO C 140 A 165 GLU C 36 GLU~? -27.32 O1 EDO C 140s coo 24.97 5.82 58.78 26.79 1.97 55.46 23.48 18.06 15.81 27.69 13.80 17.86 coo 19.46 3.44 61.93 23.95 1.12 60.13 15.48 20.46 18.00 15.72 26.44 16.52 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 19.61 26.41 3.01 20.17 25.01 1.52 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 A 14 LYS C 20 LYS~? 21.67 C1 EDO C 140 A 74 LYS C 15 LYS~? 19.87 O1 EDO C 140 A 165 GLU C 36 GLU~? -27.32 O1 EDO C 140s coo 24.97 5.82 58.78 26.79 1.97 55.46 15.48 20.46 18.00 15.72 26.44 16.52 coo 19.46 3.44 61.93 23.95 1.12 60.13 23.48 18.06 15.81 27.69 13.80 17.86 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 19.61 26.41 3.01 20.17 25.01 1.52 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 A 14 LYS C 31 LYS~? 22.12 CL CL A 141 A 74 LYS A 47 LYS~? 18.08 C5 PG4 A 142 A 165 GLU A 127 GLU^? 8.20 CL CL A 141 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.92 28.31 6.82 8.29 31.11 11.06 coo 19.46 3.44 61.93 23.95 1.12 60.13 4.15 29.38 6.95 0.12 26.77 10.99 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 2.90 34.77 -4.78 2.12 35.30 -6.66 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 16 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 15 LYS~? 13.64 CL CL A 141 B 74 LYS A 20 LYS~? -2.81 O1 PG4 A 142s B 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 4.84 5.09 23.75 3.30 1.39 27.48 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 10.43 2.88 20.75 5.72 0.41 23.95 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 16 LYS~? 4.07 C8 PG4 A 142 B 74 LYS A 20 LYS~? -2.81 O1 PG4 A 142s B 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 4.84 5.09 23.75 3.30 1.39 27.48 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 10.43 2.88 20.75 5.72 0.41 23.95 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 20 LYS~? -2.81 O1 PG4 A 142s B 74 LYS A 15 LYS~? 13.64 CL CL A 141 B 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 4.84 5.09 23.75 3.30 1.39 27.48 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 10.43 2.88 20.75 5.72 0.41 23.95 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS A 20 LYS~? -2.81 O1 PG4 A 142s B 74 LYS A 16 LYS~? 4.07 C8 PG4 A 142 B 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 4.84 5.09 23.75 3.30 1.39 27.48 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 10.43 2.88 20.75 5.72 0.41 23.95 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 B 74 LYS A 35 LYS~? 11.98 C3 PG4 A 142 B 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 4.84 5.09 23.75 3.30 1.39 27.48 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 10.43 2.88 20.75 5.72 0.41 23.95 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 B 74 LYS B 47 LYS~? 12.98 C2 PG4 A 142 B 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 4.84 5.09 23.75 3.30 1.39 27.48 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 10.43 2.88 20.75 5.72 0.41 23.95 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 B 74 LYS B 47 LYS~? 12.98 C2 PG4 A 142 B 165 GLU B 127 GLU^? 8.11 CL CL B 140 coo 4.84 5.09 23.75 3.30 1.39 27.48 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 10.43 2.88 20.75 5.72 0.41 23.95 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -28.31 39.11 17.60 -29.33 39.55 19.43 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS A 35 LYS~? 11.98 C3 PG4 A 142 B 74 LYS A 31 LYS~? 8.03 C2 PG4 A 142 B 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 4.84 5.09 23.75 3.30 1.39 27.48 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 10.43 2.88 20.75 5.72 0.41 23.95 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS B 15 LYS~? 14.97 CL CL B 140 B 74 LYS B 20 LYS~? -2.98 O4 PG4 B 142s B 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo 4.84 5.09 23.75 3.30 1.39 27.48 -27.71 47.06 15.95 -22.68 43.71 17.22 coo 10.43 2.88 20.75 5.72 0.41 23.95 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS B 16 LYS~? 5.16 C5 PG4 B 142 B 74 LYS B 20 LYS~? -2.98 O4 PG4 B 142s B 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo 4.84 5.09 23.75 3.30 1.39 27.48 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 10.43 2.88 20.75 5.72 0.41 23.95 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS B 20 LYS~? -2.98 O4 PG4 B 142s B 74 LYS B 15 LYS~? 14.97 CL CL B 140 B 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo 4.84 5.09 23.75 3.30 1.39 27.48 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 10.43 2.88 20.75 5.72 0.41 23.95 -27.71 47.06 15.95 -22.68 43.71 17.22 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS B 20 LYS~? -2.98 O4 PG4 B 142s B 74 LYS B 16 LYS~? 5.16 C5 PG4 B 142 B 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo 4.84 5.09 23.75 3.30 1.39 27.48 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 10.43 2.88 20.75 5.72 0.41 23.95 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 B 14 LYS B 47 LYS~? 12.98 C2 PG4 A 142 B 74 LYS A 31 LYS~? 8.03 C2 PG4 A 142 B 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 4.84 5.09 23.75 3.30 1.39 27.48 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 10.43 2.88 20.75 5.72 0.41 23.95 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 B 14 LYS C 15 LYS~? 19.87 O1 EDO C 140 B 74 LYS C 20 LYS~? 21.67 C1 EDO C 140 B 165 GLU C 36 GLU~? -27.32 O1 EDO C 140s coo 4.84 5.09 23.75 3.30 1.39 27.48 23.48 18.06 15.81 27.69 13.80 17.86 coo 10.43 2.88 20.75 5.72 0.41 23.95 15.48 20.46 18.00 15.72 26.44 16.52 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 19.61 26.41 3.01 20.17 25.01 1.52 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 B 14 LYS C 20 LYS~? 21.67 C1 EDO C 140 B 74 LYS C 15 LYS~? 19.87 O1 EDO C 140 B 165 GLU C 36 GLU~? -27.32 O1 EDO C 140s coo 4.84 5.09 23.75 3.30 1.39 27.48 15.48 20.46 18.00 15.72 26.44 16.52 coo 10.43 2.88 20.75 5.72 0.41 23.95 23.48 18.06 15.81 27.69 13.80 17.86 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 19.61 26.41 3.01 20.17 25.01 1.52 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 B 14 LYS C 31 LYS~? 22.12 CL CL A 141 B 74 LYS A 47 LYS~? 18.08 C5 PG4 A 142 B 165 GLU A 127 GLU^? 8.20 CL CL A 141 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.92 28.31 6.82 8.29 31.11 11.06 coo 10.43 2.88 20.75 5.72 0.41 23.95 4.15 29.38 6.95 0.12 26.77 10.99 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 2.90 34.77 -4.78 2.12 35.30 -6.66 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 16 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 16 LYS~? 4.07 C8 PG4 A 142 C 74 LYS A 20 LYS~? -2.81 O1 PG4 A 142s C 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 17.59 37.25 25.80 19.64 34.15 21.60 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 12.29 34.52 28.11 16.84 32.47 25.43 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 12.06 27.10 15.56 13.23 27.02 13.80 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS A 20 LYS~? -2.81 O1 PG4 A 142s C 74 LYS A 16 LYS~? 4.07 C8 PG4 A 142 C 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 17.59 37.25 25.80 19.64 34.15 21.60 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 12.29 34.52 28.11 16.84 32.47 25.43 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 12.06 27.10 15.56 13.23 27.02 13.80 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 C 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 C 74 LYS A 35 LYS~? 11.98 C3 PG4 A 142 C 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 17.59 37.25 25.80 19.64 34.15 21.60 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 12.29 34.52 28.11 16.84 32.47 25.43 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 12.06 27.10 15.56 13.23 27.02 13.80 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 C 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 C 74 LYS B 47 LYS~? 12.98 C2 PG4 A 142 C 165 GLU B 127 GLU^? 8.11 CL CL B 140 coo 17.59 37.25 25.80 19.64 34.15 21.60 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 12.29 34.52 28.11 16.84 32.47 25.43 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 12.06 27.10 15.56 13.23 27.02 13.80 -28.31 39.11 17.60 -29.33 39.55 19.43 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 C 14 LYS A 35 LYS~? 11.98 C3 PG4 A 142 C 74 LYS A 31 LYS~? 8.03 C2 PG4 A 142 C 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 17.59 37.25 25.80 19.64 34.15 21.60 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 12.29 34.52 28.11 16.84 32.47 25.43 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 12.06 27.10 15.56 13.23 27.02 13.80 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 C 14 LYS B 20 LYS~? -2.98 O4 PG4 B 142s C 74 LYS B 16 LYS~? 5.16 C5 PG4 B 142 C 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo 17.59 37.25 25.80 19.64 34.15 21.60 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 12.29 34.52 28.11 16.84 32.47 25.43 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 12.06 27.10 15.56 13.23 27.02 13.80 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 C 14 LYS B 47 LYS~? 12.98 C2 PG4 A 142 C 74 LYS A 31 LYS~? 8.03 C2 PG4 A 142 C 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 17.59 37.25 25.80 19.64 34.15 21.60 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 12.29 34.52 28.11 16.84 32.47 25.43 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 12.06 27.10 15.56 13.23 27.02 13.80 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 C 14 LYS C 31 LYS~? 22.12 CL CL A 141 C 74 LYS A 47 LYS~? 18.08 C5 PG4 A 142 C 165 GLU A 127 GLU^? 8.20 CL CL A 141 coo 17.59 37.25 25.80 19.64 34.15 21.60 9.92 28.31 6.82 8.29 31.11 11.06 coo 12.29 34.52 28.11 16.84 32.47 25.43 4.15 29.38 6.95 0.12 26.77 10.99 coo 12.06 27.10 15.56 13.23 27.02 13.80 2.90 34.77 -4.78 2.12 35.30 -6.66 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 8 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 15 LYS~? 13.64 CL CL A 141 D 74 LYS A 20 LYS~? -2.81 O1 PG4 A 142s D 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS A 16 LYS~? 4.07 C8 PG4 A 142 D 74 LYS A 20 LYS~? -2.81 O1 PG4 A 142s D 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS A 20 LYS~? -2.81 O1 PG4 A 142s D 74 LYS A 15 LYS~? 13.64 CL CL A 141 D 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS A 20 LYS~? -2.81 O1 PG4 A 142s D 74 LYS A 16 LYS~? 4.07 C8 PG4 A 142 D 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 D 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 D 74 LYS A 35 LYS~? 11.98 C3 PG4 A 142 D 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 D 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 D 74 LYS B 47 LYS~? 12.98 C2 PG4 A 142 D 165 GLU B 127 GLU^? 8.11 CL CL B 140 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -28.31 39.11 17.60 -29.33 39.55 19.43 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 D 14 LYS A 35 LYS~? 11.98 C3 PG4 A 142 D 74 LYS A 31 LYS~? 8.03 C2 PG4 A 142 D 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 D 14 LYS B 15 LYS~? 14.97 CL CL B 140 D 74 LYS B 20 LYS~? -2.98 O4 PG4 B 142s D 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -27.71 47.06 15.95 -22.68 43.71 17.22 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 D 14 LYS B 16 LYS~? 5.16 C5 PG4 B 142 D 74 LYS B 20 LYS~? -2.98 O4 PG4 B 142s D 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 D 14 LYS B 20 LYS~? -2.98 O4 PG4 B 142s D 74 LYS B 15 LYS~? 14.97 CL CL B 140 D 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -27.71 47.06 15.95 -22.68 43.71 17.22 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 D 14 LYS B 20 LYS~? -2.98 O4 PG4 B 142s D 74 LYS B 16 LYS~? 5.16 C5 PG4 B 142 D 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 D 14 LYS B 47 LYS~? 12.98 C2 PG4 A 142 D 74 LYS A 31 LYS~? 8.03 C2 PG4 A 142 D 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 D 14 LYS C 15 LYS~? 19.87 O1 EDO C 140 D 74 LYS C 20 LYS~? 21.67 C1 EDO C 140 D 165 GLU C 36 GLU~? -27.32 O1 EDO C 140s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 23.48 18.06 15.81 27.69 13.80 17.86 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 15.48 20.46 18.00 15.72 26.44 16.52 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 19.61 26.41 3.01 20.17 25.01 1.52 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 D 14 LYS C 20 LYS~? 21.67 C1 EDO C 140 D 74 LYS C 15 LYS~? 19.87 O1 EDO C 140 D 165 GLU C 36 GLU~? -27.32 O1 EDO C 140s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 15.48 20.46 18.00 15.72 26.44 16.52 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 23.48 18.06 15.81 27.69 13.80 17.86 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 19.61 26.41 3.01 20.17 25.01 1.52 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 D 14 LYS C 31 LYS~? 22.12 CL CL A 141 D 74 LYS A 47 LYS~? 18.08 C5 PG4 A 142 D 165 GLU A 127 GLU^? 8.20 CL CL A 141 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.92 28.31 6.82 8.29 31.11 11.06 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 4.15 29.38 6.95 0.12 26.77 10.99 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 2.90 34.77 -4.78 2.12 35.30 -6.66 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 15 hits 1kqc_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 50 ASP.? 20.38 CL CL A 141 262 LYS A 47 LYS~? 18.08 C5 PG4 A 142 336 ARG C 39 ARG~? 23.08 O1 EDO C 141 coo 61.88 50.78 12.96 63.84 50.60 13.71 11.71 33.66 5.09 12.68 31.93 4.37 coo 63.59 44.40 18.32 63.20 49.74 17.95 4.15 29.38 6.95 0.12 26.77 10.99 coo 72.60 57.42 15.86 71.61 56.68 18.70 17.00 20.76 1.74 15.55 23.42 1.18 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP A 104 ASP^? 12.12 O ACT A 139 262 LYS A 93 LYS^? 11.69 O ACT A 139 336 ARG A 111 ARG.? 7.83 OXT ACT A 139 coo 61.88 50.78 12.96 63.84 50.60 13.71 2.26 57.49 7.12 4.30 57.24 7.17 coo 63.59 44.40 18.32 63.20 49.74 17.95 3.67 49.37 7.73 5.94 48.81 2.98 coo 72.60 57.42 15.86 71.61 56.68 18.70 -9.64 52.74 3.70 -9.14 55.70 2.93 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP B 50 ASP.? 10.53 C3 PG4 A 142 262 LYS B 47 LYS~? 12.98 C2 PG4 A 142 336 ARG A 39 ARG~? 11.53 C4 PG4 A 142 coo 61.88 50.78 12.96 63.84 50.60 13.71 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 63.59 44.40 18.32 63.20 49.74 17.95 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 72.60 57.42 15.86 71.61 56.68 18.70 -9.34 34.41 10.95 -12.33 34.37 11.59 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP B 104 ASP^? 11.90 OXT ACT B 139 262 LYS B 93 LYS^? 4.13 CL CL B 141 336 ARG B 111 ARG.? 7.92 O ACT B 139 coo 61.88 50.78 12.96 63.84 50.60 13.71 -48.63 28.94 5.87 -47.34 27.30 5.89 coo 63.59 44.40 18.32 63.20 49.74 17.95 -40.82 31.70 5.12 -39.31 29.65 9.95 coo 72.60 57.42 15.86 71.61 56.68 18.70 -50.20 41.64 9.27 -52.60 39.78 9.98 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 5 3 # 5 255 ASP C 104 ASP^? 12.14 OXT ACT C 139 262 LYS C 93 LYS^? 9.06 O1 EDO C 140 336 ARG C 111 ARG.? 7.98 O ACT C 139 coo 61.88 50.78 12.96 63.84 50.60 13.71 3.02 -0.89 6.06 4.36 -2.50 5.95 coo 63.59 44.40 18.32 63.20 49.74 17.95 10.75 2.06 5.39 12.48 0.59 10.09 coo 72.60 57.42 15.86 71.61 56.68 18.70 1.09 11.93 9.22 -1.20 10.06 10.11 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 5 hits 1lam_c00 naa= 3 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 1 3 # 1 60 GLU A 127 GLU^? 8.20 CL CL A 141 198 CYH A 23 CYH.? -5.05 CL CL A 141s 229 ASN A 19 ASN~? 8.40 CL CL A 141 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 2.90 34.77 -4.78 2.12 35.30 -6.66 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -5.47 34.18 -6.27 -3.38 33.66 -6.11 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 2 3 # 2 60 GLU B 127 GLU^? 8.11 CL CL B 140 198 CYH B 23 CYH.? -4.94 CL CL B 140s 229 ASN B 19 ASN~? 8.46 CL CL B 140 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 -28.31 39.11 17.60 -29.33 39.55 19.43 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -31.83 46.76 19.25 -30.45 45.13 19.08 1lcb_c02 source 1lcb THYMIDYLATE SYNTHASE : 2 hits 1lcb_c02 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 61 ALA~? -3.67 C ACT A 140s A 317 GLY A 64 GLY~? 8.05 O ACT A 140 A 318 ASP A 62 ASP~? -3.38 O ACT A 140s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -5.79 55.28 13.25 -5.05 56.25 14.14 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -5.68 50.60 11.44 -5.90 50.48 12.19 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -9.14 53.57 16.41 -8.61 54.95 17.94 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 61 ALA~? 16.48 OXT ACT B 139 A 317 GLY B 64 GLY~? 14.04 CL CL B 141 A 318 ASP B 62 ASP~? 20.96 OXT ACT B 139 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -50.66 37.12 -0.21 -51.15 35.97 -1.06 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -46.53 39.33 1.61 -46.53 39.59 0.85 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -50.88 40.70 -3.44 -51.62 39.45 -5.01 ULMN 3 1lij_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA C 61 ALA~? -3.72 C1 EDO C 141s A 317 GLY C 64 GLY~? 8.12 O1 EDO C 141 A 318 ASP C 62 ASP~? -3.30 O1 EDO C 141s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 0.87 7.13 -0.12 0.41 6.02 -0.92 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 4.96 9.44 1.72 4.95 9.71 0.95 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 0.59 10.79 -3.25 -0.22 9.73 -4.86 1lij_c01 source 1lij ADENOSINE KINASE : 3 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 61 ALA~? -3.67 C ACT A 140s A 317 GLY A 64 GLY~? 8.05 O ACT A 140 A 318 ASP A 62 ASP~? -3.38 O ACT A 140s coo 27.04 23.54 41.85 25.72 24.19 42.18 -5.79 55.28 13.25 -5.05 56.25 14.14 coo 27.87 23.16 38.17 28.43 22.97 38.87 -5.68 50.60 11.44 -5.90 50.48 12.19 coo 32.11 22.71 40.58 33.42 24.22 39.78 -9.14 53.57 16.41 -8.61 54.95 17.94 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 61 ALA~? 16.48 OXT ACT B 139 A 317 GLY B 64 GLY~? 14.04 CL CL B 141 A 318 ASP B 62 ASP~? 20.96 OXT ACT B 139 coo 27.04 23.54 41.85 25.72 24.19 42.18 -50.66 37.12 -0.21 -51.15 35.97 -1.06 coo 27.87 23.16 38.17 28.43 22.97 38.87 -46.53 39.33 1.61 -46.53 39.59 0.85 coo 32.11 22.71 40.58 33.42 24.22 39.78 -50.88 40.70 -3.44 -51.62 39.45 -5.01 ULMN 3 1lio_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA C 61 ALA~? -3.72 C1 EDO C 141s A 317 GLY C 64 GLY~? 8.12 O1 EDO C 141 A 318 ASP C 62 ASP~? -3.30 O1 EDO C 141s coo 27.04 23.54 41.85 25.72 24.19 42.18 0.87 7.13 -0.12 0.41 6.02 -0.92 coo 27.87 23.16 38.17 28.43 22.97 38.87 4.96 9.44 1.72 4.95 9.71 0.95 coo 32.11 22.71 40.58 33.42 24.22 39.78 0.59 10.79 -3.25 -0.22 9.73 -4.86 1lio_c01 source 1lio ADENOSINE KINASE : 3 hits 1lio_c01 naa= 3 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 1 3 # 1 A 123 LYS A 35 LYS~? 11.98 C3 PG4 A 142 A 202 SER B 49 SER.? 12.95 CL CL B 141 A 226 SER B 119 SER.? 14.69 C3 PG4 A 142 coo 1.62 6.10 69.30 3.81 1.25 65.91 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 4.43 1.89 61.79 4.31 0.09 63.40 -23.84 36.86 9.13 -26.20 37.40 8.61 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 2 3 # 2 A 123 LYS A 97 LYS.? 17.22 CL CL A 141 A 202 SER A 119 SER.? 16.13 CL CL A 141 A 226 SER A 49 SER.? 14.71 CL CL A 141 coo 1.62 6.10 69.30 3.81 1.25 65.91 12.14 41.01 8.19 12.52 43.66 3.40 coo 4.43 1.89 61.79 4.31 0.09 63.40 11.23 33.92 0.93 9.27 32.55 0.99 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 3 3 # 3 A 123 LYS C 35 LYS~? 18.91 O1 EDO C 141 A 202 SER A 49 SER.? 14.71 CL CL A 141 A 226 SER A 119 SER.? 16.13 CL CL A 141 coo 1.62 6.10 69.30 3.81 1.25 65.91 14.41 24.06 5.83 10.24 22.70 1.76 coo 4.43 1.89 61.79 4.31 0.09 63.40 7.42 32.00 3.53 5.70 33.62 4.04 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 11.23 33.92 0.93 9.27 32.55 0.99 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 4 3 # 4 A 123 LYS C 97 LYS.? 16.45 O1 EDO C 140 A 202 SER C 119 SER.? 19.22 O1 EDO C 140 A 226 SER C 49 SER.? 18.04 O1 EDO C 140 coo 1.62 6.10 69.30 3.81 1.25 65.91 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 4.43 1.89 61.79 4.31 0.09 63.40 27.99 3.53 12.09 28.26 5.94 12.28 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 27.68 7.76 9.43 25.38 8.17 8.83 1m21_c00 source 1m21 PEPTIDE AMIDASE : 4 hits 1m21_c00 naa= 3 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 1 3 # 1 B 123 LYS A 35 LYS~? 11.98 C3 PG4 A 142 B 202 SER B 49 SER.? 12.95 CL CL B 141 B 226 SER B 119 SER.? 14.69 C3 PG4 A 142 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 32.81 4.27 10.70 32.87 6.07 12.31 -23.84 36.86 9.13 -26.20 37.40 8.61 coo 28.77 6.36 12.44 30.83 7.25 11.75 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 2 3 # 2 B 123 LYS A 97 LYS.? 17.22 CL CL A 141 B 202 SER A 119 SER.? 16.13 CL CL A 141 B 226 SER A 49 SER.? 14.71 CL CL A 141 coo 35.67 -0.01 18.11 33.47 4.84 14.73 12.14 41.01 8.19 12.52 43.66 3.40 coo 32.81 4.27 10.70 32.87 6.07 12.31 11.23 33.92 0.93 9.27 32.55 0.99 coo 28.77 6.36 12.44 30.83 7.25 11.75 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 3 3 # 3 B 123 LYS C 35 LYS~? 18.91 O1 EDO C 141 B 202 SER A 49 SER.? 14.71 CL CL A 141 B 226 SER A 119 SER.? 16.13 CL CL A 141 coo 35.67 -0.01 18.11 33.47 4.84 14.73 14.41 24.06 5.83 10.24 22.70 1.76 coo 32.81 4.27 10.70 32.87 6.07 12.31 7.42 32.00 3.53 5.70 33.62 4.04 coo 28.77 6.36 12.44 30.83 7.25 11.75 11.23 33.92 0.93 9.27 32.55 0.99 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 4 3 # 4 B 123 LYS C 97 LYS.? 16.45 O1 EDO C 140 B 202 SER C 119 SER.? 19.22 O1 EDO C 140 B 226 SER C 49 SER.? 18.04 O1 EDO C 140 coo 35.67 -0.01 18.11 33.47 4.84 14.73 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 32.81 4.27 10.70 32.87 6.07 12.31 27.99 3.53 12.09 28.26 5.94 12.28 coo 28.77 6.36 12.44 30.83 7.25 11.75 27.68 7.76 9.43 25.38 8.17 8.83 1m21_c01 source 1m21 PEPTIDE AMIDASE : 4 hits 1m21_c01 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP C 59 ASP.? 10.26 O1 EDO C 141 A 279 GLU A 36 GLU~? 11.76 C4 PG4 A 142 A 369 ASP C 62 ASP~? -3.30 O1 EDO C 141s coo 11.74 38.14 80.19 10.63 36.40 80.65 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 16.54 46.37 63.94 14.77 45.79 62.95 -12.87 29.42 9.52 -11.52 29.66 11.15 coo 12.19 31.08 87.29 11.13 32.66 86.38 0.59 10.79 -3.25 -0.22 9.73 -4.86 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 1 hits 1m53_c06 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG B 40 ARG~? 9.95 C3 PG4 B 142 229 SER B 33 SER~? 8.19 C1 PG4 B 142 325 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo 2.54 15.84 18.57 3.24 17.85 16.30 -28.07 54.35 5.16 -26.37 56.02 7.18 coo 10.17 13.48 15.92 9.61 15.76 15.27 -35.78 58.83 6.00 -36.15 60.63 7.64 coo 5.42 13.04 19.75 5.74 13.81 17.79 -31.60 55.95 3.54 -31.25 54.50 1.99 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 1 hits 1mbb_c00 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 16 LYS~? 4.07 C8 PG4 A 142 166 LYS A 20 LYS~? -2.81 O1 PG4 A 142s 324 SER A 72 SER~? 17.31 O ACT A 140 coo 25.93 8.11 25.51 26.40 7.80 19.66 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 27.27 1.43 25.09 29.18 5.25 22.89 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 46.32 14.55 19.93 45.95 12.72 21.27 0.42 40.55 13.73 0.47 42.26 15.43 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 16 LYS~? 4.07 C8 PG4 A 142 166 LYS A 20 LYS~? -2.81 O1 PG4 A 142s 324 SER B 119 SER.? 14.69 C3 PG4 A 142 coo 25.93 8.11 25.51 26.40 7.80 19.66 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 27.27 1.43 25.09 29.18 5.25 22.89 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 46.32 14.55 19.93 45.95 12.72 21.27 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS A 20 LYS~? -2.81 O1 PG4 A 142s 166 LYS A 15 LYS~? 13.64 CL CL A 141 324 SER B 49 SER.? 12.95 CL CL B 141 coo 25.93 8.11 25.51 26.40 7.80 19.66 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 27.27 1.43 25.09 29.18 5.25 22.89 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 46.32 14.55 19.93 45.95 12.72 21.27 -23.84 36.86 9.13 -26.20 37.40 8.61 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS A 20 LYS~? -2.81 O1 PG4 A 142s 166 LYS A 15 LYS~? 13.64 CL CL A 141 324 SER B 119 SER.? 14.69 C3 PG4 A 142 coo 25.93 8.11 25.51 26.40 7.80 19.66 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 27.27 1.43 25.09 29.18 5.25 22.89 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 46.32 14.55 19.93 45.95 12.72 21.27 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 5 3 # 5 164 LYS A 20 LYS~? -2.81 O1 PG4 A 142s 166 LYS A 16 LYS~? 4.07 C8 PG4 A 142 324 SER A 72 SER~? 17.31 O ACT A 140 coo 25.93 8.11 25.51 26.40 7.80 19.66 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 27.27 1.43 25.09 29.18 5.25 22.89 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 46.32 14.55 19.93 45.95 12.72 21.27 0.42 40.55 13.73 0.47 42.26 15.43 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 6 3 # 6 164 LYS A 20 LYS~? -2.81 O1 PG4 A 142s 166 LYS A 16 LYS~? 4.07 C8 PG4 A 142 324 SER B 49 SER.? 12.95 CL CL B 141 coo 25.93 8.11 25.51 26.40 7.80 19.66 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 27.27 1.43 25.09 29.18 5.25 22.89 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 46.32 14.55 19.93 45.95 12.72 21.27 -23.84 36.86 9.13 -26.20 37.40 8.61 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 7 3 # 7 164 LYS A 20 LYS~? -2.81 O1 PG4 A 142s 166 LYS A 16 LYS~? 4.07 C8 PG4 A 142 324 SER B 119 SER.? 14.69 C3 PG4 A 142 coo 25.93 8.11 25.51 26.40 7.80 19.66 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 27.27 1.43 25.09 29.18 5.25 22.89 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 46.32 14.55 19.93 45.95 12.72 21.27 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 8 3 # 8 164 LYS A 31 LYS~? 8.03 C2 PG4 A 142 166 LYS B 47 LYS~? 12.98 C2 PG4 A 142 324 SER A 72 SER~? 17.31 O ACT A 140 coo 25.93 8.11 25.51 26.40 7.80 19.66 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 27.27 1.43 25.09 29.18 5.25 22.89 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 46.32 14.55 19.93 45.95 12.72 21.27 0.42 40.55 13.73 0.47 42.26 15.43 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 9 3 # 9 164 LYS B 16 LYS~? 5.16 C5 PG4 B 142 166 LYS B 20 LYS~? -2.98 O4 PG4 B 142s 324 SER B 72 SER~? 14.74 CL CL B 141 coo 25.93 8.11 25.51 26.40 7.80 19.66 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 27.27 1.43 25.09 29.18 5.25 22.89 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 46.32 14.55 19.93 45.95 12.72 21.27 -34.82 39.01 -0.84 -36.29 38.18 -2.55 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 10 3 # 10 164 LYS B 20 LYS~? -2.98 O4 PG4 B 142s 166 LYS B 16 LYS~? 5.16 C5 PG4 B 142 324 SER B 72 SER~? 14.74 CL CL B 141 coo 25.93 8.11 25.51 26.40 7.80 19.66 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 27.27 1.43 25.09 29.18 5.25 22.89 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 46.32 14.55 19.93 45.95 12.72 21.27 -34.82 39.01 -0.84 -36.29 38.18 -2.55 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 11 3 # 11 164 LYS C 20 LYS~? 21.67 C1 EDO C 140 166 LYS C 15 LYS~? 19.87 O1 EDO C 140 324 SER A 49 SER.? 14.71 CL CL A 141 coo 25.93 8.11 25.51 26.40 7.80 19.66 15.48 20.46 18.00 15.72 26.44 16.52 coo 27.27 1.43 25.09 29.18 5.25 22.89 23.48 18.06 15.81 27.69 13.80 17.86 coo 46.32 14.55 19.93 45.95 12.72 21.27 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 12 3 # 12 164 LYS C 20 LYS~? 21.67 C1 EDO C 140 166 LYS C 15 LYS~? 19.87 O1 EDO C 140 324 SER A 119 SER.? 16.13 CL CL A 141 coo 25.93 8.11 25.51 26.40 7.80 19.66 15.48 20.46 18.00 15.72 26.44 16.52 coo 27.27 1.43 25.09 29.18 5.25 22.89 23.48 18.06 15.81 27.69 13.80 17.86 coo 46.32 14.55 19.93 45.95 12.72 21.27 11.23 33.92 0.93 9.27 32.55 0.99 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 13 3 # 13 164 LYS C 31 LYS~? 22.12 CL CL A 141 166 LYS A 47 LYS~? 18.08 C5 PG4 A 142 324 SER C 72 SER~? 17.51 O1 EDO C 141 coo 25.93 8.11 25.51 26.40 7.80 19.66 9.92 28.31 6.82 8.29 31.11 11.06 coo 27.27 1.43 25.09 29.18 5.25 22.89 4.15 29.38 6.95 0.12 26.77 10.99 coo 46.32 14.55 19.93 45.95 12.72 21.27 16.69 9.29 -0.73 15.39 8.20 -2.46 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 13 hits 1mdr_c01 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 76 GLY.? 22.10 CL CL A 141 A 501 ASP A 104 ASP^? 12.12 O ACT A 139 B 367 TYR B 120 TYR.? 13.58 O3 PG4 A 142 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 3.02 35.24 15.35 3.00 35.91 14.95 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 2.26 57.49 7.12 4.30 57.24 7.17 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -22.08 28.00 9.76 -23.99 27.18 7.88 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 112 GLY^? 10.97 O ACT A 139 A 501 ASP A 82 ASP.? 11.04 CH3 ACT A 140 B 367 TYR B 129 TYR^? 7.32 CL CL B 140 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -7.56 46.85 3.93 -6.95 47.44 3.87 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 2.17 52.89 21.94 0.47 52.34 23.07 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -32.31 42.16 13.95 -29.70 41.99 14.85 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 124 GLY.? 17.44 CL CL A 141 A 501 ASP C 13 ASP~? 27.02 O1 EDO C 140 B 367 TYR A 102 TYR^? -13.60 O ACT A 139s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 9.25 29.57 -1.03 9.14 29.65 -1.86 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 26.45 23.84 13.97 27.74 25.29 14.77 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 6.40 53.61 9.02 6.49 53.06 6.26 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY B 124 GLY.? 14.98 C3 PG4 A 142 A 501 ASP A 13 ASP~? 8.68 O4 PG4 A 142 B 367 TYR B 102 TYR^? 9.93 CL CL B 141 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -20.73 36.34 13.64 -20.83 36.37 14.48 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -43.22 27.21 3.69 -42.78 27.37 6.43 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY C 76 GLY.? 23.92 O1 EDO C 140 A 501 ASP C 104 ASP^? 12.14 OXT ACT C 139 B 367 TYR A 120 TYR.? -20.76 CL CL A 141s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 22.56 9.67 -2.40 21.96 9.35 -1.98 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 3.02 -0.89 6.06 4.36 -2.50 5.95 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 15.94 35.05 2.39 15.79 37.48 3.75 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 5 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 76 GLY.? 22.10 CL CL A 141 D 501 ASP A 104 ASP^? 12.12 O ACT A 139 E 367 TYR B 120 TYR.? 13.58 O3 PG4 A 142 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 3.02 35.24 15.35 3.00 35.91 14.95 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 2.26 57.49 7.12 4.30 57.24 7.17 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -22.08 28.00 9.76 -23.99 27.18 7.88 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 112 GLY^? 10.97 O ACT A 139 D 501 ASP A 82 ASP.? 11.04 CH3 ACT A 140 E 367 TYR B 129 TYR^? 7.32 CL CL B 140 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -7.56 46.85 3.93 -6.95 47.44 3.87 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 2.17 52.89 21.94 0.47 52.34 23.07 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -32.31 42.16 13.95 -29.70 41.99 14.85 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 124 GLY.? 17.44 CL CL A 141 D 501 ASP C 13 ASP~? 27.02 O1 EDO C 140 E 367 TYR A 102 TYR^? -13.60 O ACT A 139s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 9.25 29.57 -1.03 9.14 29.65 -1.86 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 26.45 23.84 13.97 27.74 25.29 14.77 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 6.40 53.61 9.02 6.49 53.06 6.26 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY B 124 GLY.? 14.98 C3 PG4 A 142 D 501 ASP A 13 ASP~? 8.68 O4 PG4 A 142 E 367 TYR B 102 TYR^? 9.93 CL CL B 141 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -20.73 36.34 13.64 -20.83 36.37 14.48 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -43.22 27.21 3.69 -42.78 27.37 6.43 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY C 76 GLY.? 23.92 O1 EDO C 140 D 501 ASP C 104 ASP^? 12.14 OXT ACT C 139 E 367 TYR A 120 TYR.? -20.76 CL CL A 141s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 22.56 9.67 -2.40 21.96 9.35 -1.98 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 3.02 -0.89 6.06 4.36 -2.50 5.95 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 15.94 35.05 2.39 15.79 37.48 3.75 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 5 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 50 ASP.? 20.38 CL CL A 141 A 55 TYR A 121 TYR.? -24.35 CL CL A 141s A 84 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 11.09 42.89 24.44 11.32 42.06 22.49 11.71 33.66 5.09 12.68 31.93 4.37 coo 4.60 40.33 20.42 7.25 39.50 20.05 16.31 29.26 0.34 18.85 29.40 1.41 coo 9.71 44.83 15.47 10.13 41.43 19.93 14.41 24.06 5.83 10.24 22.70 1.76 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP B 50 ASP.? 10.53 C3 PG4 A 142 A 55 TYR B 121 TYR.? 12.07 O3 PG4 A 142 A 84 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 11.09 42.89 24.44 11.32 42.06 22.49 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 4.60 40.33 20.42 7.25 39.50 20.05 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 9.71 44.83 15.47 10.13 41.43 19.93 -13.45 35.10 6.93 -14.45 39.53 11.08 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 2 hits 1mrq_c02 naa= 3 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 A 142 LYS A 35 LYS~? 11.98 C3 PG4 A 142 A 217 SER B 49 SER.? 12.95 CL CL B 141 A 241 SER B 119 SER.? 14.69 C3 PG4 A 142 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -23.84 36.86 9.13 -26.20 37.40 8.61 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 A 142 LYS A 97 LYS.? 17.22 CL CL A 141 A 217 SER A 119 SER.? 16.13 CL CL A 141 A 241 SER A 49 SER.? 14.71 CL CL A 141 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 12.14 41.01 8.19 12.52 43.66 3.40 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 11.23 33.92 0.93 9.27 32.55 0.99 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 A 142 LYS C 97 LYS.? 16.45 O1 EDO C 140 A 217 SER C 119 SER.? 19.22 O1 EDO C 140 A 241 SER C 49 SER.? 18.04 O1 EDO C 140 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 27.99 3.53 12.09 28.26 5.94 12.28 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 27.68 7.76 9.43 25.38 8.17 8.83 1mt5_c00 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c00 naa= 3 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 B 142 LYS A 35 LYS~? 11.98 C3 PG4 A 142 B 217 SER B 49 SER.? 12.95 CL CL B 141 B 241 SER B 119 SER.? 14.69 C3 PG4 A 142 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -13.45 35.10 6.93 -14.45 39.53 11.08 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -23.84 36.86 9.13 -26.20 37.40 8.61 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 B 142 LYS A 97 LYS.? 17.22 CL CL A 141 B 217 SER A 119 SER.? 16.13 CL CL A 141 B 241 SER A 49 SER.? 14.71 CL CL A 141 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 12.14 41.01 8.19 12.52 43.66 3.40 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 11.23 33.92 0.93 9.27 32.55 0.99 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 B 142 LYS C 35 LYS~? 18.91 O1 EDO C 141 B 217 SER A 49 SER.? 14.71 CL CL A 141 B 241 SER A 119 SER.? 16.13 CL CL A 141 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 14.41 24.06 5.83 10.24 22.70 1.76 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 7.42 32.00 3.53 5.70 33.62 4.04 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 11.23 33.92 0.93 9.27 32.55 0.99 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 B 142 LYS C 97 LYS.? 16.45 O1 EDO C 140 B 217 SER C 119 SER.? 19.22 O1 EDO C 140 B 241 SER C 49 SER.? 18.04 O1 EDO C 140 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 22.33 -0.96 4.86 22.00 -3.43 10.72 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 27.99 3.53 12.09 28.26 5.94 12.28 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 27.68 7.76 9.43 25.38 8.17 8.83 1mt5_c01 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 4 hits 1mt5_c01 naa= 3 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 C 142 LYS A 35 LYS~? 11.98 C3 PG4 A 142 C 217 SER B 49 SER.? 12.95 CL CL B 141 C 241 SER B 119 SER.? 14.69 C3 PG4 A 142 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -13.45 35.10 6.93 -14.45 39.53 11.08 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -23.84 36.86 9.13 -26.20 37.40 8.61 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 C 142 LYS A 97 LYS.? 17.22 CL CL A 141 C 217 SER A 119 SER.? 16.13 CL CL A 141 C 241 SER A 49 SER.? 14.71 CL CL A 141 coo -12.07 2.83 63.52 -8.95 7.56 61.01 12.14 41.01 8.19 12.52 43.66 3.40 coo -11.64 10.12 58.62 -9.34 9.31 58.79 11.23 33.92 0.93 9.27 32.55 0.99 coo -9.31 12.91 61.58 -8.56 11.90 59.50 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 C 142 LYS C 97 LYS.? 16.45 O1 EDO C 140 C 217 SER C 119 SER.? 19.22 O1 EDO C 140 C 241 SER C 49 SER.? 18.04 O1 EDO C 140 coo -12.07 2.83 63.52 -8.95 7.56 61.01 22.33 -0.96 4.86 22.00 -3.43 10.72 coo -11.64 10.12 58.62 -9.34 9.31 58.79 27.99 3.53 12.09 28.26 5.94 12.28 coo -9.31 12.91 61.58 -8.56 11.90 59.50 27.68 7.76 9.43 25.38 8.17 8.83 1mt5_c02 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c02 naa= 3 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 D 142 LYS A 35 LYS~? 11.98 C3 PG4 A 142 D 217 SER B 49 SER.? 12.95 CL CL B 141 D 241 SER B 119 SER.? 14.69 C3 PG4 A 142 coo 32.93 17.78 71.88 30.89 13.50 67.83 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 34.38 11.17 66.10 32.18 12.14 65.65 -23.84 36.86 9.13 -26.20 37.40 8.61 coo 31.34 7.96 67.74 31.44 9.08 65.62 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 D 142 LYS A 97 LYS.? 17.22 CL CL A 141 D 217 SER A 119 SER.? 16.13 CL CL A 141 D 241 SER A 49 SER.? 14.71 CL CL A 141 coo 32.93 17.78 71.88 30.89 13.50 67.83 12.14 41.01 8.19 12.52 43.66 3.40 coo 34.38 11.17 66.10 32.18 12.14 65.65 11.23 33.92 0.93 9.27 32.55 0.99 coo 31.34 7.96 67.74 31.44 9.08 65.62 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 D 142 LYS C 35 LYS~? 18.91 O1 EDO C 141 D 217 SER A 49 SER.? 14.71 CL CL A 141 D 241 SER A 119 SER.? 16.13 CL CL A 141 coo 32.93 17.78 71.88 30.89 13.50 67.83 14.41 24.06 5.83 10.24 22.70 1.76 coo 34.38 11.17 66.10 32.18 12.14 65.65 7.42 32.00 3.53 5.70 33.62 4.04 coo 31.34 7.96 67.74 31.44 9.08 65.62 11.23 33.92 0.93 9.27 32.55 0.99 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 D 142 LYS C 97 LYS.? 16.45 O1 EDO C 140 D 217 SER C 119 SER.? 19.22 O1 EDO C 140 D 241 SER C 49 SER.? 18.04 O1 EDO C 140 coo 32.93 17.78 71.88 30.89 13.50 67.83 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 34.38 11.17 66.10 32.18 12.14 65.65 27.99 3.53 12.09 28.26 5.94 12.28 coo 31.34 7.96 67.74 31.44 9.08 65.62 27.68 7.76 9.43 25.38 8.17 8.83 1mt5_c03 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 4 hits 1mt5_c03 naa= 3 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 E 142 LYS A 35 LYS~? 11.98 C3 PG4 A 142 E 217 SER B 49 SER.? 12.95 CL CL B 141 E 241 SER B 119 SER.? 14.69 C3 PG4 A 142 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -23.84 36.86 9.13 -26.20 37.40 8.61 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 E 142 LYS A 97 LYS.? 17.22 CL CL A 141 E 217 SER A 119 SER.? 16.13 CL CL A 141 E 241 SER A 49 SER.? 14.71 CL CL A 141 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 12.14 41.01 8.19 12.52 43.66 3.40 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 11.23 33.92 0.93 9.27 32.55 0.99 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 E 142 LYS C 97 LYS.? 16.45 O1 EDO C 140 E 217 SER C 119 SER.? 19.22 O1 EDO C 140 E 241 SER C 49 SER.? 18.04 O1 EDO C 140 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 27.99 3.53 12.09 28.26 5.94 12.28 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 27.68 7.76 9.43 25.38 8.17 8.83 1mt5_c04 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c04 naa= 3 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 F 142 LYS A 35 LYS~? 11.98 C3 PG4 A 142 F 217 SER B 49 SER.? 12.95 CL CL B 141 F 241 SER B 119 SER.? 14.69 C3 PG4 A 142 coo 85.78 13.19 64.96 85.47 13.47 58.63 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 87.43 17.13 57.15 85.84 15.39 56.76 -23.84 36.86 9.13 -26.20 37.40 8.61 coo 89.69 13.60 54.86 87.60 14.67 54.46 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 F 142 LYS A 97 LYS.? 17.22 CL CL A 141 F 217 SER A 119 SER.? 16.13 CL CL A 141 F 241 SER A 49 SER.? 14.71 CL CL A 141 coo 85.78 13.19 64.96 85.47 13.47 58.63 12.14 41.01 8.19 12.52 43.66 3.40 coo 87.43 17.13 57.15 85.84 15.39 56.76 11.23 33.92 0.93 9.27 32.55 0.99 coo 89.69 13.60 54.86 87.60 14.67 54.46 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 F 142 LYS C 35 LYS~? 18.91 O1 EDO C 141 F 217 SER A 49 SER.? 14.71 CL CL A 141 F 241 SER A 119 SER.? 16.13 CL CL A 141 coo 85.78 13.19 64.96 85.47 13.47 58.63 14.41 24.06 5.83 10.24 22.70 1.76 coo 87.43 17.13 57.15 85.84 15.39 56.76 7.42 32.00 3.53 5.70 33.62 4.04 coo 89.69 13.60 54.86 87.60 14.67 54.46 11.23 33.92 0.93 9.27 32.55 0.99 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 F 142 LYS C 97 LYS.? 16.45 O1 EDO C 140 F 217 SER C 119 SER.? 19.22 O1 EDO C 140 F 241 SER C 49 SER.? 18.04 O1 EDO C 140 coo 85.78 13.19 64.96 85.47 13.47 58.63 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 87.43 17.13 57.15 85.84 15.39 56.76 27.99 3.53 12.09 28.26 5.94 12.28 coo 89.69 13.60 54.86 87.60 14.67 54.46 27.68 7.76 9.43 25.38 8.17 8.83 1mt5_c05 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 4 hits 1mt5_c05 naa= 3 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 G 142 LYS A 97 LYS.? 17.22 CL CL A 141 G 217 SER A 119 SER.? 16.13 CL CL A 141 G 241 SER A 49 SER.? 14.71 CL CL A 141 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 12.14 41.01 8.19 12.52 43.66 3.40 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 11.23 33.92 0.93 9.27 32.55 0.99 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 G 142 LYS C 97 LYS.? 16.45 O1 EDO C 140 G 217 SER C 119 SER.? 19.22 O1 EDO C 140 G 241 SER C 49 SER.? 18.04 O1 EDO C 140 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 27.99 3.53 12.09 28.26 5.94 12.28 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 27.68 7.76 9.43 25.38 8.17 8.83 1mt5_c06 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c06 naa= 3 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 H 142 LYS A 35 LYS~? 11.98 C3 PG4 A 142 H 217 SER B 49 SER.? 12.95 CL CL B 141 H 241 SER B 119 SER.? 14.69 C3 PG4 A 142 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -23.84 36.86 9.13 -26.20 37.40 8.61 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 H 142 LYS A 97 LYS.? 17.22 CL CL A 141 H 217 SER A 119 SER.? 16.13 CL CL A 141 H 241 SER A 49 SER.? 14.71 CL CL A 141 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 12.14 41.01 8.19 12.52 43.66 3.40 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 11.23 33.92 0.93 9.27 32.55 0.99 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 H 142 LYS C 97 LYS.? 16.45 O1 EDO C 140 H 217 SER C 119 SER.? 19.22 O1 EDO C 140 H 241 SER C 49 SER.? 18.04 O1 EDO C 140 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 27.99 3.53 12.09 28.26 5.94 12.28 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 27.68 7.76 9.43 25.38 8.17 8.83 1mt5_c07 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c07 naa= 3 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 I 142 LYS A 97 LYS.? 17.22 CL CL A 141 I 217 SER A 119 SER.? 16.13 CL CL A 141 I 241 SER A 49 SER.? 14.71 CL CL A 141 coo -5.05 91.11 27.04 -1.24 87.39 30.21 12.14 41.01 8.19 12.52 43.66 3.40 coo 2.83 88.63 29.54 1.30 86.82 30.03 11.23 33.92 0.93 9.27 32.55 0.99 coo 2.37 88.32 34.25 2.82 86.58 32.61 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 I 142 LYS C 97 LYS.? 16.45 O1 EDO C 140 I 217 SER C 119 SER.? 19.22 O1 EDO C 140 I 241 SER C 49 SER.? 18.04 O1 EDO C 140 coo -5.05 91.11 27.04 -1.24 87.39 30.21 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 2.83 88.63 29.54 1.30 86.82 30.03 27.99 3.53 12.09 28.26 5.94 12.28 coo 2.37 88.32 34.25 2.82 86.58 32.61 27.68 7.76 9.43 25.38 8.17 8.83 1mt5_c08 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c08 naa= 3 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 J 142 LYS A 35 LYS~? 11.98 C3 PG4 A 142 J 217 SER B 49 SER.? 12.95 CL CL B 141 J 241 SER B 119 SER.? 14.69 C3 PG4 A 142 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -13.45 35.10 6.93 -14.45 39.53 11.08 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -23.84 36.86 9.13 -26.20 37.40 8.61 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 J 142 LYS A 97 LYS.? 17.22 CL CL A 141 J 217 SER A 119 SER.? 16.13 CL CL A 141 J 241 SER A 49 SER.? 14.71 CL CL A 141 coo -16.11 59.78 61.53 -15.92 58.68 55.43 12.14 41.01 8.19 12.52 43.66 3.40 coo -17.65 54.92 54.17 -15.81 56.46 53.79 11.23 33.92 0.93 9.27 32.55 0.99 coo -19.92 58.10 51.57 -17.75 57.08 51.34 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 J 142 LYS C 35 LYS~? 18.91 O1 EDO C 141 J 217 SER A 49 SER.? 14.71 CL CL A 141 J 241 SER A 119 SER.? 16.13 CL CL A 141 coo -16.11 59.78 61.53 -15.92 58.68 55.43 14.41 24.06 5.83 10.24 22.70 1.76 coo -17.65 54.92 54.17 -15.81 56.46 53.79 7.42 32.00 3.53 5.70 33.62 4.04 coo -19.92 58.10 51.57 -17.75 57.08 51.34 11.23 33.92 0.93 9.27 32.55 0.99 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 J 142 LYS C 97 LYS.? 16.45 O1 EDO C 140 J 217 SER C 119 SER.? 19.22 O1 EDO C 140 J 241 SER C 49 SER.? 18.04 O1 EDO C 140 coo -16.11 59.78 61.53 -15.92 58.68 55.43 22.33 -0.96 4.86 22.00 -3.43 10.72 coo -17.65 54.92 54.17 -15.81 56.46 53.79 27.99 3.53 12.09 28.26 5.94 12.28 coo -19.92 58.10 51.57 -17.75 57.08 51.34 27.68 7.76 9.43 25.38 8.17 8.83 1mt5_c09 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 4 hits 1mt5_c09 naa= 3 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 K 142 LYS A 35 LYS~? 11.98 C3 PG4 A 142 K 217 SER B 49 SER.? 12.95 CL CL B 141 K 241 SER B 119 SER.? 14.69 C3 PG4 A 142 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -13.45 35.10 6.93 -14.45 39.53 11.08 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -23.84 36.86 9.13 -26.20 37.40 8.61 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 K 142 LYS A 97 LYS.? 17.22 CL CL A 141 K 217 SER A 119 SER.? 16.13 CL CL A 141 K 241 SER A 49 SER.? 14.71 CL CL A 141 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 12.14 41.01 8.19 12.52 43.66 3.40 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 11.23 33.92 0.93 9.27 32.55 0.99 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 K 142 LYS C 97 LYS.? 16.45 O1 EDO C 140 K 217 SER C 119 SER.? 19.22 O1 EDO C 140 K 241 SER C 49 SER.? 18.04 O1 EDO C 140 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 22.33 -0.96 4.86 22.00 -3.43 10.72 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 27.99 3.53 12.09 28.26 5.94 12.28 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 27.68 7.76 9.43 25.38 8.17 8.83 1mt5_c10 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c10 naa= 3 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 L 142 LYS A 35 LYS~? 11.98 C3 PG4 A 142 L 217 SER B 49 SER.? 12.95 CL CL B 141 L 241 SER B 119 SER.? 14.69 C3 PG4 A 142 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -23.84 36.86 9.13 -26.20 37.40 8.61 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 L 142 LYS A 97 LYS.? 17.22 CL CL A 141 L 217 SER A 119 SER.? 16.13 CL CL A 141 L 241 SER A 49 SER.? 14.71 CL CL A 141 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 12.14 41.01 8.19 12.52 43.66 3.40 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 11.23 33.92 0.93 9.27 32.55 0.99 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 L 142 LYS C 35 LYS~? 18.91 O1 EDO C 141 L 217 SER A 49 SER.? 14.71 CL CL A 141 L 241 SER A 119 SER.? 16.13 CL CL A 141 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 14.41 24.06 5.83 10.24 22.70 1.76 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 7.42 32.00 3.53 5.70 33.62 4.04 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 11.23 33.92 0.93 9.27 32.55 0.99 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 L 142 LYS C 97 LYS.? 16.45 O1 EDO C 140 L 217 SER C 119 SER.? 19.22 O1 EDO C 140 L 241 SER C 49 SER.? 18.04 O1 EDO C 140 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 27.99 3.53 12.09 28.26 5.94 12.28 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 27.68 7.76 9.43 25.38 8.17 8.83 1mt5_c11 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 4 hits 1mt5_c11 naa= 3 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 M 142 LYS A 35 LYS~? 11.98 C3 PG4 A 142 M 217 SER B 49 SER.? 12.95 CL CL B 141 M 241 SER B 119 SER.? 14.69 C3 PG4 A 142 coo 57.83 99.61 24.25 54.90 95.14 20.60 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 51.07 94.66 21.52 53.18 93.49 22.20 -23.84 36.86 9.13 -26.20 37.40 8.61 coo 51.67 94.23 16.93 51.60 92.47 18.57 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 M 142 LYS A 97 LYS.? 17.22 CL CL A 141 M 217 SER A 119 SER.? 16.13 CL CL A 141 M 241 SER A 49 SER.? 14.71 CL CL A 141 coo 57.83 99.61 24.25 54.90 95.14 20.60 12.14 41.01 8.19 12.52 43.66 3.40 coo 51.07 94.66 21.52 53.18 93.49 22.20 11.23 33.92 0.93 9.27 32.55 0.99 coo 51.67 94.23 16.93 51.60 92.47 18.57 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 M 142 LYS C 97 LYS.? 16.45 O1 EDO C 140 M 217 SER C 119 SER.? 19.22 O1 EDO C 140 M 241 SER C 49 SER.? 18.04 O1 EDO C 140 coo 57.83 99.61 24.25 54.90 95.14 20.60 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 51.07 94.66 21.52 53.18 93.49 22.20 27.99 3.53 12.09 28.26 5.94 12.28 coo 51.67 94.23 16.93 51.60 92.47 18.57 27.68 7.76 9.43 25.38 8.17 8.83 1mt5_c12 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c12 naa= 3 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 N 142 LYS A 35 LYS~? 11.98 C3 PG4 A 142 N 217 SER B 49 SER.? 12.95 CL CL B 141 N 241 SER B 119 SER.? 14.69 C3 PG4 A 142 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -23.84 36.86 9.13 -26.20 37.40 8.61 coo 82.47 71.15 2.07 80.82 69.44 2.28 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 N 142 LYS A 97 LYS.? 17.22 CL CL A 141 N 217 SER A 119 SER.? 16.13 CL CL A 141 N 241 SER A 49 SER.? 14.71 CL CL A 141 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 12.14 41.01 8.19 12.52 43.66 3.40 coo 81.67 67.31 -0.58 79.53 68.28 0.00 11.23 33.92 0.93 9.27 32.55 0.99 coo 82.47 71.15 2.07 80.82 69.44 2.28 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 N 142 LYS C 35 LYS~? 18.91 O1 EDO C 141 N 217 SER A 49 SER.? 14.71 CL CL A 141 N 241 SER A 119 SER.? 16.13 CL CL A 141 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 14.41 24.06 5.83 10.24 22.70 1.76 coo 81.67 67.31 -0.58 79.53 68.28 0.00 7.42 32.00 3.53 5.70 33.62 4.04 coo 82.47 71.15 2.07 80.82 69.44 2.28 11.23 33.92 0.93 9.27 32.55 0.99 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 N 142 LYS C 97 LYS.? 16.45 O1 EDO C 140 N 217 SER C 119 SER.? 19.22 O1 EDO C 140 N 241 SER C 49 SER.? 18.04 O1 EDO C 140 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 81.67 67.31 -0.58 79.53 68.28 0.00 27.99 3.53 12.09 28.26 5.94 12.28 coo 82.47 71.15 2.07 80.82 69.44 2.28 27.68 7.76 9.43 25.38 8.17 8.83 1mt5_c13 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 4 hits 1mt5_c13 naa= 3 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 O 142 LYS A 97 LYS.? 17.22 CL CL A 141 O 217 SER A 119 SER.? 16.13 CL CL A 141 O 241 SER A 49 SER.? 14.71 CL CL A 141 coo 81.67 70.12 58.71 78.82 64.87 57.22 12.14 41.01 8.19 12.52 43.66 3.40 coo 81.62 62.23 55.05 79.32 62.93 55.20 11.23 33.92 0.93 9.27 32.55 0.99 coo 79.39 59.54 58.42 78.72 60.00 56.11 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 O 142 LYS C 97 LYS.? 16.45 O1 EDO C 140 O 217 SER C 119 SER.? 19.22 O1 EDO C 140 O 241 SER C 49 SER.? 18.04 O1 EDO C 140 coo 81.67 70.12 58.71 78.82 64.87 57.22 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 81.62 62.23 55.05 79.32 62.93 55.20 27.99 3.53 12.09 28.26 5.94 12.28 coo 79.39 59.54 58.42 78.72 60.00 56.11 27.68 7.76 9.43 25.38 8.17 8.83 1mt5_c14 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c14 naa= 3 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 P 142 LYS A 35 LYS~? 11.98 C3 PG4 A 142 P 217 SER B 49 SER.? 12.95 CL CL B 141 P 241 SER B 119 SER.? 14.69 C3 PG4 A 142 coo 37.29 55.72 69.54 38.73 59.85 65.07 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 35.55 61.40 62.96 37.72 60.41 62.66 -23.84 36.86 9.13 -26.20 37.40 8.61 coo 38.60 64.77 64.10 38.63 63.28 62.26 -23.53 32.55 11.61 -23.32 34.95 11.84 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 P 142 LYS A 97 LYS.? 17.22 CL CL A 141 P 217 SER A 119 SER.? 16.13 CL CL A 141 P 241 SER A 49 SER.? 14.71 CL CL A 141 coo 37.29 55.72 69.54 38.73 59.85 65.07 12.14 41.01 8.19 12.52 43.66 3.40 coo 35.55 61.40 62.96 37.72 60.41 62.66 11.23 33.92 0.93 9.27 32.55 0.99 coo 38.60 64.77 64.10 38.63 63.28 62.26 7.42 32.00 3.53 5.70 33.62 4.04 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 P 142 LYS C 35 LYS~? 18.91 O1 EDO C 141 P 217 SER A 49 SER.? 14.71 CL CL A 141 P 241 SER A 119 SER.? 16.13 CL CL A 141 coo 37.29 55.72 69.54 38.73 59.85 65.07 14.41 24.06 5.83 10.24 22.70 1.76 coo 35.55 61.40 62.96 37.72 60.41 62.66 7.42 32.00 3.53 5.70 33.62 4.04 coo 38.60 64.77 64.10 38.63 63.28 62.26 11.23 33.92 0.93 9.27 32.55 0.99 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 P 142 LYS C 97 LYS.? 16.45 O1 EDO C 140 P 217 SER C 119 SER.? 19.22 O1 EDO C 140 P 241 SER C 49 SER.? 18.04 O1 EDO C 140 coo 37.29 55.72 69.54 38.73 59.85 65.07 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 35.55 61.40 62.96 37.72 60.41 62.66 27.99 3.53 12.09 28.26 5.94 12.28 coo 38.60 64.77 64.10 38.63 63.28 62.26 27.68 7.76 9.43 25.38 8.17 8.83 1mt5_c15 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 4 hits 1mt5_c15 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 16 LYS~? 4.07 C8 PG4 A 142 B 169 LYS A 20 LYS~? -2.81 O1 PG4 A 142s B 327 GLU A 127 GLU^? 8.20 CL CL A 141 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 2.90 34.77 -4.78 2.12 35.30 -6.66 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 1 hits 1muc_c01 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 109 HIS.? -5.41 OXT ACT A 139s A 197 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 223 ALA A 58 ALA^? 8.62 O ACT A 140 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -8.77 57.48 -2.79 -8.58 59.56 -2.89 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -7.65 52.47 7.15 -7.34 51.97 8.48 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 131 HIS^? 7.42 CL CL A 141 A 197 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 223 ALA A 107 ALA.? 7.59 O ACT A 139 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -3.93 60.40 1.16 -3.09 61.57 0.55 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS B 109 HIS.? -5.47 O ACT B 139s A 197 ASP B 25 ASP.? 6.52 O ACT B 139 A 223 ALA B 58 ALA^? 11.90 OXT ACT B 139 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -54.00 38.48 15.75 -55.77 37.34 15.88 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -49.08 40.03 5.89 -48.46 40.08 4.54 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS B 131 HIS^? 7.27 CL CL B 140 A 197 ASP B 25 ASP.? 6.52 O ACT B 139 A 223 ALA B 107 ALA.? 7.47 OXT ACT B 139 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -42.92 41.25 13.23 -43.42 39.34 13.91 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -54.08 32.80 11.83 -54.64 31.53 12.37 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS C 109 HIS.? -5.44 O ACT C 139s A 197 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 223 ALA C 58 ALA^? 8.51 O1 EDO C 141 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -2.54 8.69 15.96 -4.15 7.36 16.15 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 4.46 12.53 17.74 4.84 11.35 19.48 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 2.32 10.24 5.90 2.90 10.23 4.51 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 197 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 223 ALA C 107 ALA.? 7.58 OXT ACT C 139 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 8.46 11.73 13.23 7.93 9.80 13.86 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 4.46 12.53 17.74 4.84 11.35 19.48 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -2.53 3.07 11.99 -3.13 1.71 12.62 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 6 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 109 HIS.? -5.41 OXT ACT A 139s B 197 ASP A 25 ASP.? 6.66 OXT ACT A 139 B 223 ALA A 58 ALA^? 8.62 O ACT A 140 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -8.77 57.48 -2.79 -8.58 59.56 -2.89 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -7.65 52.47 7.15 -7.34 51.97 8.48 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 131 HIS^? 7.42 CL CL A 141 B 197 ASP A 25 ASP.? 6.66 OXT ACT A 139 B 223 ALA A 107 ALA.? 7.59 O ACT A 139 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -3.93 60.40 1.16 -3.09 61.57 0.55 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS B 109 HIS.? -5.47 O ACT B 139s B 197 ASP B 25 ASP.? 6.52 O ACT B 139 B 223 ALA B 58 ALA^? 11.90 OXT ACT B 139 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -54.00 38.48 15.75 -55.77 37.34 15.88 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -49.08 40.03 5.89 -48.46 40.08 4.54 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS B 131 HIS^? 7.27 CL CL B 140 B 197 ASP B 25 ASP.? 6.52 O ACT B 139 B 223 ALA B 107 ALA.? 7.47 OXT ACT B 139 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -42.92 41.25 13.23 -43.42 39.34 13.91 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -54.08 32.80 11.83 -54.64 31.53 12.37 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS C 109 HIS.? -5.44 O ACT C 139s B 197 ASP C 25 ASP.? 6.36 O2 EDO C 140 B 223 ALA C 58 ALA^? 8.51 O1 EDO C 141 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -2.54 8.69 15.96 -4.15 7.36 16.15 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 4.46 12.53 17.74 4.84 11.35 19.48 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 2.32 10.24 5.90 2.90 10.23 4.51 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS C 131 HIS^? 6.39 C1 EDO C 140 B 197 ASP C 25 ASP.? 6.36 O2 EDO C 140 B 223 ALA C 107 ALA.? 7.58 OXT ACT C 139 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 8.46 11.73 13.23 7.93 9.80 13.86 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 4.46 12.53 17.74 4.84 11.35 19.48 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -2.53 3.07 11.99 -3.13 1.71 12.62 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 6 hits 1n2t_c03 naa= 3 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 A 205 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 208 HIS A 110 HIS.? -3.69 OXT ACT A 139s C 104 HIS A 109 HIS.? -5.41 OXT ACT A 139s coo 20.72 31.33 73.27 20.15 33.36 73.56 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 17.00 33.82 71.84 16.59 31.98 70.88 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 20.06 38.06 74.21 21.19 36.81 72.96 -8.77 57.48 -2.79 -8.58 59.56 -2.89 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 A 205 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 208 HIS A 110 HIS.? -3.69 OXT ACT A 139s C 104 HIS A 131 HIS^? 7.42 CL CL A 141 coo 20.72 31.33 73.27 20.15 33.36 73.56 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 17.00 33.82 71.84 16.59 31.98 70.88 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 20.06 38.06 74.21 21.19 36.81 72.96 -5.82 46.49 -0.22 -4.38 47.88 -0.81 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 3 3 # 3 A 205 ASP B 25 ASP.? 6.52 O ACT B 139 A 208 HIS B 110 HIS.? -3.67 O ACT B 139s C 104 HIS B 109 HIS.? -5.47 O ACT B 139s coo 20.72 31.33 73.27 20.15 33.36 73.56 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 17.00 33.82 71.84 16.59 31.98 70.88 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 20.06 38.06 74.21 21.19 36.81 72.96 -54.00 38.48 15.75 -55.77 37.34 15.88 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 4 3 # 4 A 205 ASP B 25 ASP.? 6.52 O ACT B 139 A 208 HIS B 110 HIS.? -3.67 O ACT B 139s C 104 HIS B 131 HIS^? 7.27 CL CL B 140 coo 20.72 31.33 73.27 20.15 33.36 73.56 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 17.00 33.82 71.84 16.59 31.98 70.88 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 20.06 38.06 74.21 21.19 36.81 72.96 -42.92 41.25 13.23 -43.42 39.34 13.91 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 5 3 # 5 A 205 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 208 HIS C 110 HIS.? 3.59 O ACT C 139s C 104 HIS C 109 HIS.? -5.44 O ACT C 139s coo 20.72 31.33 73.27 20.15 33.36 73.56 4.46 12.53 17.74 4.84 11.35 19.48 coo 17.00 33.82 71.84 16.59 31.98 70.88 4.54 8.83 15.35 4.90 7.96 17.23 coo 20.06 38.06 74.21 21.19 36.81 72.96 -2.54 8.69 15.96 -4.15 7.36 16.15 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 6 3 # 6 A 205 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 208 HIS C 110 HIS.? 3.59 O ACT C 139s C 104 HIS C 131 HIS^? 6.39 C1 EDO C 140 coo 20.72 31.33 73.27 20.15 33.36 73.56 4.46 12.53 17.74 4.84 11.35 19.48 coo 17.00 33.82 71.84 16.59 31.98 70.88 4.54 8.83 15.35 4.90 7.96 17.23 coo 20.06 38.06 74.21 21.19 36.81 72.96 8.46 11.73 13.23 7.93 9.80 13.86 1ndo_c00 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 6 hits 1ndo_c00 naa= 3 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 A 104 HIS A 109 HIS.? -5.41 OXT ACT A 139s E 205 ASP A 25 ASP.? 6.66 OXT ACT A 139 E 208 HIS A 110 HIS.? -3.69 OXT ACT A 139s coo 36.32 11.24 30.83 37.00 13.22 30.81 -8.77 57.48 -2.79 -8.58 59.56 -2.89 coo 38.79 15.70 26.44 37.66 14.35 27.62 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 34.24 14.63 26.81 34.14 16.25 25.49 -5.26 51.32 -2.26 -4.16 51.41 -4.05 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 A 104 HIS A 131 HIS^? 7.42 CL CL A 141 E 205 ASP A 25 ASP.? 6.66 OXT ACT A 139 E 208 HIS A 110 HIS.? -3.69 OXT ACT A 139s coo 36.32 11.24 30.83 37.00 13.22 30.81 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 38.79 15.70 26.44 37.66 14.35 27.62 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 34.24 14.63 26.81 34.14 16.25 25.49 -5.26 51.32 -2.26 -4.16 51.41 -4.05 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 3 3 # 3 A 104 HIS B 109 HIS.? -5.47 O ACT B 139s E 205 ASP B 25 ASP.? 6.52 O ACT B 139 E 208 HIS B 110 HIS.? -3.67 O ACT B 139s coo 36.32 11.24 30.83 37.00 13.22 30.81 -54.00 38.48 15.75 -55.77 37.34 15.88 coo 38.79 15.70 26.44 37.66 14.35 27.62 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 34.24 14.63 26.81 34.14 16.25 25.49 -46.84 38.28 15.22 -46.41 37.31 17.03 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 4 3 # 4 A 104 HIS B 131 HIS^? 7.27 CL CL B 140 E 205 ASP B 25 ASP.? 6.52 O ACT B 139 E 208 HIS B 110 HIS.? -3.67 O ACT B 139s coo 36.32 11.24 30.83 37.00 13.22 30.81 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 38.79 15.70 26.44 37.66 14.35 27.62 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 34.24 14.63 26.81 34.14 16.25 25.49 -46.84 38.28 15.22 -46.41 37.31 17.03 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 5 3 # 5 A 104 HIS C 109 HIS.? -5.44 O ACT C 139s E 205 ASP C 25 ASP.? 6.36 O2 EDO C 140 E 208 HIS C 110 HIS.? 3.59 O ACT C 139s coo 36.32 11.24 30.83 37.00 13.22 30.81 -2.54 8.69 15.96 -4.15 7.36 16.15 coo 38.79 15.70 26.44 37.66 14.35 27.62 4.46 12.53 17.74 4.84 11.35 19.48 coo 34.24 14.63 26.81 34.14 16.25 25.49 4.54 8.83 15.35 4.90 7.96 17.23 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 6 3 # 6 A 104 HIS C 131 HIS^? 6.39 C1 EDO C 140 E 205 ASP C 25 ASP.? 6.36 O2 EDO C 140 E 208 HIS C 110 HIS.? 3.59 O ACT C 139s coo 36.32 11.24 30.83 37.00 13.22 30.81 8.46 11.73 13.23 7.93 9.80 13.86 coo 38.79 15.70 26.44 37.66 14.35 27.62 4.46 12.53 17.74 4.84 11.35 19.48 coo 34.24 14.63 26.81 34.14 16.25 25.49 4.54 8.83 15.35 4.90 7.96 17.23 1ndo_c01 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 6 hits 1ndo_c01 naa= 3 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 C 205 ASP A 25 ASP.? 6.66 OXT ACT A 139 C 208 HIS A 110 HIS.? -3.69 OXT ACT A 139s E 104 HIS A 109 HIS.? -5.41 OXT ACT A 139s coo 36.50 67.03 37.59 36.77 66.38 35.61 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 33.45 66.12 34.16 32.13 66.40 35.76 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 38.29 64.94 31.33 38.08 64.16 33.27 -8.77 57.48 -2.79 -8.58 59.56 -2.89 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 C 205 ASP A 25 ASP.? 6.66 OXT ACT A 139 C 208 HIS A 110 HIS.? -3.69 OXT ACT A 139s E 104 HIS A 131 HIS^? 7.42 CL CL A 141 coo 36.50 67.03 37.59 36.77 66.38 35.61 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 33.45 66.12 34.16 32.13 66.40 35.76 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 38.29 64.94 31.33 38.08 64.16 33.27 -5.82 46.49 -0.22 -4.38 47.88 -0.81 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 3 3 # 3 C 205 ASP B 25 ASP.? 6.52 O ACT B 139 C 208 HIS B 110 HIS.? -3.67 O ACT B 139s E 104 HIS B 109 HIS.? -5.47 O ACT B 139s coo 36.50 67.03 37.59 36.77 66.38 35.61 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 33.45 66.12 34.16 32.13 66.40 35.76 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 38.29 64.94 31.33 38.08 64.16 33.27 -54.00 38.48 15.75 -55.77 37.34 15.88 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 4 3 # 4 C 205 ASP B 25 ASP.? 6.52 O ACT B 139 C 208 HIS B 110 HIS.? -3.67 O ACT B 139s E 104 HIS B 131 HIS^? 7.27 CL CL B 140 coo 36.50 67.03 37.59 36.77 66.38 35.61 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 33.45 66.12 34.16 32.13 66.40 35.76 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 38.29 64.94 31.33 38.08 64.16 33.27 -42.92 41.25 13.23 -43.42 39.34 13.91 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 5 3 # 5 C 205 ASP C 25 ASP.? 6.36 O2 EDO C 140 C 208 HIS C 110 HIS.? 3.59 O ACT C 139s E 104 HIS C 109 HIS.? -5.44 O ACT C 139s coo 36.50 67.03 37.59 36.77 66.38 35.61 4.46 12.53 17.74 4.84 11.35 19.48 coo 33.45 66.12 34.16 32.13 66.40 35.76 4.54 8.83 15.35 4.90 7.96 17.23 coo 38.29 64.94 31.33 38.08 64.16 33.27 -2.54 8.69 15.96 -4.15 7.36 16.15 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 6 3 # 6 C 205 ASP C 25 ASP.? 6.36 O2 EDO C 140 C 208 HIS C 110 HIS.? 3.59 O ACT C 139s E 104 HIS C 131 HIS^? 6.39 C1 EDO C 140 coo 36.50 67.03 37.59 36.77 66.38 35.61 4.46 12.53 17.74 4.84 11.35 19.48 coo 33.45 66.12 34.16 32.13 66.40 35.76 4.54 8.83 15.35 4.90 7.96 17.23 coo 38.29 64.94 31.33 38.08 64.16 33.27 8.46 11.73 13.23 7.93 9.80 13.86 1ndo_c02 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 6 hits 1ndo_c02 naa= 3 ULMN 3 1nmw_c00 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE user 1 3 # 1 A 59 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 113 CYH A 23 CYH.? -5.05 CL CL A 141s A 157 HIS A 131 HIS^? 7.42 CL CL A 141 coo 51.86 1.82 -1.00 52.89 0.19 -1.82 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 57.27 -1.57 -5.42 55.50 -3.10 -3.86 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 55.48 0.33 2.46 56.32 -1.35 1.53 -5.82 46.49 -0.22 -4.38 47.88 -0.81 ULMN 3 1nmw_c00 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE user 2 3 # 2 A 59 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 113 CYH A 57 CYH^? 5.51 O ACT A 139 A 157 HIS A 131 HIS^? 7.42 CL CL A 141 coo 51.86 1.82 -1.00 52.89 0.19 -1.82 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 57.27 -1.57 -5.42 55.50 -3.10 -3.86 -4.80 51.41 4.83 -3.45 51.64 2.37 coo 55.48 0.33 2.46 56.32 -1.35 1.53 -5.82 46.49 -0.22 -4.38 47.88 -0.81 ULMN 3 1nmw_c00 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE user 3 3 # 3 A 59 HIS A 131 HIS^? 7.42 CL CL A 141 A 113 CYH A 23 CYH.? -5.05 CL CL A 141s A 157 HIS A 110 HIS.? -3.69 OXT ACT A 139s coo 51.86 1.82 -1.00 52.89 0.19 -1.82 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 57.27 -1.57 -5.42 55.50 -3.10 -3.86 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 55.48 0.33 2.46 56.32 -1.35 1.53 -5.26 51.32 -2.26 -4.16 51.41 -4.05 ULMN 3 1nmw_c00 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE user 4 3 # 4 A 59 HIS A 131 HIS^? 7.42 CL CL A 141 A 113 CYH A 57 CYH^? 5.51 O ACT A 139 A 157 HIS A 110 HIS.? -3.69 OXT ACT A 139s coo 51.86 1.82 -1.00 52.89 0.19 -1.82 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 57.27 -1.57 -5.42 55.50 -3.10 -3.86 -4.80 51.41 4.83 -3.45 51.64 2.37 coo 55.48 0.33 2.46 56.32 -1.35 1.53 -5.26 51.32 -2.26 -4.16 51.41 -4.05 ULMN 3 1nmw_c00 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE user 5 3 # 5 A 59 HIS B 110 HIS.? -3.67 O ACT B 139s A 113 CYH B 23 CYH.? -4.94 CL CL B 140s A 157 HIS B 131 HIS^? 7.27 CL CL B 140 coo 51.86 1.82 -1.00 52.89 0.19 -1.82 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 57.27 -1.57 -5.42 55.50 -3.10 -3.86 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 55.48 0.33 2.46 56.32 -1.35 1.53 -42.92 41.25 13.23 -43.42 39.34 13.91 ULMN 3 1nmw_c00 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE user 6 3 # 6 A 59 HIS B 110 HIS.? -3.67 O ACT B 139s A 113 CYH B 57 CYH^? 5.44 OXT ACT B 139 A 157 HIS B 131 HIS^? 7.27 CL CL B 140 coo 51.86 1.82 -1.00 52.89 0.19 -1.82 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 57.27 -1.57 -5.42 55.50 -3.10 -3.86 -46.68 38.10 8.15 -46.29 36.73 10.60 coo 55.48 0.33 2.46 56.32 -1.35 1.53 -42.92 41.25 13.23 -43.42 39.34 13.91 ULMN 3 1nmw_c00 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE user 7 3 # 7 A 59 HIS B 131 HIS^? 7.27 CL CL B 140 A 113 CYH B 23 CYH.? -4.94 CL CL B 140s A 157 HIS B 110 HIS.? -3.67 O ACT B 139s coo 51.86 1.82 -1.00 52.89 0.19 -1.82 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 57.27 -1.57 -5.42 55.50 -3.10 -3.86 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 55.48 0.33 2.46 56.32 -1.35 1.53 -46.84 38.28 15.22 -46.41 37.31 17.03 ULMN 3 1nmw_c00 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE user 8 3 # 8 A 59 HIS B 131 HIS^? 7.27 CL CL B 140 A 113 CYH B 57 CYH^? 5.44 OXT ACT B 139 A 157 HIS B 110 HIS.? -3.67 O ACT B 139s coo 51.86 1.82 -1.00 52.89 0.19 -1.82 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 57.27 -1.57 -5.42 55.50 -3.10 -3.86 -46.68 38.10 8.15 -46.29 36.73 10.60 coo 55.48 0.33 2.46 56.32 -1.35 1.53 -46.84 38.28 15.22 -46.41 37.31 17.03 ULMN 3 1nmw_c00 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE user 9 3 # 9 A 59 HIS C 110 HIS.? 3.59 O ACT C 139s A 113 CYH C 23 CYH.? 8.42 C1 EDO C 140 A 157 HIS C 131 HIS^? 6.39 C1 EDO C 140 coo 51.86 1.82 -1.00 52.89 0.19 -1.82 4.54 8.83 15.35 4.90 7.96 17.23 coo 57.27 -1.57 -5.42 55.50 -3.10 -3.86 10.88 13.11 20.21 12.25 12.11 22.32 coo 55.48 0.33 2.46 56.32 -1.35 1.53 8.46 11.73 13.23 7.93 9.80 13.86 ULMN 3 1nmw_c00 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE user 10 3 # 10 A 59 HIS C 110 HIS.? 3.59 O ACT C 139s A 113 CYH C 57 CYH^? 5.55 OXT ACT C 139 A 157 HIS C 131 HIS^? 6.39 C1 EDO C 140 coo 51.86 1.82 -1.00 52.89 0.19 -1.82 4.54 8.83 15.35 4.90 7.96 17.23 coo 57.27 -1.57 -5.42 55.50 -3.10 -3.86 4.72 8.42 8.22 5.18 7.19 10.69 coo 55.48 0.33 2.46 56.32 -1.35 1.53 8.46 11.73 13.23 7.93 9.80 13.86 ULMN 3 1nmw_c00 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE user 11 3 # 11 A 59 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 113 CYH C 23 CYH.? 8.42 C1 EDO C 140 A 157 HIS C 110 HIS.? 3.59 O ACT C 139s coo 51.86 1.82 -1.00 52.89 0.19 -1.82 8.46 11.73 13.23 7.93 9.80 13.86 coo 57.27 -1.57 -5.42 55.50 -3.10 -3.86 10.88 13.11 20.21 12.25 12.11 22.32 coo 55.48 0.33 2.46 56.32 -1.35 1.53 4.54 8.83 15.35 4.90 7.96 17.23 ULMN 3 1nmw_c00 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE user 12 3 # 12 A 59 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 113 CYH C 57 CYH^? 5.55 OXT ACT C 139 A 157 HIS C 110 HIS.? 3.59 O ACT C 139s coo 51.86 1.82 -1.00 52.89 0.19 -1.82 8.46 11.73 13.23 7.93 9.80 13.86 coo 57.27 -1.57 -5.42 55.50 -3.10 -3.86 4.72 8.42 8.22 5.18 7.19 10.69 coo 55.48 0.33 2.46 56.32 -1.35 1.53 4.54 8.83 15.35 4.90 7.96 17.23 1nmw_c00 source 1nmw PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA- INTE: 12 hits 1nmw_c00 naa= 3 ULMN 3 1nw9_c02 CASPASE 9, APOPTOSIS-RELATED CYSTEINuser 1 3 # 1 B 237 HIS A 131 HIS^? 7.42 CL CL A 141 B 238 GLY A 112 GLY^? 10.97 O ACT A 139 B 287 CYH A 57 CYH^? 5.51 O ACT A 139 coo 51.19 11.65 88.44 53.07 12.52 88.13 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 45.40 11.66 89.13 45.79 11.98 88.49 -7.56 46.85 3.93 -6.95 47.44 3.87 coo 48.33 16.15 90.44 50.61 16.80 91.98 -4.80 51.41 4.83 -3.45 51.64 2.37 ULMN 3 1nw9_c02 CASPASE 9, APOPTOSIS-RELATED CYSTEINuser 2 3 # 2 B 237 HIS A 131 HIS^? 7.42 CL CL A 141 B 238 GLY A 130 GLY^? -4.84 CL CL A 141s B 287 CYH A 23 CYH.? -5.05 CL CL A 141s coo 51.19 11.65 88.44 53.07 12.52 88.13 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 45.40 11.66 89.13 45.79 11.98 88.49 -4.89 41.74 -0.85 -4.61 41.77 -1.61 coo 48.33 16.15 90.44 50.61 16.80 91.98 -5.66 43.81 -7.30 -4.20 43.21 -9.56 ULMN 3 1nw9_c02 CASPASE 9, APOPTOSIS-RELATED CYSTEINuser 3 3 # 3 B 237 HIS B 131 HIS^? 7.27 CL CL B 140 B 238 GLY B 112 GLY^? 10.91 OXT ACT B 139 B 287 CYH B 57 CYH^? 5.44 OXT ACT B 139 coo 51.19 11.65 88.44 53.07 12.52 88.13 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 45.40 11.66 89.13 45.79 11.98 88.49 -44.06 42.66 9.14 -44.28 41.84 9.20 coo 48.33 16.15 90.44 50.61 16.80 91.98 -46.68 38.10 8.15 -46.29 36.73 10.60 ULMN 3 1nw9_c02 CASPASE 9, APOPTOSIS-RELATED CYSTEINuser 4 3 # 4 B 237 HIS B 131 HIS^? 7.27 CL CL B 140 B 238 GLY B 130 GLY^? -4.77 CL CL B 140s B 287 CYH B 23 CYH.? -4.94 CL CL B 140s coo 51.19 11.65 88.44 53.07 12.52 88.13 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 45.40 11.66 89.13 45.79 11.98 88.49 -38.21 42.69 13.79 -38.12 42.42 14.57 coo 48.33 16.15 90.44 50.61 16.80 91.98 -40.38 42.16 20.28 -39.12 40.88 22.30 ULMN 3 1nw9_c02 CASPASE 9, APOPTOSIS-RELATED CYSTEINuser 5 3 # 5 B 237 HIS C 131 HIS^? 6.39 C1 EDO C 140 B 238 GLY C 112 GLY^? 11.00 OXT ACT C 139 B 287 CYH C 57 CYH^? 5.55 OXT ACT C 139 coo 51.19 11.65 88.44 53.07 12.52 88.13 8.46 11.73 13.23 7.93 9.80 13.86 coo 45.40 11.66 89.13 45.79 11.98 88.49 7.28 13.06 9.10 7.06 12.23 9.16 coo 48.33 16.15 90.44 50.61 16.80 91.98 4.72 8.42 8.22 5.18 7.19 10.69 ULMN 3 1nw9_c02 CASPASE 9, APOPTOSIS-RELATED CYSTEINuser 6 3 # 6 B 237 HIS C 131 HIS^? 6.39 C1 EDO C 140 B 238 GLY C 130 GLY^? 9.35 O1 EDO C 140 B 287 CYH C 23 CYH.? 8.42 C1 EDO C 140 coo 51.19 11.65 88.44 53.07 12.52 88.13 8.46 11.73 13.23 7.93 9.80 13.86 coo 45.40 11.66 89.13 45.79 11.98 88.49 13.00 13.33 13.76 13.12 13.19 14.54 coo 48.33 16.15 90.44 50.61 16.80 91.98 10.88 13.11 20.21 12.25 12.11 22.32 1nw9_c02 source 1nw9 CASPASE 9, APOPTOSIS-RELATED CYSTEINE PROTEASE: 6 hits 1nw9_c02 naa= 3 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 A 1 CYH A 57 CYH^? 5.51 O ACT A 139 A 903 GLU B 127 GLU^? 8.11 CL CL B 140 A 972 LYS B 16 LYS~? 5.16 C5 PG4 B 142 coo 88.42 112.53 24.94 87.72 110.88 27.11 -4.80 51.41 4.83 -3.45 51.64 2.37 coo 61.58 117.15 13.99 62.31 115.51 15.12 -28.31 39.11 17.60 -29.33 39.55 19.43 coo 60.18 107.64 21.53 58.13 110.55 17.14 -29.09 50.01 17.90 -28.96 54.88 21.75 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 A 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 A 903 GLU A 34 GLU~? 3.97 C2 PG4 A 142 A 972 LYS A 16 LYS~? 4.07 C8 PG4 A 142 coo 88.42 112.53 24.94 87.72 110.88 27.11 6.93 49.75 11.94 4.86 49.15 13.48 coo 61.58 117.15 13.99 62.31 115.51 15.12 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 60.18 107.64 21.53 58.13 110.55 17.14 -6.79 30.20 -4.87 -11.32 27.78 -7.03 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 3 3 # 3 A 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 A 903 GLU A 34 GLU~? 3.97 C2 PG4 A 142 A 972 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo 88.42 112.53 24.94 87.72 110.88 27.11 6.93 49.75 11.94 4.86 49.15 13.48 coo 61.58 117.15 13.99 62.31 115.51 15.12 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 60.18 107.64 21.53 58.13 110.55 17.14 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 4 3 # 4 A 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 A 903 GLU A 36 GLU~? 11.76 C4 PG4 A 142 A 972 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 88.42 112.53 24.94 87.72 110.88 27.11 6.93 49.75 11.94 4.86 49.15 13.48 coo 61.58 117.15 13.99 62.31 115.51 15.12 -12.87 29.42 9.52 -11.52 29.66 11.15 coo 60.18 107.64 21.53 58.13 110.55 17.14 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 5 3 # 5 A 1 CYH B 101 CYH^? 12.74 CL CL B 141 A 903 GLU B 34 GLU~? -4.36 C1 PG4 B 142s A 972 LYS B 16 LYS~? 5.16 C5 PG4 B 142 coo 88.42 112.53 24.94 87.72 110.88 27.11 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 61.58 117.15 13.99 62.31 115.51 15.12 -37.87 57.41 10.67 -39.60 57.08 11.90 coo 60.18 107.64 21.53 58.13 110.55 17.14 -29.09 50.01 17.90 -28.96 54.88 21.75 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 6 3 # 6 A 1 CYH B 101 CYH^? 12.74 CL CL B 141 A 903 GLU B 34 GLU~? -4.36 C1 PG4 B 142s A 972 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo 88.42 112.53 24.94 87.72 110.88 27.11 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 61.58 117.15 13.99 62.31 115.51 15.12 -37.87 57.41 10.67 -39.60 57.08 11.90 coo 60.18 107.64 21.53 58.13 110.55 17.14 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 7 3 # 7 A 1 CYH B 101 CYH^? 12.74 CL CL B 141 A 903 GLU B 36 GLU~? 11.82 C2 PG4 B 142 A 972 LYS B 31 LYS~? 7.73 C1 PG4 B 142 coo 88.42 112.53 24.94 87.72 110.88 27.11 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 61.58 117.15 13.99 62.31 115.51 15.12 -31.60 55.95 3.54 -31.25 54.50 1.99 coo 60.18 107.64 21.53 58.13 110.55 17.14 -41.17 57.91 7.48 -40.76 60.95 12.06 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 8 3 # 8 A 1 CYH B 101 CYH^? 12.74 CL CL B 141 A 903 GLU B 122 GLU.? 20.16 C3 PG4 A 142 A 972 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 88.42 112.53 24.94 87.72 110.88 27.11 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 61.58 117.15 13.99 62.31 115.51 15.12 -18.00 33.10 19.61 -16.43 34.38 20.27 coo 60.18 107.64 21.53 58.13 110.55 17.14 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 9 3 # 9 A 1 CYH C 57 CYH^? 5.55 OXT ACT C 139 A 903 GLU A 127 GLU^? 8.20 CL CL A 141 A 972 LYS A 16 LYS~? 4.07 C8 PG4 A 142 coo 88.42 112.53 24.94 87.72 110.88 27.11 4.72 8.42 8.22 5.18 7.19 10.69 coo 61.58 117.15 13.99 62.31 115.51 15.12 2.90 34.77 -4.78 2.12 35.30 -6.66 coo 60.18 107.64 21.53 58.13 110.55 17.14 -6.79 30.20 -4.87 -11.32 27.78 -7.03 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 10 3 # 10 A 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 A 903 GLU C 34 GLU~? 23.36 C1 EDO C 140 A 972 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo 88.42 112.53 24.94 87.72 110.88 27.11 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 61.58 117.15 13.99 62.31 115.51 15.12 13.37 28.10 10.00 11.57 28.19 11.09 coo 60.18 107.64 21.53 58.13 110.55 17.14 15.48 20.46 18.00 15.72 26.44 16.52 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 11 3 # 11 A 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 A 903 GLU C 36 GLU~? -27.32 O1 EDO C 140s A 972 LYS C 31 LYS~? 22.12 CL CL A 141 coo 88.42 112.53 24.94 87.72 110.88 27.11 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 61.58 117.15 13.99 62.31 115.51 15.12 19.61 26.41 3.01 20.17 25.01 1.52 coo 60.18 107.64 21.53 58.13 110.55 17.14 9.92 28.31 6.82 8.29 31.11 11.06 1ofd_c02 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 11 hits 1ofd_c02 naa= 3 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 B 1 CYH A 57 CYH^? 5.51 O ACT A 139 B 903 GLU B 127 GLU^? 8.11 CL CL B 140 B 972 LYS B 16 LYS~? 5.16 C5 PG4 B 142 coo 31.47 38.87 24.90 30.94 36.98 26.93 -4.80 51.41 4.83 -3.45 51.64 2.37 coo 4.13 40.53 14.21 5.06 38.89 15.19 -28.31 39.11 17.60 -29.33 39.55 19.43 coo 4.08 30.40 21.12 1.62 33.28 16.83 -29.09 50.01 17.90 -28.96 54.88 21.75 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 B 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 B 903 GLU A 34 GLU~? 3.97 C2 PG4 A 142 B 972 LYS A 16 LYS~? 4.07 C8 PG4 A 142 coo 31.47 38.87 24.90 30.94 36.98 26.93 6.93 49.75 11.94 4.86 49.15 13.48 coo 4.13 40.53 14.21 5.06 38.89 15.19 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 4.08 30.40 21.12 1.62 33.28 16.83 -6.79 30.20 -4.87 -11.32 27.78 -7.03 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 3 3 # 3 B 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 B 903 GLU A 34 GLU~? 3.97 C2 PG4 A 142 B 972 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo 31.47 38.87 24.90 30.94 36.98 26.93 6.93 49.75 11.94 4.86 49.15 13.48 coo 4.13 40.53 14.21 5.06 38.89 15.19 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 4.08 30.40 21.12 1.62 33.28 16.83 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 4 3 # 4 B 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 B 903 GLU A 36 GLU~? 11.76 C4 PG4 A 142 B 972 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 31.47 38.87 24.90 30.94 36.98 26.93 6.93 49.75 11.94 4.86 49.15 13.48 coo 4.13 40.53 14.21 5.06 38.89 15.19 -12.87 29.42 9.52 -11.52 29.66 11.15 coo 4.08 30.40 21.12 1.62 33.28 16.83 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 5 3 # 5 B 1 CYH A 101 CYH^? 15.14 CH3 ACT A 140 B 903 GLU B 122 GLU.? 20.16 C3 PG4 A 142 B 972 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 31.47 38.87 24.90 30.94 36.98 26.93 6.93 49.75 11.94 4.86 49.15 13.48 coo 4.13 40.53 14.21 5.06 38.89 15.19 -18.00 33.10 19.61 -16.43 34.38 20.27 coo 4.08 30.40 21.12 1.62 33.28 16.83 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 6 3 # 6 B 1 CYH B 57 CYH^? 5.44 OXT ACT B 139 B 903 GLU B 122 GLU.? 20.16 C3 PG4 A 142 B 972 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 31.47 38.87 24.90 30.94 36.98 26.93 -46.68 38.10 8.15 -46.29 36.73 10.60 coo 4.13 40.53 14.21 5.06 38.89 15.19 -18.00 33.10 19.61 -16.43 34.38 20.27 coo 4.08 30.40 21.12 1.62 33.28 16.83 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 7 3 # 7 B 1 CYH B 101 CYH^? 12.74 CL CL B 141 B 903 GLU B 34 GLU~? -4.36 C1 PG4 B 142s B 972 LYS B 16 LYS~? 5.16 C5 PG4 B 142 coo 31.47 38.87 24.90 30.94 36.98 26.93 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 4.13 40.53 14.21 5.06 38.89 15.19 -37.87 57.41 10.67 -39.60 57.08 11.90 coo 4.08 30.40 21.12 1.62 33.28 16.83 -29.09 50.01 17.90 -28.96 54.88 21.75 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 8 3 # 8 B 1 CYH B 101 CYH^? 12.74 CL CL B 141 B 903 GLU B 34 GLU~? -4.36 C1 PG4 B 142s B 972 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo 31.47 38.87 24.90 30.94 36.98 26.93 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 4.13 40.53 14.21 5.06 38.89 15.19 -37.87 57.41 10.67 -39.60 57.08 11.90 coo 4.08 30.40 21.12 1.62 33.28 16.83 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 9 3 # 9 B 1 CYH B 101 CYH^? 12.74 CL CL B 141 B 903 GLU B 36 GLU~? 11.82 C2 PG4 B 142 B 972 LYS B 31 LYS~? 7.73 C1 PG4 B 142 coo 31.47 38.87 24.90 30.94 36.98 26.93 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 4.13 40.53 14.21 5.06 38.89 15.19 -31.60 55.95 3.54 -31.25 54.50 1.99 coo 4.08 30.40 21.12 1.62 33.28 16.83 -41.17 57.91 7.48 -40.76 60.95 12.06 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 10 3 # 10 B 1 CYH B 101 CYH^? 12.74 CL CL B 141 B 903 GLU B 122 GLU.? 20.16 C3 PG4 A 142 B 972 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 31.47 38.87 24.90 30.94 36.98 26.93 -39.61 28.75 0.75 -40.12 30.79 -1.06 coo 4.13 40.53 14.21 5.06 38.89 15.19 -18.00 33.10 19.61 -16.43 34.38 20.27 coo 4.08 30.40 21.12 1.62 33.28 16.83 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 11 3 # 11 B 1 CYH C 57 CYH^? 5.55 OXT ACT C 139 B 903 GLU A 127 GLU^? 8.20 CL CL A 141 B 972 LYS A 16 LYS~? 4.07 C8 PG4 A 142 coo 31.47 38.87 24.90 30.94 36.98 26.93 4.72 8.42 8.22 5.18 7.19 10.69 coo 4.13 40.53 14.21 5.06 38.89 15.19 2.90 34.77 -4.78 2.12 35.30 -6.66 coo 4.08 30.40 21.12 1.62 33.28 16.83 -6.79 30.20 -4.87 -11.32 27.78 -7.03 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 12 3 # 12 B 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 B 903 GLU C 34 GLU~? 23.36 C1 EDO C 140 B 972 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo 31.47 38.87 24.90 30.94 36.98 26.93 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 4.13 40.53 14.21 5.06 38.89 15.19 13.37 28.10 10.00 11.57 28.19 11.09 coo 4.08 30.40 21.12 1.62 33.28 16.83 15.48 20.46 18.00 15.72 26.44 16.52 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 13 3 # 13 B 1 CYH C 101 CYH^? 15.56 C1 EDO C 141 B 903 GLU C 36 GLU~? -27.32 O1 EDO C 140s B 972 LYS C 31 LYS~? 22.12 CL CL A 141 coo 31.47 38.87 24.90 30.94 36.98 26.93 12.11 -0.99 1.20 11.66 1.09 -0.44 coo 4.13 40.53 14.21 5.06 38.89 15.19 19.61 26.41 3.01 20.17 25.01 1.52 coo 4.08 30.40 21.12 1.62 33.28 16.83 9.92 28.31 6.82 8.29 31.11 11.06 1ofd_c03 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 13 hits 1ofd_c03 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 146 TYR A 129 TYR^? 7.28 CL CL A 141 A 177 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo -3.50 124.89 25.05 -2.25 124.77 23.26 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 1.87 119.38 16.45 1.41 122.11 16.84 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 146 TYR B 129 TYR^? 7.32 CL CL B 140 A 177 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo -3.50 124.89 25.05 -2.25 124.77 23.26 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 1.87 119.38 16.45 1.41 122.11 16.84 -32.31 42.16 13.95 -29.70 41.99 14.85 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP C 13 ASP~? 27.02 O1 EDO C 140 A 146 TYR C 129 TYR^? 13.46 O1 EDO C 140 A 177 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo -3.50 124.89 25.05 -2.25 124.77 23.26 26.45 23.84 13.97 27.74 25.29 14.77 coo 1.87 119.38 16.45 1.41 122.11 16.84 18.89 13.20 13.92 21.55 13.21 14.74 coo -2.59 124.07 12.67 -0.91 126.17 18.42 15.48 20.46 18.00 15.72 26.44 16.52 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 A 24 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 146 TYR A 121 TYR.? -24.35 CL CL A 141s A 177 LYS C 31 LYS~? 22.12 CL CL A 141 coo -3.50 124.89 25.05 -2.25 124.77 23.26 7.61 19.22 2.17 7.62 20.80 3.62 coo 1.87 119.38 16.45 1.41 122.11 16.84 16.31 29.26 0.34 18.85 29.40 1.41 coo -2.59 124.07 12.67 -0.91 126.17 18.42 9.92 28.31 6.82 8.29 31.11 11.06 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 13 ASP~? 8.68 O4 PG4 A 142 B 146 TYR A 129 TYR^? 7.28 CL CL A 141 B 177 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo -7.43 109.06 51.23 -5.84 110.54 50.86 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP B 13 ASP~? 8.48 C4 PG4 B 142 B 146 TYR B 129 TYR^? 7.32 CL CL B 140 B 177 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo -7.43 109.06 51.23 -5.84 110.54 50.86 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -32.31 42.16 13.95 -29.70 41.99 14.85 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP C 13 ASP~? 27.02 O1 EDO C 140 B 146 TYR C 129 TYR^? 13.46 O1 EDO C 140 B 177 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo -7.43 109.06 51.23 -5.84 110.54 50.86 26.45 23.84 13.97 27.74 25.29 14.77 coo 0.22 114.56 44.62 -0.76 115.18 47.18 18.89 13.20 13.92 21.55 13.21 14.74 coo -4.18 120.17 46.85 -4.02 115.31 51.00 15.48 20.46 18.00 15.72 26.44 16.52 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 B 24 ASP C 135 ASP.? 16.41 O1 EDO C 141 B 146 TYR A 121 TYR.? -24.35 CL CL A 141s B 177 LYS C 31 LYS~? 22.12 CL CL A 141 coo -7.43 109.06 51.23 -5.84 110.54 50.86 7.61 19.22 2.17 7.62 20.80 3.62 coo 0.22 114.56 44.62 -0.76 115.18 47.18 16.31 29.26 0.34 18.85 29.40 1.41 coo -4.18 120.17 46.85 -4.02 115.31 51.00 9.92 28.31 6.82 8.29 31.11 11.06 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 13 ASP~? 8.68 O4 PG4 A 142 C 146 TYR A 129 TYR^? 7.28 CL CL A 141 C 177 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo -13.49 79.65 43.90 -12.13 80.29 45.45 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP B 13 ASP~? 8.48 C4 PG4 B 142 C 146 TYR B 129 TYR^? 7.32 CL CL B 140 C 177 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo -13.49 79.65 43.90 -12.13 80.29 45.45 -24.74 52.92 14.33 -24.14 54.73 15.30 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -32.31 42.16 13.95 -29.70 41.99 14.85 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP C 13 ASP~? 27.02 O1 EDO C 140 C 146 TYR C 129 TYR^? 13.46 O1 EDO C 140 C 177 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo -13.49 79.65 43.90 -12.13 80.29 45.45 26.45 23.84 13.97 27.74 25.29 14.77 coo -5.65 86.78 48.49 -7.16 84.72 49.65 18.89 13.20 13.92 21.55 13.21 14.74 coo -11.22 87.18 53.49 -10.94 81.64 50.31 15.48 20.46 18.00 15.72 26.44 16.52 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 C 24 ASP C 135 ASP.? 16.41 O1 EDO C 141 C 146 TYR A 121 TYR.? -24.35 CL CL A 141s C 177 LYS C 31 LYS~? 22.12 CL CL A 141 coo -13.49 79.65 43.90 -12.13 80.29 45.45 7.61 19.22 2.17 7.62 20.80 3.62 coo -5.65 86.78 48.49 -7.16 84.72 49.65 16.31 29.26 0.34 18.85 29.40 1.41 coo -11.22 87.18 53.49 -10.94 81.64 50.31 9.92 28.31 6.82 8.29 31.11 11.06 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 13 ASP~? 8.68 O4 PG4 A 142 D 146 TYR A 129 TYR^? 7.28 CL CL A 141 D 177 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo -13.44 77.36 13.12 -12.53 75.97 14.48 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP B 13 ASP~? 8.48 C4 PG4 B 142 D 146 TYR B 129 TYR^? 7.32 CL CL B 140 D 177 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo -13.44 77.36 13.12 -12.53 75.97 14.48 -24.74 52.92 14.33 -24.14 54.73 15.30 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -32.31 42.16 13.95 -29.70 41.99 14.85 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP C 13 ASP~? 27.02 O1 EDO C 140 D 146 TYR C 129 TYR^? 13.46 O1 EDO C 140 D 177 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo -13.44 77.36 13.12 -12.53 75.97 14.48 26.45 23.84 13.97 27.74 25.29 14.77 coo -7.85 74.44 22.75 -9.22 72.86 20.89 18.89 13.20 13.92 21.55 13.21 14.74 coo -14.24 70.61 23.48 -12.55 71.73 17.42 15.48 20.46 18.00 15.72 26.44 16.52 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 D 24 ASP C 135 ASP.? 16.41 O1 EDO C 141 D 146 TYR A 121 TYR.? -24.35 CL CL A 141s D 177 LYS C 31 LYS~? 22.12 CL CL A 141 coo -13.44 77.36 13.12 -12.53 75.97 14.48 7.61 19.22 2.17 7.62 20.80 3.62 coo -7.85 74.44 22.75 -9.22 72.86 20.89 16.31 29.26 0.34 18.85 29.40 1.41 coo -14.24 70.61 23.48 -12.55 71.73 17.42 9.92 28.31 6.82 8.29 31.11 11.06 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 13 ASP~? 8.68 O4 PG4 A 142 E 146 TYR A 129 TYR^? 7.28 CL CL A 141 E 177 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo -7.12 105.25 1.43 -6.30 103.34 0.77 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP B 13 ASP~? 8.48 C4 PG4 B 142 E 146 TYR B 129 TYR^? 7.32 CL CL B 140 E 177 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo -7.12 105.25 1.43 -6.30 103.34 0.77 -24.74 52.92 14.33 -24.14 54.73 15.30 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -32.31 42.16 13.95 -29.70 41.99 14.85 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP C 13 ASP~? 27.02 O1 EDO C 140 E 146 TYR C 129 TYR^? 13.46 O1 EDO C 140 E 177 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo -7.12 105.25 1.43 -6.30 103.34 0.77 26.45 23.84 13.97 27.74 25.29 14.77 coo -3.11 94.55 3.01 -3.83 95.92 0.66 18.89 13.20 13.92 21.55 13.21 14.74 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 15.48 20.46 18.00 15.72 26.44 16.52 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 E 24 ASP C 135 ASP.? 16.41 O1 EDO C 141 E 146 TYR A 121 TYR.? -24.35 CL CL A 141s E 177 LYS C 31 LYS~? 22.12 CL CL A 141 coo -7.12 105.25 1.43 -6.30 103.34 0.77 7.61 19.22 2.17 7.62 20.80 3.62 coo -3.11 94.55 3.01 -3.83 95.92 0.66 16.31 29.26 0.34 18.85 29.40 1.41 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 9.92 28.31 6.82 8.29 31.11 11.06 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 13 ASP~? 8.68 O4 PG4 A 142 F 146 TYR A 129 TYR^? 7.28 CL CL A 141 F 177 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo -44.75 128.15 10.28 -45.68 129.67 11.55 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP B 13 ASP~? 8.48 C4 PG4 B 142 F 146 TYR B 129 TYR^? 7.32 CL CL B 140 F 177 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo -44.75 128.15 10.28 -45.68 129.67 11.55 -24.74 52.92 14.33 -24.14 54.73 15.30 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -32.31 42.16 13.95 -29.70 41.99 14.85 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP C 13 ASP~? 27.02 O1 EDO C 140 F 146 TYR C 129 TYR^? 13.46 O1 EDO C 140 F 177 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo -44.75 128.15 10.28 -45.68 129.67 11.55 26.45 23.84 13.97 27.74 25.29 14.77 coo -50.43 131.90 19.60 -49.04 133.31 17.60 18.89 13.20 13.92 21.55 13.21 14.74 coo -44.10 135.86 19.99 -45.67 134.21 14.07 15.48 20.46 18.00 15.72 26.44 16.52 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 F 24 ASP C 135 ASP.? 16.41 O1 EDO C 141 F 146 TYR A 121 TYR.? -24.35 CL CL A 141s F 177 LYS C 31 LYS~? 22.12 CL CL A 141 coo -44.75 128.15 10.28 -45.68 129.67 11.55 7.61 19.22 2.17 7.62 20.80 3.62 coo -50.43 131.90 19.60 -49.04 133.31 17.60 16.31 29.26 0.34 18.85 29.40 1.41 coo -44.10 135.86 19.99 -45.67 134.21 14.07 9.92 28.31 6.82 8.29 31.11 11.06 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 13 ASP~? 8.68 O4 PG4 A 142 G 146 TYR A 129 TYR^? 7.28 CL CL A 141 G 177 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo -44.97 128.78 41.20 -46.32 128.26 42.83 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP B 13 ASP~? 8.48 C4 PG4 B 142 G 146 TYR B 129 TYR^? 7.32 CL CL B 140 G 177 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo -44.97 128.78 41.20 -46.32 128.26 42.83 -24.74 52.92 14.33 -24.14 54.73 15.30 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -32.31 42.16 13.95 -29.70 41.99 14.85 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP C 13 ASP~? 27.02 O1 EDO C 140 G 146 TYR C 129 TYR^? 13.46 O1 EDO C 140 G 177 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo -44.97 128.78 41.20 -46.32 128.26 42.83 26.45 23.84 13.97 27.74 25.29 14.77 coo -52.83 122.13 46.42 -51.31 124.30 47.39 18.89 13.20 13.92 21.55 13.21 14.74 coo -47.30 122.24 51.49 -47.46 127.44 47.81 15.48 20.46 18.00 15.72 26.44 16.52 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 G 24 ASP C 135 ASP.? 16.41 O1 EDO C 141 G 146 TYR A 121 TYR.? -24.35 CL CL A 141s G 177 LYS C 31 LYS~? 22.12 CL CL A 141 coo -44.97 128.78 41.20 -46.32 128.26 42.83 7.61 19.22 2.17 7.62 20.80 3.62 coo -52.83 122.13 46.42 -51.31 124.30 47.39 16.31 29.26 0.34 18.85 29.40 1.41 coo -47.30 122.24 51.49 -47.46 127.44 47.81 9.92 28.31 6.82 8.29 31.11 11.06 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 13 ASP~? 8.68 O4 PG4 A 142 H 146 TYR A 129 TYR^? 7.28 CL CL A 141 H 177 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo -51.11 100.30 51.41 -52.67 98.82 51.12 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP B 13 ASP~? 8.48 C4 PG4 B 142 H 146 TYR B 129 TYR^? 7.32 CL CL B 140 H 177 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo -51.11 100.30 51.41 -52.67 98.82 51.12 -24.74 52.92 14.33 -24.14 54.73 15.30 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -32.31 42.16 13.95 -29.70 41.99 14.85 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP C 13 ASP~? 27.02 O1 EDO C 140 H 146 TYR C 129 TYR^? 13.46 O1 EDO C 140 H 177 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo -51.11 100.30 51.41 -52.67 98.82 51.12 26.45 23.84 13.97 27.74 25.29 14.77 coo -58.70 94.17 45.32 -57.76 93.82 47.92 18.89 13.20 13.92 21.55 13.21 14.74 coo -54.32 88.79 48.13 -54.61 94.04 51.74 15.48 20.46 18.00 15.72 26.44 16.52 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 H 24 ASP C 135 ASP.? 16.41 O1 EDO C 141 H 146 TYR A 121 TYR.? -24.35 CL CL A 141s H 177 LYS C 31 LYS~? 22.12 CL CL A 141 coo -51.11 100.30 51.41 -52.67 98.82 51.12 7.61 19.22 2.17 7.62 20.80 3.62 coo -58.70 94.17 45.32 -57.76 93.82 47.92 16.31 29.26 0.34 18.85 29.40 1.41 coo -54.32 88.79 48.13 -54.61 94.04 51.74 9.92 28.31 6.82 8.29 31.11 11.06 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 13 ASP~? 8.68 O4 PG4 A 142 I 146 TYR A 129 TYR^? 7.28 CL CL A 141 I 177 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo -54.65 81.97 26.87 -55.88 81.89 25.07 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP B 13 ASP~? 8.48 C4 PG4 B 142 I 146 TYR B 129 TYR^? 7.32 CL CL B 140 I 177 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo -54.65 81.97 26.87 -55.88 81.89 25.07 -24.74 52.92 14.33 -24.14 54.73 15.30 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -32.31 42.16 13.95 -29.70 41.99 14.85 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP C 13 ASP~? 27.02 O1 EDO C 140 I 146 TYR C 129 TYR^? 13.46 O1 EDO C 140 I 177 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo -54.65 81.97 26.87 -55.88 81.89 25.07 26.45 23.84 13.97 27.74 25.29 14.77 coo -59.92 86.62 17.74 -59.42 83.94 18.40 18.89 13.20 13.92 21.55 13.21 14.74 coo -55.38 81.61 14.50 -57.11 80.05 20.41 15.48 20.46 18.00 15.72 26.44 16.52 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 I 24 ASP C 135 ASP.? 16.41 O1 EDO C 141 I 146 TYR A 121 TYR.? -24.35 CL CL A 141s I 177 LYS C 31 LYS~? 22.12 CL CL A 141 coo -54.65 81.97 26.87 -55.88 81.89 25.07 7.61 19.22 2.17 7.62 20.80 3.62 coo -59.92 86.62 17.74 -59.42 83.94 18.40 16.31 29.26 0.34 18.85 29.40 1.41 coo -55.38 81.61 14.50 -57.11 80.05 20.41 9.92 28.31 6.82 8.29 31.11 11.06 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 13 ASP~? 8.68 O4 PG4 A 142 J 146 TYR A 129 TYR^? 7.28 CL CL A 141 J 177 LYS A 20 LYS~? -2.81 O1 PG4 A 142s coo -50.64 99.08 1.52 -51.52 100.83 0.67 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -9.64 36.15 -5.16 -14.58 33.43 -3.36 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP B 13 ASP~? 8.48 C4 PG4 B 142 J 146 TYR B 129 TYR^? 7.32 CL CL B 140 J 177 LYS B 20 LYS~? -2.98 O4 PG4 B 142s coo -50.64 99.08 1.52 -51.52 100.83 0.67 -24.74 52.92 14.33 -24.14 54.73 15.30 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -32.31 42.16 13.95 -29.70 41.99 14.85 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -35.63 49.45 18.32 -35.72 55.05 16.66 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP C 13 ASP~? 27.02 O1 EDO C 140 J 146 TYR C 129 TYR^? 13.46 O1 EDO C 140 J 177 LYS C 20 LYS~? 21.67 C1 EDO C 140 coo -50.64 99.08 1.52 -51.52 100.83 0.67 26.45 23.84 13.97 27.74 25.29 14.77 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 18.89 13.20 13.92 21.55 13.21 14.74 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 15.48 20.46 18.00 15.72 26.44 16.52 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 J 24 ASP C 135 ASP.? 16.41 O1 EDO C 141 J 146 TYR A 121 TYR.? -24.35 CL CL A 141s J 177 LYS C 31 LYS~? 22.12 CL CL A 141 coo -50.64 99.08 1.52 -51.52 100.83 0.67 7.61 19.22 2.17 7.62 20.80 3.62 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 16.31 29.26 0.34 18.85 29.40 1.41 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 9.92 28.31 6.82 8.29 31.11 11.06 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 96 GLU A 34 GLU~? 3.97 C2 PG4 A 142 A 132 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 31.23 12.29 16.44 30.82 11.56 18.39 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 26.82 3.20 24.36 27.99 4.86 24.98 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 29.99 0.62 22.18 30.38 6.69 20.81 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 96 GLU A 36 GLU~? 11.76 C4 PG4 A 142 A 132 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 31.23 12.29 16.44 30.82 11.56 18.39 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 26.82 3.20 24.36 27.99 4.86 24.98 -12.87 29.42 9.52 -11.52 29.66 11.15 coo 29.99 0.62 22.18 30.38 6.69 20.81 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 96 GLU B 34 GLU~? -4.36 C1 PG4 B 142s A 132 LYS B 35 LYS~? 12.61 C1 PG4 B 142 coo 31.23 12.29 16.44 30.82 11.56 18.39 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 26.82 3.20 24.36 27.99 4.86 24.98 -37.87 57.41 10.67 -39.60 57.08 11.90 coo 29.99 0.62 22.18 30.38 6.69 20.81 -36.80 53.61 6.27 -41.39 52.63 2.26 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 96 GLU B 36 GLU~? 11.82 C2 PG4 B 142 A 132 LYS B 35 LYS~? 12.61 C1 PG4 B 142 coo 31.23 12.29 16.44 30.82 11.56 18.39 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 26.82 3.20 24.36 27.99 4.86 24.98 -31.60 55.95 3.54 -31.25 54.50 1.99 coo 29.99 0.62 22.18 30.38 6.69 20.81 -36.80 53.61 6.27 -41.39 52.63 2.26 ULMN 3 1onr_c00 TRANSALDOLASE B user 5 3 # 5 A 17 ASP C 13 ASP~? 27.02 O1 EDO C 140 A 96 GLU C 34 GLU~? 23.36 C1 EDO C 140 A 132 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 31.23 12.29 16.44 30.82 11.56 18.39 26.45 23.84 13.97 27.74 25.29 14.77 coo 26.82 3.20 24.36 27.99 4.86 24.98 13.37 28.10 10.00 11.57 28.19 11.09 coo 29.99 0.62 22.18 30.38 6.69 20.81 14.41 24.06 5.83 10.24 22.70 1.76 ULMN 3 1onr_c00 TRANSALDOLASE B user 6 3 # 6 A 17 ASP C 13 ASP~? 27.02 O1 EDO C 140 A 96 GLU C 36 GLU~? -27.32 O1 EDO C 140s A 132 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 31.23 12.29 16.44 30.82 11.56 18.39 26.45 23.84 13.97 27.74 25.29 14.77 coo 26.82 3.20 24.36 27.99 4.86 24.98 19.61 26.41 3.01 20.17 25.01 1.52 coo 29.99 0.62 22.18 30.38 6.69 20.81 14.41 24.06 5.83 10.24 22.70 1.76 1onr_c00 source 1onr TRANSALDOLASE B : 6 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 13 ASP~? 8.68 O4 PG4 A 142 B 96 GLU A 34 GLU~? 3.97 C2 PG4 A 142 B 132 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 26.69 48.45 7.18 27.85 50.13 7.74 -17.39 34.05 2.60 -18.36 35.64 1.56 coo 29.82 45.80 5.07 30.26 51.81 3.56 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 13 ASP~? 8.68 O4 PG4 A 142 B 96 GLU A 36 GLU~? 11.76 C4 PG4 A 142 B 132 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 26.69 48.45 7.18 27.85 50.13 7.74 -12.87 29.42 9.52 -11.52 29.66 11.15 coo 29.82 45.80 5.07 30.26 51.81 3.56 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP B 13 ASP~? 8.48 C4 PG4 B 142 B 96 GLU B 34 GLU~? -4.36 C1 PG4 B 142s B 132 LYS B 35 LYS~? 12.61 C1 PG4 B 142 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 26.69 48.45 7.18 27.85 50.13 7.74 -37.87 57.41 10.67 -39.60 57.08 11.90 coo 29.82 45.80 5.07 30.26 51.81 3.56 -36.80 53.61 6.27 -41.39 52.63 2.26 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP B 13 ASP~? 8.48 C4 PG4 B 142 B 96 GLU B 36 GLU~? 11.82 C2 PG4 B 142 B 132 LYS B 35 LYS~? 12.61 C1 PG4 B 142 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 26.69 48.45 7.18 27.85 50.13 7.74 -31.60 55.95 3.54 -31.25 54.50 1.99 coo 29.82 45.80 5.07 30.26 51.81 3.56 -36.80 53.61 6.27 -41.39 52.63 2.26 ULMN 3 1onr_c01 TRANSALDOLASE B user 5 3 # 5 B 17 ASP C 13 ASP~? 27.02 O1 EDO C 140 B 96 GLU C 34 GLU~? 23.36 C1 EDO C 140 B 132 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 31.16 57.31 -0.94 30.73 56.64 1.01 26.45 23.84 13.97 27.74 25.29 14.77 coo 26.69 48.45 7.18 27.85 50.13 7.74 13.37 28.10 10.00 11.57 28.19 11.09 coo 29.82 45.80 5.07 30.26 51.81 3.56 14.41 24.06 5.83 10.24 22.70 1.76 ULMN 3 1onr_c01 TRANSALDOLASE B user 6 3 # 6 B 17 ASP C 13 ASP~? 27.02 O1 EDO C 140 B 96 GLU C 36 GLU~? -27.32 O1 EDO C 140s B 132 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 31.16 57.31 -0.94 30.73 56.64 1.01 26.45 23.84 13.97 27.74 25.29 14.77 coo 26.69 48.45 7.18 27.85 50.13 7.74 19.61 26.41 3.01 20.17 25.01 1.52 coo 29.82 45.80 5.07 30.26 51.81 3.56 14.41 24.06 5.83 10.24 22.70 1.76 1onr_c01 source 1onr TRANSALDOLASE B : 6 hits 1onr_c01 naa= 3 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 A 102 ASP A 50 ASP.? 20.38 CL CL A 141 A 167 LYS C 31 LYS~? 22.12 CL CL A 141 A 201 LYS A 47 LYS~? 18.08 C5 PG4 A 142 coo 26.53 8.31 20.37 28.45 8.41 19.40 11.71 33.66 5.09 12.68 31.93 4.37 coo 24.92 6.08 13.38 27.75 4.33 18.83 9.92 28.31 6.82 8.29 31.11 11.06 coo 29.08 5.53 11.69 30.46 5.61 17.93 4.15 29.38 6.95 0.12 26.77 10.99 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 A 102 ASP A 50 ASP.? 20.38 CL CL A 141 A 167 LYS C 31 LYS~? 22.12 CL CL A 141 A 201 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 26.53 8.31 20.37 28.45 8.41 19.40 11.71 33.66 5.09 12.68 31.93 4.37 coo 24.92 6.08 13.38 27.75 4.33 18.83 9.92 28.31 6.82 8.29 31.11 11.06 coo 29.08 5.53 11.69 30.46 5.61 17.93 14.41 24.06 5.83 10.24 22.70 1.76 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 3 3 # 3 A 102 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 167 LYS A 35 LYS~? 11.98 C3 PG4 A 142 A 201 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 26.53 8.31 20.37 28.45 8.41 19.40 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 24.92 6.08 13.38 27.75 4.33 18.83 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 29.08 5.53 11.69 30.46 5.61 17.93 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 4 3 # 4 A 102 ASP B 50 ASP.? 10.53 C3 PG4 A 142 A 167 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 201 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 26.53 8.31 20.37 28.45 8.41 19.40 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 24.92 6.08 13.38 27.75 4.33 18.83 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 29.08 5.53 11.69 30.46 5.61 17.93 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 5 3 # 5 A 102 ASP B 50 ASP.? 10.53 C3 PG4 A 142 A 167 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 201 LYS B 47 LYS~? 12.98 C2 PG4 A 142 coo 26.53 8.31 20.37 28.45 8.41 19.40 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 24.92 6.08 13.38 27.75 4.33 18.83 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 29.08 5.53 11.69 30.46 5.61 17.93 -23.16 41.10 5.81 -22.85 46.07 1.96 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 6 3 # 6 A 102 ASP B 135 ASP.? 12.47 O1 PG4 B 142 A 167 LYS B 35 LYS~? 12.61 C1 PG4 B 142 A 201 LYS B 31 LYS~? 7.73 C1 PG4 B 142 coo 26.53 8.31 20.37 28.45 8.41 19.40 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 24.92 6.08 13.38 27.75 4.33 18.83 -36.80 53.61 6.27 -41.39 52.63 2.26 coo 29.08 5.53 11.69 30.46 5.61 17.93 -41.17 57.91 7.48 -40.76 60.95 12.06 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 7 3 # 7 A 102 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 167 LYS C 35 LYS~? 18.91 O1 EDO C 141 A 201 LYS C 31 LYS~? 22.12 CL CL A 141 coo 26.53 8.31 20.37 28.45 8.41 19.40 7.61 19.22 2.17 7.62 20.80 3.62 coo 24.92 6.08 13.38 27.75 4.33 18.83 14.41 24.06 5.83 10.24 22.70 1.76 coo 29.08 5.53 11.69 30.46 5.61 17.93 9.92 28.31 6.82 8.29 31.11 11.06 1p1x_c00 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 7 hits 1p1x_c00 naa= 3 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 B1102 ASP A 50 ASP.? 20.38 CL CL A 141 B1167 LYS C 31 LYS~? 22.12 CL CL A 141 B1201 LYS A 47 LYS~? 18.08 C5 PG4 A 142 coo 26.10 12.11 49.61 24.19 12.48 50.51 11.71 33.66 5.09 12.68 31.93 4.37 coo 27.70 11.69 56.92 24.82 8.55 52.12 9.92 28.31 6.82 8.29 31.11 11.06 coo 23.50 11.64 58.67 22.19 10.19 52.59 4.15 29.38 6.95 0.12 26.77 10.99 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 B1102 ASP A 50 ASP.? 20.38 CL CL A 141 B1167 LYS C 31 LYS~? 22.12 CL CL A 141 B1201 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 26.10 12.11 49.61 24.19 12.48 50.51 11.71 33.66 5.09 12.68 31.93 4.37 coo 27.70 11.69 56.92 24.82 8.55 52.12 9.92 28.31 6.82 8.29 31.11 11.06 coo 23.50 11.64 58.67 22.19 10.19 52.59 14.41 24.06 5.83 10.24 22.70 1.76 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 3 3 # 3 B1102 ASP A 135 ASP.? 12.08 C3 PG4 A 142 B1167 LYS A 35 LYS~? 11.98 C3 PG4 A 142 B1201 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 26.10 12.11 49.61 24.19 12.48 50.51 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 27.70 11.69 56.92 24.82 8.55 52.12 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 23.50 11.64 58.67 22.19 10.19 52.59 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 4 3 # 4 B1102 ASP B 50 ASP.? 10.53 C3 PG4 A 142 B1167 LYS A 31 LYS~? 8.03 C2 PG4 A 142 B1201 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 26.10 12.11 49.61 24.19 12.48 50.51 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 27.70 11.69 56.92 24.82 8.55 52.12 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 23.50 11.64 58.67 22.19 10.19 52.59 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 5 3 # 5 B1102 ASP B 50 ASP.? 10.53 C3 PG4 A 142 B1167 LYS A 31 LYS~? 8.03 C2 PG4 A 142 B1201 LYS B 47 LYS~? 12.98 C2 PG4 A 142 coo 26.10 12.11 49.61 24.19 12.48 50.51 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 27.70 11.69 56.92 24.82 8.55 52.12 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 23.50 11.64 58.67 22.19 10.19 52.59 -23.16 41.10 5.81 -22.85 46.07 1.96 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 6 3 # 6 B1102 ASP B 135 ASP.? 12.47 O1 PG4 B 142 B1167 LYS B 35 LYS~? 12.61 C1 PG4 B 142 B1201 LYS B 31 LYS~? 7.73 C1 PG4 B 142 coo 26.10 12.11 49.61 24.19 12.48 50.51 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 27.70 11.69 56.92 24.82 8.55 52.12 -36.80 53.61 6.27 -41.39 52.63 2.26 coo 23.50 11.64 58.67 22.19 10.19 52.59 -41.17 57.91 7.48 -40.76 60.95 12.06 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 7 3 # 7 B1102 ASP C 135 ASP.? 16.41 O1 EDO C 141 B1167 LYS C 35 LYS~? 18.91 O1 EDO C 141 B1201 LYS C 31 LYS~? 22.12 CL CL A 141 coo 26.10 12.11 49.61 24.19 12.48 50.51 7.61 19.22 2.17 7.62 20.80 3.62 coo 27.70 11.69 56.92 24.82 8.55 52.12 14.41 24.06 5.83 10.24 22.70 1.76 coo 23.50 11.64 58.67 22.19 10.19 52.59 9.92 28.31 6.82 8.29 31.11 11.06 1p1x_c01 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 7 hits 1p1x_c01 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS A 73 HIS~? 21.61 O ACT A 140 A 259 TYR A 77 TYR.? 19.05 CL CL A 141 A 552 ASP C 104 ASP^? 12.14 OXT ACT C 139 coo 11.34 95.90 25.54 12.13 96.42 23.67 -2.08 37.56 18.58 -2.41 35.99 19.94 coo 14.91 97.39 18.63 13.39 95.60 20.20 5.38 39.08 12.89 6.76 38.23 10.57 coo 46.37 82.54 38.83 45.97 84.66 38.77 3.02 -0.89 6.06 4.36 -2.50 5.95 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 259 TYR A 91 TYR^? -8.03 O ACT A 139s A 552 ASP C 59 ASP.? 10.26 O1 EDO C 141 coo 11.34 95.90 25.54 12.13 96.42 23.67 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 14.91 97.39 18.63 13.39 95.60 20.20 0.50 53.22 4.73 2.11 51.22 3.73 coo 46.37 82.54 38.83 45.97 84.66 38.77 -1.96 12.33 5.23 -2.08 13.48 6.95 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 3 3 # 3 A 225 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 259 TYR A 106 TYR.? -4.43 O ACT A 139s A 552 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo 11.34 95.90 25.54 12.13 96.42 23.67 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 14.91 97.39 18.63 13.39 95.60 20.20 -3.42 56.19 3.13 -4.04 54.71 0.79 coo 46.37 82.54 38.83 45.97 84.66 38.77 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 4 3 # 4 A 225 HIS B 73 HIS~? 18.37 O1 PG4 A 142 A 259 TYR B 77 TYR.? 13.05 CL CL B 141 A 552 ASP A 104 ASP^? 12.12 O ACT A 139 coo 11.34 95.90 25.54 12.13 96.42 23.67 -33.47 42.81 -5.64 -32.31 44.01 -6.92 coo 14.91 97.39 18.63 13.39 95.60 20.20 -31.17 35.51 -0.12 -29.59 34.67 2.09 coo 46.37 82.54 38.83 45.97 84.66 38.77 2.26 57.49 7.12 4.30 57.24 7.17 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 5 3 # 5 A 225 HIS B 110 HIS.? -3.67 O ACT B 139s A 259 TYR B 91 TYR^? 6.76 CL CL B 141 A 552 ASP A 59 ASP.? 10.45 O ACT A 140 coo 11.34 95.90 25.54 12.13 96.42 23.67 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 14.91 97.39 18.63 13.39 95.60 20.20 -45.69 32.60 8.25 -43.08 32.05 9.08 coo 46.37 82.54 38.83 45.97 84.66 38.77 -11.63 55.20 7.79 -12.68 54.74 6.05 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 6 3 # 6 A 225 HIS C 110 HIS.? 3.59 O ACT C 139s A 259 TYR C 106 TYR.? -4.43 OXT ACT C 139s A 552 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo 11.34 95.90 25.54 12.13 96.42 23.67 4.54 8.83 15.35 4.90 7.96 17.23 coo 14.91 97.39 18.63 13.39 95.60 20.20 1.32 4.77 9.99 2.33 6.07 12.30 coo 46.37 82.54 38.83 45.97 84.66 38.77 -12.78 43.39 10.70 -14.12 42.52 9.22 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 6 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 67 ALA~? 12.13 O ACT A 140 A 126 LEU A 66 LEU~? 10.51 O ACT A 140 A 158 GLU A 63 GLU~? 7.87 O ACT A 140 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -5.90 45.50 12.19 -6.05 46.10 10.79 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -8.21 47.33 15.56 -9.57 45.91 16.65 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -11.40 51.79 11.95 -12.40 52.61 10.19 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 67 ALA~? 12.13 O ACT A 140 A 126 LEU A 134 LEU.? 12.12 O ACT A 140 A 158 GLU A 63 GLU~? 7.87 O ACT A 140 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -5.90 45.50 12.19 -6.05 46.10 10.79 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -9.54 46.58 8.31 -8.62 48.40 7.58 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -11.40 51.79 11.95 -12.40 52.61 10.19 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA B 67 ALA~? 13.10 CL CL B 141 A 126 LEU B 66 LEU~? 19.00 CL CL B 141 A 158 GLU B 63 GLU~? 16.01 OXT ACT B 139 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -42.21 42.04 0.87 -42.80 41.77 2.27 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -45.01 43.12 -2.62 -44.57 45.10 -3.39 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -50.25 43.77 1.04 -51.29 44.45 2.77 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA B 67 ALA~? 13.10 CL CL B 141 A 126 LEU B 134 LEU.? 13.82 OXT ACT B 139 A 158 GLU B 63 GLU~? 16.01 OXT ACT B 139 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -42.21 42.04 0.87 -42.80 41.77 2.27 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -44.97 44.65 4.78 -46.05 42.93 5.57 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -50.25 43.77 1.04 -51.29 44.45 2.77 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA C 67 ALA~? 12.01 O1 EDO C 141 A 126 LEU C 66 LEU~? 10.22 O1 EDO C 141 A 158 GLU C 63 GLU~? 7.77 O1 EDO C 141 coo -2.29 37.66 144.73 -1.46 37.12 145.87 9.23 12.17 0.82 8.63 11.92 2.24 coo -4.62 32.83 147.14 -5.50 32.85 149.12 6.36 13.22 -2.53 6.93 15.17 -3.43 coo -0.83 29.57 149.77 -0.39 31.47 148.95 1.11 13.80 1.11 0.04 14.34 2.91 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA C 67 ALA~? 12.01 O1 EDO C 141 A 126 LEU C 134 LEU.? 12.00 O1 EDO C 141 A 158 GLU C 63 GLU~? 7.77 O1 EDO C 141 coo -2.29 37.66 144.73 -1.46 37.12 145.87 9.23 12.17 0.82 8.63 11.92 2.24 coo -4.62 32.83 147.14 -5.50 32.85 149.12 6.41 14.95 4.68 5.41 13.16 5.46 coo -0.83 29.57 149.77 -0.39 31.47 148.95 1.11 13.80 1.11 0.04 14.34 2.91 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 6 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 67 ALA~? 12.13 O ACT A 140 B 126 LEU A 66 LEU~? 10.51 O ACT A 140 B 158 GLU A 63 GLU~? 7.87 O ACT A 140 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -5.90 45.50 12.19 -6.05 46.10 10.79 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -8.21 47.33 15.56 -9.57 45.91 16.65 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -11.40 51.79 11.95 -12.40 52.61 10.19 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 67 ALA~? 12.13 O ACT A 140 B 126 LEU A 134 LEU.? 12.12 O ACT A 140 B 158 GLU A 63 GLU~? 7.87 O ACT A 140 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -5.90 45.50 12.19 -6.05 46.10 10.79 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -9.54 46.58 8.31 -8.62 48.40 7.58 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -11.40 51.79 11.95 -12.40 52.61 10.19 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA B 67 ALA~? 13.10 CL CL B 141 B 126 LEU B 66 LEU~? 19.00 CL CL B 141 B 158 GLU B 63 GLU~? 16.01 OXT ACT B 139 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -42.21 42.04 0.87 -42.80 41.77 2.27 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -45.01 43.12 -2.62 -44.57 45.10 -3.39 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -50.25 43.77 1.04 -51.29 44.45 2.77 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA B 67 ALA~? 13.10 CL CL B 141 B 126 LEU B 134 LEU.? 13.82 OXT ACT B 139 B 158 GLU B 63 GLU~? 16.01 OXT ACT B 139 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -42.21 42.04 0.87 -42.80 41.77 2.27 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -44.97 44.65 4.78 -46.05 42.93 5.57 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -50.25 43.77 1.04 -51.29 44.45 2.77 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA C 67 ALA~? 12.01 O1 EDO C 141 B 126 LEU C 66 LEU~? 10.22 O1 EDO C 141 B 158 GLU C 63 GLU~? 7.77 O1 EDO C 141 coo -39.79 4.61 147.27 -39.61 5.56 148.47 9.23 12.17 0.82 8.63 11.92 2.24 coo -34.22 5.06 149.25 -33.65 4.24 151.15 6.36 13.22 -2.53 6.93 15.17 -3.43 coo -33.03 9.93 151.71 -34.98 9.38 151.11 1.11 13.80 1.11 0.04 14.34 2.91 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA C 67 ALA~? 12.01 O1 EDO C 141 B 126 LEU C 134 LEU.? 12.00 O1 EDO C 141 B 158 GLU C 63 GLU~? 7.77 O1 EDO C 141 coo -39.79 4.61 147.27 -39.61 5.56 148.47 9.23 12.17 0.82 8.63 11.92 2.24 coo -34.22 5.06 149.25 -33.65 4.24 151.15 6.41 14.95 4.68 5.41 13.16 5.46 coo -33.03 9.93 151.71 -34.98 9.38 151.11 1.11 13.80 1.11 0.04 14.34 2.91 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 6 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 67 ALA~? 12.13 O ACT A 140 C 126 LEU A 66 LEU~? 10.51 O ACT A 140 C 158 GLU A 63 GLU~? 7.87 O ACT A 140 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -5.90 45.50 12.19 -6.05 46.10 10.79 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -8.21 47.33 15.56 -9.57 45.91 16.65 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -11.40 51.79 11.95 -12.40 52.61 10.19 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 67 ALA~? 12.13 O ACT A 140 C 126 LEU A 134 LEU.? 12.12 O ACT A 140 C 158 GLU A 63 GLU~? 7.87 O ACT A 140 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -5.90 45.50 12.19 -6.05 46.10 10.79 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -9.54 46.58 8.31 -8.62 48.40 7.58 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -11.40 51.79 11.95 -12.40 52.61 10.19 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA B 67 ALA~? 13.10 CL CL B 141 C 126 LEU B 66 LEU~? 19.00 CL CL B 141 C 158 GLU B 63 GLU~? 16.01 OXT ACT B 139 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -42.21 42.04 0.87 -42.80 41.77 2.27 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -45.01 43.12 -2.62 -44.57 45.10 -3.39 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -50.25 43.77 1.04 -51.29 44.45 2.77 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA B 67 ALA~? 13.10 CL CL B 141 C 126 LEU B 134 LEU.? 13.82 OXT ACT B 139 C 158 GLU B 63 GLU~? 16.01 OXT ACT B 139 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -42.21 42.04 0.87 -42.80 41.77 2.27 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -44.97 44.65 4.78 -46.05 42.93 5.57 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -50.25 43.77 1.04 -51.29 44.45 2.77 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA C 67 ALA~? 12.01 O1 EDO C 141 C 126 LEU C 66 LEU~? 10.22 O1 EDO C 141 C 158 GLU C 63 GLU~? 7.77 O1 EDO C 141 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 9.23 12.17 0.82 8.63 11.92 2.24 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 6.36 13.22 -2.53 6.93 15.17 -3.43 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 1.11 13.80 1.11 0.04 14.34 2.91 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA C 67 ALA~? 12.01 O1 EDO C 141 C 126 LEU C 134 LEU.? 12.00 O1 EDO C 141 C 158 GLU C 63 GLU~? 7.77 O1 EDO C 141 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 9.23 12.17 0.82 8.63 11.92 2.24 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 6.41 14.95 4.68 5.41 13.16 5.46 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 1.11 13.80 1.11 0.04 14.34 2.91 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 6 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP A 50 ASP.? 20.38 CL CL A 141 B 270 LYS A 47 LYS~? 18.08 C5 PG4 A 142 B 382 MET A 128 MET?? -5.74 CL CL A 141s coo -11.82 154.51 43.38 -12.86 152.74 43.79 11.71 33.66 5.09 12.68 31.93 4.37 coo -5.09 158.39 43.41 -0.74 158.80 47.15 4.15 29.38 6.95 0.12 26.77 10.99 coo -2.79 145.52 50.38 -5.75 148.14 51.66 1.64 39.79 -2.32 2.10 43.99 -2.11 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 2 3 # 2 B 248 ASP A 50 ASP.? 20.38 CL CL A 141 B 270 LYS A 97 LYS.? 17.22 CL CL A 141 B 382 MET A 128 MET?? -5.74 CL CL A 141s coo -11.82 154.51 43.38 -12.86 152.74 43.79 11.71 33.66 5.09 12.68 31.93 4.37 coo -5.09 158.39 43.41 -0.74 158.80 47.15 12.14 41.01 8.19 12.52 43.66 3.40 coo -2.79 145.52 50.38 -5.75 148.14 51.66 1.64 39.79 -2.32 2.10 43.99 -2.11 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 3 3 # 3 B 248 ASP B 50 ASP.? 10.53 C3 PG4 A 142 B 270 LYS B 47 LYS~? 12.98 C2 PG4 A 142 B 382 MET B 128 MET?? 4.41 CL CL B 141 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -23.12 32.36 7.43 -21.08 32.27 8.01 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -23.16 41.10 5.81 -22.85 46.07 1.96 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -33.32 37.95 15.09 -36.75 35.43 14.89 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 4 3 # 4 B 248 ASP C 50 ASP.? 22.48 O1 EDO C 140 B 270 LYS C 47 LYS~? 26.80 O1 EDO C 140 B 382 MET C 128 MET?? 5.50 O1 EDO C 140 coo -11.82 154.51 43.38 -12.86 152.74 43.79 28.54 3.26 7.93 30.44 3.42 8.82 coo -5.09 158.39 43.41 -0.74 158.80 47.15 28.25 11.83 5.90 28.26 16.33 1.39 coo -2.79 145.52 50.38 -5.75 148.14 51.66 18.11 8.89 15.27 14.72 6.36 15.27 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 5 3 # 5 B 248 ASP C 50 ASP.? 22.48 O1 EDO C 140 B 270 LYS C 97 LYS.? 16.45 O1 EDO C 140 B 382 MET C 128 MET?? 5.50 O1 EDO C 140 coo -11.82 154.51 43.38 -12.86 152.74 43.79 28.54 3.26 7.93 30.44 3.42 8.82 coo -5.09 158.39 43.41 -0.74 158.80 47.15 22.33 -0.96 4.86 22.00 -3.43 10.72 coo -2.79 145.52 50.38 -5.75 148.14 51.66 18.11 8.89 15.27 14.72 6.36 15.27 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 5 hits 1pjq_c03 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 9 LEU.? 9.25 C5 PG4 A 142 A 58 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 120 LYS A 15 LYS~? 13.64 CL CL A 141 coo 34.02 69.29 75.26 34.82 67.82 76.74 -6.54 24.35 3.68 -7.68 26.01 2.84 coo 34.46 72.45 78.57 32.82 72.75 77.28 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 28.96 77.64 81.19 29.05 74.53 77.51 -3.53 30.44 -3.03 2.12 29.06 -5.24 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 A 48 LEU A 9 LEU.? 9.25 C5 PG4 A 142 A 58 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 120 LYS A 16 LYS~? 4.07 C8 PG4 A 142 coo 34.02 69.29 75.26 34.82 67.82 76.74 -6.54 24.35 3.68 -7.68 26.01 2.84 coo 34.46 72.45 78.57 32.82 72.75 77.28 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 28.96 77.64 81.19 29.05 74.53 77.51 -6.79 30.20 -4.87 -11.32 27.78 -7.03 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 A 48 LEU A 134 LEU.? 12.12 O ACT A 140 A 58 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 120 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 34.02 69.29 75.26 34.82 67.82 76.74 -9.54 46.58 8.31 -8.62 48.40 7.58 coo 34.46 72.45 78.57 32.82 72.75 77.28 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 28.96 77.64 81.19 29.05 74.53 77.51 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 A 48 LEU B 9 LEU.? 9.43 C3 PG4 B 142 A 58 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 120 LYS B 15 LYS~? 14.97 CL CL B 140 coo 34.02 69.29 75.26 34.82 67.82 76.74 -24.03 52.89 9.35 -26.07 52.94 10.11 coo 34.46 72.45 78.57 32.82 72.75 77.28 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 28.96 77.64 81.19 29.05 74.53 77.51 -27.71 47.06 15.95 -22.68 43.71 17.22 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 5 3 # 5 A 48 LEU B 9 LEU.? 9.43 C3 PG4 B 142 A 58 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 120 LYS B 16 LYS~? 5.16 C5 PG4 B 142 coo 34.02 69.29 75.26 34.82 67.82 76.74 -24.03 52.89 9.35 -26.07 52.94 10.11 coo 34.46 72.45 78.57 32.82 72.75 77.28 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 28.96 77.64 81.19 29.05 74.53 77.51 -29.09 50.01 17.90 -28.96 54.88 21.75 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 6 3 # 6 A 48 LEU B 134 LEU.? 13.82 OXT ACT B 139 A 58 ASP B 135 ASP.? 12.47 O1 PG4 B 142 A 120 LYS B 35 LYS~? 12.61 C1 PG4 B 142 coo 34.02 69.29 75.26 34.82 67.82 76.74 -44.97 44.65 4.78 -46.05 42.93 5.57 coo 34.46 72.45 78.57 32.82 72.75 77.28 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 28.96 77.64 81.19 29.05 74.53 77.51 -36.80 53.61 6.27 -41.39 52.63 2.26 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 7 3 # 7 A 48 LEU C 9 LEU.? 25.88 O1 EDO C 140 A 58 ASP C 13 ASP~? 27.02 O1 EDO C 140 A 120 LYS C 15 LYS~? 19.87 O1 EDO C 140 coo 34.02 69.29 75.26 34.82 67.82 76.74 27.34 23.62 8.90 25.54 23.29 10.03 coo 34.46 72.45 78.57 32.82 72.75 77.28 26.45 23.84 13.97 27.74 25.29 14.77 coo 28.96 77.64 81.19 29.05 74.53 77.51 23.48 18.06 15.81 27.69 13.80 17.86 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 8 3 # 8 A 48 LEU C 134 LEU.? 12.00 O1 EDO C 141 A 58 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 120 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 34.02 69.29 75.26 34.82 67.82 76.74 6.41 14.95 4.68 5.41 13.16 5.46 coo 34.46 72.45 78.57 32.82 72.75 77.28 7.61 19.22 2.17 7.62 20.80 3.62 coo 28.96 77.64 81.19 29.05 74.53 77.51 14.41 24.06 5.83 10.24 22.70 1.76 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 8 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 9 LEU.? 9.25 C5 PG4 A 142 B 58 ASP A 13 ASP~? 8.68 O4 PG4 A 142 B 120 LYS A 15 LYS~? 13.64 CL CL A 141 coo 54.50 104.32 58.69 55.83 105.69 59.81 -6.54 24.35 3.68 -7.68 26.01 2.84 coo 57.63 101.19 59.83 56.60 100.89 57.99 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 61.58 95.88 55.22 58.18 99.30 54.71 -3.53 30.44 -3.03 2.12 29.06 -5.24 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 B 48 LEU A 9 LEU.? 9.25 C5 PG4 A 142 B 58 ASP A 13 ASP~? 8.68 O4 PG4 A 142 B 120 LYS A 16 LYS~? 4.07 C8 PG4 A 142 coo 54.50 104.32 58.69 55.83 105.69 59.81 -6.54 24.35 3.68 -7.68 26.01 2.84 coo 57.63 101.19 59.83 56.60 100.89 57.99 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 61.58 95.88 55.22 58.18 99.30 54.71 -6.79 30.20 -4.87 -11.32 27.78 -7.03 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 B 48 LEU A 134 LEU.? 12.12 O ACT A 140 B 58 ASP A 135 ASP.? 12.08 C3 PG4 A 142 B 120 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 54.50 104.32 58.69 55.83 105.69 59.81 -9.54 46.58 8.31 -8.62 48.40 7.58 coo 57.63 101.19 59.83 56.60 100.89 57.99 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 61.58 95.88 55.22 58.18 99.30 54.71 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 B 48 LEU B 9 LEU.? 9.43 C3 PG4 B 142 B 58 ASP B 13 ASP~? 8.48 C4 PG4 B 142 B 120 LYS B 15 LYS~? 14.97 CL CL B 140 coo 54.50 104.32 58.69 55.83 105.69 59.81 -24.03 52.89 9.35 -26.07 52.94 10.11 coo 57.63 101.19 59.83 56.60 100.89 57.99 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 61.58 95.88 55.22 58.18 99.30 54.71 -27.71 47.06 15.95 -22.68 43.71 17.22 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 5 3 # 5 B 48 LEU B 9 LEU.? 9.43 C3 PG4 B 142 B 58 ASP B 13 ASP~? 8.48 C4 PG4 B 142 B 120 LYS B 16 LYS~? 5.16 C5 PG4 B 142 coo 54.50 104.32 58.69 55.83 105.69 59.81 -24.03 52.89 9.35 -26.07 52.94 10.11 coo 57.63 101.19 59.83 56.60 100.89 57.99 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 61.58 95.88 55.22 58.18 99.30 54.71 -29.09 50.01 17.90 -28.96 54.88 21.75 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 6 3 # 6 B 48 LEU B 134 LEU.? 13.82 OXT ACT B 139 B 58 ASP B 135 ASP.? 12.47 O1 PG4 B 142 B 120 LYS B 35 LYS~? 12.61 C1 PG4 B 142 coo 54.50 104.32 58.69 55.83 105.69 59.81 -44.97 44.65 4.78 -46.05 42.93 5.57 coo 57.63 101.19 59.83 56.60 100.89 57.99 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 61.58 95.88 55.22 58.18 99.30 54.71 -36.80 53.61 6.27 -41.39 52.63 2.26 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 7 3 # 7 B 48 LEU C 9 LEU.? 25.88 O1 EDO C 140 B 58 ASP C 13 ASP~? 27.02 O1 EDO C 140 B 120 LYS C 15 LYS~? 19.87 O1 EDO C 140 coo 54.50 104.32 58.69 55.83 105.69 59.81 27.34 23.62 8.90 25.54 23.29 10.03 coo 57.63 101.19 59.83 56.60 100.89 57.99 26.45 23.84 13.97 27.74 25.29 14.77 coo 61.58 95.88 55.22 58.18 99.30 54.71 23.48 18.06 15.81 27.69 13.80 17.86 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 8 3 # 8 B 48 LEU C 134 LEU.? 12.00 O1 EDO C 141 B 58 ASP C 135 ASP.? 16.41 O1 EDO C 141 B 120 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 54.50 104.32 58.69 55.83 105.69 59.81 6.41 14.95 4.68 5.41 13.16 5.46 coo 57.63 101.19 59.83 56.60 100.89 57.99 7.61 19.22 2.17 7.62 20.80 3.62 coo 61.58 95.88 55.22 58.18 99.30 54.71 14.41 24.06 5.83 10.24 22.70 1.76 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 8 hits 1pym_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 68 ALA A 14 ALA~? 9.78 C5 PG4 A 142 A 72 LEU A 18 LEU~? 8.82 C4 PG4 A 142 coo 46.76 7.59 18.65 45.27 6.01 18.52 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 48.88 4.35 16.59 48.73 5.09 15.20 -4.96 28.55 -0.04 -3.75 28.32 0.84 coo 53.89 6.25 15.09 52.88 7.92 14.14 -4.71 34.52 -0.91 -4.38 34.37 1.25 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 68 ALA A 14 ALA~? 9.78 C5 PG4 A 142 A 72 LEU A 44 LEU~? 13.01 C5 PG4 A 142 coo 46.76 7.59 18.65 45.27 6.01 18.52 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 48.88 4.35 16.59 48.73 5.09 15.20 -4.96 28.55 -0.04 -3.75 28.32 0.84 coo 53.89 6.25 15.09 52.88 7.92 14.14 -1.92 27.45 4.90 -1.55 25.94 3.31 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP A 59 ASP.? 10.45 O ACT A 140 A 68 ALA A 58 ALA^? 8.62 O ACT A 140 A 72 LEU A 134 LEU.? 12.12 O ACT A 140 coo 46.76 7.59 18.65 45.27 6.01 18.52 -11.63 55.20 7.79 -12.68 54.74 6.05 coo 48.88 4.35 16.59 48.73 5.09 15.20 -7.65 52.47 7.15 -7.34 51.97 8.48 coo 53.89 6.25 15.09 52.88 7.92 14.14 -9.54 46.58 8.31 -8.62 48.40 7.58 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 68 ALA B 14 ALA~? 9.79 C3 PG4 B 142 A 72 LEU B 18 LEU~? 9.03 C2 PG4 B 142 coo 46.76 7.59 18.65 45.27 6.01 18.52 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 48.88 4.35 16.59 48.73 5.09 15.20 -26.82 49.29 13.00 -26.06 48.38 12.05 coo 53.89 6.25 15.09 52.88 7.92 14.14 -31.72 46.14 13.93 -31.53 45.93 11.74 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 5 3 # 5 A 67 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 68 ALA B 14 ALA~? 9.79 C3 PG4 B 142 A 72 LEU B 44 LEU~? 13.20 C3 PG4 B 142 coo 46.76 7.59 18.65 45.27 6.01 18.52 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 48.88 4.35 16.59 48.73 5.09 15.20 -26.82 49.29 13.00 -26.06 48.38 12.05 coo 53.89 6.25 15.09 52.88 7.92 14.14 -24.53 47.30 8.00 -22.95 47.61 9.45 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 6 3 # 6 A 67 ASP B 59 ASP.? 11.98 O ACT B 139 A 68 ALA B 58 ALA^? 11.90 OXT ACT B 139 A 72 LEU B 134 LEU.? 13.82 OXT ACT B 139 coo 46.76 7.59 18.65 45.27 6.01 18.52 -53.34 42.20 5.44 -53.68 42.89 7.35 coo 48.88 4.35 16.59 48.73 5.09 15.20 -49.08 40.03 5.89 -48.46 40.08 4.54 coo 53.89 6.25 15.09 52.88 7.92 14.14 -44.97 44.65 4.78 -46.05 42.93 5.57 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 7 3 # 7 A 67 ASP C 13 ASP~? 27.02 O1 EDO C 140 A 68 ALA C 14 ALA~? 21.53 O1 EDO C 140 A 72 LEU C 18 LEU~? 15.89 O1 EDO C 140 coo 46.76 7.59 18.65 45.27 6.01 18.52 26.45 23.84 13.97 27.74 25.29 14.77 coo 48.88 4.35 16.59 48.73 5.09 15.20 24.38 20.21 12.78 25.17 19.28 11.83 coo 53.89 6.25 15.09 52.88 7.92 14.14 19.47 17.03 13.73 19.69 16.73 11.59 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 8 3 # 8 A 67 ASP C 13 ASP~? 27.02 O1 EDO C 140 A 68 ALA C 14 ALA~? 21.53 O1 EDO C 140 A 72 LEU C 44 LEU~? 23.67 O1 EDO C 140 coo 46.76 7.59 18.65 45.27 6.01 18.52 26.45 23.84 13.97 27.74 25.29 14.77 coo 48.88 4.35 16.59 48.73 5.09 15.20 24.38 20.21 12.78 25.17 19.28 11.83 coo 53.89 6.25 15.09 52.88 7.92 14.14 26.88 18.07 7.82 28.28 18.37 9.48 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 9 3 # 9 A 67 ASP C 59 ASP.? 10.26 O1 EDO C 141 A 68 ALA C 58 ALA^? 8.51 O1 EDO C 141 A 72 LEU C 134 LEU.? 12.00 O1 EDO C 141 coo 46.76 7.59 18.65 45.27 6.01 18.52 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 48.88 4.35 16.59 48.73 5.09 15.20 2.32 10.24 5.90 2.90 10.23 4.51 coo 53.89 6.25 15.09 52.88 7.92 14.14 6.41 14.95 4.68 5.41 13.16 5.46 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 9 hits 1q6l_c05 naa= 3 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 1 3 # 1 A 348 HIS A 109 HIS.? -5.41 OXT ACT A 139s A 378 CYH A 57 CYH^? 5.51 O ACT A 139 A 380 GLY A 112 GLY^? 10.97 O ACT A 139 coo 28.93 -15.66 12.20 27.40 -15.25 10.79 -8.77 57.48 -2.79 -8.58 59.56 -2.89 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 -4.80 51.41 4.83 -3.45 51.64 2.37 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 -7.56 46.85 3.93 -6.95 47.44 3.87 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 2 3 # 2 A 348 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 378 CYH A 23 CYH.? -5.05 CL CL A 141s A 380 GLY A 130 GLY^? -4.84 CL CL A 141s coo 28.93 -15.66 12.20 27.40 -15.25 10.79 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 -4.89 41.74 -0.85 -4.61 41.77 -1.61 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 3 3 # 3 A 348 HIS B 109 HIS.? -5.47 O ACT B 139s A 378 CYH B 57 CYH^? 5.44 OXT ACT B 139 A 380 GLY B 112 GLY^? 10.91 OXT ACT B 139 coo 28.93 -15.66 12.20 27.40 -15.25 10.79 -54.00 38.48 15.75 -55.77 37.34 15.88 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 -46.68 38.10 8.15 -46.29 36.73 10.60 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 -44.06 42.66 9.14 -44.28 41.84 9.20 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 4 3 # 4 A 348 HIS B 110 HIS.? -3.67 O ACT B 139s A 378 CYH B 23 CYH.? -4.94 CL CL B 140s A 380 GLY B 130 GLY^? -4.77 CL CL B 140s coo 28.93 -15.66 12.20 27.40 -15.25 10.79 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 -38.21 42.69 13.79 -38.12 42.42 14.57 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 5 3 # 5 A 348 HIS C 109 HIS.? -5.44 O ACT C 139s A 378 CYH C 57 CYH^? 5.55 OXT ACT C 139 A 380 GLY C 112 GLY^? 11.00 OXT ACT C 139 coo 28.93 -15.66 12.20 27.40 -15.25 10.79 -2.54 8.69 15.96 -4.15 7.36 16.15 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 4.72 8.42 8.22 5.18 7.19 10.69 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 7.28 13.06 9.10 7.06 12.23 9.16 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 6 3 # 6 A 348 HIS C 110 HIS.? 3.59 O ACT C 139s A 378 CYH C 23 CYH.? 8.42 C1 EDO C 140 A 380 GLY C 130 GLY^? 9.35 O1 EDO C 140 coo 28.93 -15.66 12.20 27.40 -15.25 10.79 4.54 8.83 15.35 4.90 7.96 17.23 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 10.88 13.11 20.21 12.25 12.11 22.32 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 13.00 13.33 13.76 13.12 13.19 14.54 1qfl_c00 source 1qfl ACETOACETYL-COA THIOLASE : 6 hits 1qfl_c00 naa= 3 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 1 3 # 1 B 348 HIS A 109 HIS.? -5.41 OXT ACT A 139s B 378 CYH A 57 CYH^? 5.51 O ACT A 139 B 380 GLY A 112 GLY^? 10.97 O ACT A 139 coo 13.24 15.55 12.21 14.75 15.10 10.80 -8.77 57.48 -2.79 -8.58 59.56 -2.89 coo 20.14 17.58 5.68 19.50 18.95 7.99 -4.80 51.41 4.83 -3.45 51.64 2.37 coo 24.06 14.49 10.58 24.24 14.15 9.79 -7.56 46.85 3.93 -6.95 47.44 3.87 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 2 3 # 2 B 348 HIS A 110 HIS.? -3.69 OXT ACT A 139s B 378 CYH A 23 CYH.? -5.05 CL CL A 141s B 380 GLY A 130 GLY^? -4.84 CL CL A 141s coo 13.24 15.55 12.21 14.75 15.10 10.80 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 20.14 17.58 5.68 19.50 18.95 7.99 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 24.06 14.49 10.58 24.24 14.15 9.79 -4.89 41.74 -0.85 -4.61 41.77 -1.61 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 3 3 # 3 B 348 HIS B 109 HIS.? -5.47 O ACT B 139s B 378 CYH B 57 CYH^? 5.44 OXT ACT B 139 B 380 GLY B 112 GLY^? 10.91 OXT ACT B 139 coo 13.24 15.55 12.21 14.75 15.10 10.80 -54.00 38.48 15.75 -55.77 37.34 15.88 coo 20.14 17.58 5.68 19.50 18.95 7.99 -46.68 38.10 8.15 -46.29 36.73 10.60 coo 24.06 14.49 10.58 24.24 14.15 9.79 -44.06 42.66 9.14 -44.28 41.84 9.20 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 4 3 # 4 B 348 HIS B 110 HIS.? -3.67 O ACT B 139s B 378 CYH B 23 CYH.? -4.94 CL CL B 140s B 380 GLY B 130 GLY^? -4.77 CL CL B 140s coo 13.24 15.55 12.21 14.75 15.10 10.80 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 20.14 17.58 5.68 19.50 18.95 7.99 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 24.06 14.49 10.58 24.24 14.15 9.79 -38.21 42.69 13.79 -38.12 42.42 14.57 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 5 3 # 5 B 348 HIS C 109 HIS.? -5.44 O ACT C 139s B 378 CYH C 57 CYH^? 5.55 OXT ACT C 139 B 380 GLY C 112 GLY^? 11.00 OXT ACT C 139 coo 13.24 15.55 12.21 14.75 15.10 10.80 -2.54 8.69 15.96 -4.15 7.36 16.15 coo 20.14 17.58 5.68 19.50 18.95 7.99 4.72 8.42 8.22 5.18 7.19 10.69 coo 24.06 14.49 10.58 24.24 14.15 9.79 7.28 13.06 9.10 7.06 12.23 9.16 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 6 3 # 6 B 348 HIS C 110 HIS.? 3.59 O ACT C 139s B 378 CYH C 23 CYH.? 8.42 C1 EDO C 140 B 380 GLY C 130 GLY^? 9.35 O1 EDO C 140 coo 13.24 15.55 12.21 14.75 15.10 10.80 4.54 8.83 15.35 4.90 7.96 17.23 coo 20.14 17.58 5.68 19.50 18.95 7.99 10.88 13.11 20.21 12.25 12.11 22.32 coo 24.06 14.49 10.58 24.24 14.15 9.79 13.00 13.33 13.76 13.12 13.19 14.54 1qfl_c01 source 1qfl ACETOACETYL-COA THIOLASE : 6 hits 1qfl_c01 naa= 3 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 1 3 # 1 C 348 HIS A 109 HIS.? -5.41 OXT ACT A 139s C 378 CYH A 57 CYH^? 5.51 O ACT A 139 C 380 GLY A 112 GLY^? 10.97 O ACT A 139 coo 39.92 0.27 55.80 38.80 1.56 57.03 -8.77 57.48 -2.79 -8.58 59.56 -2.89 coo 38.90 7.44 62.34 40.19 7.59 59.85 -4.80 51.41 4.83 -3.45 51.64 2.37 coo 34.29 9.51 57.55 33.93 9.43 58.29 -7.56 46.85 3.93 -6.95 47.44 3.87 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 2 3 # 2 C 348 HIS A 110 HIS.? -3.69 OXT ACT A 139s C 378 CYH A 23 CYH.? -5.05 CL CL A 141s C 380 GLY A 130 GLY^? -4.84 CL CL A 141s coo 39.92 0.27 55.80 38.80 1.56 57.03 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 38.90 7.44 62.34 40.19 7.59 59.85 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 34.29 9.51 57.55 33.93 9.43 58.29 -4.89 41.74 -0.85 -4.61 41.77 -1.61 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 3 3 # 3 C 348 HIS B 109 HIS.? -5.47 O ACT B 139s C 378 CYH B 57 CYH^? 5.44 OXT ACT B 139 C 380 GLY B 112 GLY^? 10.91 OXT ACT B 139 coo 39.92 0.27 55.80 38.80 1.56 57.03 -54.00 38.48 15.75 -55.77 37.34 15.88 coo 38.90 7.44 62.34 40.19 7.59 59.85 -46.68 38.10 8.15 -46.29 36.73 10.60 coo 34.29 9.51 57.55 33.93 9.43 58.29 -44.06 42.66 9.14 -44.28 41.84 9.20 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 4 3 # 4 C 348 HIS B 110 HIS.? -3.67 O ACT B 139s C 378 CYH B 23 CYH.? -4.94 CL CL B 140s C 380 GLY B 130 GLY^? -4.77 CL CL B 140s coo 39.92 0.27 55.80 38.80 1.56 57.03 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 38.90 7.44 62.34 40.19 7.59 59.85 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 34.29 9.51 57.55 33.93 9.43 58.29 -38.21 42.69 13.79 -38.12 42.42 14.57 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 5 3 # 5 C 348 HIS C 109 HIS.? -5.44 O ACT C 139s C 378 CYH C 57 CYH^? 5.55 OXT ACT C 139 C 380 GLY C 112 GLY^? 11.00 OXT ACT C 139 coo 39.92 0.27 55.80 38.80 1.56 57.03 -2.54 8.69 15.96 -4.15 7.36 16.15 coo 38.90 7.44 62.34 40.19 7.59 59.85 4.72 8.42 8.22 5.18 7.19 10.69 coo 34.29 9.51 57.55 33.93 9.43 58.29 7.28 13.06 9.10 7.06 12.23 9.16 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 6 3 # 6 C 348 HIS C 110 HIS.? 3.59 O ACT C 139s C 378 CYH C 23 CYH.? 8.42 C1 EDO C 140 C 380 GLY C 130 GLY^? 9.35 O1 EDO C 140 coo 39.92 0.27 55.80 38.80 1.56 57.03 4.54 8.83 15.35 4.90 7.96 17.23 coo 38.90 7.44 62.34 40.19 7.59 59.85 10.88 13.11 20.21 12.25 12.11 22.32 coo 34.29 9.51 57.55 33.93 9.43 58.29 13.00 13.33 13.76 13.12 13.19 14.54 1qfl_c02 source 1qfl ACETOACETYL-COA THIOLASE : 6 hits 1qfl_c02 naa= 3 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 1 3 # 1 D 348 HIS A 109 HIS.? -5.41 OXT ACT A 139s D 378 CYH A 57 CYH^? 5.51 O ACT A 139 D 380 GLY A 112 GLY^? 10.97 O ACT A 139 coo 4.85 0.61 57.13 5.96 -0.63 58.38 -8.77 57.48 -2.79 -8.58 59.56 -2.89 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 -4.80 51.41 4.83 -3.45 51.64 2.37 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 -7.56 46.85 3.93 -6.95 47.44 3.87 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 2 3 # 2 D 348 HIS A 110 HIS.? -3.69 OXT ACT A 139s D 378 CYH A 23 CYH.? -5.05 CL CL A 141s D 380 GLY A 130 GLY^? -4.84 CL CL A 141s coo 4.85 0.61 57.13 5.96 -0.63 58.38 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 -4.89 41.74 -0.85 -4.61 41.77 -1.61 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 3 3 # 3 D 348 HIS B 109 HIS.? -5.47 O ACT B 139s D 378 CYH B 57 CYH^? 5.44 OXT ACT B 139 D 380 GLY B 112 GLY^? 10.91 OXT ACT B 139 coo 4.85 0.61 57.13 5.96 -0.63 58.38 -54.00 38.48 15.75 -55.77 37.34 15.88 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 -46.68 38.10 8.15 -46.29 36.73 10.60 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 -44.06 42.66 9.14 -44.28 41.84 9.20 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 4 3 # 4 D 348 HIS B 110 HIS.? -3.67 O ACT B 139s D 378 CYH B 23 CYH.? -4.94 CL CL B 140s D 380 GLY B 130 GLY^? -4.77 CL CL B 140s coo 4.85 0.61 57.13 5.96 -0.63 58.38 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 -38.21 42.69 13.79 -38.12 42.42 14.57 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 5 3 # 5 D 348 HIS C 109 HIS.? -5.44 O ACT C 139s D 378 CYH C 57 CYH^? 5.55 OXT ACT C 139 D 380 GLY C 112 GLY^? 11.00 OXT ACT C 139 coo 4.85 0.61 57.13 5.96 -0.63 58.38 -2.54 8.69 15.96 -4.15 7.36 16.15 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 4.72 8.42 8.22 5.18 7.19 10.69 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 7.28 13.06 9.10 7.06 12.23 9.16 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 6 3 # 6 D 348 HIS C 110 HIS.? 3.59 O ACT C 139s D 378 CYH C 23 CYH.? 8.42 C1 EDO C 140 D 380 GLY C 130 GLY^? 9.35 O1 EDO C 140 coo 4.85 0.61 57.13 5.96 -0.63 58.38 4.54 8.83 15.35 4.90 7.96 17.23 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 10.88 13.11 20.21 12.25 12.11 22.32 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 13.00 13.33 13.76 13.12 13.19 14.54 1qfl_c03 source 1qfl ACETOACETYL-COA THIOLASE : 6 hits 1qfl_c03 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 39 ARG~? 11.53 C4 PG4 A 142 C 163 TYR B 121 TYR.? 12.07 O3 PG4 A 142 C 236 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo 39.01 29.77 22.02 37.48 31.30 19.84 -9.34 34.41 10.95 -12.33 34.37 11.59 coo 39.51 34.34 13.63 37.63 32.61 14.79 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 45.78 31.11 9.51 44.25 30.06 10.53 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG C 39 ARG~? 23.08 O1 EDO C 141 C 163 TYR A 121 TYR.? -24.35 CL CL A 141s C 236 ASP A 50 ASP.? 20.38 CL CL A 141 coo 39.01 29.77 22.02 37.48 31.30 19.84 17.00 20.76 1.74 15.55 23.42 1.18 coo 39.51 34.34 13.63 37.63 32.61 14.79 16.31 29.26 0.34 18.85 29.40 1.41 coo 45.78 31.11 9.51 44.25 30.06 10.53 11.71 33.66 5.09 12.68 31.93 4.37 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 39 ARG~? 11.53 C4 PG4 A 142 D 163 TYR B 121 TYR.? 12.07 O3 PG4 A 142 D 236 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -9.34 34.41 10.95 -12.33 34.37 11.59 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG C 39 ARG~? 23.08 O1 EDO C 141 D 163 TYR A 121 TYR.? -24.35 CL CL A 141s D 236 ASP A 50 ASP.? 20.38 CL CL A 141 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 17.00 20.76 1.74 15.55 23.42 1.18 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 16.31 29.26 0.34 18.85 29.40 1.41 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 11.71 33.66 5.09 12.68 31.93 4.37 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 121 TYR.? -24.35 CL CL A 141s A 236 ASP A 50 ASP.? 20.38 CL CL A 141 C 110 ARG C 39 ARG~? 23.08 O1 EDO C 141 coo 55.48 26.51 40.65 55.39 23.99 39.43 16.31 29.26 0.34 18.85 29.40 1.41 coo 48.87 29.19 44.63 49.10 27.34 43.63 11.71 33.66 5.09 12.68 31.93 4.37 coo 52.39 23.42 32.10 54.51 23.27 34.29 17.00 20.76 1.74 15.55 23.42 1.18 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 121 TYR.? 12.07 O3 PG4 A 142 A 236 ASP B 50 ASP.? 10.53 C3 PG4 A 142 C 110 ARG A 39 ARG~? 11.53 C4 PG4 A 142 coo 55.48 26.51 40.65 55.39 23.99 39.43 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 48.87 29.19 44.63 49.10 27.34 43.63 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 52.39 23.42 32.10 54.51 23.27 34.29 -9.34 34.41 10.95 -12.33 34.37 11.59 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 121 TYR.? -24.35 CL CL A 141s B 236 ASP A 50 ASP.? 20.38 CL CL A 141 D 110 ARG C 39 ARG~? 23.08 O1 EDO C 141 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 16.31 29.26 0.34 18.85 29.40 1.41 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 11.71 33.66 5.09 12.68 31.93 4.37 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 17.00 20.76 1.74 15.55 23.42 1.18 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 121 TYR.? 12.07 O3 PG4 A 142 B 236 ASP B 50 ASP.? 10.53 C3 PG4 A 142 D 110 ARG A 39 ARG~? 11.53 C4 PG4 A 142 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -9.34 34.41 10.95 -12.33 34.37 11.59 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 39 ARG~? 11.53 C4 PG4 A 142 G 163 TYR B 121 TYR.? 12.07 O3 PG4 A 142 G 236 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -9.34 34.41 10.95 -12.33 34.37 11.59 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG C 39 ARG~? 23.08 O1 EDO C 141 G 163 TYR A 121 TYR.? -24.35 CL CL A 141s G 236 ASP A 50 ASP.? 20.38 CL CL A 141 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 17.00 20.76 1.74 15.55 23.42 1.18 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 16.31 29.26 0.34 18.85 29.40 1.41 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 11.71 33.66 5.09 12.68 31.93 4.37 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 39 ARG~? 11.53 C4 PG4 A 142 H 163 TYR B 121 TYR.? 12.07 O3 PG4 A 142 H 236 ASP B 50 ASP.? 10.53 C3 PG4 A 142 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -9.34 34.41 10.95 -12.33 34.37 11.59 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -23.12 32.36 7.43 -21.08 32.27 8.01 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG C 39 ARG~? 23.08 O1 EDO C 141 H 163 TYR A 121 TYR.? -24.35 CL CL A 141s H 236 ASP A 50 ASP.? 20.38 CL CL A 141 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 17.00 20.76 1.74 15.55 23.42 1.18 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 16.31 29.26 0.34 18.85 29.40 1.41 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 11.71 33.66 5.09 12.68 31.93 4.37 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 121 TYR.? -24.35 CL CL A 141s E 236 ASP A 50 ASP.? 20.38 CL CL A 141 G 110 ARG C 39 ARG~? 23.08 O1 EDO C 141 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 16.31 29.26 0.34 18.85 29.40 1.41 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 11.71 33.66 5.09 12.68 31.93 4.37 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 17.00 20.76 1.74 15.55 23.42 1.18 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 121 TYR.? 12.07 O3 PG4 A 142 E 236 ASP B 50 ASP.? 10.53 C3 PG4 A 142 G 110 ARG A 39 ARG~? 11.53 C4 PG4 A 142 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -9.34 34.41 10.95 -12.33 34.37 11.59 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 121 TYR.? -24.35 CL CL A 141s F 236 ASP A 50 ASP.? 20.38 CL CL A 141 H 110 ARG C 39 ARG~? 23.08 O1 EDO C 141 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 16.31 29.26 0.34 18.85 29.40 1.41 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 11.71 33.66 5.09 12.68 31.93 4.37 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 17.00 20.76 1.74 15.55 23.42 1.18 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 121 TYR.? 12.07 O3 PG4 A 142 F 236 ASP B 50 ASP.? 10.53 C3 PG4 A 142 H 110 ARG A 39 ARG~? 11.53 C4 PG4 A 142 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -9.34 34.41 10.95 -12.33 34.37 11.59 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 62 ASP~? -3.38 O ACT A 140s A 147 THR A 60 THR~? -4.25 O ACT A 140s A 294 ASP A 104 ASP^? 12.12 O ACT A 139 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -9.14 53.57 16.41 -8.61 54.95 17.94 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -8.81 56.04 11.16 -10.72 55.57 12.06 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 2.26 57.49 7.12 4.30 57.24 7.17 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP A 62 ASP~? -3.38 O ACT A 140s A 147 THR A 60 THR~? -4.25 O ACT A 140s A 294 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -9.14 53.57 16.41 -8.61 54.95 17.94 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -8.81 56.04 11.16 -10.72 55.57 12.06 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 3 3 # 3 A 49 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 147 THR B 11 THR~? 14.82 C3 PG4 B 142 A 294 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -22.01 47.86 13.55 -21.15 45.90 13.39 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 4 3 # 4 A 49 ASP B 62 ASP~? 20.96 OXT ACT B 139 A 147 THR B 60 THR~? 16.44 OXT ACT B 139 A 294 ASP B 104 ASP^? 11.90 OXT ACT B 139 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -50.88 40.70 -3.44 -51.62 39.45 -5.01 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -52.83 39.39 1.93 -53.45 41.24 0.91 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -48.63 28.94 5.87 -47.34 27.30 5.89 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 5 3 # 5 A 49 ASP B 62 ASP~? 20.96 OXT ACT B 139 A 147 THR B 60 THR~? 16.44 OXT ACT B 139 A 294 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -50.88 40.70 -3.44 -51.62 39.45 -5.01 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -52.83 39.39 1.93 -53.45 41.24 0.91 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 6 3 # 6 A 49 ASP C 62 ASP~? -3.30 O1 EDO C 141s A 147 THR C 60 THR~? -3.93 O1 EDO C 141s A 294 ASP C 104 ASP^? 12.14 OXT ACT C 139 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 0.59 10.79 -3.25 -0.22 9.73 -4.86 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -1.35 9.41 1.95 -1.92 11.26 0.92 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 3.02 -0.89 6.06 4.36 -2.50 5.95 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 7 3 # 7 A 49 ASP C 62 ASP~? -3.30 O1 EDO C 141s A 147 THR C 60 THR~? -3.93 O1 EDO C 141s A 294 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 0.59 10.79 -3.25 -0.22 9.73 -4.86 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -1.35 9.41 1.95 -1.92 11.26 0.92 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 7.61 19.22 2.17 7.62 20.80 3.62 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 7 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 59 ASP.? 10.45 O ACT A 140 A 256 GLU A 63 GLU~? 7.87 O ACT A 140 A 329 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo 28.46 69.88 26.74 30.40 70.70 26.53 -11.63 55.20 7.79 -12.68 54.74 6.05 coo 30.54 71.65 32.58 31.73 72.26 30.92 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1qho_c04 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 62 ASP~? -3.38 O ACT A 140s A 256 GLU A 63 GLU~? 7.87 O ACT A 140 A 329 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo 28.46 69.88 26.74 30.40 70.70 26.53 -9.14 53.57 16.41 -8.61 54.95 17.94 coo 30.54 71.65 32.58 31.73 72.26 30.92 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1qho_c04 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 59 ASP.? 11.98 O ACT B 139 A 256 GLU B 63 GLU~? 16.01 OXT ACT B 139 A 329 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo 28.46 69.88 26.74 30.40 70.70 26.53 -53.34 42.20 5.44 -53.68 42.89 7.35 coo 30.54 71.65 32.58 31.73 72.26 30.92 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 37.87 70.12 31.80 36.61 69.74 30.15 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1qho_c04 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 62 ASP~? 20.96 OXT ACT B 139 A 256 GLU B 63 GLU~? 16.01 OXT ACT B 139 A 329 ASP B 59 ASP.? 11.98 O ACT B 139 coo 28.46 69.88 26.74 30.40 70.70 26.53 -50.88 40.70 -3.44 -51.62 39.45 -5.01 coo 30.54 71.65 32.58 31.73 72.26 30.92 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 37.87 70.12 31.80 36.61 69.74 30.15 -53.34 42.20 5.44 -53.68 42.89 7.35 ULMN 3 1qho_c04 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 62 ASP~? 20.96 OXT ACT B 139 A 256 GLU B 63 GLU~? 16.01 OXT ACT B 139 A 329 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo 28.46 69.88 26.74 30.40 70.70 26.53 -50.88 40.70 -3.44 -51.62 39.45 -5.01 coo 30.54 71.65 32.58 31.73 72.26 30.92 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 37.87 70.12 31.80 36.61 69.74 30.15 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1qho_c04 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP C 59 ASP.? 10.26 O1 EDO C 141 A 256 GLU C 63 GLU~? 7.77 O1 EDO C 141 A 329 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 28.46 69.88 26.74 30.40 70.70 26.53 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 30.54 71.65 32.58 31.73 72.26 30.92 1.11 13.80 1.11 0.04 14.34 2.91 coo 37.87 70.12 31.80 36.61 69.74 30.15 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1qho_c04 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP C 62 ASP~? -3.30 O1 EDO C 141s A 256 GLU C 63 GLU~? 7.77 O1 EDO C 141 A 329 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 28.46 69.88 26.74 30.40 70.70 26.53 0.59 10.79 -3.25 -0.22 9.73 -4.86 coo 30.54 71.65 32.58 31.73 72.26 30.92 1.11 13.80 1.11 0.04 14.34 2.91 coo 37.87 70.12 31.80 36.61 69.74 30.15 7.61 19.22 2.17 7.62 20.80 3.62 1qho_c04 source 1qho ALPHA-AMYLASE : 7 hits 1qho_c04 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 62 ASP~? -3.38 O ACT A 140s A 261 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 329 ASP A 59 ASP.? 10.45 O ACT A 140 coo 28.46 69.88 26.74 30.40 70.70 26.53 -9.14 53.57 16.41 -8.61 54.95 17.94 coo 34.02 79.89 42.60 34.73 78.01 41.86 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 37.87 70.12 31.80 36.61 69.74 30.15 -11.63 55.20 7.79 -12.68 54.74 6.05 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 261 ASP A 104 ASP^? 12.12 O ACT A 139 A 329 ASP A 59 ASP.? 10.45 O ACT A 140 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 34.02 79.89 42.60 34.73 78.01 41.86 2.26 57.49 7.12 4.30 57.24 7.17 coo 37.87 70.12 31.80 36.61 69.74 30.15 -11.63 55.20 7.79 -12.68 54.74 6.05 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 261 ASP A 104 ASP^? 12.12 O ACT A 139 A 329 ASP A 62 ASP~? -3.38 O ACT A 140s coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 34.02 79.89 42.60 34.73 78.01 41.86 2.26 57.49 7.12 4.30 57.24 7.17 coo 37.87 70.12 31.80 36.61 69.74 30.15 -9.14 53.57 16.41 -8.61 54.95 17.94 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 135 ASP.? 12.47 O1 PG4 B 142 A 261 ASP B 104 ASP^? 11.90 OXT ACT B 139 A 329 ASP B 59 ASP.? 11.98 O ACT B 139 coo 28.46 69.88 26.74 30.40 70.70 26.53 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 34.02 79.89 42.60 34.73 78.01 41.86 -48.63 28.94 5.87 -47.34 27.30 5.89 coo 37.87 70.12 31.80 36.61 69.74 30.15 -53.34 42.20 5.44 -53.68 42.89 7.35 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 135 ASP.? 12.47 O1 PG4 B 142 A 261 ASP B 104 ASP^? 11.90 OXT ACT B 139 A 329 ASP B 62 ASP~? 20.96 OXT ACT B 139 coo 28.46 69.88 26.74 30.40 70.70 26.53 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 34.02 79.89 42.60 34.73 78.01 41.86 -48.63 28.94 5.87 -47.34 27.30 5.89 coo 37.87 70.12 31.80 36.61 69.74 30.15 -50.88 40.70 -3.44 -51.62 39.45 -5.01 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP C 62 ASP~? -3.30 O1 EDO C 141s A 261 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 329 ASP C 59 ASP.? 10.26 O1 EDO C 141 coo 28.46 69.88 26.74 30.40 70.70 26.53 0.59 10.79 -3.25 -0.22 9.73 -4.86 coo 34.02 79.89 42.60 34.73 78.01 41.86 4.46 12.53 17.74 4.84 11.35 19.48 coo 37.87 70.12 31.80 36.61 69.74 30.15 -1.96 12.33 5.23 -2.08 13.48 6.95 ULMN 3 1qho_c05 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 261 ASP C 104 ASP^? 12.14 OXT ACT C 139 A 329 ASP C 59 ASP.? 10.26 O1 EDO C 141 coo 28.46 69.88 26.74 30.40 70.70 26.53 7.61 19.22 2.17 7.62 20.80 3.62 coo 34.02 79.89 42.60 34.73 78.01 41.86 3.02 -0.89 6.06 4.36 -2.50 5.95 coo 37.87 70.12 31.80 36.61 69.74 30.15 -1.96 12.33 5.23 -2.08 13.48 6.95 ULMN 3 1qho_c05 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 261 ASP C 104 ASP^? 12.14 OXT ACT C 139 A 329 ASP C 62 ASP~? -3.30 O1 EDO C 141s coo 28.46 69.88 26.74 30.40 70.70 26.53 7.61 19.22 2.17 7.62 20.80 3.62 coo 34.02 79.89 42.60 34.73 78.01 41.86 3.02 -0.89 6.06 4.36 -2.50 5.95 coo 37.87 70.12 31.80 36.61 69.74 30.15 0.59 10.79 -3.25 -0.22 9.73 -4.86 1qho_c05 source 1qho ALPHA-AMYLASE : 8 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 59 ASP.? 10.45 O ACT A 140 A 260 ASP A 104 ASP^? 12.12 O ACT A 139 A 329 ASP A 62 ASP~? -3.38 O ACT A 140s coo 28.46 69.88 26.74 30.40 70.70 26.53 -11.63 55.20 7.79 -12.68 54.74 6.05 coo 30.73 81.29 37.61 31.23 82.07 35.69 2.26 57.49 7.12 4.30 57.24 7.17 coo 37.87 70.12 31.80 36.61 69.74 30.15 -9.14 53.57 16.41 -8.61 54.95 17.94 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 59 ASP.? 10.45 O ACT A 140 A 260 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 329 ASP A 62 ASP~? -3.38 O ACT A 140s coo 28.46 69.88 26.74 30.40 70.70 26.53 -11.63 55.20 7.79 -12.68 54.74 6.05 coo 30.73 81.29 37.61 31.23 82.07 35.69 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 37.87 70.12 31.80 36.61 69.74 30.15 -9.14 53.57 16.41 -8.61 54.95 17.94 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 59 ASP.? 10.45 O ACT A 140 A 260 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 329 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo 28.46 69.88 26.74 30.40 70.70 26.53 -11.63 55.20 7.79 -12.68 54.74 6.05 coo 30.73 81.29 37.61 31.23 82.07 35.69 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 62 ASP~? -3.38 O ACT A 140s A 260 ASP A 104 ASP^? 12.12 O ACT A 139 A 329 ASP A 59 ASP.? 10.45 O ACT A 140 coo 28.46 69.88 26.74 30.40 70.70 26.53 -9.14 53.57 16.41 -8.61 54.95 17.94 coo 30.73 81.29 37.61 31.23 82.07 35.69 2.26 57.49 7.12 4.30 57.24 7.17 coo 37.87 70.12 31.80 36.61 69.74 30.15 -11.63 55.20 7.79 -12.68 54.74 6.05 ULMN 3 1qho_c07 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP A 62 ASP~? -3.38 O ACT A 140s A 260 ASP A 104 ASP^? 12.12 O ACT A 139 A 329 ASP A 82 ASP.? 11.04 CH3 ACT A 140 coo 28.46 69.88 26.74 30.40 70.70 26.53 -9.14 53.57 16.41 -8.61 54.95 17.94 coo 30.73 81.29 37.61 31.23 82.07 35.69 2.26 57.49 7.12 4.30 57.24 7.17 coo 37.87 70.12 31.80 36.61 69.74 30.15 2.17 52.89 21.94 0.47 52.34 23.07 ULMN 3 1qho_c07 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP A 62 ASP~? -3.38 O ACT A 140s A 260 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 329 ASP A 59 ASP.? 10.45 O ACT A 140 coo 28.46 69.88 26.74 30.40 70.70 26.53 -9.14 53.57 16.41 -8.61 54.95 17.94 coo 30.73 81.29 37.61 31.23 82.07 35.69 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 37.87 70.12 31.80 36.61 69.74 30.15 -11.63 55.20 7.79 -12.68 54.74 6.05 ULMN 3 1qho_c07 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP A 62 ASP~? -3.38 O ACT A 140s A 260 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 329 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo 28.46 69.88 26.74 30.40 70.70 26.53 -9.14 53.57 16.41 -8.61 54.95 17.94 coo 30.73 81.29 37.61 31.23 82.07 35.69 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1qho_c07 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP A 82 ASP.? 11.04 CH3 ACT A 140 A 260 ASP A 104 ASP^? 12.12 O ACT A 139 A 329 ASP A 62 ASP~? -3.38 O ACT A 140s coo 28.46 69.88 26.74 30.40 70.70 26.53 2.17 52.89 21.94 0.47 52.34 23.07 coo 30.73 81.29 37.61 31.23 82.07 35.69 2.26 57.49 7.12 4.30 57.24 7.17 coo 37.87 70.12 31.80 36.61 69.74 30.15 -9.14 53.57 16.41 -8.61 54.95 17.94 ULMN 3 1qho_c07 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 260 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 329 ASP A 59 ASP.? 10.45 O ACT A 140 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 30.73 81.29 37.61 31.23 82.07 35.69 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 37.87 70.12 31.80 36.61 69.74 30.15 -11.63 55.20 7.79 -12.68 54.74 6.05 ULMN 3 1qho_c07 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 260 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 329 ASP A 59 ASP.? 10.45 O ACT A 140 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 30.73 81.29 37.61 31.23 82.07 35.69 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 37.87 70.12 31.80 36.61 69.74 30.15 -11.63 55.20 7.79 -12.68 54.74 6.05 ULMN 3 1qho_c07 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 260 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 329 ASP A 62 ASP~? -3.38 O ACT A 140s coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 30.73 81.29 37.61 31.23 82.07 35.69 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 37.87 70.12 31.80 36.61 69.74 30.15 -9.14 53.57 16.41 -8.61 54.95 17.94 ULMN 3 1qho_c07 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP B 59 ASP.? 11.98 O ACT B 139 A 260 ASP B 104 ASP^? 11.90 OXT ACT B 139 A 329 ASP B 62 ASP~? 20.96 OXT ACT B 139 coo 28.46 69.88 26.74 30.40 70.70 26.53 -53.34 42.20 5.44 -53.68 42.89 7.35 coo 30.73 81.29 37.61 31.23 82.07 35.69 -48.63 28.94 5.87 -47.34 27.30 5.89 coo 37.87 70.12 31.80 36.61 69.74 30.15 -50.88 40.70 -3.44 -51.62 39.45 -5.01 ULMN 3 1qho_c07 ALPHA-AMYLASE user 13 3 # 13 A 228 ASP B 62 ASP~? 20.96 OXT ACT B 139 A 260 ASP B 104 ASP^? 11.90 OXT ACT B 139 A 329 ASP B 59 ASP.? 11.98 O ACT B 139 coo 28.46 69.88 26.74 30.40 70.70 26.53 -50.88 40.70 -3.44 -51.62 39.45 -5.01 coo 30.73 81.29 37.61 31.23 82.07 35.69 -48.63 28.94 5.87 -47.34 27.30 5.89 coo 37.87 70.12 31.80 36.61 69.74 30.15 -53.34 42.20 5.44 -53.68 42.89 7.35 ULMN 3 1qho_c07 ALPHA-AMYLASE user 14 3 # 14 A 228 ASP B 135 ASP.? 12.47 O1 PG4 B 142 A 260 ASP B 25 ASP.? 6.52 O ACT B 139 A 329 ASP B 59 ASP.? 11.98 O ACT B 139 coo 28.46 69.88 26.74 30.40 70.70 26.53 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 30.73 81.29 37.61 31.23 82.07 35.69 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 37.87 70.12 31.80 36.61 69.74 30.15 -53.34 42.20 5.44 -53.68 42.89 7.35 ULMN 3 1qho_c07 ALPHA-AMYLASE user 15 3 # 15 A 228 ASP C 59 ASP.? 10.26 O1 EDO C 141 A 260 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 329 ASP C 62 ASP~? -3.30 O1 EDO C 141s coo 28.46 69.88 26.74 30.40 70.70 26.53 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 30.73 81.29 37.61 31.23 82.07 35.69 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 37.87 70.12 31.80 36.61 69.74 30.15 0.59 10.79 -3.25 -0.22 9.73 -4.86 ULMN 3 1qho_c07 ALPHA-AMYLASE user 16 3 # 16 A 228 ASP C 59 ASP.? 10.26 O1 EDO C 141 A 260 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 329 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 28.46 69.88 26.74 30.40 70.70 26.53 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 30.73 81.29 37.61 31.23 82.07 35.69 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 37.87 70.12 31.80 36.61 69.74 30.15 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1qho_c07 ALPHA-AMYLASE user 17 3 # 17 A 228 ASP C 59 ASP.? 10.26 O1 EDO C 141 A 260 ASP C 104 ASP^? 12.14 OXT ACT C 139 A 329 ASP C 62 ASP~? -3.30 O1 EDO C 141s coo 28.46 69.88 26.74 30.40 70.70 26.53 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 30.73 81.29 37.61 31.23 82.07 35.69 3.02 -0.89 6.06 4.36 -2.50 5.95 coo 37.87 70.12 31.80 36.61 69.74 30.15 0.59 10.79 -3.25 -0.22 9.73 -4.86 ULMN 3 1qho_c07 ALPHA-AMYLASE user 18 3 # 18 A 228 ASP C 62 ASP~? -3.30 O1 EDO C 141s A 260 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 329 ASP C 59 ASP.? 10.26 O1 EDO C 141 coo 28.46 69.88 26.74 30.40 70.70 26.53 0.59 10.79 -3.25 -0.22 9.73 -4.86 coo 30.73 81.29 37.61 31.23 82.07 35.69 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 37.87 70.12 31.80 36.61 69.74 30.15 -1.96 12.33 5.23 -2.08 13.48 6.95 ULMN 3 1qho_c07 ALPHA-AMYLASE user 19 3 # 19 A 228 ASP C 62 ASP~? -3.30 O1 EDO C 141s A 260 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 329 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 28.46 69.88 26.74 30.40 70.70 26.53 0.59 10.79 -3.25 -0.22 9.73 -4.86 coo 30.73 81.29 37.61 31.23 82.07 35.69 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 37.87 70.12 31.80 36.61 69.74 30.15 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1qho_c07 ALPHA-AMYLASE user 20 3 # 20 A 228 ASP C 62 ASP~? -3.30 O1 EDO C 141s A 260 ASP C 104 ASP^? 12.14 OXT ACT C 139 A 329 ASP C 59 ASP.? 10.26 O1 EDO C 141 coo 28.46 69.88 26.74 30.40 70.70 26.53 0.59 10.79 -3.25 -0.22 9.73 -4.86 coo 30.73 81.29 37.61 31.23 82.07 35.69 3.02 -0.89 6.06 4.36 -2.50 5.95 coo 37.87 70.12 31.80 36.61 69.74 30.15 -1.96 12.33 5.23 -2.08 13.48 6.95 ULMN 3 1qho_c07 ALPHA-AMYLASE user 21 3 # 21 A 228 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 260 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 329 ASP C 59 ASP.? 10.26 O1 EDO C 141 coo 28.46 69.88 26.74 30.40 70.70 26.53 7.61 19.22 2.17 7.62 20.80 3.62 coo 30.73 81.29 37.61 31.23 82.07 35.69 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 37.87 70.12 31.80 36.61 69.74 30.15 -1.96 12.33 5.23 -2.08 13.48 6.95 ULMN 3 1qho_c07 ALPHA-AMYLASE user 22 3 # 22 A 228 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 260 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 329 ASP C 62 ASP~? -3.30 O1 EDO C 141s coo 28.46 69.88 26.74 30.40 70.70 26.53 7.61 19.22 2.17 7.62 20.80 3.62 coo 30.73 81.29 37.61 31.23 82.07 35.69 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 37.87 70.12 31.80 36.61 69.74 30.15 0.59 10.79 -3.25 -0.22 9.73 -4.86 ULMN 3 1qho_c07 ALPHA-AMYLASE user 23 3 # 23 A 228 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 260 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 329 ASP C 59 ASP.? 10.26 O1 EDO C 141 coo 28.46 69.88 26.74 30.40 70.70 26.53 7.61 19.22 2.17 7.62 20.80 3.62 coo 30.73 81.29 37.61 31.23 82.07 35.69 4.46 12.53 17.74 4.84 11.35 19.48 coo 37.87 70.12 31.80 36.61 69.74 30.15 -1.96 12.33 5.23 -2.08 13.48 6.95 1qho_c07 source 1qho ALPHA-AMYLASE : 23 hits 1qho_c07 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA A 27 ALA.? 10.44 O2 PG4 A 142 A 148 HIS A 131 HIS^? 7.42 CL CL A 141 A 163 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 1.42 19.18 21.84 1.11 19.57 23.28 -11.26 44.90 0.82 -10.52 44.54 2.10 coo 0.71 19.67 27.92 2.43 19.16 26.83 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 7.15 16.22 27.50 6.15 18.00 27.94 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 A 51 ALA B 27 ALA.? 10.43 O1 PG4 B 142 A 148 HIS B 131 HIS^? 7.27 CL CL B 140 A 163 ASP B 25 ASP.? 6.52 O ACT B 139 coo 1.42 19.18 21.84 1.11 19.57 23.28 -44.16 46.71 12.37 -43.44 46.31 11.09 coo 0.71 19.67 27.92 2.43 19.16 26.83 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 7.15 16.22 27.50 6.15 18.00 27.94 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 A 51 ALA C 27 ALA.? 12.87 C1 EDO C 140 A 148 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 163 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 1.42 19.18 21.84 1.11 19.57 23.28 7.09 17.23 12.10 7.71 16.76 10.77 coo 0.71 19.67 27.92 2.43 19.16 26.83 8.46 11.73 13.23 7.93 9.80 13.86 coo 7.15 16.22 27.50 6.15 18.00 27.94 4.46 12.53 17.74 4.84 11.35 19.48 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA A 27 ALA.? 10.44 O2 PG4 A 142 B 148 HIS A 131 HIS^? 7.42 CL CL A 141 B 163 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -11.26 44.90 0.82 -10.52 44.54 2.10 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 B 51 ALA B 27 ALA.? 10.43 O1 PG4 B 142 B 148 HIS B 131 HIS^? 7.27 CL CL B 140 B 163 ASP B 25 ASP.? 6.52 O ACT B 139 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -44.16 46.71 12.37 -43.44 46.31 11.09 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -42.92 41.25 13.23 -43.42 39.34 13.91 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 B 51 ALA C 27 ALA.? 12.87 C1 EDO C 140 B 148 HIS C 131 HIS^? 6.39 C1 EDO C 140 B 163 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo -33.97 19.78 54.18 -33.40 20.11 52.82 7.09 17.23 12.10 7.71 16.76 10.77 coo -33.17 20.01 48.16 -34.95 19.37 49.06 8.46 11.73 13.23 7.93 9.80 13.86 coo -39.82 16.62 48.85 -38.59 18.24 48.48 4.46 12.53 17.74 4.84 11.35 19.48 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA A 27 ALA.? 10.44 O2 PG4 A 142 C 148 HIS A 131 HIS^? 7.42 CL CL A 141 C 163 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -11.26 44.90 0.82 -10.52 44.54 2.10 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 C 51 ALA B 27 ALA.? 10.43 O1 PG4 B 142 C 148 HIS B 131 HIS^? 7.27 CL CL B 140 C 163 ASP B 25 ASP.? 6.52 O ACT B 139 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -44.16 46.71 12.37 -43.44 46.31 11.09 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -42.92 41.25 13.23 -43.42 39.34 13.91 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 C 51 ALA C 27 ALA.? 12.87 C1 EDO C 140 C 148 HIS C 131 HIS^? 6.39 C1 EDO C 140 C 163 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 7.09 17.23 12.10 7.71 16.76 10.77 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 8.46 11.73 13.23 7.93 9.80 13.86 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 4.46 12.53 17.74 4.84 11.35 19.48 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA A 27 ALA.? 10.44 O2 PG4 A 142 D 148 HIS A 131 HIS^? 7.42 CL CL A 141 D 163 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -11.26 44.90 0.82 -10.52 44.54 2.10 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 D 51 ALA B 27 ALA.? 10.43 O1 PG4 B 142 D 148 HIS B 131 HIS^? 7.27 CL CL B 140 D 163 ASP B 25 ASP.? 6.52 O ACT B 139 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -44.16 46.71 12.37 -43.44 46.31 11.09 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -42.92 41.25 13.23 -43.42 39.34 13.91 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 D 51 ALA C 27 ALA.? 12.87 C1 EDO C 140 D 148 HIS C 131 HIS^? 6.39 C1 EDO C 140 D 163 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 7.09 17.23 12.10 7.71 16.76 10.77 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 8.46 11.73 13.23 7.93 9.80 13.86 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 4.46 12.53 17.74 4.84 11.35 19.48 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c03 naa= 3 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 E 51 ALA A 27 ALA.? 10.44 O2 PG4 A 142 E 148 HIS A 131 HIS^? 7.42 CL CL A 141 E 163 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -11.26 44.90 0.82 -10.52 44.54 2.10 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 E 51 ALA B 27 ALA.? 10.43 O1 PG4 B 142 E 148 HIS B 131 HIS^? 7.27 CL CL B 140 E 163 ASP B 25 ASP.? 6.52 O ACT B 139 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -44.16 46.71 12.37 -43.44 46.31 11.09 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 E 51 ALA C 27 ALA.? 12.87 C1 EDO C 140 E 148 HIS C 131 HIS^? 6.39 C1 EDO C 140 E 163 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 7.09 17.23 12.10 7.71 16.76 10.77 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 8.46 11.73 13.23 7.93 9.80 13.86 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 4.46 12.53 17.74 4.84 11.35 19.48 1qol_c04 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c04 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA A 27 ALA.? 10.44 O2 PG4 A 142 F 148 HIS A 131 HIS^? 7.42 CL CL A 141 F 163 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -11.26 44.90 0.82 -10.52 44.54 2.10 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 F 51 ALA B 27 ALA.? 10.43 O1 PG4 B 142 F 148 HIS B 131 HIS^? 7.27 CL CL B 140 F 163 ASP B 25 ASP.? 6.52 O ACT B 139 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -44.16 46.71 12.37 -43.44 46.31 11.09 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 F 51 ALA C 27 ALA.? 12.87 C1 EDO C 140 F 148 HIS C 131 HIS^? 6.39 C1 EDO C 140 F 163 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 7.09 17.23 12.10 7.71 16.76 10.77 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 8.46 11.73 13.23 7.93 9.80 13.86 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 4.46 12.53 17.74 4.84 11.35 19.48 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c05 naa= 3 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 G 51 ALA A 27 ALA.? 10.44 O2 PG4 A 142 G 148 HIS A 131 HIS^? 7.42 CL CL A 141 G 163 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -11.26 44.90 0.82 -10.52 44.54 2.10 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 G 51 ALA B 27 ALA.? 10.43 O1 PG4 B 142 G 148 HIS B 131 HIS^? 7.27 CL CL B 140 G 163 ASP B 25 ASP.? 6.52 O ACT B 139 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -44.16 46.71 12.37 -43.44 46.31 11.09 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -42.92 41.25 13.23 -43.42 39.34 13.91 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 G 51 ALA C 27 ALA.? 12.87 C1 EDO C 140 G 148 HIS C 131 HIS^? 6.39 C1 EDO C 140 G 163 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 7.09 17.23 12.10 7.71 16.76 10.77 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 8.46 11.73 13.23 7.93 9.80 13.86 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 4.46 12.53 17.74 4.84 11.35 19.48 1qol_c06 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c06 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA A 27 ALA.? 10.44 O2 PG4 A 142 H 148 HIS A 131 HIS^? 7.42 CL CL A 141 H 163 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -11.26 44.90 0.82 -10.52 44.54 2.10 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 H 51 ALA B 27 ALA.? 10.43 O1 PG4 B 142 H 148 HIS B 131 HIS^? 7.27 CL CL B 140 H 163 ASP B 25 ASP.? 6.52 O ACT B 139 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -44.16 46.71 12.37 -43.44 46.31 11.09 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -42.92 41.25 13.23 -43.42 39.34 13.91 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 H 51 ALA C 27 ALA.? 12.87 C1 EDO C 140 H 148 HIS C 131 HIS^? 6.39 C1 EDO C 140 H 163 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 7.09 17.23 12.10 7.71 16.76 10.77 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 8.46 11.73 13.23 7.93 9.80 13.86 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 4.46 12.53 17.74 4.84 11.35 19.48 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c07 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS A 109 HIS.? -5.41 OXT ACT A 139s A 646 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 739 GLY A 88 GLY.? 6.36 OXT ACT A 140 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -8.77 57.48 -2.79 -8.58 59.56 -2.89 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -7.82 61.10 9.16 -7.39 60.58 9.65 ULMN 3 1qrz_c20 PLASMINOGEN user 2 3 # 2 A 603 HIS B 109 HIS.? -5.47 O ACT B 139s A 646 ASP B 25 ASP.? 6.52 O ACT B 139 A 739 GLY B 88 GLY.? 14.05 OXT ACT B 139 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -54.00 38.48 15.75 -55.77 37.34 15.88 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -56.66 36.05 3.82 -56.03 35.91 3.31 ULMN 3 1qrz_c20 PLASMINOGEN user 3 3 # 3 A 603 HIS C 109 HIS.? -5.44 O ACT C 139s A 646 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 739 GLY C 88 GLY.? -5.77 O2 EDO C 141s coo -20.72 2.99 34.37 -21.94 1.82 35.61 -2.54 8.69 15.96 -4.15 7.36 16.15 coo -18.83 7.68 26.86 -20.89 7.78 26.56 4.46 12.53 17.74 4.84 11.35 19.48 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -5.16 6.02 3.89 -4.51 5.85 3.40 1qrz_c20 source 1qrz PLASMINOGEN : 3 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS A 109 HIS.? -5.41 OXT ACT A 139s B 646 ASP A 25 ASP.? 6.66 OXT ACT A 139 B 739 GLY A 88 GLY.? 6.36 OXT ACT A 140 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -8.77 57.48 -2.79 -8.58 59.56 -2.89 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -7.82 61.10 9.16 -7.39 60.58 9.65 ULMN 3 1qrz_c21 PLASMINOGEN user 2 3 # 2 B 603 HIS B 109 HIS.? -5.47 O ACT B 139s B 646 ASP B 25 ASP.? 6.52 O ACT B 139 B 739 GLY B 88 GLY.? 14.05 OXT ACT B 139 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -54.00 38.48 15.75 -55.77 37.34 15.88 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -56.66 36.05 3.82 -56.03 35.91 3.31 ULMN 3 1qrz_c21 PLASMINOGEN user 3 3 # 3 B 603 HIS C 109 HIS.? -5.44 O ACT C 139s B 646 ASP C 25 ASP.? 6.36 O2 EDO C 140 B 739 GLY C 88 GLY.? -5.77 O2 EDO C 141s coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -2.54 8.69 15.96 -4.15 7.36 16.15 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 4.46 12.53 17.74 4.84 11.35 19.48 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -5.16 6.02 3.89 -4.51 5.85 3.40 1qrz_c21 source 1qrz PLASMINOGEN : 3 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS A 109 HIS.? -5.41 OXT ACT A 139s C 646 ASP A 25 ASP.? 6.66 OXT ACT A 139 C 739 GLY A 88 GLY.? 6.36 OXT ACT A 140 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -8.77 57.48 -2.79 -8.58 59.56 -2.89 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 7.82 1.25 3.03 7.30 1.31 3.65 -7.82 61.10 9.16 -7.39 60.58 9.65 ULMN 3 1qrz_c22 PLASMINOGEN user 2 3 # 2 C 603 HIS B 109 HIS.? -5.47 O ACT B 139s C 646 ASP B 25 ASP.? 6.52 O ACT B 139 C 739 GLY B 88 GLY.? 14.05 OXT ACT B 139 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -54.00 38.48 15.75 -55.77 37.34 15.88 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 7.82 1.25 3.03 7.30 1.31 3.65 -56.66 36.05 3.82 -56.03 35.91 3.31 ULMN 3 1qrz_c22 PLASMINOGEN user 3 3 # 3 C 603 HIS C 109 HIS.? -5.44 O ACT C 139s C 646 ASP C 25 ASP.? 6.36 O2 EDO C 140 C 739 GLY C 88 GLY.? -5.77 O2 EDO C 141s coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -2.54 8.69 15.96 -4.15 7.36 16.15 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 4.46 12.53 17.74 4.84 11.35 19.48 coo 7.82 1.25 3.03 7.30 1.31 3.65 -5.16 6.02 3.89 -4.51 5.85 3.40 1qrz_c22 source 1qrz PLASMINOGEN : 3 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS A 109 HIS.? -5.41 OXT ACT A 139s D 646 ASP A 25 ASP.? 6.66 OXT ACT A 139 D 739 GLY A 88 GLY.? 6.36 OXT ACT A 140 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -8.77 57.48 -2.79 -8.58 59.56 -2.89 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -7.82 61.10 9.16 -7.39 60.58 9.65 ULMN 3 1qrz_c23 PLASMINOGEN user 2 3 # 2 D 603 HIS B 109 HIS.? -5.47 O ACT B 139s D 646 ASP B 25 ASP.? 6.52 O ACT B 139 D 739 GLY B 88 GLY.? 14.05 OXT ACT B 139 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -54.00 38.48 15.75 -55.77 37.34 15.88 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -56.66 36.05 3.82 -56.03 35.91 3.31 ULMN 3 1qrz_c23 PLASMINOGEN user 3 3 # 3 D 603 HIS C 109 HIS.? -5.44 O ACT C 139s D 646 ASP C 25 ASP.? 6.36 O2 EDO C 140 D 739 GLY C 88 GLY.? -5.77 O2 EDO C 141s coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -2.54 8.69 15.96 -4.15 7.36 16.15 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 4.46 12.53 17.74 4.84 11.35 19.48 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -5.16 6.02 3.89 -4.51 5.85 3.40 1qrz_c23 source 1qrz PLASMINOGEN : 3 hits 1qrz_c23 naa= 3 ULMN 3 1qtn_c02 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 1 3 # 1 A 317 HIS A 131 HIS^? 7.42 CL CL A 141 A 318 GLY A 112 GLY^? 10.97 O ACT A 139 A 360 CYH A 57 CYH^? 5.51 O ACT A 139 coo -8.43 39.80 36.26 -8.18 39.59 38.31 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo -11.14 38.10 31.61 -11.46 38.10 32.37 -7.56 46.85 3.93 -6.95 47.44 3.87 coo -11.95 34.09 34.07 -11.89 34.73 36.80 -4.80 51.41 4.83 -3.45 51.64 2.37 ULMN 3 1qtn_c02 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 2 3 # 2 A 317 HIS B 131 HIS^? 7.27 CL CL B 140 A 318 GLY B 112 GLY^? 10.91 OXT ACT B 139 A 360 CYH B 57 CYH^? 5.44 OXT ACT B 139 coo -8.43 39.80 36.26 -8.18 39.59 38.31 -42.92 41.25 13.23 -43.42 39.34 13.91 coo -11.14 38.10 31.61 -11.46 38.10 32.37 -44.06 42.66 9.14 -44.28 41.84 9.20 coo -11.95 34.09 34.07 -11.89 34.73 36.80 -46.68 38.10 8.15 -46.29 36.73 10.60 ULMN 3 1qtn_c02 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 3 3 # 3 A 317 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 318 GLY C 112 GLY^? 11.00 OXT ACT C 139 A 360 CYH C 57 CYH^? 5.55 OXT ACT C 139 coo -8.43 39.80 36.26 -8.18 39.59 38.31 8.46 11.73 13.23 7.93 9.80 13.86 coo -11.14 38.10 31.61 -11.46 38.10 32.37 7.28 13.06 9.10 7.06 12.23 9.16 coo -11.95 34.09 34.07 -11.89 34.73 36.80 4.72 8.42 8.22 5.18 7.19 10.69 ULMN 3 1qtn_c02 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 4 3 # 4 A 317 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 318 GLY C 130 GLY^? 9.35 O1 EDO C 140 A 360 CYH C 23 CYH.? 8.42 C1 EDO C 140 coo -8.43 39.80 36.26 -8.18 39.59 38.31 8.46 11.73 13.23 7.93 9.80 13.86 coo -11.14 38.10 31.61 -11.46 38.10 32.37 13.00 13.33 13.76 13.12 13.19 14.54 coo -11.95 34.09 34.07 -11.89 34.73 36.80 10.88 13.11 20.21 12.25 12.11 22.32 1qtn_c02 source 1qtn ACETYL-ILE-GLU-THR-ASP-ALDEHYDE : 4 hits 1qtn_c02 naa= 3 ULMN 3 1qx3_c00 APOPAIN user 1 3 # 1 A 121 HIS A 131 HIS^? 7.42 CL CL A 141 A 122 GLY A 112 GLY^? 10.97 O ACT A 139 A 163 CYH A 57 CYH^? 5.51 O ACT A 139 coo 2.23 29.11 15.20 1.24 27.27 15.13 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 2.54 34.86 14.60 1.83 34.53 14.82 -7.56 46.85 3.93 -6.95 47.44 3.87 coo -1.20 35.13 11.95 -2.11 32.67 12.98 -4.80 51.41 4.83 -3.45 51.64 2.37 ULMN 3 1qx3_c00 APOPAIN user 2 3 # 2 A 121 HIS B 131 HIS^? 7.27 CL CL B 140 A 122 GLY B 112 GLY^? 10.91 OXT ACT B 139 A 163 CYH B 57 CYH^? 5.44 OXT ACT B 139 coo 2.23 29.11 15.20 1.24 27.27 15.13 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 2.54 34.86 14.60 1.83 34.53 14.82 -44.06 42.66 9.14 -44.28 41.84 9.20 coo -1.20 35.13 11.95 -2.11 32.67 12.98 -46.68 38.10 8.15 -46.29 36.73 10.60 ULMN 3 1qx3_c00 APOPAIN user 3 3 # 3 A 121 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 122 GLY C 112 GLY^? 11.00 OXT ACT C 139 A 163 CYH C 57 CYH^? 5.55 OXT ACT C 139 coo 2.23 29.11 15.20 1.24 27.27 15.13 8.46 11.73 13.23 7.93 9.80 13.86 coo 2.54 34.86 14.60 1.83 34.53 14.82 7.28 13.06 9.10 7.06 12.23 9.16 coo -1.20 35.13 11.95 -2.11 32.67 12.98 4.72 8.42 8.22 5.18 7.19 10.69 1qx3_c00 source 1qx3 APOPAIN : 3 hits 1qx3_c00 naa= 3 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 1 3 # 1 A 608 ASP B 25 ASP.? 6.52 O ACT B 139 A 610 HIS B 131 HIS^? 7.27 CL CL B 140 A 661 HIS B 109 HIS.? -5.47 O ACT B 139s coo 75.99 81.56 1.86 73.91 81.34 2.28 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 71.04 78.84 0.46 71.54 76.90 1.02 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 75.40 81.38 12.06 74.88 79.42 12.63 -54.00 38.48 15.75 -55.77 37.34 15.88 1req_c10 source 1req METHYLMALONYL-COA MUTASE : 1 hits 1req_c10 naa= 3 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 1 3 # 1 C 608 ASP B 25 ASP.? 6.52 O ACT B 139 C 610 HIS B 131 HIS^? 7.27 CL CL B 140 C 661 HIS B 109 HIS.? -5.47 O ACT B 139s coo -17.65 80.52 58.00 -16.23 80.79 56.41 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -42.92 41.25 13.23 -43.42 39.34 13.91 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -54.00 38.48 15.75 -55.77 37.34 15.88 1req_c11 source 1req METHYLMALONYL-COA MUTASE : 1 hits 1req_c11 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS A 131 HIS^? 7.42 CL CL A 141 B 84 ASP A 25 ASP.? 6.66 OXT ACT A 139 B 140 GLY A 64 GLY~? 8.05 O ACT A 140 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -5.68 50.60 11.44 -5.90 50.48 12.19 ULMN 3 1rgq_c01 NS4A PEPTIDE user 2 3 # 2 B 60 HIS B 131 HIS^? 7.27 CL CL B 140 B 84 ASP B 25 ASP.? 6.52 O ACT B 139 B 140 GLY B 64 GLY~? 14.04 CL CL B 141 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -46.53 39.33 1.61 -46.53 39.59 0.85 ULMN 3 1rgq_c01 NS4A PEPTIDE user 3 3 # 3 B 60 HIS C 131 HIS^? 6.39 C1 EDO C 140 B 84 ASP C 25 ASP.? 6.36 O2 EDO C 140 B 140 GLY C 64 GLY~? 8.12 O1 EDO C 141 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 8.46 11.73 13.23 7.93 9.80 13.86 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 4.46 12.53 17.74 4.84 11.35 19.48 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 4.96 9.44 1.72 4.95 9.71 0.95 1rgq_c01 source 1rgq NS4A PEPTIDE : 3 hits 1rgq_c01 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 110 HIS.? -3.69 OXT ACT A 139s B 102 ASP A 25 ASP.? 6.66 OXT ACT A 139 B 193 GLY A 55 GLY^? 10.36 O ACT A 139 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -6.81 22.81 34.74 -6.42 23.54 34.62 0.71 47.46 4.43 0.16 46.85 4.76 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS A 131 HIS^? 7.42 CL CL A 141 B 102 ASP A 25 ASP.? 6.66 OXT ACT A 139 B 193 GLY A 55 GLY^? 10.36 O ACT A 139 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -6.81 22.81 34.74 -6.42 23.54 34.62 0.71 47.46 4.43 0.16 46.85 4.76 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS B 110 HIS.? -3.67 O ACT B 139s B 102 ASP B 25 ASP.? 6.52 O ACT B 139 B 193 GLY B 55 GLY^? 4.13 CL CL B 141 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -46.84 38.28 15.22 -46.41 37.31 17.03 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -40.59 35.18 8.37 -40.32 35.97 8.08 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 3 # 4 B 57 HIS B 131 HIS^? 7.27 CL CL B 140 B 102 ASP B 25 ASP.? 6.52 O ACT B 139 B 193 GLY B 55 GLY^? 4.13 CL CL B 141 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -42.92 41.25 13.23 -43.42 39.34 13.91 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -40.59 35.18 8.37 -40.32 35.97 8.08 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 5 3 # 5 B 57 HIS C 110 HIS.? 3.59 O ACT C 139s B 102 ASP C 25 ASP.? 6.36 O2 EDO C 140 B 193 GLY C 55 GLY^? 8.81 O1 EDO C 140 coo -4.60 27.52 42.88 -4.63 27.41 40.76 4.54 8.83 15.35 4.90 7.96 17.23 coo -0.27 31.24 43.51 -1.49 29.62 42.98 4.46 12.53 17.74 4.84 11.35 19.48 coo -6.81 22.81 34.74 -6.42 23.54 34.62 10.94 5.65 8.59 11.17 6.44 8.27 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 6 3 # 6 B 57 HIS C 131 HIS^? 6.39 C1 EDO C 140 B 102 ASP C 25 ASP.? 6.36 O2 EDO C 140 B 193 GLY C 55 GLY^? 8.81 O1 EDO C 140 coo -4.60 27.52 42.88 -4.63 27.41 40.76 8.46 11.73 13.23 7.93 9.80 13.86 coo -0.27 31.24 43.51 -1.49 29.62 42.98 4.46 12.53 17.74 4.84 11.35 19.48 coo -6.81 22.81 34.74 -6.42 23.54 34.62 10.94 5.65 8.59 11.17 6.44 8.27 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 6 hits 1rtf_c06 naa= 3 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 102 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 193 GLY A 55 GLY^? 10.36 O ACT A 139 coo 15.02 29.17 19.44 15.63 29.96 17.60 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 19.67 30.58 22.61 18.30 29.87 21.17 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 14.52 29.10 10.01 15.08 29.66 10.19 0.71 47.46 4.43 0.16 46.85 4.76 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS A 131 HIS^? 7.42 CL CL A 141 A 102 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 193 GLY A 55 GLY^? 10.36 O ACT A 139 coo 15.02 29.17 19.44 15.63 29.96 17.60 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 19.67 30.58 22.61 18.30 29.87 21.17 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 14.52 29.10 10.01 15.08 29.66 10.19 0.71 47.46 4.43 0.16 46.85 4.76 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS B 110 HIS.? -3.67 O ACT B 139s A 102 ASP B 25 ASP.? 6.52 O ACT B 139 A 193 GLY B 55 GLY^? 4.13 CL CL B 141 coo 15.02 29.17 19.44 15.63 29.96 17.60 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 19.67 30.58 22.61 18.30 29.87 21.17 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 14.52 29.10 10.01 15.08 29.66 10.19 -40.59 35.18 8.37 -40.32 35.97 8.08 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 4 3 # 4 A 57 HIS B 131 HIS^? 7.27 CL CL B 140 A 102 ASP B 25 ASP.? 6.52 O ACT B 139 A 193 GLY B 55 GLY^? 4.13 CL CL B 141 coo 15.02 29.17 19.44 15.63 29.96 17.60 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 19.67 30.58 22.61 18.30 29.87 21.17 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 14.52 29.10 10.01 15.08 29.66 10.19 -40.59 35.18 8.37 -40.32 35.97 8.08 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 5 3 # 5 A 57 HIS C 110 HIS.? 3.59 O ACT C 139s A 102 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 193 GLY C 55 GLY^? 8.81 O1 EDO C 140 coo 15.02 29.17 19.44 15.63 29.96 17.60 4.54 8.83 15.35 4.90 7.96 17.23 coo 19.67 30.58 22.61 18.30 29.87 21.17 4.46 12.53 17.74 4.84 11.35 19.48 coo 14.52 29.10 10.01 15.08 29.66 10.19 10.94 5.65 8.59 11.17 6.44 8.27 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 6 3 # 6 A 57 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 102 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 193 GLY C 55 GLY^? 8.81 O1 EDO C 140 coo 15.02 29.17 19.44 15.63 29.96 17.60 8.46 11.73 13.23 7.93 9.80 13.86 coo 19.67 30.58 22.61 18.30 29.87 21.17 4.46 12.53 17.74 4.84 11.35 19.48 coo 14.52 29.10 10.01 15.08 29.66 10.19 10.94 5.65 8.59 11.17 6.44 8.27 1ssx_c02 source 1ssx ALPHA-LYTIC PROTEASE : 6 hits 1ssx_c02 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 50 ASP.? 20.38 CL CL A 141 E 168 LYS C 31 LYS~? 22.12 CL CL A 141 E 201 THR A 46 THR~? 14.87 CL CL A 141 coo 5.36 16.20 22.10 3.88 17.00 23.31 11.71 33.66 5.09 12.68 31.93 4.37 coo 5.06 22.32 18.11 1.02 22.08 22.74 9.92 28.31 6.82 8.29 31.11 11.06 coo -1.79 18.29 19.05 -1.19 20.28 19.71 2.59 32.57 5.50 1.31 33.68 6.79 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP B 50 ASP.? 10.53 C3 PG4 A 142 E 168 LYS A 31 LYS~? 8.03 C2 PG4 A 142 E 201 THR B 46 THR~? 13.77 CL CL B 141 coo 5.36 16.20 22.10 3.88 17.00 23.31 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 5.06 22.32 18.11 1.02 22.08 22.74 -19.32 36.76 5.88 -23.26 35.95 1.25 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -26.72 40.90 7.30 -28.39 41.56 6.14 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 2 hits 1stc_c02 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 61 ALA~? -3.67 C ACT A 140s A 251 GLY A 64 GLY~? 8.05 O ACT A 140 A 252 ASP A 62 ASP~? -3.38 O ACT A 140s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -5.79 55.28 13.25 -5.05 56.25 14.14 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -5.68 50.60 11.44 -5.90 50.48 12.19 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -9.14 53.57 16.41 -8.61 54.95 17.94 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA C 61 ALA~? -3.72 C1 EDO C 141s A 251 GLY C 64 GLY~? 8.12 O1 EDO C 141 A 252 ASP C 62 ASP~? -3.30 O1 EDO C 141s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 0.87 7.13 -0.12 0.41 6.02 -0.92 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 4.96 9.44 1.72 4.95 9.71 0.95 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 0.59 10.79 -3.25 -0.22 9.73 -4.86 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 2 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 61 ALA~? -3.67 C ACT A 140s B 251 GLY A 64 GLY~? 8.05 O ACT A 140 B 252 ASP A 62 ASP~? -3.38 O ACT A 140s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -5.79 55.28 13.25 -5.05 56.25 14.14 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -5.68 50.60 11.44 -5.90 50.48 12.19 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -9.14 53.57 16.41 -8.61 54.95 17.94 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA C 61 ALA~? -3.72 C1 EDO C 141s B 251 GLY C 64 GLY~? 8.12 O1 EDO C 141 B 252 ASP C 62 ASP~? -3.30 O1 EDO C 141s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 0.87 7.13 -0.12 0.41 6.02 -0.92 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 4.96 9.44 1.72 4.95 9.71 0.95 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 0.59 10.79 -3.25 -0.22 9.73 -4.86 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 2 hits 1tz3_c03 naa= 3 ULMN 3 1uk7_c00 3.07.01.0009 user 1 3 # 1 A 103 ALA A 27 ALA.? 10.44 O2 PG4 A 142 A 224 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 252 HIS A 131 HIS^? 7.42 CL CL A 141 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -11.26 44.90 0.82 -10.52 44.54 2.10 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -5.82 46.49 -0.22 -4.38 47.88 -0.81 ULMN 3 1uk7_c00 3.07.01.0009 user 2 3 # 2 A 103 ALA C 27 ALA.? 12.87 C1 EDO C 140 A 224 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 252 HIS C 131 HIS^? 6.39 C1 EDO C 140 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 7.09 17.23 12.10 7.71 16.76 10.77 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 4.46 12.53 17.74 4.84 11.35 19.48 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 8.46 11.73 13.23 7.93 9.80 13.86 1uk7_c00 source 1uk7 3.07.01.0009 : 2 hits 1uk7_c00 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 59 ASP.? 10.45 O ACT A 140 255 GLU A 63 GLU~? 7.87 O ACT A 140 329 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo 49.16 35.16 15.19 51.08 34.43 15.65 -11.63 55.20 7.79 -12.68 54.74 6.05 coo 52.57 37.12 10.17 53.37 35.95 11.75 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 62 ASP~? -3.38 O ACT A 140s 255 GLU A 63 GLU~? 7.87 O ACT A 140 329 ASP A 135 ASP.? 12.08 C3 PG4 A 142 coo 49.16 35.16 15.19 51.08 34.43 15.65 -9.14 53.57 16.41 -8.61 54.95 17.94 coo 52.57 37.12 10.17 53.37 35.95 11.75 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 -12.78 43.39 10.70 -14.12 42.52 9.22 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 59 ASP.? 11.98 O ACT B 139 255 GLU B 63 GLU~? 16.01 OXT ACT B 139 329 ASP B 135 ASP.? 12.47 O1 PG4 B 142 coo 49.16 35.16 15.19 51.08 34.43 15.65 -53.34 42.20 5.44 -53.68 42.89 7.35 coo 52.57 37.12 10.17 53.37 35.95 11.75 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 59.16 37.82 13.95 57.63 37.03 15.12 -43.74 49.08 2.60 -43.70 50.44 4.24 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 62 ASP~? 20.96 OXT ACT B 139 255 GLU B 63 GLU~? 16.01 OXT ACT B 139 329 ASP B 59 ASP.? 11.98 O ACT B 139 coo 49.16 35.16 15.19 51.08 34.43 15.65 -50.88 40.70 -3.44 -51.62 39.45 -5.01 coo 52.57 37.12 10.17 53.37 35.95 11.75 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 59.16 37.82 13.95 57.63 37.03 15.12 -53.34 42.20 5.44 -53.68 42.89 7.35 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP C 59 ASP.? 10.26 O1 EDO C 141 255 GLU C 63 GLU~? 7.77 O1 EDO C 141 329 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 49.16 35.16 15.19 51.08 34.43 15.65 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 52.57 37.12 10.17 53.37 35.95 11.75 1.11 13.80 1.11 0.04 14.34 2.91 coo 59.16 37.82 13.95 57.63 37.03 15.12 7.61 19.22 2.17 7.62 20.80 3.62 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP C 62 ASP~? -3.30 O1 EDO C 141s 255 GLU C 63 GLU~? 7.77 O1 EDO C 141 329 ASP C 135 ASP.? 16.41 O1 EDO C 141 coo 49.16 35.16 15.19 51.08 34.43 15.65 0.59 10.79 -3.25 -0.22 9.73 -4.86 coo 52.57 37.12 10.17 53.37 35.95 11.75 1.11 13.80 1.11 0.04 14.34 2.91 coo 59.16 37.82 13.95 57.63 37.03 15.12 7.61 19.22 2.17 7.62 20.80 3.62 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 6 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 62 ASP~? -3.38 O ACT A 140s 218 GLU A 127 GLU^? 8.20 CL CL A 141 329 ASP A 59 ASP.? 10.45 O ACT A 140 coo 49.16 35.16 15.19 51.08 34.43 15.65 -9.14 53.57 16.41 -8.61 54.95 17.94 coo 70.09 11.71 8.46 70.56 12.89 6.77 2.90 34.77 -4.78 2.12 35.30 -6.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 -11.63 55.20 7.79 -12.68 54.74 6.05 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 62 ASP~? 20.96 OXT ACT B 139 218 GLU B 127 GLU^? 8.11 CL CL B 140 329 ASP B 59 ASP.? 11.98 O ACT B 139 coo 49.16 35.16 15.19 51.08 34.43 15.65 -50.88 40.70 -3.44 -51.62 39.45 -5.01 coo 70.09 11.71 8.46 70.56 12.89 6.77 -28.31 39.11 17.60 -29.33 39.55 19.43 coo 59.16 37.82 13.95 57.63 37.03 15.12 -53.34 42.20 5.44 -53.68 42.89 7.35 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP C 135 ASP.? 16.41 O1 EDO C 141 218 GLU B 122 GLU.? 20.16 C3 PG4 A 142 329 ASP C 59 ASP.? 10.26 O1 EDO C 141 coo 49.16 35.16 15.19 51.08 34.43 15.65 7.61 19.22 2.17 7.62 20.80 3.62 coo 70.09 11.71 8.46 70.56 12.89 6.77 -18.00 33.10 19.61 -16.43 34.38 20.27 coo 59.16 37.82 13.95 57.63 37.03 15.12 -1.96 12.33 5.23 -2.08 13.48 6.95 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 3 hits 1uok_c04 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN B 126 ASN.? 13.70 CL CL B 141 457 GLY B 123 GLY.? 16.67 C3 PG4 A 142 459 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -26.16 33.99 16.45 -25.15 32.54 15.21 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -18.03 36.67 16.32 -18.74 36.23 16.11 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -18.00 33.10 19.61 -16.43 34.38 20.27 1vom_c00 source 1vom MYOSIN : 1 hits 1vom_c00 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 71 TYR~? 13.98 CL CL A 141 A 40 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 103 LEU A 132 LEU^? 9.00 CL CL A 141 coo 12.09 16.13 10.57 11.28 18.80 10.73 -3.80 41.21 9.78 -5.71 41.25 7.73 coo 7.55 25.51 14.34 9.65 25.73 14.24 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 11.83 18.73 16.99 10.99 19.71 15.26 -6.85 40.71 3.28 -5.83 39.05 2.38 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR B 71 TYR~? 11.95 CL CL B 141 A 40 ASP B 135 ASP.? 12.47 O1 PG4 B 142 A 103 LEU B 132 LEU^? 8.96 CL CL B 140 coo 12.09 16.13 10.57 11.28 18.80 10.73 -37.36 42.24 3.20 -38.26 43.87 5.26 coo 7.55 25.51 14.34 9.65 25.73 14.24 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 11.83 18.73 16.99 10.99 19.71 15.26 -38.39 45.08 9.70 -36.46 44.99 10.68 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR C 71 TYR~? 15.80 O1 EDO C 140 A 40 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 103 LEU C 132 LEU^? 13.22 O1 EDO C 140 coo 12.09 16.13 10.57 11.28 18.80 10.73 13.97 12.69 3.28 12.99 14.27 5.33 coo 7.55 25.51 14.34 9.65 25.73 14.24 7.61 19.22 2.17 7.62 20.80 3.62 coo 11.83 18.73 16.99 10.99 19.71 15.26 12.86 15.51 9.60 14.79 15.72 10.59 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 3 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 71 TYR~? 13.98 CL CL A 141 B 40 ASP A 135 ASP.? 12.08 C3 PG4 A 142 B 103 LEU A 132 LEU^? 9.00 CL CL A 141 coo 14.25 20.09 37.35 13.48 17.40 37.38 -3.80 41.21 9.78 -5.71 41.25 7.73 coo 9.39 10.77 34.53 11.50 10.63 34.41 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 12.89 17.60 31.13 12.34 16.51 32.90 -6.85 40.71 3.28 -5.83 39.05 2.38 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR B 71 TYR~? 11.95 CL CL B 141 B 40 ASP B 135 ASP.? 12.47 O1 PG4 B 142 B 103 LEU B 132 LEU^? 8.96 CL CL B 140 coo 14.25 20.09 37.35 13.48 17.40 37.38 -37.36 42.24 3.20 -38.26 43.87 5.26 coo 9.39 10.77 34.53 11.50 10.63 34.41 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 12.89 17.60 31.13 12.34 16.51 32.90 -38.39 45.08 9.70 -36.46 44.99 10.68 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR C 71 TYR~? 15.80 O1 EDO C 140 B 40 ASP C 135 ASP.? 16.41 O1 EDO C 141 B 103 LEU C 132 LEU^? 13.22 O1 EDO C 140 coo 14.25 20.09 37.35 13.48 17.40 37.38 13.97 12.69 3.28 12.99 14.27 5.33 coo 9.39 10.77 34.53 11.50 10.63 34.41 7.61 19.22 2.17 7.62 20.80 3.62 coo 12.89 17.60 31.13 12.34 16.51 32.90 12.86 15.51 9.60 14.79 15.72 10.59 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 3 hits 1vzz_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 109 HIS.? -5.41 OXT ACT A 139s A 169 ASP A 59 ASP.? 10.45 O ACT A 140 A 288 GLU A 63 GLU~? 7.87 O ACT A 140 coo 67.72 35.99 30.87 69.77 36.13 31.33 -8.77 57.48 -2.79 -8.58 59.56 -2.89 coo 73.17 30.66 22.56 72.87 30.30 20.46 -11.63 55.20 7.79 -12.68 54.74 6.05 coo 74.06 28.51 15.92 73.77 29.56 17.73 -11.40 51.79 11.95 -12.40 52.61 10.19 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 2 3 # 2 A 105 HIS B 109 HIS.? -5.47 O ACT B 139s A 169 ASP B 59 ASP.? 11.98 O ACT B 139 A 288 GLU B 63 GLU~? 16.01 OXT ACT B 139 coo 67.72 35.99 30.87 69.77 36.13 31.33 -54.00 38.48 15.75 -55.77 37.34 15.88 coo 73.17 30.66 22.56 72.87 30.30 20.46 -53.34 42.20 5.44 -53.68 42.89 7.35 coo 74.06 28.51 15.92 73.77 29.56 17.73 -50.25 43.77 1.04 -51.29 44.45 2.77 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 3 3 # 3 A 105 HIS C 109 HIS.? -5.44 O ACT C 139s A 169 ASP C 59 ASP.? 10.26 O1 EDO C 141 A 288 GLU C 63 GLU~? 7.77 O1 EDO C 141 coo 67.72 35.99 30.87 69.77 36.13 31.33 -2.54 8.69 15.96 -4.15 7.36 16.15 coo 73.17 30.66 22.56 72.87 30.30 20.46 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 74.06 28.51 15.92 73.77 29.56 17.73 1.11 13.80 1.11 0.04 14.34 2.91 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 3 hits 1w1o_c00 naa= 3 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 105 ALA A 27 ALA.? 10.44 O2 PG4 A 142 A 244 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 271 HIS A 131 HIS^? 7.42 CL CL A 141 coo 15.05 3.71 6.93 14.58 4.88 7.78 -11.26 44.90 0.82 -10.52 44.54 2.10 coo 9.85 8.15 0.76 10.61 7.04 2.39 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 10.61 7.65 6.01 12.39 6.55 6.23 -5.82 46.49 -0.22 -4.38 47.88 -0.81 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 105 ALA B 27 ALA.? 10.43 O1 PG4 B 142 A 244 ASP B 25 ASP.? 6.52 O ACT B 139 A 271 HIS B 131 HIS^? 7.27 CL CL B 140 coo 15.05 3.71 6.93 14.58 4.88 7.78 -44.16 46.71 12.37 -43.44 46.31 11.09 coo 9.85 8.15 0.76 10.61 7.04 2.39 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 10.61 7.65 6.01 12.39 6.55 6.23 -42.92 41.25 13.23 -43.42 39.34 13.91 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 3 3 # 3 A 105 ALA C 27 ALA.? 12.87 C1 EDO C 140 A 244 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 271 HIS C 131 HIS^? 6.39 C1 EDO C 140 coo 15.05 3.71 6.93 14.58 4.88 7.78 7.09 17.23 12.10 7.71 16.76 10.77 coo 9.85 8.15 0.76 10.61 7.04 2.39 4.46 12.53 17.74 4.84 11.35 19.48 coo 10.61 7.65 6.01 12.39 6.55 6.23 8.46 11.73 13.23 7.93 9.80 13.86 1xqw_c00 source 1xqw PROLINE IMINOPEPTIDASE : 3 hits 1xqw_c00 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 64 GLY~? 8.05 O ACT A 140 B 175 ARG A 111 ARG.? 7.83 OXT ACT A 139 B 242 TYR A 91 TYR^? -8.03 O ACT A 139s coo 99.45 58.28 3.33 99.57 58.61 4.10 -5.68 50.60 11.44 -5.90 50.48 12.19 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -9.64 52.74 3.70 -9.14 55.70 2.93 coo 100.93 69.04 4.38 99.52 68.48 2.09 0.50 53.22 4.73 2.11 51.22 3.73 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY A 64 GLY~? 8.05 O ACT A 140 B 175 ARG A 111 ARG.? 7.83 OXT ACT A 139 B 242 TYR A 106 TYR.? -4.43 O ACT A 139s coo 99.45 58.28 3.33 99.57 58.61 4.10 -5.68 50.60 11.44 -5.90 50.48 12.19 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -9.64 52.74 3.70 -9.14 55.70 2.93 coo 100.93 69.04 4.38 99.52 68.48 2.09 -3.42 56.19 3.13 -4.04 54.71 0.79 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY A 88 GLY.? 6.36 OXT ACT A 140 B 175 ARG A 111 ARG.? 7.83 OXT ACT A 139 B 242 TYR A 91 TYR^? -8.03 O ACT A 139s coo 99.45 58.28 3.33 99.57 58.61 4.10 -7.82 61.10 9.16 -7.39 60.58 9.65 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -9.64 52.74 3.70 -9.14 55.70 2.93 coo 100.93 69.04 4.38 99.52 68.48 2.09 0.50 53.22 4.73 2.11 51.22 3.73 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY A 88 GLY.? 6.36 OXT ACT A 140 B 175 ARG A 111 ARG.? 7.83 OXT ACT A 139 B 242 TYR A 106 TYR.? -4.43 O ACT A 139s coo 99.45 58.28 3.33 99.57 58.61 4.10 -7.82 61.10 9.16 -7.39 60.58 9.65 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -9.64 52.74 3.70 -9.14 55.70 2.93 coo 100.93 69.04 4.38 99.52 68.48 2.09 -3.42 56.19 3.13 -4.04 54.71 0.79 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 5 3 # 5 B 137 GLY B 64 GLY~? 14.04 CL CL B 141 B 175 ARG B 111 ARG.? 7.92 O ACT B 139 B 242 TYR B 91 TYR^? 6.76 CL CL B 141 coo 99.45 58.28 3.33 99.57 58.61 4.10 -46.53 39.33 1.61 -46.53 39.59 0.85 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -50.20 41.64 9.27 -52.60 39.78 9.98 coo 100.93 69.04 4.38 99.52 68.48 2.09 -45.69 32.60 8.25 -43.08 32.05 9.08 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 6 3 # 6 B 137 GLY B 64 GLY~? 14.04 CL CL B 141 B 175 ARG B 111 ARG.? 7.92 O ACT B 139 B 242 TYR B 106 TYR.? -4.35 OXT ACT B 139s coo 99.45 58.28 3.33 99.57 58.61 4.10 -46.53 39.33 1.61 -46.53 39.59 0.85 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -50.20 41.64 9.27 -52.60 39.78 9.98 coo 100.93 69.04 4.38 99.52 68.48 2.09 -50.21 34.52 9.84 -49.25 35.77 12.19 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 7 3 # 7 B 137 GLY B 88 GLY.? 14.05 OXT ACT B 139 B 175 ARG B 111 ARG.? 7.92 O ACT B 139 B 242 TYR B 91 TYR^? 6.76 CL CL B 141 coo 99.45 58.28 3.33 99.57 58.61 4.10 -56.66 36.05 3.82 -56.03 35.91 3.31 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -50.20 41.64 9.27 -52.60 39.78 9.98 coo 100.93 69.04 4.38 99.52 68.48 2.09 -45.69 32.60 8.25 -43.08 32.05 9.08 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 8 3 # 8 B 137 GLY B 88 GLY.? 14.05 OXT ACT B 139 B 175 ARG B 111 ARG.? 7.92 O ACT B 139 B 242 TYR B 106 TYR.? -4.35 OXT ACT B 139s coo 99.45 58.28 3.33 99.57 58.61 4.10 -56.66 36.05 3.82 -56.03 35.91 3.31 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -50.20 41.64 9.27 -52.60 39.78 9.98 coo 100.93 69.04 4.38 99.52 68.48 2.09 -50.21 34.52 9.84 -49.25 35.77 12.19 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 9 3 # 9 B 137 GLY C 64 GLY~? 8.12 O1 EDO C 141 B 175 ARG C 111 ARG.? 7.98 O ACT C 139 B 242 TYR C 91 TYR^? -7.96 OXT ACT C 139s coo 99.45 58.28 3.33 99.57 58.61 4.10 4.96 9.44 1.72 4.95 9.71 0.95 coo 106.37 63.53 0.89 108.02 63.40 -1.62 1.09 11.93 9.22 -1.20 10.06 10.11 coo 100.93 69.04 4.38 99.52 68.48 2.09 5.87 2.89 8.45 8.51 2.56 9.46 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 10 3 # 10 B 137 GLY C 64 GLY~? 8.12 O1 EDO C 141 B 175 ARG C 111 ARG.? 7.98 O ACT C 139 B 242 TYR C 106 TYR.? -4.43 OXT ACT C 139s coo 99.45 58.28 3.33 99.57 58.61 4.10 4.96 9.44 1.72 4.95 9.71 0.95 coo 106.37 63.53 0.89 108.02 63.40 -1.62 1.09 11.93 9.22 -1.20 10.06 10.11 coo 100.93 69.04 4.38 99.52 68.48 2.09 1.32 4.77 9.99 2.33 6.07 12.30 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 11 3 # 11 B 137 GLY C 88 GLY.? -5.77 O2 EDO C 141s B 175 ARG C 111 ARG.? 7.98 O ACT C 139 B 242 TYR C 91 TYR^? -7.96 OXT ACT C 139s coo 99.45 58.28 3.33 99.57 58.61 4.10 -5.16 6.02 3.89 -4.51 5.85 3.40 coo 106.37 63.53 0.89 108.02 63.40 -1.62 1.09 11.93 9.22 -1.20 10.06 10.11 coo 100.93 69.04 4.38 99.52 68.48 2.09 5.87 2.89 8.45 8.51 2.56 9.46 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 12 3 # 12 B 137 GLY C 88 GLY.? -5.77 O2 EDO C 141s B 175 ARG C 111 ARG.? 7.98 O ACT C 139 B 242 TYR C 106 TYR.? -4.43 OXT ACT C 139s coo 99.45 58.28 3.33 99.57 58.61 4.10 -5.16 6.02 3.89 -4.51 5.85 3.40 coo 106.37 63.53 0.89 108.02 63.40 -1.62 1.09 11.93 9.22 -1.20 10.06 10.11 coo 100.93 69.04 4.38 99.52 68.48 2.09 1.32 4.77 9.99 2.33 6.07 12.30 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 12 hits 1xva_c03 naa= 3 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 A 164 SER A 37 SER~? 5.05 O3 PG4 A 142 A 178 TYR B 121 TYR.? 12.07 O3 PG4 A 142 A 182 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 81.46 10.53 21.66 82.20 10.82 19.39 -11.55 30.40 5.05 -13.38 29.33 4.03 coo 87.67 8.69 17.10 86.62 10.83 18.52 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 85.30 6.17 22.83 87.26 11.02 23.50 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 A 164 SER C 37 SER~? 25.30 O1 EDO C 140 A 178 TYR A 121 TYR.? -24.35 CL CL A 141s A 182 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 81.46 10.53 21.66 82.20 10.82 19.39 19.44 24.86 7.68 19.21 27.10 8.59 coo 87.67 8.69 17.10 86.62 10.83 18.52 16.31 29.26 0.34 18.85 29.40 1.41 coo 85.30 6.17 22.83 87.26 11.02 23.50 14.41 24.06 5.83 10.24 22.70 1.76 1ybv_c00 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 2 hits 1ybv_c00 naa= 3 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 B 164 SER A 37 SER~? 5.05 O3 PG4 A 142 B 178 TYR B 121 TYR.? 12.07 O3 PG4 A 142 B 182 LYS A 35 LYS~? 11.98 C3 PG4 A 142 coo 61.22 3.61 34.51 60.46 1.86 35.98 -11.55 30.40 5.05 -13.38 29.33 4.03 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -17.06 30.29 11.99 -16.35 28.08 10.43 coo 57.40 2.23 30.19 55.43 5.44 33.87 -13.45 35.10 6.93 -14.45 39.53 11.08 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 B 164 SER C 37 SER~? 25.30 O1 EDO C 140 B 178 TYR A 121 TYR.? -24.35 CL CL A 141s B 182 LYS C 35 LYS~? 18.91 O1 EDO C 141 coo 61.22 3.61 34.51 60.46 1.86 35.98 19.44 24.86 7.68 19.21 27.10 8.59 coo 54.99 -1.20 35.40 56.04 1.15 36.44 16.31 29.26 0.34 18.85 29.40 1.41 coo 57.40 2.23 30.19 55.43 5.44 33.87 14.41 24.06 5.83 10.24 22.70 1.76 1ybv_c01 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 2 hits 1ybv_c01 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 15 LYS~? 13.64 CL CL A 141 A 74 LYS A 20 LYS~? -2.81 O1 PG4 A 142s A 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 18.28 7.83 36.39 22.82 8.75 39.52 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 14.16 13.09 37.03 20.00 12.44 37.49 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 22.22 16.06 48.76 23.94 15.33 49.78 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 16 LYS~? 4.07 C8 PG4 A 142 A 74 LYS A 20 LYS~? -2.81 O1 PG4 A 142s A 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 18.28 7.83 36.39 22.82 8.75 39.52 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 14.16 13.09 37.03 20.00 12.44 37.49 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 22.22 16.06 48.76 23.94 15.33 49.78 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 20 LYS~? -2.81 O1 PG4 A 142s A 74 LYS A 15 LYS~? 13.64 CL CL A 141 A 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 18.28 7.83 36.39 22.82 8.75 39.52 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 14.16 13.09 37.03 20.00 12.44 37.49 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 22.22 16.06 48.76 23.94 15.33 49.78 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS A 20 LYS~? -2.81 O1 PG4 A 142s A 74 LYS A 16 LYS~? 4.07 C8 PG4 A 142 A 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 18.28 7.83 36.39 22.82 8.75 39.52 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 14.16 13.09 37.03 20.00 12.44 37.49 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 22.22 16.06 48.76 23.94 15.33 49.78 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 74 LYS A 35 LYS~? 11.98 C3 PG4 A 142 A 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 18.28 7.83 36.39 22.82 8.75 39.52 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 14.16 13.09 37.03 20.00 12.44 37.49 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 22.22 16.06 48.76 23.94 15.33 49.78 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 74 LYS B 47 LYS~? 12.98 C2 PG4 A 142 A 165 GLU B 127 GLU^? 8.11 CL CL B 140 coo 18.28 7.83 36.39 22.82 8.75 39.52 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 14.16 13.09 37.03 20.00 12.44 37.49 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 22.22 16.06 48.76 23.94 15.33 49.78 -28.31 39.11 17.60 -29.33 39.55 19.43 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS A 35 LYS~? 11.98 C3 PG4 A 142 A 74 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 18.28 7.83 36.39 22.82 8.75 39.52 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 14.16 13.09 37.03 20.00 12.44 37.49 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 22.22 16.06 48.76 23.94 15.33 49.78 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS B 20 LYS~? -2.98 O4 PG4 B 142s A 74 LYS B 15 LYS~? 14.97 CL CL B 140 A 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo 18.28 7.83 36.39 22.82 8.75 39.52 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 14.16 13.09 37.03 20.00 12.44 37.49 -27.71 47.06 15.95 -22.68 43.71 17.22 coo 22.22 16.06 48.76 23.94 15.33 49.78 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS B 20 LYS~? -2.98 O4 PG4 B 142s A 74 LYS B 16 LYS~? 5.16 C5 PG4 B 142 A 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo 18.28 7.83 36.39 22.82 8.75 39.52 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 14.16 13.09 37.03 20.00 12.44 37.49 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 22.22 16.06 48.76 23.94 15.33 49.78 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS B 47 LYS~? 12.98 C2 PG4 A 142 A 74 LYS A 31 LYS~? 8.03 C2 PG4 A 142 A 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 18.28 7.83 36.39 22.82 8.75 39.52 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 14.16 13.09 37.03 20.00 12.44 37.49 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 22.22 16.06 48.76 23.94 15.33 49.78 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS C 20 LYS~? 21.67 C1 EDO C 140 A 74 LYS C 15 LYS~? 19.87 O1 EDO C 140 A 165 GLU C 36 GLU~? -27.32 O1 EDO C 140s coo 18.28 7.83 36.39 22.82 8.75 39.52 15.48 20.46 18.00 15.72 26.44 16.52 coo 14.16 13.09 37.03 20.00 12.44 37.49 23.48 18.06 15.81 27.69 13.80 17.86 coo 22.22 16.06 48.76 23.94 15.33 49.78 19.61 26.41 3.01 20.17 25.01 1.52 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS C 31 LYS~? 22.12 CL CL A 141 A 74 LYS A 47 LYS~? 18.08 C5 PG4 A 142 A 165 GLU A 127 GLU^? 8.20 CL CL A 141 coo 18.28 7.83 36.39 22.82 8.75 39.52 9.92 28.31 6.82 8.29 31.11 11.06 coo 14.16 13.09 37.03 20.00 12.44 37.49 4.15 29.38 6.95 0.12 26.77 10.99 coo 22.22 16.06 48.76 23.94 15.33 49.78 2.90 34.77 -4.78 2.12 35.30 -6.66 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 12 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 16 LYS~? 4.07 C8 PG4 A 142 B 74 LYS A 20 LYS~? -2.81 O1 PG4 A 142s B 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 13.51 0.92 76.10 12.98 6.13 74.68 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 21.39 11.56 68.52 20.24 13.13 67.73 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 20 LYS~? -2.81 O1 PG4 A 142s B 74 LYS A 16 LYS~? 4.07 C8 PG4 A 142 B 165 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 13.51 0.92 76.10 12.98 6.13 74.68 -9.64 36.15 -5.16 -14.58 33.43 -3.36 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 21.39 11.56 68.52 20.24 13.13 67.73 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 B 74 LYS A 35 LYS~? 11.98 C3 PG4 A 142 B 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 13.51 0.92 76.10 12.98 6.13 74.68 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 21.39 11.56 68.52 20.24 13.13 67.73 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS A 31 LYS~? 8.03 C2 PG4 A 142 B 74 LYS B 47 LYS~? 12.98 C2 PG4 A 142 B 165 GLU B 127 GLU^? 8.11 CL CL B 140 coo 13.51 0.92 76.10 12.98 6.13 74.68 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 21.39 11.56 68.52 20.24 13.13 67.73 -28.31 39.11 17.60 -29.33 39.55 19.43 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS A 35 LYS~? 11.98 C3 PG4 A 142 B 74 LYS A 31 LYS~? 8.03 C2 PG4 A 142 B 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 13.51 0.92 76.10 12.98 6.13 74.68 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 21.39 11.56 68.52 20.24 13.13 67.73 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS B 20 LYS~? -2.98 O4 PG4 B 142s B 74 LYS B 16 LYS~? 5.16 C5 PG4 B 142 B 165 GLU B 36 GLU~? 11.82 C2 PG4 B 142 coo 13.51 0.92 76.10 12.98 6.13 74.68 -35.63 49.45 18.32 -35.72 55.05 16.66 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 21.39 11.56 68.52 20.24 13.13 67.73 -31.60 55.95 3.54 -31.25 54.50 1.99 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS B 47 LYS~? 12.98 C2 PG4 A 142 B 74 LYS A 31 LYS~? 8.03 C2 PG4 A 142 B 165 GLU B 122 GLU.? 20.16 C3 PG4 A 142 coo 13.51 0.92 76.10 12.98 6.13 74.68 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -19.32 36.76 5.88 -23.26 35.95 1.25 coo 21.39 11.56 68.52 20.24 13.13 67.73 -18.00 33.10 19.61 -16.43 34.38 20.27 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS C 31 LYS~? 22.12 CL CL A 141 B 74 LYS A 47 LYS~? 18.08 C5 PG4 A 142 B 165 GLU A 127 GLU^? 8.20 CL CL A 141 coo 13.51 0.92 76.10 12.98 6.13 74.68 9.92 28.31 6.82 8.29 31.11 11.06 coo 19.89 -0.55 76.51 17.10 4.32 77.43 4.15 29.38 6.95 0.12 26.77 10.99 coo 21.39 11.56 68.52 20.24 13.13 67.73 2.90 34.77 -4.78 2.12 35.30 -6.66 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 8 hits 1ylu_c01 naa= 3 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 371 LYS A 15 LYS~? 13.64 CL CL A 141 A 407 THR A 11 THR~? 14.98 O4 PG4 A 142 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -1.34 25.09 -0.69 0.81 25.31 -0.69 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 371 LYS A 16 LYS~? 4.07 C8 PG4 A 142 A 407 THR A 11 THR~? 14.98 O4 PG4 A 142 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -1.34 25.09 -0.69 0.81 25.31 -0.69 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 371 LYS B 15 LYS~? 14.97 CL CL B 140 A 407 THR B 11 THR~? 14.82 C3 PG4 B 142 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -24.74 52.92 14.33 -24.14 54.73 15.30 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -27.71 47.06 15.95 -22.68 43.71 17.22 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -22.01 47.86 13.55 -21.15 45.90 13.39 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 4 3 # 4 A 369 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 371 LYS B 16 LYS~? 5.16 C5 PG4 B 142 A 407 THR B 11 THR~? 14.82 C3 PG4 B 142 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -24.74 52.92 14.33 -24.14 54.73 15.30 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -29.09 50.01 17.90 -28.96 54.88 21.75 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -22.01 47.86 13.55 -21.15 45.90 13.39 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 5 3 # 5 A 369 ASP C 13 ASP~? 27.02 O1 EDO C 140 A 371 LYS C 15 LYS~? 19.87 O1 EDO C 140 A 407 THR C 11 THR~? 23.65 O1 EDO C 140 coo -5.17 31.09 15.73 -7.07 31.12 16.73 26.45 23.84 13.97 27.74 25.29 14.77 coo -4.43 30.92 22.89 -6.61 31.91 19.71 23.48 18.06 15.81 27.69 13.80 17.86 coo -8.38 36.02 19.06 -8.83 34.10 19.89 29.19 18.84 13.45 30.01 16.83 13.39 1zrz_c02 source 1zrz PROTEIN KINASE C, IOTA : 5 hits 1zrz_c02 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP B 62 ASP~? 20.96 OXT ACT B 139 219 GLU B 63 GLU~? 16.01 OXT ACT B 139 294 ASP B 59 ASP.? 11.98 O ACT B 139 coo 27.89 102.52 14.98 29.35 101.92 13.57 -50.88 40.70 -3.44 -51.62 39.45 -5.01 coo 25.84 105.87 9.06 27.86 105.55 8.74 -50.25 43.77 1.04 -51.29 44.45 2.77 coo 33.16 106.80 7.72 33.34 104.87 6.92 -53.34 42.20 5.44 -53.68 42.89 7.35 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 1 hits 2amg_c02 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG C 39 ARG~? 23.08 O1 EDO C 141 A 161 ASP A 50 ASP.? 20.38 CL CL A 141 A 174 TYR A 120 TYR.? -20.76 CL CL A 141s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 17.00 20.76 1.74 15.55 23.42 1.18 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 11.71 33.66 5.09 12.68 31.93 4.37 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 15.94 35.05 2.39 15.79 37.48 3.75 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG C 39 ARG~? 23.08 O1 EDO C 141 B 161 ASP A 50 ASP.? 20.38 CL CL A 141 B 174 TYR A 120 TYR.? -20.76 CL CL A 141s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 17.00 20.76 1.74 15.55 23.42 1.18 coo -14.86 10.19 8.14 -14.82 12.31 8.42 11.71 33.66 5.09 12.68 31.93 4.37 coo -21.46 12.70 8.53 -19.04 12.30 7.24 15.94 35.05 2.39 15.79 37.48 3.75 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 39 ARG~? 11.53 C4 PG4 A 142 C 161 ASP B 50 ASP.? 10.53 C3 PG4 A 142 C 174 TYR B 120 TYR.? 13.58 O3 PG4 A 142 coo 2.84 19.43 40.34 1.59 20.35 37.65 -9.34 34.41 10.95 -12.33 34.37 11.59 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 5.94 13.28 27.17 3.53 13.05 28.58 -22.08 28.00 9.76 -23.99 27.18 7.88 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG C 39 ARG~? 23.08 O1 EDO C 141 C 161 ASP A 50 ASP.? 20.38 CL CL A 141 C 174 TYR A 120 TYR.? -20.76 CL CL A 141s coo 2.84 19.43 40.34 1.59 20.35 37.65 17.00 20.76 1.74 15.55 23.42 1.18 coo -0.62 11.10 28.05 -0.65 13.15 27.46 11.71 33.66 5.09 12.68 31.93 4.37 coo 5.94 13.28 27.17 3.53 13.05 28.58 15.94 35.05 2.39 15.79 37.48 3.75 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG C 39 ARG~? 23.08 O1 EDO C 141 D 161 ASP A 50 ASP.? 20.38 CL CL A 141 D 174 TYR A 120 TYR.? -20.76 CL CL A 141s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 17.00 20.76 1.74 15.55 23.42 1.18 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 11.71 33.66 5.09 12.68 31.93 4.37 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 15.94 35.05 2.39 15.79 37.48 3.75 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c11 naa= 3 ULMN 3 2esd_c02 1.02.01.0009 user 1 3 # 1 C 154 ASN A 19 ASN~? 8.40 CL CL A 141 C 250 ALA A 27 ALA.? 10.44 O2 PG4 A 142 C 284 CYH A 23 CYH.? -5.05 CL CL A 141s coo -155.36 18.42 28.93 -154.49 20.30 29.39 -5.47 34.18 -6.27 -3.38 33.66 -6.11 coo -150.95 29.02 32.87 -150.10 27.86 32.40 -11.26 44.90 0.82 -10.52 44.54 2.10 coo -155.22 25.64 26.33 -154.78 25.20 29.09 -5.66 43.81 -7.30 -4.20 43.21 -9.56 2esd_c02 source 2esd 1.02.01.0009 : 1 hits 2esd_c02 naa= 3 ULMN 3 2esd_c03 1.02.01.0009 user 1 3 # 1 D 154 ASN A 19 ASN~? 8.40 CL CL A 141 D 250 ALA A 27 ALA.? 10.44 O2 PG4 A 142 D 284 CYH A 23 CYH.? -5.05 CL CL A 141s coo -138.05 57.23 54.59 -137.96 55.47 53.43 -5.47 34.18 -6.27 -3.38 33.66 -6.11 coo -139.97 46.71 48.80 -139.25 47.90 48.19 -11.26 44.90 0.82 -10.52 44.54 2.10 coo -135.22 50.13 55.22 -137.25 50.94 53.65 -5.66 43.81 -7.30 -4.20 43.21 -9.56 2esd_c03 source 2esd 1.02.01.0009 : 1 hits 2esd_c03 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 137 PHE.? 13.51 C4 PG4 A 142 A 245 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 273 LYS B 47 LYS~? 12.98 C2 PG4 A 142 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -6.61 37.64 11.75 -5.17 36.03 10.04 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -12.78 43.39 10.70 -14.12 42.52 9.22 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -23.16 41.10 5.81 -22.85 46.07 1.96 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE C 137 PHE.? 20.25 O1 EDO C 140 A 245 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 273 LYS A 47 LYS~? 18.08 C5 PG4 A 142 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 15.58 16.76 1.11 17.72 16.39 2.83 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 7.61 19.22 2.17 7.62 20.80 3.62 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 4.15 29.38 6.95 0.12 26.77 10.99 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 2 hits 2gsa_c04 naa= 3 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 1 3 # 1 B 185 HIS A 110 HIS.? -3.69 OXT ACT A 139s B 188 HIS A 109 HIS.? -5.41 OXT ACT A 139s B 190 TYR A 106 TYR.? -4.43 O ACT A 139s coo -2.40 8.56 71.48 -2.16 8.28 69.42 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo -0.71 6.39 65.98 -1.92 4.69 66.21 -8.77 57.48 -2.79 -8.58 59.56 -2.89 coo 0.03 12.24 67.96 -1.63 12.38 65.68 -3.42 56.19 3.13 -4.04 54.71 0.79 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 2 3 # 2 B 185 HIS B 110 HIS.? -3.67 O ACT B 139s B 188 HIS B 109 HIS.? -5.47 O ACT B 139s B 190 TYR B 106 TYR.? -4.35 OXT ACT B 139s coo -2.40 8.56 71.48 -2.16 8.28 69.42 -46.84 38.28 15.22 -46.41 37.31 17.03 coo -0.71 6.39 65.98 -1.92 4.69 66.21 -54.00 38.48 15.75 -55.77 37.34 15.88 coo 0.03 12.24 67.96 -1.63 12.38 65.68 -50.21 34.52 9.84 -49.25 35.77 12.19 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 3 3 # 3 B 185 HIS C 110 HIS.? 3.59 O ACT C 139s B 188 HIS C 109 HIS.? -5.44 O ACT C 139s B 190 TYR C 106 TYR.? -4.43 OXT ACT C 139s coo -2.40 8.56 71.48 -2.16 8.28 69.42 4.54 8.83 15.35 4.90 7.96 17.23 coo -0.71 6.39 65.98 -1.92 4.69 66.21 -2.54 8.69 15.96 -4.15 7.36 16.15 coo 0.03 12.24 67.96 -1.63 12.38 65.68 1.32 4.77 9.99 2.33 6.07 12.30 2hsa_c00 source 2hsa 12-OXOPHYTODIENOATE REDUCTASE 3 : 3 hits 2hsa_c00 naa= 3 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 1 3 # 1 A 185 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 188 HIS A 109 HIS.? -5.41 OXT ACT A 139s A 190 TYR A 106 TYR.? -4.43 O ACT A 139s coo 17.28 -0.40 35.65 16.37 -0.39 37.54 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 14.39 1.55 40.83 12.71 2.07 39.67 -8.77 57.48 -2.79 -8.58 59.56 -2.89 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 -3.42 56.19 3.13 -4.04 54.71 0.79 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 2 3 # 2 A 185 HIS B 110 HIS.? -3.67 O ACT B 139s A 188 HIS B 109 HIS.? -5.47 O ACT B 139s A 190 TYR B 106 TYR.? -4.35 OXT ACT B 139s coo 17.28 -0.40 35.65 16.37 -0.39 37.54 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 14.39 1.55 40.83 12.71 2.07 39.67 -54.00 38.48 15.75 -55.77 37.34 15.88 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 -50.21 34.52 9.84 -49.25 35.77 12.19 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 3 3 # 3 A 185 HIS C 110 HIS.? 3.59 O ACT C 139s A 188 HIS C 109 HIS.? -5.44 O ACT C 139s A 190 TYR C 106 TYR.? -4.43 OXT ACT C 139s coo 17.28 -0.40 35.65 16.37 -0.39 37.54 4.54 8.83 15.35 4.90 7.96 17.23 coo 14.39 1.55 40.83 12.71 2.07 39.67 -2.54 8.69 15.96 -4.15 7.36 16.15 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 1.32 4.77 9.99 2.33 6.07 12.30 2hsa_c01 source 2hsa 12-OXOPHYTODIENOATE REDUCTASE 3 : 3 hits 2hsa_c01 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 102 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 193 GLY A 55 GLY^? 10.36 O ACT A 139 coo 14.96 29.22 19.55 15.62 29.93 17.67 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 19.64 30.69 22.61 18.18 29.94 21.25 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 14.54 28.99 9.76 15.06 29.59 10.02 0.71 47.46 4.43 0.16 46.85 4.76 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS A 131 HIS^? 7.42 CL CL A 141 A 102 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 193 GLY A 55 GLY^? 10.36 O ACT A 139 coo 14.96 29.22 19.55 15.62 29.93 17.67 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 19.64 30.69 22.61 18.18 29.94 21.25 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo 14.54 28.99 9.76 15.06 29.59 10.02 0.71 47.46 4.43 0.16 46.85 4.76 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS B 110 HIS.? -3.67 O ACT B 139s A 102 ASP B 25 ASP.? 6.52 O ACT B 139 A 193 GLY B 55 GLY^? 4.13 CL CL B 141 coo 14.96 29.22 19.55 15.62 29.93 17.67 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 19.64 30.69 22.61 18.18 29.94 21.25 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 14.54 28.99 9.76 15.06 29.59 10.02 -40.59 35.18 8.37 -40.32 35.97 8.08 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 4 3 # 4 A 57 HIS B 131 HIS^? 7.27 CL CL B 140 A 102 ASP B 25 ASP.? 6.52 O ACT B 139 A 193 GLY B 55 GLY^? 4.13 CL CL B 141 coo 14.96 29.22 19.55 15.62 29.93 17.67 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 19.64 30.69 22.61 18.18 29.94 21.25 -46.76 41.93 17.76 -46.46 40.65 19.39 coo 14.54 28.99 9.76 15.06 29.59 10.02 -40.59 35.18 8.37 -40.32 35.97 8.08 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 5 3 # 5 A 57 HIS C 110 HIS.? 3.59 O ACT C 139s A 102 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 193 GLY C 55 GLY^? 8.81 O1 EDO C 140 coo 14.96 29.22 19.55 15.62 29.93 17.67 4.54 8.83 15.35 4.90 7.96 17.23 coo 19.64 30.69 22.61 18.18 29.94 21.25 4.46 12.53 17.74 4.84 11.35 19.48 coo 14.54 28.99 9.76 15.06 29.59 10.02 10.94 5.65 8.59 11.17 6.44 8.27 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 6 3 # 6 A 57 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 102 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 193 GLY C 55 GLY^? 8.81 O1 EDO C 140 coo 14.96 29.22 19.55 15.62 29.93 17.67 8.46 11.73 13.23 7.93 9.80 13.86 coo 19.64 30.69 22.61 18.18 29.94 21.25 4.46 12.53 17.74 4.84 11.35 19.48 coo 14.54 28.99 9.76 15.06 29.59 10.02 10.94 5.65 8.59 11.17 6.44 8.27 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 6 hits 2lpr_c02 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 137 PHE.? 13.51 C4 PG4 A 142 A 263 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 292 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 51.51 50.32 16.39 52.13 49.68 13.75 -6.61 37.64 11.75 -5.17 36.03 10.04 coo 54.43 44.82 23.74 55.21 45.06 21.80 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 63.95 45.30 16.71 59.11 49.15 16.05 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE B 137 PHE.? 13.84 C2 PG4 B 142 A 263 ASP B 135 ASP.? 12.47 O1 PG4 B 142 A 292 LYS B 31 LYS~? 7.73 C1 PG4 B 142 coo 51.51 50.32 16.39 52.13 49.68 13.75 -35.71 46.57 1.24 -33.59 46.16 2.95 coo 54.43 44.82 23.74 55.21 45.06 21.80 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 63.95 45.30 16.71 59.11 49.15 16.05 -41.17 57.91 7.48 -40.76 60.95 12.06 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE C 137 PHE.? 20.25 O1 EDO C 140 A 263 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 292 LYS C 31 LYS~? 22.12 CL CL A 141 coo 51.51 50.32 16.39 52.13 49.68 13.75 15.58 16.76 1.11 17.72 16.39 2.83 coo 54.43 44.82 23.74 55.21 45.06 21.80 7.61 19.22 2.17 7.62 20.80 3.62 coo 63.95 45.30 16.71 59.11 49.15 16.05 9.92 28.31 6.82 8.29 31.11 11.06 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 3 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 137 PHE.? 13.51 C4 PG4 A 142 B 263 ASP A 135 ASP.? 12.08 C3 PG4 A 142 B 292 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 49.99 26.05 6.28 51.46 26.87 8.49 -6.61 37.64 11.75 -5.17 36.03 10.04 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 60.53 31.67 0.97 57.79 27.51 3.63 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE B 137 PHE.? 13.84 C2 PG4 B 142 B 263 ASP B 135 ASP.? 12.47 O1 PG4 B 142 B 292 LYS B 31 LYS~? 7.73 C1 PG4 B 142 coo 49.99 26.05 6.28 51.46 26.87 8.49 -35.71 46.57 1.24 -33.59 46.16 2.95 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 60.53 31.67 0.97 57.79 27.51 3.63 -41.17 57.91 7.48 -40.76 60.95 12.06 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE C 137 PHE.? 20.25 O1 EDO C 140 B 263 ASP C 135 ASP.? 16.41 O1 EDO C 141 B 292 LYS C 31 LYS~? 22.12 CL CL A 141 coo 49.99 26.05 6.28 51.46 26.87 8.49 15.58 16.76 1.11 17.72 16.39 2.83 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 7.61 19.22 2.17 7.62 20.80 3.62 coo 60.53 31.67 0.97 57.79 27.51 3.63 9.92 28.31 6.82 8.29 31.11 11.06 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 3 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 137 PHE.? 13.51 C4 PG4 A 142 C 263 ASP A 135 ASP.? 12.08 C3 PG4 A 142 C 292 LYS A 31 LYS~? 8.03 C2 PG4 A 142 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -6.61 37.64 11.75 -5.17 36.03 10.04 coo 19.84 12.02 9.33 18.68 11.23 7.75 -12.78 43.39 10.70 -14.12 42.52 9.22 coo 12.82 3.49 4.98 17.80 5.59 1.90 -19.32 36.76 5.88 -23.26 35.95 1.25 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE B 137 PHE.? 13.84 C2 PG4 B 142 C 263 ASP B 135 ASP.? 12.47 O1 PG4 B 142 C 292 LYS B 31 LYS~? 7.73 C1 PG4 B 142 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -35.71 46.57 1.24 -33.59 46.16 2.95 coo 19.84 12.02 9.33 18.68 11.23 7.75 -43.74 49.08 2.60 -43.70 50.44 4.24 coo 12.82 3.49 4.98 17.80 5.59 1.90 -41.17 57.91 7.48 -40.76 60.95 12.06 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE C 137 PHE.? 20.25 O1 EDO C 140 C 263 ASP C 135 ASP.? 16.41 O1 EDO C 141 C 292 LYS C 31 LYS~? 22.12 CL CL A 141 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 15.58 16.76 1.11 17.72 16.39 2.83 coo 19.84 12.02 9.33 18.68 11.23 7.75 7.61 19.22 2.17 7.62 20.80 3.62 coo 12.82 3.49 4.98 17.80 5.59 1.90 9.92 28.31 6.82 8.29 31.11 11.06 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 3 hits 2oat_c05 naa= 3 ULMN 3 2phk_c02 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 151 LYS A 15 LYS~? 13.64 CL CL A 141 A 186 THR A 11 THR~? 14.98 O4 PG4 A 142 coo 41.42 17.90 44.98 43.39 18.36 45.61 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 45.75 16.58 39.61 47.43 18.26 45.54 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 45.88 23.02 44.72 46.99 21.16 44.68 -1.34 25.09 -0.69 0.81 25.31 -0.69 ULMN 3 2phk_c02 MC-PEPTIDE user 2 3 # 2 A 149 ASP A 13 ASP~? 8.68 O4 PG4 A 142 A 151 LYS A 16 LYS~? 4.07 C8 PG4 A 142 A 186 THR A 11 THR~? 14.98 O4 PG4 A 142 coo 41.42 17.90 44.98 43.39 18.36 45.61 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 45.75 16.58 39.61 47.43 18.26 45.54 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 45.88 23.02 44.72 46.99 21.16 44.68 -1.34 25.09 -0.69 0.81 25.31 -0.69 ULMN 3 2phk_c02 MC-PEPTIDE user 3 3 # 3 A 149 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 151 LYS B 15 LYS~? 14.97 CL CL B 140 A 186 THR B 11 THR~? 14.82 C3 PG4 B 142 coo 41.42 17.90 44.98 43.39 18.36 45.61 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 45.75 16.58 39.61 47.43 18.26 45.54 -27.71 47.06 15.95 -22.68 43.71 17.22 coo 45.88 23.02 44.72 46.99 21.16 44.68 -22.01 47.86 13.55 -21.15 45.90 13.39 ULMN 3 2phk_c02 MC-PEPTIDE user 4 3 # 4 A 149 ASP B 13 ASP~? 8.48 C4 PG4 B 142 A 151 LYS B 16 LYS~? 5.16 C5 PG4 B 142 A 186 THR B 11 THR~? 14.82 C3 PG4 B 142 coo 41.42 17.90 44.98 43.39 18.36 45.61 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 45.75 16.58 39.61 47.43 18.26 45.54 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 45.88 23.02 44.72 46.99 21.16 44.68 -22.01 47.86 13.55 -21.15 45.90 13.39 ULMN 3 2phk_c02 MC-PEPTIDE user 5 3 # 5 A 149 ASP C 13 ASP~? 27.02 O1 EDO C 140 A 151 LYS C 15 LYS~? 19.87 O1 EDO C 140 A 186 THR C 11 THR~? 23.65 O1 EDO C 140 coo 41.42 17.90 44.98 43.39 18.36 45.61 26.45 23.84 13.97 27.74 25.29 14.77 coo 45.75 16.58 39.61 47.43 18.26 45.54 23.48 18.06 15.81 27.69 13.80 17.86 coo 45.88 23.02 44.72 46.99 21.16 44.68 29.19 18.84 13.45 30.01 16.83 13.39 2phk_c02 source 2phk MC-PEPTIDE : 5 hits 2phk_c02 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 62 ASP~? -3.38 O ACT A 140s 166 GLY B 123 GLY.? 16.67 C3 PG4 A 142 169 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 8.28 6.87 1.62 10.08 5.77 1.34 -9.14 53.57 16.41 -8.61 54.95 17.94 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.03 36.67 16.32 -18.74 36.23 16.11 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 62 ASP~? -3.38 O ACT A 140s 166 GLY B 123 GLY.? 16.67 C3 PG4 A 142 169 GLU B 127 GLU^? 8.11 CL CL B 140 coo 8.28 6.87 1.62 10.08 5.77 1.34 -9.14 53.57 16.41 -8.61 54.95 17.94 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.03 36.67 16.32 -18.74 36.23 16.11 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -28.31 39.11 17.60 -29.33 39.55 19.43 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 104 ASP^? 12.12 O ACT A 139 166 GLY A 130 GLY^? -4.84 CL CL A 141s 169 GLU A 127 GLU^? 8.20 CL CL A 141 coo 8.28 6.87 1.62 10.08 5.77 1.34 2.26 57.49 7.12 4.30 57.24 7.17 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -4.89 41.74 -0.85 -4.61 41.77 -1.61 coo -16.67 7.89 2.78 -17.65 6.56 1.49 2.90 34.77 -4.78 2.12 35.30 -6.66 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP B 13 ASP~? 8.48 C4 PG4 B 142 166 GLY B 123 GLY.? 16.67 C3 PG4 A 142 169 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 8.28 6.87 1.62 10.08 5.77 1.34 -24.74 52.92 14.33 -24.14 54.73 15.30 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.03 36.67 16.32 -18.74 36.23 16.11 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP B 13 ASP~? 8.48 C4 PG4 B 142 166 GLY B 124 GLY.? 14.98 C3 PG4 A 142 169 GLU A 36 GLU~? 11.76 C4 PG4 A 142 coo 8.28 6.87 1.62 10.08 5.77 1.34 -24.74 52.92 14.33 -24.14 54.73 15.30 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -20.73 36.34 13.64 -20.83 36.37 14.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -12.87 29.42 9.52 -11.52 29.66 11.15 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP B 104 ASP^? 11.90 OXT ACT B 139 166 GLY B 130 GLY^? -4.77 CL CL B 140s 169 GLU B 127 GLU^? 8.11 CL CL B 140 coo 8.28 6.87 1.62 10.08 5.77 1.34 -48.63 28.94 5.87 -47.34 27.30 5.89 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -38.21 42.69 13.79 -38.12 42.42 14.57 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -28.31 39.11 17.60 -29.33 39.55 19.43 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP C 62 ASP~? -3.30 O1 EDO C 141s 166 GLY A 123 GLY.? 19.54 CL CL A 141 169 GLU A 127 GLU^? 8.20 CL CL A 141 coo 8.28 6.87 1.62 10.08 5.77 1.34 0.59 10.79 -3.25 -0.22 9.73 -4.86 coo -8.58 13.22 3.21 -8.90 13.15 4.05 10.21 27.06 -3.71 10.24 27.88 -3.50 coo -16.67 7.89 2.78 -17.65 6.56 1.49 2.90 34.77 -4.78 2.12 35.30 -6.66 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP C 62 ASP~? -3.30 O1 EDO C 141s 166 GLY A 123 GLY.? 19.54 CL CL A 141 169 GLU C 36 GLU~? -27.32 O1 EDO C 140s coo 8.28 6.87 1.62 10.08 5.77 1.34 0.59 10.79 -3.25 -0.22 9.73 -4.86 coo -8.58 13.22 3.21 -8.90 13.15 4.05 10.21 27.06 -3.71 10.24 27.88 -3.50 coo -16.67 7.89 2.78 -17.65 6.56 1.49 19.61 26.41 3.01 20.17 25.01 1.52 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 8 hits 2tdt_c00 naa= 3 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 106 TYR.? -4.43 O ACT A 139s A 172 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 267 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 26.78 20.44 0.03 28.51 18.26 0.09 -3.42 56.19 3.13 -4.04 54.71 0.79 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR B 106 TYR.? -4.35 OXT ACT B 139s A 172 HIS B 110 HIS.? -3.67 O ACT B 139s A 267 ASP B 25 ASP.? 6.52 O ACT B 139 coo 26.78 20.44 0.03 28.51 18.26 0.09 -50.21 34.52 9.84 -49.25 35.77 12.19 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 A 169 TYR C 106 TYR.? -4.43 OXT ACT C 139s A 172 HIS C 110 HIS.? 3.59 O ACT C 139s A 267 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 26.78 20.44 0.03 28.51 18.26 0.09 1.32 4.77 9.99 2.33 6.07 12.30 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 4.54 8.83 15.35 4.90 7.96 17.23 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 4.46 12.53 17.74 4.84 11.35 19.48 2tmd_c00 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 3 hits 2tmd_c00 naa= 3 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 106 TYR.? -4.43 O ACT A 139s B 172 HIS A 110 HIS.? -3.69 OXT ACT A 139s B 267 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 44.86 1.98 33.27 42.75 1.12 31.67 -3.42 56.19 3.13 -4.04 54.71 0.79 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR B 106 TYR.? -4.35 OXT ACT B 139s B 172 HIS B 110 HIS.? -3.67 O ACT B 139s B 267 ASP B 25 ASP.? 6.52 O ACT B 139 coo 44.86 1.98 33.27 42.75 1.12 31.67 -50.21 34.52 9.84 -49.25 35.77 12.19 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 B 169 TYR C 106 TYR.? -4.43 OXT ACT C 139s B 172 HIS C 110 HIS.? 3.59 O ACT C 139s B 267 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 44.86 1.98 33.27 42.75 1.12 31.67 1.32 4.77 9.99 2.33 6.07 12.30 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 4.54 8.83 15.35 4.90 7.96 17.23 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 4.46 12.53 17.74 4.84 11.35 19.48 2tmd_c01 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 3 hits 2tmd_c01 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 71 TYR~? 13.98 CL CL A 141 A 214 ASP A 135 ASP.? 12.08 C3 PG4 A 142 A 256 LYS B 47 LYS~? 12.98 C2 PG4 A 142 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -3.80 41.21 9.78 -5.71 41.25 7.73 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -12.78 43.39 10.70 -14.12 42.52 9.22 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -23.16 41.10 5.81 -22.85 46.07 1.96 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR C 71 TYR~? 15.80 O1 EDO C 140 A 214 ASP C 135 ASP.? 16.41 O1 EDO C 141 A 256 LYS A 47 LYS~? 18.08 C5 PG4 A 142 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 13.97 12.69 3.28 12.99 14.27 5.33 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 7.61 19.22 2.17 7.62 20.80 3.62 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 4.15 29.38 6.95 0.12 26.77 10.99 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 2 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 71 TYR~? 13.98 CL CL A 141 B 214 ASP A 135 ASP.? 12.08 C3 PG4 A 142 B 256 LYS B 47 LYS~? 12.98 C2 PG4 A 142 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -3.80 41.21 9.78 -5.71 41.25 7.73 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -12.78 43.39 10.70 -14.12 42.52 9.22 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -23.16 41.10 5.81 -22.85 46.07 1.96 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR C 71 TYR~? 15.80 O1 EDO C 140 B 214 ASP C 135 ASP.? 16.41 O1 EDO C 141 B 256 LYS A 47 LYS~? 18.08 C5 PG4 A 142 coo -32.67 22.74 10.17 -32.85 23.98 7.70 13.97 12.69 3.28 12.99 14.27 5.33 coo -26.88 17.61 16.89 -26.08 17.11 15.00 7.61 19.22 2.17 7.62 20.80 3.62 coo -16.04 12.06 11.09 -17.97 10.54 5.71 4.15 29.38 6.95 0.12 26.77 10.99 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 2 hits 2tpl_c05 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 19 ASN~? 8.40 CL CL A 141 coo 5.80 63.03 55.85 5.52 65.03 56.45 -5.47 34.18 -6.27 -3.38 33.66 -6.11 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 22 ASN.? 4.68 CL CL A 141 coo 5.80 63.03 55.85 5.52 65.03 56.45 -5.54 39.12 -7.49 -3.92 39.63 -8.80 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 95 ASN^? 17.50 CL CL A 141 coo 5.80 63.03 55.85 5.52 65.03 56.45 9.19 45.75 7.76 10.53 44.74 6.44 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 98 ASN.? 20.43 CL CL A 141 coo 5.80 63.03 55.85 5.52 65.03 56.45 14.36 45.07 8.83 12.99 46.22 7.72 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 126 ASN.? 14.45 CL CL A 141 coo 5.80 63.03 55.85 5.52 65.03 56.45 8.44 35.40 -3.89 10.18 35.21 -2.70 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN B 8 ASN.? 16.24 O ACT A 140 coo 5.80 63.03 55.85 5.52 65.03 56.45 -19.89 54.67 6.40 -20.05 54.35 4.28 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN B 19 ASN~? 8.46 CL CL B 140 coo 5.80 63.03 55.85 5.52 65.03 56.45 -31.83 46.76 19.25 -30.45 45.13 19.08 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 22 ASN.? 4.58 CL CL B 140 coo 5.80 63.03 55.85 5.52 65.03 56.45 -36.08 44.16 20.41 -35.99 42.40 21.63 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN B 95 ASN^? 8.94 CL CL B 141 coo 5.80 63.03 55.85 5.52 65.03 56.45 -34.95 28.63 4.74 -33.53 27.80 6.13 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN B 98 ASN.? 11.50 CL CL B 141 coo 5.80 63.03 55.85 5.52 65.03 56.45 -31.91 24.54 3.64 -33.68 25.20 4.62 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN B 126 ASN.? 13.70 CL CL B 141 coo 5.80 63.03 55.85 5.52 65.03 56.45 -26.16 33.99 16.45 -25.15 32.54 15.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN C 19 ASN~? 15.53 O1 EDO C 140 coo 5.80 63.03 55.85 5.52 65.03 56.45 19.24 17.98 19.14 20.52 16.30 19.33 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN C 22 ASN.? 10.99 C1 EDO C 140 coo 5.80 63.03 55.85 5.52 65.03 56.45 15.07 15.33 20.31 15.13 13.86 21.83 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN C 95 ASN^? 15.21 O1 EDO C 140 coo 5.80 63.03 55.85 5.52 65.03 56.45 16.76 -0.79 5.39 18.34 -1.36 6.71 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN C 98 ASN.? 17.50 O1 EDO C 140 coo 5.80 63.03 55.85 5.52 65.03 56.45 19.88 -4.91 4.36 18.11 -4.23 5.28 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN C 126 ASN.? 16.94 O1 EDO C 140 coo 5.80 63.03 55.85 5.52 65.03 56.45 25.29 5.14 16.83 26.51 3.77 15.70 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 16 hits 1kbk_p00 naa= 1 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR A 129 TYR^? 7.28 CL CL A 141 A 112 PHE A 21 PHE.? 5.40 O2 PG4 A 142 A 140 ASN A 22 ASN.? 4.68 CL CL A 141 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -8.98 38.97 -1.25 -10.83 37.74 0.41 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -5.54 39.12 -7.49 -3.92 39.63 -8.80 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 2 3 # 2 A 56 TYR B 129 TYR^? 7.32 CL CL B 140 A 112 PHE B 21 PHE.? 5.26 O1 PG4 B 142 A 140 ASN B 22 ASN.? 4.58 CL CL B 140 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -32.31 42.16 13.95 -29.70 41.99 14.85 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -37.81 47.58 14.44 -37.79 49.81 12.79 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -36.08 44.16 20.41 -35.99 42.40 21.63 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 3 3 # 3 A 56 TYR C 129 TYR^? 13.46 O1 EDO C 140 A 112 PHE C 21 PHE.? 15.03 C1 EDO C 140 A 140 ASN C 22 ASN.? 10.99 C1 EDO C 140 coo -6.29 44.15 17.65 -9.00 44.92 17.68 18.89 13.20 13.92 21.55 13.21 14.74 coo -7.38 52.77 16.75 -5.54 52.71 18.82 13.33 18.43 14.15 13.28 20.66 12.46 coo -4.46 50.64 12.29 -5.69 49.89 13.85 15.07 15.33 20.31 15.13 13.86 21.83 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 3 hits 1o8s_p00 naa= 3 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 1 3 # 1 A 459 ASN A 95 ASN^? 17.50 CL CL A 141 A 460 GLY A 99 GLY.? 22.26 CL CL A 141 A 461 ASN A 98 ASN.? 20.43 CL CL A 141 coo 15.00 94.38 6.97 13.00 93.59 6.99 9.19 45.75 7.76 10.53 44.74 6.44 coo 19.48 94.04 5.03 19.26 94.00 5.78 11.11 45.17 12.38 11.21 45.57 11.70 coo 20.23 95.69 9.16 21.55 97.37 9.20 14.36 45.07 8.83 12.99 46.22 7.72 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 2 3 # 2 A 459 ASN A 98 ASN.? 20.43 CL CL A 141 A 460 GLY A 99 GLY.? 22.26 CL CL A 141 A 461 ASN A 95 ASN^? 17.50 CL CL A 141 coo 15.00 94.38 6.97 13.00 93.59 6.99 14.36 45.07 8.83 12.99 46.22 7.72 coo 19.48 94.04 5.03 19.26 94.00 5.78 11.11 45.17 12.38 11.21 45.57 11.70 coo 20.23 95.69 9.16 21.55 97.37 9.20 9.19 45.75 7.76 10.53 44.74 6.44 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 3 3 # 3 A 459 ASN B 95 ASN^? 8.94 CL CL B 141 A 460 GLY B 99 GLY.? 13.44 CL CL B 141 A 461 ASN B 98 ASN.? 11.50 CL CL B 141 coo 15.00 94.38 6.97 13.00 93.59 6.99 -34.95 28.63 4.74 -33.53 27.80 6.13 coo 19.48 94.04 5.03 19.26 94.00 5.78 -33.56 27.44 0.16 -33.84 27.10 0.81 coo 20.23 95.69 9.16 21.55 97.37 9.20 -31.91 24.54 3.64 -33.68 25.20 4.62 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 4 3 # 4 A 459 ASN B 98 ASN.? 11.50 CL CL B 141 A 460 GLY B 99 GLY.? 13.44 CL CL B 141 A 461 ASN B 95 ASN^? 8.94 CL CL B 141 coo 15.00 94.38 6.97 13.00 93.59 6.99 -31.91 24.54 3.64 -33.68 25.20 4.62 coo 19.48 94.04 5.03 19.26 94.00 5.78 -33.56 27.44 0.16 -33.84 27.10 0.81 coo 20.23 95.69 9.16 21.55 97.37 9.20 -34.95 28.63 4.74 -33.53 27.80 6.13 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 5 3 # 5 A 459 ASN C 95 ASN^? 15.21 O1 EDO C 140 A 460 GLY C 99 GLY.? 20.09 O1 EDO C 140 A 461 ASN C 98 ASN.? 17.50 O1 EDO C 140 coo 15.00 94.38 6.97 13.00 93.59 6.99 16.76 -0.79 5.39 18.34 -1.36 6.71 coo 19.48 94.04 5.03 19.26 94.00 5.78 18.17 -2.27 0.74 17.88 -2.54 1.41 coo 20.23 95.69 9.16 21.55 97.37 9.20 19.88 -4.91 4.36 18.11 -4.23 5.28 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 6 3 # 6 A 459 ASN C 98 ASN.? 17.50 O1 EDO C 140 A 460 GLY C 96 GLY.? 17.66 O1 EDO C 140 A 461 ASN C 95 ASN^? 15.21 O1 EDO C 140 coo 15.00 94.38 6.97 13.00 93.59 6.99 19.88 -4.91 4.36 18.11 -4.23 5.28 coo 19.48 94.04 5.03 19.26 94.00 5.78 20.22 1.91 3.52 20.16 1.24 3.96 coo 20.23 95.69 9.16 21.55 97.37 9.20 16.76 -0.79 5.39 18.34 -1.36 6.71 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 7 3 # 7 A 459 ASN C 98 ASN.? 17.50 O1 EDO C 140 A 460 GLY C 99 GLY.? 20.09 O1 EDO C 140 A 461 ASN C 95 ASN^? 15.21 O1 EDO C 140 coo 15.00 94.38 6.97 13.00 93.59 6.99 19.88 -4.91 4.36 18.11 -4.23 5.28 coo 19.48 94.04 5.03 19.26 94.00 5.78 18.17 -2.27 0.74 17.88 -2.54 1.41 coo 20.23 95.69 9.16 21.55 97.37 9.20 16.76 -0.79 5.39 18.34 -1.36 6.71 2qv4_p00 source 2qv4 PANCREATIC ALPHA-AMYLASE : 7 hits 2qv4_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN B 8 ASN.? 16.24 O ACT A 140 A 384 ASN B 126 ASN.? 13.70 CL CL B 141 A 385 GLU B 127 GLU^? 8.11 CL CL B 140 coo 22.28 63.17 110.61 22.47 65.06 111.53 -19.89 54.67 6.40 -20.05 54.35 4.28 coo 7.06 50.07 96.17 8.50 48.54 96.31 -26.16 33.99 16.45 -25.15 32.54 15.21 coo 11.59 49.83 99.41 10.92 47.97 100.16 -28.31 39.11 17.60 -29.33 39.55 19.43 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 1 hits 2v3r_p00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 91 TYR^? -8.03 O ACT A 139s I 306 VAL A 90 VAL^? 7.90 O ACT A 140 I 308 VAL A 85 VAL.? 4.83 CH3 ACT A 140 coo 26.18 35.24 6.87 24.33 35.18 8.97 0.50 53.22 4.73 2.11 51.22 3.73 coo 23.55 29.53 9.81 23.15 27.39 10.24 -3.78 56.12 7.90 -4.14 55.60 9.99 coo 16.43 30.18 9.35 15.05 30.67 11.01 -1.46 58.56 15.67 -3.00 58.28 17.20 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 91 TYR^? -8.03 O ACT A 139s I 306 VAL A 90 VAL^? 7.90 O ACT A 140 I 308 VAL A 86 VAL.? -6.73 OXT ACT A 140s coo 26.18 35.24 6.87 24.33 35.18 8.97 0.50 53.22 4.73 2.11 51.22 3.73 coo 23.55 29.53 9.81 23.15 27.39 10.24 -3.78 56.12 7.90 -4.14 55.60 9.99 coo 16.43 30.18 9.35 15.05 30.67 11.01 -2.54 61.15 13.09 -1.32 60.64 11.34 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 129 TYR^? 7.28 CL CL A 141 I 306 VAL A 115 VAL^? 9.26 CL CL A 141 I 308 VAL A 113 VAL^? 10.83 CL CL A 141 coo 26.18 35.24 6.87 24.33 35.18 8.97 -1.60 36.85 -1.08 -0.19 34.61 -1.92 coo 23.55 29.53 9.81 23.15 27.39 10.24 0.40 40.97 2.98 -0.31 39.59 4.55 coo 16.43 30.18 9.35 15.05 30.67 11.01 -4.32 44.96 4.32 -4.01 44.19 6.37 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR B 91 TYR^? 6.76 CL CL B 141 I 306 VAL B 90 VAL^? 11.34 OXT ACT B 139 I 308 VAL B 85 VAL.? 19.04 OXT ACT B 139 coo 26.18 35.24 6.87 24.33 35.18 8.97 -45.69 32.60 8.25 -43.08 32.05 9.08 coo 23.55 29.53 9.81 23.15 27.39 10.24 -50.35 34.89 5.01 -50.09 35.44 2.89 coo 16.43 30.18 9.35 15.05 30.67 11.01 -51.42 31.80 -2.77 -51.91 33.36 -4.23 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR B 91 TYR^? 6.76 CL CL B 141 I 306 VAL B 90 VAL^? 11.34 OXT ACT B 139 I 308 VAL B 86 VAL.? -15.78 OXT ACT B 139s coo 26.18 35.24 6.87 24.33 35.18 8.97 -45.69 32.60 8.25 -43.08 32.05 9.08 coo 23.55 29.53 9.81 23.15 27.39 10.24 -50.35 34.89 5.01 -50.09 35.44 2.89 coo 16.43 30.18 9.35 15.05 30.67 11.01 -54.17 31.44 -0.18 -53.08 30.56 1.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR B 129 TYR^? 7.32 CL CL B 140 I 306 VAL B 115 VAL^? 7.17 CL CL B 141 I 308 VAL B 113 VAL^? 8.58 CL CL B 141 coo 26.18 35.24 6.87 24.33 35.18 8.97 -32.31 42.16 13.95 -29.70 41.99 14.85 coo 23.55 29.53 9.81 23.15 27.39 10.24 -35.01 38.55 9.91 -34.20 39.91 8.49 coo 16.43 30.18 9.35 15.05 30.67 11.01 -40.84 40.81 8.64 -39.97 40.93 6.62 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR C 91 TYR^? -7.96 OXT ACT C 139s I 306 VAL C 90 VAL^? 7.96 C2 EDO C 141 I 308 VAL C 85 VAL.? 5.33 C2 EDO C 141 coo 26.18 35.24 6.87 24.33 35.18 8.97 5.87 2.89 8.45 8.51 2.56 9.46 coo 23.55 29.53 9.81 23.15 27.39 10.24 1.16 5.05 5.16 1.33 5.67 3.06 coo 16.43 30.18 9.35 15.05 30.67 11.01 0.22 1.77 -2.53 -0.22 3.27 -4.03 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR C 91 TYR^? -7.96 OXT ACT C 139s I 306 VAL C 90 VAL^? 7.96 C2 EDO C 141 I 308 VAL C 86 VAL.? -6.64 C2 EDO C 141s coo 26.18 35.24 6.87 24.33 35.18 8.97 5.87 2.89 8.45 8.51 2.56 9.46 coo 23.55 29.53 9.81 23.15 27.39 10.24 1.16 5.05 5.16 1.33 5.67 3.06 coo 16.43 30.18 9.35 15.05 30.67 11.01 -2.57 1.43 0.04 -1.48 0.61 1.80 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR C 129 TYR^? 13.46 O1 EDO C 140 I 306 VAL C 115 VAL^? 11.57 O1 EDO C 140 I 308 VAL C 113 VAL^? 11.48 O1 EDO C 140 coo 26.18 35.24 6.87 24.33 35.18 8.97 18.89 13.20 13.92 21.55 13.21 14.74 coo 23.55 29.53 9.81 23.15 27.39 10.24 16.37 9.17 10.07 17.13 10.52 8.54 coo 16.43 30.18 9.35 15.05 30.67 11.01 10.57 11.31 8.67 11.34 11.45 6.59 1cqt_d00 source 1cqt GENE REGULATION/DNA : 9 hits 1cqt_d00 naa= 3 ULMN 4 1dsz_d00 TRANSCRIPTION/DNA user 1 4 # 1 A1153 GLU B 34 GLU~? -4.36 C1 PG4 B 142s A1156 LYS B 35 LYS~? 12.61 C1 PG4 B 142 A1160 ARG B 39 ARG~? 11.86 C2 PG4 B 142 A1161 ARG B 40 ARG~? 9.95 C3 PG4 B 142 coo 24.91 6.66 1.99 23.65 5.59 0.65 -37.87 57.41 10.67 -39.60 57.08 11.90 coo 18.15 8.28 2.24 21.63 3.94 -0.54 -36.80 53.61 6.27 -41.39 52.63 2.26 coo 15.01 1.75 1.61 16.32 0.90 4.30 -34.24 50.49 2.21 -35.83 53.07 1.56 coo 14.98 2.34 8.97 17.45 4.34 8.92 -28.07 54.35 5.16 -26.37 56.02 7.18 1dsz_d00 source 1dsz TRANSCRIPTION/DNA : 1 hits 1dsz_d00 naa= 4 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 28 PRO.? 7.21 C2 PG4 A 142 A 272 LEU A 30 LEU.? 5.15 C3 PG4 A 142 A 276 ARG A 39 ARG~? 11.53 C4 PG4 A 142 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -13.90 41.50 0.15 -14.06 43.59 0.81 coo 10.97 0.43 16.73 11.31 2.11 18.06 -15.49 38.41 4.39 -13.98 38.17 2.91 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -9.34 34.41 10.95 -12.33 34.37 11.59 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO A 32 PRO~? 10.43 C3 PG4 A 142 A 272 LEU A 30 LEU.? 5.15 C3 PG4 A 142 A 276 ARG A 39 ARG~? 11.53 C4 PG4 A 142 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -20.21 35.69 10.01 -18.57 35.31 8.56 coo 10.97 0.43 16.73 11.31 2.11 18.06 -15.49 38.41 4.39 -13.98 38.17 2.91 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -9.34 34.41 10.95 -12.33 34.37 11.59 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO A 133 PRO.? 9.25 C3 PG4 A 142 A 272 LEU A 134 LEU.? 12.12 O ACT A 140 A 276 ARG A 111 ARG.? 7.83 OXT ACT A 139 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -11.49 40.98 4.42 -9.90 42.51 4.81 coo 10.97 0.43 16.73 11.31 2.11 18.06 -9.54 46.58 8.31 -8.62 48.40 7.58 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -9.64 52.74 3.70 -9.14 55.70 2.93 ULMN 3 1emh_d00 HYDROLASE/DNA user 4 3 # 4 A 271 PRO B 28 PRO.? 7.52 O1 PG4 B 142 A 272 LEU B 30 LEU.? 5.55 O1 PG4 B 142 A 276 ARG B 39 ARG~? 11.86 C2 PG4 B 142 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -42.40 50.48 13.49 -44.33 49.80 12.52 coo 10.97 0.43 16.73 11.31 2.11 18.06 -40.62 53.76 8.90 -39.66 52.53 10.44 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -34.24 50.49 2.21 -35.83 53.07 1.56 ULMN 3 1emh_d00 HYDROLASE/DNA user 5 3 # 5 A 271 PRO B 32 PRO~? 10.92 C1 PG4 B 142 A 272 LEU B 30 LEU.? 5.55 O1 PG4 B 142 A 276 ARG B 39 ARG~? 11.86 C2 PG4 B 142 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -40.71 59.29 3.30 -39.55 57.97 4.77 coo 10.97 0.43 16.73 11.31 2.11 18.06 -40.62 53.76 8.90 -39.66 52.53 10.44 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -34.24 50.49 2.21 -35.83 53.07 1.56 ULMN 3 1emh_d00 HYDROLASE/DNA user 6 3 # 6 A 271 PRO B 133 PRO.? 9.28 O1 PG4 B 142 A 272 LEU B 134 LEU.? 13.82 OXT ACT B 139 A 276 ARG B 111 ARG.? 7.92 O ACT B 139 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -41.06 48.99 8.68 -41.50 46.85 8.30 coo 10.97 0.43 16.73 11.31 2.11 18.06 -44.97 44.65 4.78 -46.05 42.93 5.57 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -50.20 41.64 9.27 -52.60 39.78 9.98 ULMN 3 1emh_d00 HYDROLASE/DNA user 7 3 # 7 A 271 PRO C 28 PRO.? 15.75 C1 EDO C 140 A 272 LEU C 30 LEU.? 19.79 C1 EDO C 140 A 276 ARG C 39 ARG~? 23.08 O1 EDO C 141 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 8.70 21.26 12.80 6.79 20.36 12.09 coo 10.97 0.43 16.73 11.31 2.11 18.06 10.56 24.24 8.41 11.50 23.07 9.96 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 17.00 20.76 1.74 15.55 23.42 1.18 ULMN 3 1emh_d00 HYDROLASE/DNA user 8 3 # 8 A 271 PRO C 32 PRO~? 20.41 CL CL A 141 A 272 LEU C 30 LEU.? 19.79 C1 EDO C 140 A 276 ARG C 39 ARG~? 23.08 O1 EDO C 141 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 10.28 29.47 2.62 11.50 28.33 4.11 coo 10.97 0.43 16.73 11.31 2.11 18.06 10.56 24.24 8.41 11.50 23.07 9.96 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 17.00 20.76 1.74 15.55 23.42 1.18 ULMN 3 1emh_d00 HYDROLASE/DNA user 9 3 # 9 A 271 PRO C 133 PRO.? 15.63 C1 EDO C 140 A 272 LEU C 134 LEU.? 12.00 O1 EDO C 141 A 276 ARG C 111 ARG.? 7.98 O ACT C 139 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 10.17 19.43 8.44 9.76 17.24 8.14 coo 10.97 0.43 16.73 11.31 2.11 18.06 6.41 14.95 4.68 5.41 13.16 5.46 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 1.09 11.93 9.22 -1.20 10.06 10.11 1emh_d00 source 1emh HYDROLASE/DNA : 9 hits 1emh_d00 naa= 3 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG A 39 ARG~? 11.53 C4 PG4 A 142 C 71 LYS A 35 LYS~? 11.98 C3 PG4 A 142 C 72 VAL A 38 VAL~? 5.28 C4 PG4 A 142 coo 23.89 33.54 29.21 26.59 34.86 28.68 -9.34 34.41 10.95 -12.33 34.37 11.59 coo 25.82 26.89 29.68 23.33 22.98 25.84 -13.45 35.10 6.93 -14.45 39.53 11.08 coo 28.86 29.08 30.37 28.04 31.02 29.93 -9.43 33.41 4.30 -9.69 35.24 3.17 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG B 39 ARG~? 11.86 C2 PG4 B 142 C 71 LYS B 35 LYS~? 12.61 C1 PG4 B 142 C 72 VAL B 38 VAL~? 5.58 C2 PG4 B 142 coo 23.89 33.54 29.21 26.59 34.86 28.68 -34.24 50.49 2.21 -35.83 53.07 1.56 coo 25.82 26.89 29.68 23.33 22.98 25.84 -36.80 53.61 6.27 -41.39 52.63 2.26 coo 28.86 29.08 30.37 28.04 31.02 29.93 -33.32 50.87 8.85 -35.20 50.28 9.85 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 3 3 # 3 C 70 ARG B 40 ARG~? 9.95 C3 PG4 B 142 C 71 LYS B 35 LYS~? 12.61 C1 PG4 B 142 C 72 VAL B 38 VAL~? 5.58 C2 PG4 B 142 coo 23.89 33.54 29.21 26.59 34.86 28.68 -28.07 54.35 5.16 -26.37 56.02 7.18 coo 25.82 26.89 29.68 23.33 22.98 25.84 -36.80 53.61 6.27 -41.39 52.63 2.26 coo 28.86 29.08 30.37 28.04 31.02 29.93 -33.32 50.87 8.85 -35.20 50.28 9.85 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 4 3 # 4 C 70 ARG C 39 ARG~? 23.08 O1 EDO C 141 C 71 LYS C 35 LYS~? 18.91 O1 EDO C 141 C 72 VAL C 38 VAL~? 19.34 O1 EDO C 140 coo 23.89 33.54 29.21 26.59 34.86 28.68 17.00 20.76 1.74 15.55 23.42 1.18 coo 25.82 26.89 29.68 23.33 22.98 25.84 14.41 24.06 5.83 10.24 22.70 1.76 coo 28.86 29.08 30.37 28.04 31.02 29.93 17.93 21.50 8.51 16.11 20.88 9.50 1hwt_d00 source 1hwt GENE REGULATION/DNA : 4 hits 1hwt_d00 naa= 3 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG B 39 ARG~? 11.86 C2 PG4 B 142 E 41 TYR B 71 TYR~? 11.95 CL CL B 141 E 83 ARG C 111 ARG.? 7.98 O ACT C 139 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -34.24 50.49 2.21 -35.83 53.07 1.56 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -37.36 42.24 3.20 -38.26 43.87 5.26 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 1.09 11.93 9.22 -1.20 10.06 10.11 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 1 hits 1id3_d00 naa= 3 ULMN 4 1kb6_d00 TRANSCRIPTION/DNA user 1 4 # 1 B 242 GLU B 34 GLU~? -4.36 C1 PG4 B 142s B 245 LYS B 35 LYS~? 12.61 C1 PG4 B 142 B 249 ARG B 39 ARG~? 11.86 C2 PG4 B 142 B 250 ARG B 40 ARG~? 9.95 C3 PG4 B 142 coo -0.89 32.39 60.42 -0.92 32.12 58.30 -37.87 57.41 10.67 -39.60 57.08 11.90 coo -4.54 26.92 60.10 0.40 29.01 56.76 -36.80 53.61 6.27 -41.39 52.63 2.26 coo 0.78 21.41 59.82 1.77 24.31 59.87 -34.24 50.49 2.21 -35.83 53.07 1.56 coo 0.56 22.39 66.71 0.61 25.40 66.07 -28.07 54.35 5.16 -26.37 56.02 7.18 1kb6_d00 source 1kb6 TRANSCRIPTION/DNA : 1 hits 1kb6_d00 naa= 4 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 1 3 # 1 A 40 LYS A 15 LYS~? 13.64 CL CL A 141 A 41 LYS A 16 LYS~? 4.07 C8 PG4 A 142 A 42 ILE A 17 ILE~? 4.04 C5 PG4 A 142 coo 36.07 63.73 124.22 32.72 60.75 122.39 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 38.49 66.12 125.64 35.69 66.71 131.25 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 41.08 63.27 123.17 40.13 62.43 122.44 -8.69 31.18 -0.49 -9.36 30.58 0.59 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 2 3 # 2 A 40 LYS A 16 LYS~? 4.07 C8 PG4 A 142 A 41 LYS A 15 LYS~? 13.64 CL CL A 141 A 42 ILE A 17 ILE~? 4.04 C5 PG4 A 142 coo 36.07 63.73 124.22 32.72 60.75 122.39 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 38.49 66.12 125.64 35.69 66.71 131.25 -3.53 30.44 -3.03 2.12 29.06 -5.24 coo 41.08 63.27 123.17 40.13 62.43 122.44 -8.69 31.18 -0.49 -9.36 30.58 0.59 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 3 3 # 3 A 40 LYS B 15 LYS~? 14.97 CL CL B 140 A 41 LYS B 16 LYS~? 5.16 C5 PG4 B 142 A 42 ILE B 17 ILE~? -4.23 C3 PG4 B 142s coo 36.07 63.73 124.22 32.72 60.75 122.39 -27.71 47.06 15.95 -22.68 43.71 17.22 coo 38.49 66.12 125.64 35.69 66.71 131.25 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 41.08 63.27 123.17 40.13 62.43 122.44 -30.93 51.19 13.57 -30.77 52.02 12.48 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 4 3 # 4 A 40 LYS B 16 LYS~? 5.16 C5 PG4 B 142 A 41 LYS B 15 LYS~? 14.97 CL CL B 140 A 42 ILE B 17 ILE~? -4.23 C3 PG4 B 142s coo 36.07 63.73 124.22 32.72 60.75 122.39 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 38.49 66.12 125.64 35.69 66.71 131.25 -27.71 47.06 15.95 -22.68 43.71 17.22 coo 41.08 63.27 123.17 40.13 62.43 122.44 -30.93 51.19 13.57 -30.77 52.02 12.48 1pyi_d00 source 1pyi PROTEIN (PYRIMIDINE PATHWAY REGULATOR 1) : 4 hits 1pyi_d00 naa= 3 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 563 LYS B 35 LYS~? 12.61 C1 PG4 B 142 A 564 VAL B 38 VAL~? 5.58 C2 PG4 B 142 A 568 ARG B 40 ARG~? 9.95 C3 PG4 B 142 coo -6.60 80.79 55.64 -8.55 79.48 61.01 -36.80 53.61 6.27 -41.39 52.63 2.26 coo -9.25 78.14 55.31 -11.11 77.94 56.39 -33.32 50.87 8.85 -35.20 50.28 9.85 coo -12.31 74.86 52.32 -13.99 74.91 54.92 -28.07 54.35 5.16 -26.37 56.02 7.18 1r4i_d00 source 1r4i TRANSCRIPTION/DNA : 1 hits 1r4i_d00 naa= 3 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 1 3 # 1 A1290 LYS A 16 LYS~? 4.07 C8 PG4 A 142 A1294 ASN A 19 ASN~? 8.40 CL CL A 141 A1297 GLU A 127 GLU^? 8.20 CL CL A 141 coo 39.24 18.84-161.99 36.62 21.47-165.99 -6.79 30.20 -4.87 -11.32 27.78 -7.03 coo 33.53 17.37-161.81 34.31 17.81-163.76 -5.47 34.18 -6.27 -3.38 33.66 -6.11 coo 29.78 23.31-161.30 31.23 23.66-162.84 2.90 34.77 -4.78 2.12 35.30 -6.66 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 2 3 # 2 A1290 LYS B 16 LYS~? 5.16 C5 PG4 B 142 A1294 ASN B 19 ASN~? 8.46 CL CL B 140 A1297 GLU B 127 GLU^? 8.11 CL CL B 140 coo 39.24 18.84-161.99 36.62 21.47-165.99 -29.09 50.01 17.90 -28.96 54.88 21.75 coo 33.53 17.37-161.81 34.31 17.81-163.76 -31.83 46.76 19.25 -30.45 45.13 19.08 coo 29.78 23.31-161.30 31.23 23.66-162.84 -28.31 39.11 17.60 -29.33 39.55 19.43 1xpx_d00 source 1xpx TRANSCRIPTION REGULATION/DNA : 2 hits 1xpx_d00 naa= 3 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 119 SER.? 16.13 CL CL A 141 B 37 ASN A 126 ASN.? 14.45 CL CL A 141 B 45 THR A 11 THR~? 14.98 O4 PG4 A 142 coo -19.49 41.97 71.08 -17.37 40.80 71.17 11.23 33.92 0.93 9.27 32.55 0.99 coo -23.05 39.62 69.74 -22.86 39.59 67.61 8.44 35.40 -3.89 10.18 35.21 -2.70 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -1.34 25.09 -0.69 0.81 25.31 -0.69 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER B 119 SER.? 14.69 C3 PG4 A 142 B 37 ASN B 126 ASN.? 13.70 CL CL B 141 B 45 THR B 11 THR~? 14.82 C3 PG4 B 142 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -23.53 32.55 11.61 -23.32 34.95 11.84 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -26.16 33.99 16.45 -25.15 32.54 15.21 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -22.01 47.86 13.55 -21.15 45.90 13.39 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER C 119 SER.? 19.22 O1 EDO C 140 B 37 ASN C 126 ASN.? 16.94 O1 EDO C 140 B 45 THR C 11 THR~? 23.65 O1 EDO C 140 coo -19.49 41.97 71.08 -17.37 40.80 71.17 27.99 3.53 12.09 28.26 5.94 12.28 coo -23.05 39.62 69.74 -22.86 39.59 67.61 25.29 5.14 16.83 26.51 3.77 15.70 coo -30.87 34.84 80.57 -28.94 34.51 81.49 29.19 18.84 13.45 30.01 16.83 13.39 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 3 hits 2z3x_d00 naa= 3 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 21 GLN A 118 GLN^? 11.96 CL CL A 141 A 41 TYR A 120 TYR.? -20.76 CL CL A 141s A 43 ASN A 126 ASN.? 14.45 CL CL A 141 coo 22.03 6.35 12.16 20.71 6.08 10.54 8.79 39.38 1.33 8.57 40.42 -0.51 coo 18.67 0.21 9.03 16.70 -1.66 8.55 15.94 35.05 2.39 15.79 37.48 3.75 coo 14.90 7.30 8.78 14.25 8.14 6.97 8.44 35.40 -3.89 10.18 35.21 -2.70 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 21 GLN B 118 GLN^? 8.34 CL CL B 141 A 41 TYR B 120 TYR.? 13.58 O3 PG4 A 142 A 43 ASN B 126 ASN.? 13.70 CL CL B 141 coo 22.03 6.35 12.16 20.71 6.08 10.54 -29.49 31.92 11.27 -30.35 31.49 13.17 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -22.08 28.00 9.76 -23.99 27.18 7.88 coo 14.90 7.30 8.78 14.25 8.14 6.97 -26.16 33.99 16.45 -25.15 32.54 15.21 3ssc_d00 source 3ssc DNA BINDING PROTEIN/DNA : 2 hits 3ssc_d00 naa= 3 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 1 3 # 1 B 442 LYS B 35 LYS~? 12.61 C1 PG4 B 142 B 443 VAL B 38 VAL~? 5.58 C2 PG4 B 142 B 447 ARG B 40 ARG~? 9.95 C3 PG4 B 142 coo -11.49 8.72 29.13 -11.20 3.78 25.16 -36.80 53.61 6.27 -41.39 52.63 2.26 coo -11.96 6.22 31.96 -10.74 4.61 32.81 -33.32 50.87 8.85 -35.20 50.28 9.85 coo -14.58 4.58 36.41 -12.11 2.82 36.84 -28.07 54.35 5.16 -26.37 56.02 7.18 4hn5_d00 source 4hn5 TRANSCRIPTION/DNA : 1 hits 4hn5_d00 naa= 3 ULMN 3 1hq0_o00 CYTOTOXIC NECROTIZING FACTOR 1 user 1 3 # 1 A 833 VAL A 113 VAL^? 10.83 CL CL A 141 A 866 CYH A 23 CYH.? -5.05 CL CL A 141s A 881 HIS A 131 HIS^? 7.42 CL CL A 141 coo 14.42 17.43 18.29 12.57 16.27 18.27 -4.32 44.96 4.32 -4.01 44.19 6.37 coo 12.88 23.75 28.18 13.64 25.11 25.83 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo 12.85 19.92 23.16 14.49 20.89 24.04 -5.82 46.49 -0.22 -4.38 47.88 -0.81 ULMN 3 1hq0_o00 CYTOTOXIC NECROTIZING FACTOR 1 user 2 3 # 2 A 833 VAL B 113 VAL^? 8.58 CL CL B 141 A 866 CYH B 23 CYH.? -4.94 CL CL B 140s A 881 HIS B 131 HIS^? 7.27 CL CL B 140 coo 14.42 17.43 18.29 12.57 16.27 18.27 -40.84 40.81 8.64 -39.97 40.93 6.62 coo 12.88 23.75 28.18 13.64 25.11 25.83 -40.38 42.16 20.28 -39.12 40.88 22.30 coo 12.85 19.92 23.16 14.49 20.89 24.04 -42.92 41.25 13.23 -43.42 39.34 13.91 ULMN 3 1hq0_o00 CYTOTOXIC NECROTIZING FACTOR 1 user 3 3 # 3 A 833 VAL C 113 VAL^? 11.48 O1 EDO C 140 A 866 CYH C 23 CYH.? 8.42 C1 EDO C 140 A 881 HIS C 131 HIS^? 6.39 C1 EDO C 140 coo 14.42 17.43 18.29 12.57 16.27 18.27 10.57 11.31 8.67 11.34 11.45 6.59 coo 12.88 23.75 28.18 13.64 25.11 25.83 10.88 13.11 20.21 12.25 12.11 22.32 coo 12.85 19.92 23.16 14.49 20.89 24.04 8.46 11.73 13.23 7.93 9.80 13.86 1hq0_o00 source 1Hq0 CYTOTOXIC NECROTIZING FACTOR 1 : 3 hits 1hq0_o00 naa= 3 ULMN 3 1ukf_o00 AVIRULENCE PROTEIN AVRPPH3 user 1 3 # 1 A 98 CYH A 57 CYH^? 5.51 O ACT A 139 A 212 HIS A 131 HIS^? 7.42 CL CL A 141 A 227 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 32.24 40.70 41.87 34.94 39.83 42.22 -4.80 51.41 4.83 -3.45 51.64 2.37 coo 35.63 37.64 46.24 33.55 37.41 46.24 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 30.05 37.79 50.12 31.66 36.75 49.22 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 1ukf_o00 AVIRULENCE PROTEIN AVRPPH3 user 2 3 # 2 A 98 CYH B 57 CYH^? 5.44 OXT ACT B 139 A 212 HIS B 131 HIS^? 7.27 CL CL B 140 A 227 ASP B 25 ASP.? 6.52 O ACT B 139 coo 32.24 40.70 41.87 34.94 39.83 42.22 -46.68 38.10 8.15 -46.29 36.73 10.60 coo 35.63 37.64 46.24 33.55 37.41 46.24 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 30.05 37.79 50.12 31.66 36.75 49.22 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 1ukf_o00 AVIRULENCE PROTEIN AVRPPH3 user 3 3 # 3 A 98 CYH C 57 CYH^? 5.55 OXT ACT C 139 A 212 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 227 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 32.24 40.70 41.87 34.94 39.83 42.22 4.72 8.42 8.22 5.18 7.19 10.69 coo 35.63 37.64 46.24 33.55 37.41 46.24 8.46 11.73 13.23 7.93 9.80 13.86 coo 30.05 37.79 50.12 31.66 36.75 49.22 4.46 12.53 17.74 4.84 11.35 19.48 1ukf_o00 source 1UKF AVIRULENCE PROTEIN AVRPPH3 : 3 hits 1ukf_o00 naa= 3 ULMN 3 2ebf_o00 DERMONECROTIC TOXIN user 1 3 # 1 X1165 CYH A 57 CYH^? 5.51 O ACT A 139 X1205 HIS A 109 HIS.? -5.41 OXT ACT A 139s X1220 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo -26.56 24.53 92.56 -24.57 23.58 94.36 -4.80 51.41 4.83 -3.45 51.64 2.37 coo -19.40 30.09 91.63 -20.33 29.86 93.49 -8.77 57.48 -2.79 -8.58 59.56 -2.89 coo -21.03 32.79 97.44 -20.59 31.13 96.21 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 2ebf_o00 DERMONECROTIC TOXIN user 2 3 # 2 X1165 CYH A 57 CYH^? 5.51 O ACT A 139 X1205 HIS A 131 HIS^? 7.42 CL CL A 141 X1220 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo -26.56 24.53 92.56 -24.57 23.58 94.36 -4.80 51.41 4.83 -3.45 51.64 2.37 coo -19.40 30.09 91.63 -20.33 29.86 93.49 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo -21.03 32.79 97.44 -20.59 31.13 96.21 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 2ebf_o00 DERMONECROTIC TOXIN user 3 3 # 3 X1165 CYH B 57 CYH^? 5.44 OXT ACT B 139 X1205 HIS B 109 HIS.? -5.47 O ACT B 139s X1220 ASP B 25 ASP.? 6.52 O ACT B 139 coo -26.56 24.53 92.56 -24.57 23.58 94.36 -46.68 38.10 8.15 -46.29 36.73 10.60 coo -19.40 30.09 91.63 -20.33 29.86 93.49 -54.00 38.48 15.75 -55.77 37.34 15.88 coo -21.03 32.79 97.44 -20.59 31.13 96.21 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 2ebf_o00 DERMONECROTIC TOXIN user 4 3 # 4 X1165 CYH C 57 CYH^? 5.55 OXT ACT C 139 X1205 HIS C 109 HIS.? -5.44 O ACT C 139s X1220 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo -26.56 24.53 92.56 -24.57 23.58 94.36 4.72 8.42 8.22 5.18 7.19 10.69 coo -19.40 30.09 91.63 -20.33 29.86 93.49 -2.54 8.69 15.96 -4.15 7.36 16.15 coo -21.03 32.79 97.44 -20.59 31.13 96.21 4.46 12.53 17.74 4.84 11.35 19.48 2ebf_o00 source 2EBF DERMONECROTIC TOXIN : 4 hits 2ebf_o00 naa= 3 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 208 ASP A 59 ASP.? 10.45 O ACT A 140 A 296 SER A 37 SER~? 5.05 O3 PG4 A 142 coo 12.72 17.48 24.71 12.80 19.37 23.81 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 18.47 29.19 29.68 19.30 29.17 27.75 -11.63 55.20 7.79 -12.68 54.74 6.05 coo 6.89 17.22 46.63 5.08 16.21 47.91 -11.55 30.40 5.05 -13.38 29.33 4.03 ULMN 3 2odj_o00 PORIN D user 2 3 # 2 A 156 HIS A 131 HIS^? 7.42 CL CL A 141 A 208 ASP A 59 ASP.? 10.45 O ACT A 140 A 296 SER B 49 SER.? 12.95 CL CL B 141 coo 12.72 17.48 24.71 12.80 19.37 23.81 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 18.47 29.19 29.68 19.30 29.17 27.75 -11.63 55.20 7.79 -12.68 54.74 6.05 coo 6.89 17.22 46.63 5.08 16.21 47.91 -23.84 36.86 9.13 -26.20 37.40 8.61 ULMN 3 2odj_o00 PORIN D user 3 3 # 3 A 156 HIS B 110 HIS.? -3.67 O ACT B 139s A 208 ASP B 59 ASP.? 11.98 O ACT B 139 A 296 SER B 37 SER~? 4.81 O2 PG4 B 142 coo 12.72 17.48 24.71 12.80 19.37 23.81 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 18.47 29.19 29.68 19.30 29.17 27.75 -53.34 42.20 5.44 -53.68 42.89 7.35 coo 6.89 17.22 46.63 5.08 16.21 47.91 -31.75 54.24 8.19 -32.12 56.34 9.40 ULMN 3 2odj_o00 PORIN D user 4 3 # 4 A 156 HIS C 110 HIS.? 3.59 O ACT C 139s A 208 ASP C 59 ASP.? 10.26 O1 EDO C 141 A 296 SER C 37 SER~? 25.30 O1 EDO C 140 coo 12.72 17.48 24.71 12.80 19.37 23.81 4.54 8.83 15.35 4.90 7.96 17.23 coo 18.47 29.19 29.68 19.30 29.17 27.75 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 6.89 17.22 46.63 5.08 16.21 47.91 19.44 24.86 7.68 19.21 27.10 8.59 ULMN 3 2odj_o00 PORIN D user 5 3 # 5 A 156 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 208 ASP C 59 ASP.? 10.26 O1 EDO C 141 A 296 SER A 49 SER.? 14.71 CL CL A 141 coo 12.72 17.48 24.71 12.80 19.37 23.81 8.46 11.73 13.23 7.93 9.80 13.86 coo 18.47 29.19 29.68 19.30 29.17 27.75 -1.96 12.33 5.23 -2.08 13.48 6.95 coo 6.89 17.22 46.63 5.08 16.21 47.91 7.42 32.00 3.53 5.70 33.62 4.04 2odj_o00 source 2ODJ PORIN D : 5 hits 2odj_o00 naa= 3 ULMN 3 2odj_o01 PORIN D user 1 3 # 1 B 156 HIS A 110 HIS.? -3.69 OXT ACT A 139s B 208 ASP A 59 ASP.? 10.45 O ACT A 140 B 296 SER A 37 SER~? 5.05 O3 PG4 A 142 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -11.63 55.20 7.79 -12.68 54.74 6.05 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -11.55 30.40 5.05 -13.38 29.33 4.03 ULMN 3 2odj_o01 PORIN D user 2 3 # 2 B 156 HIS A 131 HIS^? 7.42 CL CL A 141 B 208 ASP A 59 ASP.? 10.45 O ACT A 140 B 296 SER B 49 SER.? 12.95 CL CL B 141 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -11.63 55.20 7.79 -12.68 54.74 6.05 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -23.84 36.86 9.13 -26.20 37.40 8.61 ULMN 3 2odj_o01 PORIN D user 3 3 # 3 B 156 HIS B 110 HIS.? -3.67 O ACT B 139s B 208 ASP B 59 ASP.? 11.98 O ACT B 139 B 296 SER B 37 SER~? 4.81 O2 PG4 B 142 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -46.84 38.28 15.22 -46.41 37.31 17.03 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -53.34 42.20 5.44 -53.68 42.89 7.35 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -31.75 54.24 8.19 -32.12 56.34 9.40 ULMN 3 2odj_o01 PORIN D user 4 3 # 4 B 156 HIS C 110 HIS.? 3.59 O ACT C 139s B 208 ASP C 59 ASP.? 10.26 O1 EDO C 141 B 296 SER C 37 SER~? 25.30 O1 EDO C 140 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 4.54 8.83 15.35 4.90 7.96 17.23 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -1.96 12.33 5.23 -2.08 13.48 6.95 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 19.44 24.86 7.68 19.21 27.10 8.59 ULMN 3 2odj_o01 PORIN D user 5 3 # 5 B 156 HIS C 131 HIS^? 6.39 C1 EDO C 140 B 208 ASP C 59 ASP.? 10.26 O1 EDO C 141 B 296 SER A 49 SER.? 14.71 CL CL A 141 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 8.46 11.73 13.23 7.93 9.80 13.86 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -1.96 12.33 5.23 -2.08 13.48 6.95 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 7.42 32.00 3.53 5.70 33.62 4.04 2odj_o01 source 2ODJ PORIN D : 5 hits 2odj_o01 naa= 3 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 E 49 ASP A 25 ASP.? 6.66 OXT ACT A 139 E 86 HIS A 131 HIS^? 7.42 CL CL A 141 E 250 ALA A 58 ALA^? 8.62 O ACT A 140 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -7.65 52.47 7.15 -7.34 51.97 8.48 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 E 49 ASP B 25 ASP.? 6.52 O ACT B 139 E 86 HIS B 131 HIS^? 7.27 CL CL B 140 E 250 ALA B 58 ALA^? 11.90 OXT ACT B 139 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -42.92 41.25 13.23 -43.42 39.34 13.91 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -49.08 40.03 5.89 -48.46 40.08 4.54 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 E 49 ASP C 25 ASP.? 6.36 O2 EDO C 140 E 86 HIS C 131 HIS^? 6.39 C1 EDO C 140 E 250 ALA C 58 ALA^? 8.51 O1 EDO C 141 coo -36.18 24.97 18.78 -36.93 26.11 17.11 4.46 12.53 17.74 4.84 11.35 19.48 coo -36.85 29.32 15.06 -38.90 29.14 15.48 8.46 11.73 13.23 7.93 9.80 13.86 coo -44.49 29.68 13.98 -43.47 28.67 13.52 2.32 10.24 5.90 2.90 10.23 4.51 2wwt_o04 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 3 hits 2wwt_o04 naa= 3 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 F 49 ASP A 25 ASP.? 6.66 OXT ACT A 139 F 86 HIS A 110 HIS.? -3.69 OXT ACT A 139s F 250 ALA A 58 ALA^? 8.62 O ACT A 140 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -7.65 52.47 7.15 -7.34 51.97 8.48 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 F 49 ASP A 25 ASP.? 6.66 OXT ACT A 139 F 86 HIS A 131 HIS^? 7.42 CL CL A 141 F 250 ALA A 58 ALA^? 8.62 O ACT A 140 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -7.65 52.47 7.15 -7.34 51.97 8.48 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 F 49 ASP B 25 ASP.? 6.52 O ACT B 139 F 86 HIS B 110 HIS.? -3.67 O ACT B 139s F 250 ALA B 58 ALA^? 11.90 OXT ACT B 139 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -46.84 38.28 15.22 -46.41 37.31 17.03 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -49.08 40.03 5.89 -48.46 40.08 4.54 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 F 49 ASP B 25 ASP.? 6.52 O ACT B 139 F 86 HIS B 131 HIS^? 7.27 CL CL B 140 F 250 ALA B 58 ALA^? 11.90 OXT ACT B 139 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -42.92 41.25 13.23 -43.42 39.34 13.91 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -49.08 40.03 5.89 -48.46 40.08 4.54 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 F 49 ASP C 25 ASP.? 6.36 O2 EDO C 140 F 86 HIS C 110 HIS.? 3.59 O ACT C 139s F 250 ALA C 58 ALA^? 8.51 O1 EDO C 141 coo -82.12 8.55 35.60 -81.93 9.84 37.19 4.46 12.53 17.74 4.84 11.35 19.48 coo -84.21 11.81 39.90 -82.43 12.70 39.26 4.54 8.83 15.35 4.90 7.96 17.23 coo -78.49 17.13 41.31 -79.25 15.85 41.61 2.32 10.24 5.90 2.90 10.23 4.51 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 F 49 ASP C 25 ASP.? 6.36 O2 EDO C 140 F 86 HIS C 131 HIS^? 6.39 C1 EDO C 140 F 250 ALA C 58 ALA^? 8.51 O1 EDO C 141 coo -82.12 8.55 35.60 -81.93 9.84 37.19 4.46 12.53 17.74 4.84 11.35 19.48 coo -84.21 11.81 39.90 -82.43 12.70 39.26 8.46 11.73 13.23 7.93 9.80 13.86 coo -78.49 17.13 41.31 -79.25 15.85 41.61 2.32 10.24 5.90 2.90 10.23 4.51 2wwt_o05 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 6 hits 2wwt_o05 naa= 3 ULMN 3 3b21_o00 SHIGELLA FLEXNERI EFFECTOR OSPI user 1 3 # 1 A 62 CYH A 57 CYH^? 5.51 O ACT A 139 A 145 HIS A 131 HIS^? 7.42 CL CL A 141 A 160 ASP A 25 ASP.? 6.66 OXT ACT A 139 coo 9.35 16.69 -4.00 10.08 14.08 -3.37 -4.80 51.41 4.83 -3.45 51.64 2.37 coo 12.85 24.01 -5.47 14.14 22.37 -5.23 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 18.70 21.56 -2.53 17.15 21.34 -3.98 -8.51 49.58 -4.69 -7.35 49.81 -6.41 ULMN 3 3b21_o00 SHIGELLA FLEXNERI EFFECTOR OSPI user 2 3 # 2 A 62 CYH B 57 CYH^? 5.44 OXT ACT B 139 A 145 HIS B 131 HIS^? 7.27 CL CL B 140 A 160 ASP B 25 ASP.? 6.52 O ACT B 139 coo 9.35 16.69 -4.00 10.08 14.08 -3.37 -46.68 38.10 8.15 -46.29 36.73 10.60 coo 12.85 24.01 -5.47 14.14 22.37 -5.23 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 18.70 21.56 -2.53 17.15 21.34 -3.98 -46.76 41.93 17.76 -46.46 40.65 19.39 ULMN 3 3b21_o00 SHIGELLA FLEXNERI EFFECTOR OSPI user 3 3 # 3 A 62 CYH C 57 CYH^? 5.55 OXT ACT C 139 A 145 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 160 ASP C 25 ASP.? 6.36 O2 EDO C 140 coo 9.35 16.69 -4.00 10.08 14.08 -3.37 4.72 8.42 8.22 5.18 7.19 10.69 coo 12.85 24.01 -5.47 14.14 22.37 -5.23 8.46 11.73 13.23 7.93 9.80 13.86 coo 18.70 21.56 -2.53 17.15 21.34 -3.98 4.46 12.53 17.74 4.84 11.35 19.48 3b21_o00 source 3B21 SHIGELLA FLEXNERI EFFECTOR OSPI : 3 hits 3b21_o00 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 87 GLU.? -6.93 OXT ACT A 140s A 44 ASP A 59 ASP.? 10.45 O ACT A 140 A 50 THR A 60 THR~? -4.25 O ACT A 140s coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -6.70 64.26 13.84 -7.80 66.10 14.16 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -11.63 55.20 7.79 -12.68 54.74 6.05 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -8.81 56.04 11.16 -10.72 55.57 12.06 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU A 87 GLU.? -6.93 OXT ACT A 140s A 44 ASP A 62 ASP~? -3.38 O ACT A 140s A 50 THR A 60 THR~? -4.25 O ACT A 140s coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -6.70 64.26 13.84 -7.80 66.10 14.16 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -9.14 53.57 16.41 -8.61 54.95 17.94 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -8.81 56.04 11.16 -10.72 55.57 12.06 ULMN 3 3hde_o00 LYSOZYME user 3 3 # 3 A 35 GLU B 87 GLU.? -20.60 OXT ACT B 139s A 44 ASP B 59 ASP.? 11.98 O ACT B 139 A 50 THR B 60 THR~? 16.44 OXT ACT B 139 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -58.88 33.80 -0.95 -60.97 33.69 -1.19 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -53.34 42.20 5.44 -53.68 42.89 7.35 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -52.83 39.39 1.93 -53.45 41.24 0.91 ULMN 3 3hde_o00 LYSOZYME user 4 3 # 4 A 35 GLU B 87 GLU.? -20.60 OXT ACT B 139s A 44 ASP B 62 ASP~? 20.96 OXT ACT B 139 A 50 THR B 60 THR~? 16.44 OXT ACT B 139 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -58.88 33.80 -0.95 -60.97 33.69 -1.19 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -50.88 40.70 -3.44 -51.62 39.45 -5.01 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -52.83 39.39 1.93 -53.45 41.24 0.91 ULMN 3 3hde_o00 LYSOZYME user 5 3 # 5 A 35 GLU C 87 GLU.? 6.56 O2 EDO C 141s A 44 ASP C 59 ASP.? 10.26 O1 EDO C 141 A 50 THR C 60 THR~? -3.93 O1 EDO C 141s coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -7.39 3.44 -0.70 -9.50 3.44 -0.94 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -1.96 12.33 5.23 -2.08 13.48 6.95 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -1.35 9.41 1.95 -1.92 11.26 0.92 ULMN 3 3hde_o00 LYSOZYME user 6 3 # 6 A 35 GLU C 87 GLU.? 6.56 O2 EDO C 141s A 44 ASP C 62 ASP~? -3.30 O1 EDO C 141s A 50 THR C 60 THR~? -3.93 O1 EDO C 141s coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -7.39 3.44 -0.70 -9.50 3.44 -0.94 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 0.59 10.79 -3.25 -0.22 9.73 -4.86 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -1.35 9.41 1.95 -1.92 11.26 0.92 3hde_o00 source 3HDE LYSOZYME : 6 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 63 GLU~? 7.87 O ACT A 140 B 44 ASP B 13 ASP~? 8.48 C4 PG4 B 142 B 50 THR B 10 THR~? 12.38 C3 PG4 B 142 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -11.40 51.79 11.95 -12.40 52.61 10.19 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -24.74 52.92 14.33 -24.14 54.73 15.30 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -20.91 51.38 12.52 -20.63 52.82 14.06 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU A 63 GLU~? 7.87 O ACT A 140 B 44 ASP B 13 ASP~? 8.48 C4 PG4 B 142 B 50 THR B 11 THR~? 14.82 C3 PG4 B 142 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -11.40 51.79 11.95 -12.40 52.61 10.19 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -24.74 52.92 14.33 -24.14 54.73 15.30 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -22.01 47.86 13.55 -21.15 45.90 13.39 3hde_o01 source 3HDE LYSOZYME : 2 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 63 GLU~? 7.87 O ACT A 140 C 44 ASP B 13 ASP~? 8.48 C4 PG4 B 142 C 50 THR B 10 THR~? 12.38 C3 PG4 B 142 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 25.48 4.87 1.60 23.90 4.95 0.15 -20.91 51.38 12.52 -20.63 52.82 14.06 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU A 63 GLU~? 7.87 O ACT A 140 C 44 ASP B 13 ASP~? 8.48 C4 PG4 B 142 C 50 THR B 11 THR~? 14.82 C3 PG4 B 142 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -11.40 51.79 11.95 -12.40 52.61 10.19 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -24.74 52.92 14.33 -24.14 54.73 15.30 coo 25.48 4.87 1.60 23.90 4.95 0.15 -22.01 47.86 13.55 -21.15 45.90 13.39 ULMN 3 3hde_o02 LYSOZYME user 3 3 # 3 C 35 GLU C 63 GLU~? 7.77 O1 EDO C 141 C 44 ASP A 13 ASP~? 8.68 O4 PG4 A 142 C 50 THR A 11 THR~? 14.98 O4 PG4 A 142 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 1.11 13.80 1.11 0.04 14.34 2.91 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -7.05 24.91 -1.30 -7.93 23.21 -2.19 coo 25.48 4.87 1.60 23.90 4.95 0.15 -1.34 25.09 -0.69 0.81 25.31 -0.69 3hde_o02 source 3HDE LYSOZYME : 3 hits 3hde_o02 naa= 3 ULMN 3 3iu0_o00 PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANuser 1 3 # 1 A 110 CYH A 23 CYH.? -5.05 CL CL A 141s A 301 ASP A 25 ASP.? 6.66 OXT ACT A 139 A 320 HIS A 131 HIS^? 7.42 CL CL A 141 coo -1.82 -20.48 -11.98 0.91 -20.78 -13.68 -5.66 43.81 -7.30 -4.20 43.21 -9.56 coo -1.58 -17.18 -17.34 -1.56 -16.12 -15.50 -8.51 49.58 -4.69 -7.35 49.81 -6.41 coo -4.05 -14.06 -11.86 -3.22 -12.14 -12.04 -5.82 46.49 -0.22 -4.38 47.88 -0.81 ULMN 3 3iu0_o00 PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANuser 2 3 # 2 A 110 CYH B 23 CYH.? -4.94 CL CL B 140s A 301 ASP B 25 ASP.? 6.52 O ACT B 139 A 320 HIS B 131 HIS^? 7.27 CL CL B 140 coo -1.82 -20.48 -11.98 0.91 -20.78 -13.68 -40.38 42.16 20.28 -39.12 40.88 22.30 coo -1.58 -17.18 -17.34 -1.56 -16.12 -15.50 -46.76 41.93 17.76 -46.46 40.65 19.39 coo -4.05 -14.06 -11.86 -3.22 -12.14 -12.04 -42.92 41.25 13.23 -43.42 39.34 13.91 ULMN 3 3iu0_o00 PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANuser 3 3 # 3 A 110 CYH C 23 CYH.? 8.42 C1 EDO C 140 A 301 ASP C 25 ASP.? 6.36 O2 EDO C 140 A 320 HIS C 131 HIS^? 6.39 C1 EDO C 140 coo -1.82 -20.48 -11.98 0.91 -20.78 -13.68 10.88 13.11 20.21 12.25 12.11 22.32 coo -1.58 -17.18 -17.34 -1.56 -16.12 -15.50 4.46 12.53 17.74 4.84 11.35 19.48 coo -4.05 -14.06 -11.86 -3.22 -12.14 -12.04 8.46 11.73 13.23 7.93 9.80 13.86 3iu0_o00 source 3IU0 PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE : 3 hits 3iu0_o00 naa= 3 ULMN 3 3o0p_o00 ILUS-RELATED SORTASE C OF GROUP B STuser 1 3 # 1 A 157 HIS A 110 HIS.? -3.69 OXT ACT A 139s A 219 CYH A 57 CYH^? 5.51 O ACT A 139 A 228 ARG A 111 ARG.? 7.83 OXT ACT A 139 coo -0.49 -3.10 19.35 -0.75 -2.22 21.24 -5.26 51.32 -2.26 -4.16 51.41 -4.05 coo 4.22 -5.75 23.73 3.56 -3.19 23.44 -4.80 51.41 4.83 -3.45 51.64 2.37 coo 7.51 -3.06 24.47 5.76 -1.31 26.31 -9.64 52.74 3.70 -9.14 55.70 2.93 ULMN 3 3o0p_o00 ILUS-RELATED SORTASE C OF GROUP B STuser 2 3 # 2 A 157 HIS A 131 HIS^? 7.42 CL CL A 141 A 219 CYH A 57 CYH^? 5.51 O ACT A 139 A 228 ARG A 111 ARG.? 7.83 OXT ACT A 139 coo -0.49 -3.10 19.35 -0.75 -2.22 21.24 -5.82 46.49 -0.22 -4.38 47.88 -0.81 coo 4.22 -5.75 23.73 3.56 -3.19 23.44 -4.80 51.41 4.83 -3.45 51.64 2.37 coo 7.51 -3.06 24.47 5.76 -1.31 26.31 -9.64 52.74 3.70 -9.14 55.70 2.93 ULMN 3 3o0p_o00 ILUS-RELATED SORTASE C OF GROUP B STuser 3 3 # 3 A 157 HIS B 110 HIS.? -3.67 O ACT B 139s A 219 CYH B 57 CYH^? 5.44 OXT ACT B 139 A 228 ARG B 111 ARG.? 7.92 O ACT B 139 coo -0.49 -3.10 19.35 -0.75 -2.22 21.24 -46.84 38.28 15.22 -46.41 37.31 17.03 coo 4.22 -5.75 23.73 3.56 -3.19 23.44 -46.68 38.10 8.15 -46.29 36.73 10.60 coo 7.51 -3.06 24.47 5.76 -1.31 26.31 -50.20 41.64 9.27 -52.60 39.78 9.98 ULMN 3 3o0p_o00 ILUS-RELATED SORTASE C OF GROUP B STuser 4 3 # 4 A 157 HIS B 131 HIS^? 7.27 CL CL B 140 A 219 CYH B 57 CYH^? 5.44 OXT ACT B 139 A 228 ARG B 111 ARG.? 7.92 O ACT B 139 coo -0.49 -3.10 19.35 -0.75 -2.22 21.24 -42.92 41.25 13.23 -43.42 39.34 13.91 coo 4.22 -5.75 23.73 3.56 -3.19 23.44 -46.68 38.10 8.15 -46.29 36.73 10.60 coo 7.51 -3.06 24.47 5.76 -1.31 26.31 -50.20 41.64 9.27 -52.60 39.78 9.98 ULMN 3 3o0p_o00 ILUS-RELATED SORTASE C OF GROUP B STuser 5 3 # 5 A 157 HIS C 110 HIS.? 3.59 O ACT C 139s A 219 CYH C 57 CYH^? 5.55 OXT ACT C 139 A 228 ARG C 111 ARG.? 7.98 O ACT C 139 coo -0.49 -3.10 19.35 -0.75 -2.22 21.24 4.54 8.83 15.35 4.90 7.96 17.23 coo 4.22 -5.75 23.73 3.56 -3.19 23.44 4.72 8.42 8.22 5.18 7.19 10.69 coo 7.51 -3.06 24.47 5.76 -1.31 26.31 1.09 11.93 9.22 -1.20 10.06 10.11 ULMN 3 3o0p_o00 ILUS-RELATED SORTASE C OF GROUP B STuser 6 3 # 6 A 157 HIS C 131 HIS^? 6.39 C1 EDO C 140 A 219 CYH C 57 CYH^? 5.55 OXT ACT C 139 A 228 ARG C 111 ARG.? 7.98 O ACT C 139 coo -0.49 -3.10 19.35 -0.75 -2.22 21.24 8.46 11.73 13.23 7.93 9.80 13.86 coo 4.22 -5.75 23.73 3.56 -3.19 23.44 4.72 8.42 8.22 5.18 7.19 10.69 coo 7.51 -3.06 24.47 5.76 -1.31 26.31 1.09 11.93 9.22 -1.20 10.06 10.11 3o0p_o00 source 3O0p ILUS-RELATED SORTASE C OF GROUP B STREPTOCOCCU: 6 hits 3o0p_o00 naa= 3 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 1 3 # 1 A 29 ASP A 50 ASP.? 20.38 CL CL A 141 A 117 LYS A 47 LYS~? 18.08 C5 PG4 A 142 A 150 CYH A 117 CYH^? 10.83 CL CL A 141 coo 37.97 47.82 5.46 38.65 48.02 7.40 11.71 33.66 5.09 12.68 31.93 4.37 coo 41.02 51.33 13.36 40.18 47.06 9.99 4.15 29.38 6.95 0.12 26.77 10.99 coo 39.17 42.30 8.54 40.94 44.26 7.78 5.07 37.09 1.73 2.71 35.97 2.45 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 2 3 # 2 A 29 ASP A 50 ASP.? 20.38 CL CL A 141 A 117 LYS A 97 LYS.? 17.22 CL CL A 141 A 150 CYH A 117 CYH^? 10.83 CL CL A 141 coo 37.97 47.82 5.46 38.65 48.02 7.40 11.71 33.66 5.09 12.68 31.93 4.37 coo 41.02 51.33 13.36 40.18 47.06 9.99 12.14 41.01 8.19 12.52 43.66 3.40 coo 39.17 42.30 8.54 40.94 44.26 7.78 5.07 37.09 1.73 2.71 35.97 2.45 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 3 3 # 3 A 29 ASP B 50 ASP.? 10.53 C3 PG4 A 142 A 117 LYS B 47 LYS~? 12.98 C2 PG4 A 142 A 150 CYH B 117 CYH^? 10.38 CL CL B 141 coo 37.97 47.82 5.46 38.65 48.02 7.40 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 41.02 51.33 13.36 40.18 47.06 9.99 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 39.17 42.30 8.54 40.94 44.26 7.78 -29.38 36.33 11.07 -29.51 38.97 10.51 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 4 3 # 4 A 29 ASP C 50 ASP.? 22.48 O1 EDO C 140 A 117 LYS C 47 LYS~? 26.80 O1 EDO C 140 A 150 CYH C 117 CYH^? 14.56 O1 EDO C 140 coo 37.97 47.82 5.46 38.65 48.02 7.40 28.54 3.26 7.93 30.44 3.42 8.82 coo 41.02 51.33 13.36 40.18 47.06 9.99 28.25 11.83 5.90 28.26 16.33 1.39 coo 39.17 42.30 8.54 40.94 44.26 7.78 22.08 7.27 11.28 21.72 9.99 10.50 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 5 3 # 5 A 29 ASP C 50 ASP.? 22.48 O1 EDO C 140 A 117 LYS C 97 LYS.? 16.45 O1 EDO C 140 A 150 CYH C 117 CYH^? 14.56 O1 EDO C 140 coo 37.97 47.82 5.46 38.65 48.02 7.40 28.54 3.26 7.93 30.44 3.42 8.82 coo 41.02 51.33 13.36 40.18 47.06 9.99 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 39.17 42.30 8.54 40.94 44.26 7.78 22.08 7.27 11.28 21.72 9.99 10.50 3uao_o00 source 3UAO PUTATIVE ISOCHORISMATASE : 5 hits 3uao_o00 naa= 3 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 1 3 # 1 B 29 ASP A 50 ASP.? 20.38 CL CL A 141 B 117 LYS A 47 LYS~? 18.08 C5 PG4 A 142 B 150 CYH A 117 CYH^? 10.83 CL CL A 141 coo 33.94 43.16 45.29 35.02 43.05 43.47 11.71 33.66 5.09 12.68 31.93 4.37 coo 38.53 39.60 38.22 36.76 43.89 41.37 4.15 29.38 6.95 0.12 26.77 10.99 coo 35.77 48.61 42.57 37.40 46.62 43.48 5.07 37.09 1.73 2.71 35.97 2.45 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 2 3 # 2 B 29 ASP A 50 ASP.? 20.38 CL CL A 141 B 117 LYS A 97 LYS.? 17.22 CL CL A 141 B 150 CYH A 117 CYH^? 10.83 CL CL A 141 coo 33.94 43.16 45.29 35.02 43.05 43.47 11.71 33.66 5.09 12.68 31.93 4.37 coo 38.53 39.60 38.22 36.76 43.89 41.37 12.14 41.01 8.19 12.52 43.66 3.40 coo 35.77 48.61 42.57 37.40 46.62 43.48 5.07 37.09 1.73 2.71 35.97 2.45 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 3 3 # 3 B 29 ASP B 50 ASP.? 10.53 C3 PG4 A 142 B 117 LYS B 47 LYS~? 12.98 C2 PG4 A 142 B 150 CYH B 117 CYH^? 10.38 CL CL B 141 coo 33.94 43.16 45.29 35.02 43.05 43.47 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 38.53 39.60 38.22 36.76 43.89 41.37 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 35.77 48.61 42.57 37.40 46.62 43.48 -29.38 36.33 11.07 -29.51 38.97 10.51 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 4 3 # 4 B 29 ASP C 50 ASP.? 22.48 O1 EDO C 140 B 117 LYS C 47 LYS~? 26.80 O1 EDO C 140 B 150 CYH C 117 CYH^? 14.56 O1 EDO C 140 coo 33.94 43.16 45.29 35.02 43.05 43.47 28.54 3.26 7.93 30.44 3.42 8.82 coo 38.53 39.60 38.22 36.76 43.89 41.37 28.25 11.83 5.90 28.26 16.33 1.39 coo 35.77 48.61 42.57 37.40 46.62 43.48 22.08 7.27 11.28 21.72 9.99 10.50 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 5 3 # 5 B 29 ASP C 50 ASP.? 22.48 O1 EDO C 140 B 117 LYS C 97 LYS.? 16.45 O1 EDO C 140 B 150 CYH C 117 CYH^? 14.56 O1 EDO C 140 coo 33.94 43.16 45.29 35.02 43.05 43.47 28.54 3.26 7.93 30.44 3.42 8.82 coo 38.53 39.60 38.22 36.76 43.89 41.37 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 35.77 48.61 42.57 37.40 46.62 43.48 22.08 7.27 11.28 21.72 9.99 10.50 3uao_o01 source 3UAO PUTATIVE ISOCHORISMATASE : 5 hits 3uao_o01 naa= 3 ULMN 3 3uao_o02 PUTATIVE ISOCHORISMATASE user 1 3 # 1 C 29 ASP A 50 ASP.? 20.38 CL CL A 141 C 117 LYS A 47 LYS~? 18.08 C5 PG4 A 142 C 150 CYH A 117 CYH^? 10.83 CL CL A 141 coo 54.62 -9.81 68.84 52.97 -9.23 67.61 11.71 33.66 5.09 12.68 31.93 4.37 coo 46.74 -10.34 64.36 51.80 -7.96 65.19 4.15 29.38 6.95 0.12 26.77 10.99 coo 55.78 -5.03 64.48 55.52 -7.79 64.07 5.07 37.09 1.73 2.71 35.97 2.45 ULMN 3 3uao_o02 PUTATIVE ISOCHORISMATASE user 2 3 # 2 C 29 ASP A 50 ASP.? 20.38 CL CL A 141 C 117 LYS A 97 LYS.? 17.22 CL CL A 141 C 150 CYH A 117 CYH^? 10.83 CL CL A 141 coo 54.62 -9.81 68.84 52.97 -9.23 67.61 11.71 33.66 5.09 12.68 31.93 4.37 coo 46.74 -10.34 64.36 51.80 -7.96 65.19 12.14 41.01 8.19 12.52 43.66 3.40 coo 55.78 -5.03 64.48 55.52 -7.79 64.07 5.07 37.09 1.73 2.71 35.97 2.45 ULMN 3 3uao_o02 PUTATIVE ISOCHORISMATASE user 3 3 # 3 C 29 ASP B 50 ASP.? 10.53 C3 PG4 A 142 C 117 LYS B 47 LYS~? 12.98 C2 PG4 A 142 C 150 CYH B 117 CYH^? 10.38 CL CL B 141 coo 54.62 -9.81 68.84 52.97 -9.23 67.61 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 46.74 -10.34 64.36 51.80 -7.96 65.19 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 55.78 -5.03 64.48 55.52 -7.79 64.07 -29.38 36.33 11.07 -29.51 38.97 10.51 ULMN 3 3uao_o02 PUTATIVE ISOCHORISMATASE user 4 3 # 4 C 29 ASP C 50 ASP.? 22.48 O1 EDO C 140 C 117 LYS C 47 LYS~? 26.80 O1 EDO C 140 C 150 CYH C 117 CYH^? 14.56 O1 EDO C 140 coo 54.62 -9.81 68.84 52.97 -9.23 67.61 28.54 3.26 7.93 30.44 3.42 8.82 coo 46.74 -10.34 64.36 51.80 -7.96 65.19 28.25 11.83 5.90 28.26 16.33 1.39 coo 55.78 -5.03 64.48 55.52 -7.79 64.07 22.08 7.27 11.28 21.72 9.99 10.50 ULMN 3 3uao_o02 PUTATIVE ISOCHORISMATASE user 5 3 # 5 C 29 ASP C 50 ASP.? 22.48 O1 EDO C 140 C 117 LYS C 97 LYS.? 16.45 O1 EDO C 140 C 150 CYH C 117 CYH^? 14.56 O1 EDO C 140 coo 54.62 -9.81 68.84 52.97 -9.23 67.61 28.54 3.26 7.93 30.44 3.42 8.82 coo 46.74 -10.34 64.36 51.80 -7.96 65.19 22.33 -0.96 4.86 22.00 -3.43 10.72 coo 55.78 -5.03 64.48 55.52 -7.79 64.07 22.08 7.27 11.28 21.72 9.99 10.50 3uao_o02 source 3UAO PUTATIVE ISOCHORISMATASE : 5 hits 3uao_o02 naa= 3 ULMN 3 3uao_o03 PUTATIVE ISOCHORISMATASE user 1 3 # 1 D 29 ASP A 50 ASP.? 20.38 CL CL A 141 D 117 LYS A 47 LYS~? 18.08 C5 PG4 A 142 D 150 CYH A 117 CYH^? 10.83 CL CL A 141 coo 25.05 13.27 54.10 26.66 12.10 53.60 11.71 33.66 5.09 12.68 31.93 4.37 coo 33.45 10.03 51.76 28.31 9.37 53.37 4.15 29.38 6.95 0.12 26.77 10.99 coo 24.32 7.20 55.59 24.80 8.07 53.08 5.07 37.09 1.73 2.71 35.97 2.45 ULMN 3 3uao_o03 PUTATIVE ISOCHORISMATASE user 2 3 # 2 D 29 ASP A 50 ASP.? 20.38 CL CL A 141 D 117 LYS A 97 LYS.? 17.22 CL CL A 141 D 150 CYH A 117 CYH^? 10.83 CL CL A 141 coo 25.05 13.27 54.10 26.66 12.10 53.60 11.71 33.66 5.09 12.68 31.93 4.37 coo 33.45 10.03 51.76 28.31 9.37 53.37 12.14 41.01 8.19 12.52 43.66 3.40 coo 24.32 7.20 55.59 24.80 8.07 53.08 5.07 37.09 1.73 2.71 35.97 2.45 ULMN 3 3uao_o03 PUTATIVE ISOCHORISMATASE user 3 3 # 3 D 29 ASP B 50 ASP.? 10.53 C3 PG4 A 142 D 117 LYS B 47 LYS~? 12.98 C2 PG4 A 142 D 150 CYH B 117 CYH^? 10.38 CL CL B 141 coo 25.05 13.27 54.10 26.66 12.10 53.60 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 33.45 10.03 51.76 28.31 9.37 53.37 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 24.32 7.20 55.59 24.80 8.07 53.08 -29.38 36.33 11.07 -29.51 38.97 10.51 3uao_o03 source 3UAO PUTATIVE ISOCHORISMATASE : 3 hits 3uao_o03 naa= 3 ULMN 3 3uao_o04 PUTATIVE ISOCHORISMATASE user 1 3 # 1 E 29 ASP A 50 ASP.? 20.38 CL CL A 141 E 117 LYS A 47 LYS~? 18.08 C5 PG4 A 142 E 150 CYH A 117 CYH^? 10.83 CL CL A 141 coo 54.17 11.77 49.20 52.64 11.40 50.63 11.71 33.66 5.09 12.68 31.93 4.37 coo 45.83 11.66 53.42 50.97 10.25 52.77 4.15 29.38 6.95 0.12 26.77 10.99 coo 55.28 7.50 53.67 54.71 10.14 54.01 5.07 37.09 1.73 2.71 35.97 2.45 ULMN 3 3uao_o04 PUTATIVE ISOCHORISMATASE user 2 3 # 2 E 29 ASP A 50 ASP.? 20.38 CL CL A 141 E 117 LYS A 97 LYS.? 17.22 CL CL A 141 E 150 CYH A 117 CYH^? 10.83 CL CL A 141 coo 54.17 11.77 49.20 52.64 11.40 50.63 11.71 33.66 5.09 12.68 31.93 4.37 coo 45.83 11.66 53.42 50.97 10.25 52.77 12.14 41.01 8.19 12.52 43.66 3.40 coo 55.28 7.50 53.67 54.71 10.14 54.01 5.07 37.09 1.73 2.71 35.97 2.45 ULMN 3 3uao_o04 PUTATIVE ISOCHORISMATASE user 3 3 # 3 E 29 ASP B 50 ASP.? 10.53 C3 PG4 A 142 E 117 LYS B 47 LYS~? 12.98 C2 PG4 A 142 E 150 CYH B 117 CYH^? 10.38 CL CL B 141 coo 54.17 11.77 49.20 52.64 11.40 50.63 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 45.83 11.66 53.42 50.97 10.25 52.77 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 55.28 7.50 53.67 54.71 10.14 54.01 -29.38 36.33 11.07 -29.51 38.97 10.51 3uao_o04 source 3UAO PUTATIVE ISOCHORISMATASE : 3 hits 3uao_o04 naa= 3 ULMN 3 3uao_o05 PUTATIVE ISOCHORISMATASE user 1 3 # 1 F 29 ASP A 50 ASP.? 20.38 CL CL A 141 F 117 LYS A 47 LYS~? 18.08 C5 PG4 A 142 F 150 CYH A 117 CYH^? 10.83 CL CL A 141 coo 41.67 65.37 28.64 40.76 63.70 27.74 11.71 33.66 5.09 12.68 31.93 4.37 coo 38.34 58.97 23.05 39.26 61.42 28.02 4.15 29.38 6.95 0.12 26.77 10.99 coo 39.64 61.25 32.92 38.08 62.62 31.22 5.07 37.09 1.73 2.71 35.97 2.45 ULMN 3 3uao_o05 PUTATIVE ISOCHORISMATASE user 2 3 # 2 F 29 ASP A 50 ASP.? 20.38 CL CL A 141 F 117 LYS A 97 LYS.? 17.22 CL CL A 141 F 150 CYH A 117 CYH^? 10.83 CL CL A 141 coo 41.67 65.37 28.64 40.76 63.70 27.74 11.71 33.66 5.09 12.68 31.93 4.37 coo 38.34 58.97 23.05 39.26 61.42 28.02 12.14 41.01 8.19 12.52 43.66 3.40 coo 39.64 61.25 32.92 38.08 62.62 31.22 5.07 37.09 1.73 2.71 35.97 2.45 ULMN 3 3uao_o05 PUTATIVE ISOCHORISMATASE user 3 3 # 3 F 29 ASP B 50 ASP.? 10.53 C3 PG4 A 142 F 117 LYS B 47 LYS~? 12.98 C2 PG4 A 142 F 150 CYH B 117 CYH^? 10.38 CL CL B 141 coo 41.67 65.37 28.64 40.76 63.70 27.74 -23.12 32.36 7.43 -21.08 32.27 8.01 coo 38.34 58.97 23.05 39.26 61.42 28.02 -23.16 41.10 5.81 -22.85 46.07 1.96 coo 39.64 61.25 32.92 38.08 62.62 31.22 -29.38 36.33 11.07 -29.51 38.97 10.51 3uao_o05 source 3UAO PUTATIVE ISOCHORISMATASE : 3 hits 3uao_o05 naa= 3 ULMN 3 3uao_o06 PUTATIVE ISOCHORISMATASE user 1 3 # 1 G 29 ASP A 50 ASP.? 20.38 CL CL A 141 G 117 LYS A 47 LYS~? 18.08 C5 PG4 A 142 G 150 CYH A 117 CYH^? 10.83 CL CL A 141 coo 26.53 -14.13 63.27 28.07 -12.63 63.49 11.71 33.66 5.09 12.68 31.93 4.37 coo 34.28 -10.03 65.81 29.08 -9.98 63.85 4.15 29.38 6.95 0.12 26.77 10.99 coo 25.24 -8.30 61.46 25.55 -9.17 63.98 5.07 37.09 1.73 2.71 35.97 2.45 ULMN 3 3uao_o06 PUTATIVE ISOCHORISMATASE user 2 3 # 2 G 29 ASP A 50 ASP.? 20.38 CL CL A 141 G 117 LYS A 97 LYS.? 17.22 CL CL A 141 G 150 CYH A 117 CYH^? 10.83 CL CL A 141 coo 26.53 -14.13 63.27 28.07 -12.63 63.49 11.71 33.66 5.09 12.68 31.93 4.37 coo 34.28 -10.03 65.81 29.08 -9.98 63.85 12.14 41.01 8.19 12.52 43.66 3.40 coo 25.24 -8.30 61.46 25.55 -9.17 63.98 5.07 37.09 1.73 2.71 35.97 2.45 3uao_o06 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o06 naa= 3 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 1 3 # 1 H 28 VAL A 90 VAL^? 7.90 O ACT A 140 H 117 LYS A 93 LYS^? 11.69 O ACT A 139 H 150 CYH A 57 CYH^? 5.51 O ACT A 139 coo 45.82 27.58 23.40 45.30 28.87 21.66 -3.78 56.12 7.90 -4.14 55.60 9.99 coo 38.01 32.08 28.20 39.46 29.85 23.57 3.67 49.37 7.73 5.94 48.81 2.98 coo 41.19 29.62 18.76 39.21 28.51 20.32 -4.80 51.41 4.83 -3.45 51.64 2.37 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 2 3 # 2 H 28 VAL A 113 VAL^? 10.83 CL CL A 141 H 117 LYS A 93 LYS^? 11.69 O ACT A 139 H 150 CYH A 57 CYH^? 5.51 O ACT A 139 coo 45.82 27.58 23.40 45.30 28.87 21.66 -4.32 44.96 4.32 -4.01 44.19 6.37 coo 38.01 32.08 28.20 39.46 29.85 23.57 3.67 49.37 7.73 5.94 48.81 2.98 coo 41.19 29.62 18.76 39.21 28.51 20.32 -4.80 51.41 4.83 -3.45 51.64 2.37 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 3 3 # 3 H 28 VAL B 90 VAL^? 11.34 OXT ACT B 139 H 117 LYS B 93 LYS^? 4.13 CL CL B 141 H 150 CYH B 57 CYH^? 5.44 OXT ACT B 139 coo 45.82 27.58 23.40 45.30 28.87 21.66 -50.35 34.89 5.01 -50.09 35.44 2.89 coo 38.01 32.08 28.20 39.46 29.85 23.57 -40.82 31.70 5.12 -39.31 29.65 9.95 coo 41.19 29.62 18.76 39.21 28.51 20.32 -46.68 38.10 8.15 -46.29 36.73 10.60 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 4 3 # 4 H 28 VAL B 113 VAL^? 8.58 CL CL B 141 H 117 LYS B 93 LYS^? 4.13 CL CL B 141 H 150 CYH B 57 CYH^? 5.44 OXT ACT B 139 coo 45.82 27.58 23.40 45.30 28.87 21.66 -40.84 40.81 8.64 -39.97 40.93 6.62 coo 38.01 32.08 28.20 39.46 29.85 23.57 -40.82 31.70 5.12 -39.31 29.65 9.95 coo 41.19 29.62 18.76 39.21 28.51 20.32 -46.68 38.10 8.15 -46.29 36.73 10.60 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 5 3 # 5 H 28 VAL C 90 VAL^? 7.96 C2 EDO C 141 H 117 LYS C 93 LYS^? 9.06 O1 EDO C 140 H 150 CYH C 57 CYH^? 5.55 OXT ACT C 139 coo 45.82 27.58 23.40 45.30 28.87 21.66 1.16 5.05 5.16 1.33 5.67 3.06 coo 38.01 32.08 28.20 39.46 29.85 23.57 10.75 2.06 5.39 12.48 0.59 10.09 coo 41.19 29.62 18.76 39.21 28.51 20.32 4.72 8.42 8.22 5.18 7.19 10.69 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 6 3 # 6 H 28 VAL C 113 VAL^? 11.48 O1 EDO C 140 H 117 LYS C 93 LYS^? 9.06 O1 EDO C 140 H 150 CYH C 57 CYH^? 5.55 OXT ACT C 139 coo 45.82 27.58 23.40 45.30 28.87 21.66 10.57 11.31 8.67 11.34 11.45 6.59 coo 38.01 32.08 28.20 39.46 29.85 23.57 10.75 2.06 5.39 12.48 0.59 10.09 coo 41.19 29.62 18.76 39.21 28.51 20.32 4.72 8.42 8.22 5.18 7.19 10.69 3uao_o07 source 3UAO PUTATIVE ISOCHORISMATASE : 6 hits 3uao_o07 naa= 3